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Abstract 
For the creation of carbon-nitrogen bonds and to access b-amino 
carbonylic compounds, together with the Mannich reaction, the aza-Michael 
reaction is considered one of the more appealing methodologies. It consists on 
the conjugate addition of a nucleophilic nitrogen source to an a,b-unsaturated 
system. This reaction has acquired a special relevance in its intramolecular 
version as it conducts to the formation of nitrogen heterocycles in a very 
straightforward manner. Furthermore, when the activated olefin contains 
prochiral centers, there are generated one or more stereogenic centers through 
the addition process. Thus, the asymmetric version of this transformation would 
allow the preparation of stereoselective functionalized nitrogen-containing 
compounds. 
Whereas the conjugate addition of chiral amines to electronic deficient 
olefins has been the most employed strategy among the asymmetric aza-
Michael reactions, the emergence of catalytic variants came late. Likewise, the 
asymmetric version of the intramolecular aza-Michael reaction has practically 
remained unexplored, being just organocatalyzed processes the few described 
examples. 
The main constraint of the organocatalytic enantioselective aza-Micheal 
reaction is that the Michael acceptors are generally a,b-unsaturated aldehydes. 
The greater difficulty that implies the generation of the corresponding iminium 
ion with ketones has made the catalysis with these substrates a more 
compromised task. In this way, the use of primary amines, where the kinetic for 
the formation of the iminium intermediate is more favorable, has enabled a 
more efficient use of this transformation in its intermolecular version. 
Similarly, the employment of a,b-unsaturated esters as Michael 
acceptors is not very extended and even less within the organocatalysis field. In 
this cases the activation process will always be through hydrogen bondings, 
since the ester group is not enough reactive as to form the iminium salt 
observed with aldehydes and ketones. Due to this poor reactivity of the 
conjugated esters, there have been developed a great variety of synthetic 
equivalents that either show an enhanced reactivity as electrophiles or they 
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facilitate the activation process and the formation of a more stable transition 
state through their hydrogen-bonding acceptors. 
Taking the aforementioned into account and given the relevance of the 
asymmetric synthesis in organic chemistry, the objectives of the present PhD 
Thesis are focused on one hand, in the design of more general methodologies 
of organocatalytic enantioselective intramolecular aza-Michael reactions 
(IMAMR) for a,b-unsaturated ketones and esters; and on the other hand, in the 
application of those methodologies to the synthesis of structures of high 
interest, such as sultams. 
The starting materials required to study the IMAMR are prepared through 
a cross-metathesis (CM) reaction between the a,b-unsaturated carbonylic 
compounds and the corresponding properly protected amines. The latter will be 
in turn obtained following procedures similar to those described in the literature. 
Once with the IMAMR substrates in hand, there will be studied the reaction 
conditions (solvent, temperature, catalyst, additive, …) to execute the 
intramolecular addition in an enantioselective fashion. 
In conclusion, there have been developed several highly enantioselective 
protocols for the preparation of nitrogen heterocycles containing b-amino 
carbonylic motifs, applying chiral organocatalysts to activate a,b-unsaturated 
ketones and ester surrogates in the intramolecular aza-Michael reaction. 
Moreover, it has been achieved the application of one of these methodologies 
for the preparation of bicyclic sultams with a structural composition not 
described to date. 
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Resumen 
Una de las metodologías más importantes, junto con la reacción de 
Mannich, para formar enlaces carbono-nitrógeno y acceder a compuestos b-
amino carbonílicos, es la reacción aza-Michael, que consiste en la adición 
conjugada de una fuente de nitrógeno nucleófila a un sistema a,b-insaturado. 
Esta reacción adquiere una especial relevancia en su versión intramolecular ya 
que conduce a la formación de heterociclos nitrogenados de forma sencilla. 
Además, cuando la olefina activada contiene centros proquirales, en el proceso 
de adición se generan uno o más centros estereogénicos, por lo que la versión 
asimétrica de esta reacción permitiría obtener compuestos nitrogenados 
funcionalizados de forma estereoselectiva. 
Mientras que la adición conjugada de aminas quirales a olefinas 
electrónicamente deficientes ha sido la estrategia más utilizada en la reacción 
aza-Michael asimétrica, la aparición de las variantes catalíticas ha sido mucho 
más tardía. De la misma forma, la versión asimétrica de la reacción aza-
Michael intramolecular ha permanecido prácticamente inexplorada, y los 
ejemplos descritos hasta la fecha se basan en el empleo de 
organocatalizadores. 
La principal limitación que presenta la reacción aza-Michael 
organocatalítica enantioselectiva es que habitualmente los aceptores de 
Michael son aldehídos a,b-insaturados. La mayor dificultad que supone generar 
la correspondiente sal de iminio con cetonas ha hecho que la catálisis con 
estos sustratos sea más comprometida. En este sentido, el empleo de aminas 
primarias, donde la formación de la sal de iminio tiene una cinética más 
favorable, ha permitido efectuar esta transformación de forma eficaz en su 
versión intermolecular. 
Asimismo, la utilización de ésteres a,b-insaturados como aceptores de 
Michael no está muy extendida y aún menos en el campo de la organocatálisis. 
En estos casos la activación será siempre por enlaces de hidrógeno, puesto 
que el grupo éster es muy poco reactivo como para dar lugar a la formación del 
ion iminio observado con aldehídos y cetonas. Debido a esta baja reactividad 
de los ésteres conjugados, se han descrito muchos equivalentes sintéticos que 
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o bien presentan una mayor reactividad como electrófilos o bien permiten una 
mayor activación y fijación del estado de transición por presentar más puntos 
de anclaje de enlaces de hidrógeno. 
Teniendo en cuenta lo expuesto anteriormente y dada la importancia de 
la síntesis asimétrica en química orgánica, los objetivos de la presente Tesis 
Doctoral se centran, por un lado, en el diseño de metodologías más generales 
de reacciones aza-Michael intramoleculares (AMIM) enantioselectivas y 
organocatalíticas para cetonas y ésteres a,b-insaturados; y por otra parte, en la 
aplicación de dichas metodologías a la síntesis de estructuras de elevado 
interés biológico, como por ejemplo las sultamas. 
Los compuestos de partida para llevar a cabo las reacciones AMIM se 
prepararán a través de una reacción de metátesis cruzada (CM, cross-
metathesis) entre los compuestos carbonílicos a,b-insaturados y las 
correspondientes aminas adecuadamente protegidas. Éstas últimas se 
obtendrán a su vez siguiendo procedimientos similares a los descritos en la 
bibliografía. Una vez preparados los sustratos para la reacción aza-Michael, se 
estudiarán las condiciones de reacción (disolvente, temperatura, catalizador, 
aditivo, …) que permitan efectuar esta adición intramolecular de forma 
enantioselectiva. 
En conclusión, se han desarrollado diversos protocolos altamente 
enantioselectivos para la preparación de heterociclos nitrogenados con 
unidades b-amino carbonílicas empleando organocatalizadores quirales para la 
activación de la reacción aza-Michael intramolecular con cetonas y 
equivalentes de ésteres a,b-insaturados. Además, se ha conseguido aplicar 
una de estas metodologías para la preparación de sultamas bicíclicas con una 
distribución estructural no descrita hasta el momento. 
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Resum 
Una de les metodologies més importants, junt amb la reacció de 
Mannich, per la formació d’enllaços carboni-nitrogen i per accedir a compostos 
b-amino carbonílics, és la reacció aza-Michael, que consisteix en l’addició 
conjugada d’una font de nitrogen nucleòfila a un sistema a,b-insaturat. Aquesta 
reacció adquireix una especial rellevància a la seua versió intramolecular ja que 
condueix a la formació d’heterocicles nitrogenats de forma senzilla. A més, 
quan l’olefina activada conté centres proquirals, al procés d’addició es generen 
un o més centres estereogènics, pel que la versió asimètrica d’esta reacció 
permetria obtenir compostos nitrogenats funcionalitats de forma 
estereoselectiva. 
Mentre que l’addició conjugada de amines quirals a olefines 
electrònicament deficients ha sigut l’estratègia més utilitzada a la reacció aza-
Michael asimètrica, l’aparició de les variants catalítiques ha sigut molt més 
tardana. De la mateixa manera, la versió asimètrica de la reacció aza-Michael 
intramolecular ha romàs pràcticament inexplorada, i els exemples descrits fins 
la data es basen en la utilització d’organocatalitzadors. 
La principal limitació que presenta la reacció aza-Michael 
organocatalítica enantioselectiva és que habitualment els acceptors de Michael 
són aldehids a,b-insaturats. La major dificultat que suposa generar la 
corresponent sal d’imini amb cetones ha fet que la catàlisi amb aquests 
substrats estiga més compromesa. En aquest sentit, la utilització de amines 
primàries, on la formació de la sal d’imini té una cinètica més favorable, ha 
permès efectuar aquesta transformació de forma eficaç en la seua versió 
intermolecular. 
Així mateix, la utilització d’èsters a,b-insaturats com acceptors de 
Michael no està molt estesa i encara menys al camp de l’organocatàlisi. En 
aquests casos l’activació serà sempre per enllaços d’hidrogen, posat que el 
grup èster és molt poc reactiu com per donar lloc a la formació de l’ió imini 
observat amb aldehids i cetones. Degut a aquesta baixa reactivitat dels èsters 
conjugats, s’han descrit molts equivalents sintètics que o bé presenten una 
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major reactivitat com a electròfils o bé permeten una major activació i fixació de 
l’estat de transició al presentar més punts d’ancoratge d’enllaços d’hidrogen. 
Tenint en compte l’exposat anteriorment i donada la importància de la 
síntesi asimètrica en química orgànica, els objectius de la present Tesi Doctoral 
es centren, por una banda, en el disseny de metodologies més generales de 
reaccions aza-Michael intramoleculars (AMIM) enantioselectives i 
organocatalítiques per cetones y èsters a,b-insaturats; i por altra banda, en 
l’aplicació de dites metodologies a la síntesi d’estructures d’elevat interès 
biològic, com per exemple les sultames. 
Els substrats de partida per realitzar les reaccions AMIM es prepararan a 
través d’una reacció de metàtesi creuada (CM, cross-metathesis) entre els 
compostos carbonílics a,b-insaturats i les corresponents amines 
adequadament protegides. Aquestes últimes s’obtindran a la seua vegada 
seguint procediments similars als descrits a la bibliografia. Una vegada 
preparats els substrats per la reacció aza-Michael, s’estudiaran les condicions 
de reacció (dissolvent, temperatura, catalitzador, additiu, …) què permeten 
efectuar aquesta addició intramolecular de forma enantioselectiva. 
En conclusió, s’han desenvolupat diversos protocols altament 
enantioselectius per la preparació d’heterocicles nitrogenats amb unitats b-
amino carboníliques utilitzant organocatalitzadors quirals per l’activació de la 
reacció aza-Michael intramolecular amb cetones i equivalents d’èsters a,b-
insaturats. A més, s’ha aconseguit aplicar una d’aquestes metodologies per la 
preparació de sultames bicícliques amb una distribució estructural no descrita 
fins el moment. 
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0.1. General Introduction 
0.1.1. ASYMMETRIC SYNTHESIS 
Among the diverse areas of influence of organic chemistry research, 
design and synthesis of new drugs occupy a prominent place, and amazing 
amount of resources are devoted to this endeavour due to the relevance of this 
task. The main goal of drug design is to prepare defined molecular structures 
with an expected therapeutic action. Therefore, the study of new synthetic 
methods that gains access to those tailor-made compounds can have a 
significant impact in the drug discovery process. At the same time, the need of 
more green and environmentally friendly processes drives current research 
efforts for the preparation of both new and existing drugs. 
Asymmetric synthesis plays a key role in drug development, since one 
half of the currently marketed drugs contain at least one stereocenter, and 
among the top ten best selling drugs nine are composed of chiral molecules. 
The importance of the concept of chirality in Nature and in research it is known 
since long time ago, and the first to coin the term chiral (from Greek kheir: hand) 
was Lord Kelvin by the end of the nineteenth century.1 Besides, the significance 
of stereoisomerism in relation to biological activity has been recognized by 
scientists since 1848, when Louis Pasteur discovered the optical isomerism of 
tartaric acid.  
Nevertheless, the tools for either the resolution of racemates or for the 
synthesis of enantiomerically pure drugs were discovered and developed 
slowly. The pharmaceutical companies were already marketing demanded 
drugs in racemic form,2 not being noticed the relevance of the exploration of the 
in vivo differences between enantiomers, or other chemically equivalent forms, 
until the early 1960’s with the tragedy of thalidomide.3 Then, in 1987, the FDA 
issued a set of guidelines on the submission of New Drug Applications, where 
the question of stereochemistry was approached directly in the guideline on the 
                                            
1 Cintas, P. Angew. Chem. Int. Ed. 2007, 46, 4016–4024. 
2 Camp, W. H. D. E. Chirality 1989, 1, 2–6. 
3 Rubey, W. W.; Morse, P. M.; Tatum, E. L. Science. 1962, 137, 497–497. 
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manufacturing of drug substances.4 Such marketing regulations for synthetic 
drugs, coupled with recent progress in stereoselective organic synthesis, 
resulted in a significant increase in the proportion of single-enantiomer drugs. 
In the case of thalidomide (Figure 0.1.a), the racemate (mixture of the 
(+)-(R)- and (-)-(S)-enantiomers) was introduced as a sleep-inducing agent in 
1956, but it was withdrawn in 1961 for causing fetal malformations, that were 
lately related just to the levogyre enantiomer.5 This is the most famous one, but 
not the only case of undesirable side effects caused by the different behaviour 
of each enantiomer of a given drug in the human body.6 In 1982 was taken off 
the market a racemic preparation of benoxaprofen (Figure 0.1.b), Oraflex, once 
British physicians had written about its problems and after 26 patients who had 
taken it died of liver or kidney disorders.7 Benoxaprofen is an anti-inflammatory 
compound that was at an advanced stage of clinical evaluation, when it was 
found that the (-)-(R)-enantiomer was inverted to the (+)-(S)-form in vivo, which 
was traduced in the accumulation of the eutomer8 and the appearance of the 
overdose symptoms.9  
 
Figure 0.1. Drugs with different behaviour in each enantiomer. 
Until the early seventies the scientific knowledge about asymmetric 
synthesis and asymmetric induction wasn’t very wide. Then in 1983 it was 
finally published a five-volume treatise 10  that included the last 10 years 
advances in the field of asymmetric synthesis. From this starting point, the 
                                            
4 Office of Drug Evaluation and Research (HFD-loo), F. and D. A. Guideline for Submitting 
Supporting Documentation in Drug Applications for the Manufacture of Drug Substances; 5600 
Fishers Lane, Rockville, MD 20857, 1987; pp 3–4. 
5 Eriksson, T.; Bjöurkman, S.; Roth, B.; Fyge, Å.; Höuglund, P. Chirality 1995, 7, 44–52. 
6 Simonyi, M. Med. Res. Rev. 1984, 4, 359–413. 
7 Marshall, E. Science 1985, 229, 1071–1071. 
8 Patocka, J.; Dworak, A. J. Appl. Biomed. 2004, 2, 95–100. 
9 Srinivas, N. R.; Barbhaiya, R. H.; Midha, K. K. J. Pharm. Sci. 2001, 90, 1205–1215. 
10 Asymmetric Synthesis, Academic P.; Morrison, J.D., Ed.: Orlando, 1983. 
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literature continues to grow at such a rate that comprehensive coverage is now 
impossible.11 Initially, practical access to pure enantiomers relied largely on 
biochemical or biological methods. However, the scope of such methods using 
enzymes, cell cultures, or whole microorganisms is limited because of the 
inherent single-handed, lock-and-key specificity of biocatalysts. On the other 
hand, a chemical approach constitutes a complementary method, allowing for 
the flexible synthesis of a wide array of enantioenriched organic substances.  
The practical asymmetric synthesis features which should be fulfilled 
include high stereoselectivity, high rate and productivity, atom economy, cost 
efficiency, operational simplicity, environmental friendliness, and low-energy 
consumption. The decision of how to produce a molecule in enantiomerically 
pure form requires that the experimentalist balance the pros and cons of the 
available methods.12 One of the easiest ways would be to purchase the chiral 
compound, as this is a very convenient and fast method; however, the 
availability of some specific molecules is limited and moreover the cost, in many 
cases, is too high, especially for academic research labs, or they are just 
affordable in small quantities. Apart from that, the most important and widely 
used methods for this purpose are commented below: 
Ê Chiral pool: The convenience and time saving that implies the use of a 
commercially available chiral substrate makes it rarely cost effective to 
prepare it oneself, if the molecule is reachable at a reasonable price. 
However, it may not be so easy to find an appropriate compound to be 
purchased, for three main reasons, either the desired substructure does 
not yet exist, the price is beyond a laboratory’s means, or it is only 
affordable in small quantities. 
Ê Classical resolution: It can be a practical and scalable method with a 
great reproducibility, generally. But at the same time, it can be tedious 
either finding the right conditions for a successful resolution in certain 
cases, or the scale-up of the process. Besides, it is considered by many 
chemists as an inelegant method that generates to much waste since the 
unwanted enantiomer is discarded. 
                                            
11 Gawley, R. E.; Aubé, J. In Principles of Asymmetric Synthesis; 2012; Vol. 1, pp 1–62. 
12 Gawley, R. E.; Aubé, J. In Principles of Asymmetric Synthesis; 2012; Vol. 2, pp 63–95. 
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Ê Chromatographic separation: It is an effective method on a small scale 
that affords both enantiomers directly. This could be useful when 
studying effect of chirality on a molecule’s biological activity. The 
drawback is that it is tiresome to validate and perform all the process with 
the inherent limitation of scalability, as large scale chromatographic 
separations are very expensive. 
Ê Kinetic resolution: This could be a robust synthetic method suitable for 
large scale preparations, as long as the separation of the product from 
the unreacted starting material is feasible. But here come along also the 
disadvantages of the classical resolution indicated above. 
Ê Chiral auxiliaries: They constitute a general tool for the synthesis of 
enantiomerically pure compounds, given the great amount of highly 
selective reactions mediated by them. The use of chiral auxiliaries in the 
total synthesis of natural products and biologically relevant molecules is 
widespread in the literature. Their cost and the inefficiency of having two 
additional steps are the main handicaps in this case. 
Ê Asymmetric catalysis: Performing a truly effective asymmetric catalyst 
is hard to beat, it would be the most elegant and efficient method. 
However, it can be hard to find the appropriate catalyst, if time is of the 
essence, the need to screen various catalysts for a new reaction can be 
a bottleneck.  
The choice of the last one as the best option was reinforced by the fact 
that in 2001, William S. Knowles, Ryoji Noyori and K. Barry Sharpless were 
awarded the Nobel Prize in Chemistry by the Royal Swedish Academy of 
Sciencies, for their great contribution in the development of asymmetric 
catalysis.13 Since then the field of asymmetric catalysis has evolved and grown 
exponentially. The novel asymmetric catalysis methodologies developed were 
effectively applied for preparing important structural motifs found in biologically 
active molecules. However, the difficulties in preparing substances enriched in a 
particular enantiomer persist because the number of catalytic enantioselective 
transformations available still remain limited. Therefore, the development of new 
                                            
13 a) Knowles, W. S. Angew. Chem. Int. Ed. Engl. 2002, 41, 1999–2007. b) Noyori, R. Angew. 
Chem. Int. Ed. 2002, 41, 2008–2022. c) Sharpless, K. B. Angew. Chem. Int. Ed. 2002, 41, 
2024–2032. 
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methodologies of asymmetric catalysis is invariably of high interest. Taking into 
account that the symbiotic relationship between total synthesis and method 
development can continue to expand the understanding of catalysis on both 
fundamental and practical levels.14 
0.1.2. ORGANOCATALYSIS 
Traditionally, the two pillars where asymmetric catalysis was sustained 
had been the use of enzymes and transition metal complexes bearing chiral 
ligands. The use of organic molecules as catalysts has only been documented 
sporadically over the past century, and those chemical studies were viewed 
more as unique chemical reactions than as integral parts of a larger, 
interconnected field.15 Finally in the late 1990s, things began to change when it 
was demonstrated that the use of small organic molecules as catalysts could be 
used to solve important problems in chemical synthesis. This trend was initiated 
by the use of enantiomerically pure ketones as catalysts for the asymmetric 
epoxydation of simple alkenes; 16  an briefly afterwards when the Strecker 
reaction was performed by hydrogen-bonding catalysis with organic compounds 
rather than with organometallic complexes.17 
Eventually, the term organocatalysis was introduced to the chemical 
literature in 2000 by MacMillan and co-workers18 when they described a general 
activation strategy of iminium catalysis providing a more advantageous 
alternative for LUMO activation (Scheme 0.1.a). Simultaneously, it was 
published a complementary organocatalytic study by Barbas, Lerner and List19 
on enamine catalysis (Scheme 0.1.b). They described that proline can perform 
as a novel amine-based asymmetric class I aldolase mimics showing that this 
simple a-amino acid catalysed the direct aldol reaction with comparable 
                                            
14 Mohr, J. T.; Krout, M. R.; Stoltz, B. M. Nature 2008, 455, 323–332. 
15 a) Hajos, Z. G.; Parrish, D. R. J. Org. Chem. 1974, 39, 1615–1621. b) U. Eder, G. Sauer and 
R. Wiechert, Angew. Chem., Int. Ed. Engl., 1971, 10, 496-497. 
16 a) Tu, Y.; Wang, Z.; Shi, Y. J. Am. Chem. Soc. 1996, 118, 9806–9807. b) Yang, D.; Yip, Y.-
C.; Tang, M.-W.; Wong, M.-K.; Zheng, J.-H.; Cheung, K.-K. J. Am. Chem. Soc. 1996, 118, 491–
492. c) Denmark, S. E.; Wu, Z.; Crudden, C. M.; Matsuhashi, H. J. Org. Chem. 1997, 62, 8288–
8289. 
17 a) Sigman, M. S.; Jacobsen, E. N. J. Am. Chem. Soc. 1998, 120, 4901–4902. b) Corey, E. J.; 
Grogan, M. J. Org. Lett. 1999, 1, 157–160. 
18 Ahrendt, K. A.; Borths, C. J.; MacMillan, D. W. C. J. Am. Chem. Soc. 2000, 122, 4243–4244. 
19 List, B.; Lerner, R. A.; Barbas, C. F. J. Am. Chem. Soc. 2000, 122, 2395–2396. 
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efficiency to the best organometallic catalyst,20 using similar mechanisms than 
enzymes to accomplish the HOMO activation.  
 
Scheme 0.1. First organocatalytic reactions 
Once the organocatalysis had been introduced, it emerged as a 
promising strategy in asymmetric catalysis. Its exponential growth in a very 
short period of time (Figure 0.2) converted organocatalysis in the third pillar of 
asymmetric synthesis, mainly due to the real advantages that this methodology 
offered to the scientific researchers. Among all its benefits, the main aspects 
are the savings in cost, time and energy, an easier experimental procedure, and 
reductions in chemical waste. Organic molecule catalysts are generally stable 
for being insensitive to oxygen and moisture in the air. A wide variety of them 
are often based on natural compounds, such as sugars, peptides or amino 
acids, which are available from biological sources as single enantiomers, so 
they are cheap to prepare and readily accessible in a range of quantities. 
Additionally, small organic molecules are typically non-toxic and 
environmentally friendly, unlike it happens with the most of the organometallic 
systems. Apart from that, organocatalysts can easily be linked to a solid 
support, making them useful for industrial applications. These features 
transformed organocatalysis into a complementary methodology to the 
                                            
20 Yoshikawa, N.; Yamada, Y. M. A.; Das, J.; Sasai, H.; Shibasaki, M. J. Am. Chem. Soc. 1999, 
121, 4168–4178. 
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traditional and highly developed inorganic and biological approaches to 
asymmetric catalysis.21  
 
Figure 0.2. The number of publications on organocatalysis since it was coined in 
the literature. Data were obtained by search of Scifinder in December 2015 for 
the keywords organocatalysis and organocatalyst, having been substracted the 
entries from “Abstract of Papers” and “Chemtracts” or with “No Corporate Source 
data available”. 
Another relevant feature responsible for the success of organocatalysis 
was the identification of generic modes of catalyst activation, induction and 
reactivity. This consists of reactive species formed by the interaction of a single 
chiral catalyst with a principal functional group in a highly organized and 
predictable manner. Their value is that under this frame, it is a relatively 
straightforward issue to design new enantioselective reactions using these 
principles. 
From a mechanistic perspective, organocatalytic modes of activation can 
be classified according to two aspects, the first the covalent or noncovalent 
character of the substrate–catalyst interaction; and the second the 
chemical nature (Lewis base, Lewis acid, Brønsted base, Brønsted acid) of the 
organocatalyst. 22  It is important to keep in mind, however, that many 
organocatalysts act through both covalent and noncovalent interactions and/or 
display a dual acid–base character, giving way to a group known as bifunctional 
catalysts.  
                                            
21 a) List, B.; Yang, J. W. Science 2006, 313, 1584–1586. b) MacMillan, D. W. C. Nature 2008, 
455, 304–308. 
22 Seayad, J.; List, B. Org. Biomol. Chem. 2005, 3, 719-724. 
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Among the currently operative mechanisms in asymmetric 
organocatalysis, the most important groups are aminocatalysis, carbene 
catalysis and Lewis base organocatalysis with covalent interactions; and 
hydrogen-bonding activation, bifunctional catalysis, phase-transfer and 
asymmetric counteraction-directed catalysis within the noncovalent 
organocatalysis modes. 23  Hereafter there will be mentioned the more 
established modes for their length of standing and the more related ones to the 
current research work. 
a) Covalent organocatalysis 
AMINOCATALYSIS 
The term aminocatalysis has been coined 24  to designate reactions 
catalysed by primary and secondary amines. This field was discovered in the 
early 1970s15 but it remained as a laboratory curiosity for almost thirty 
years.18,19 Now, catalysis with chiral amines has become a well-established and 
powerful synthetic tool for the chemo- and enantioselective functionalisation of 
carbonyl compounds. In the last fifteen years, this field has grown at such a 
breathtaking pace that it is now recognized as an independent area of synthetic 
chemistry. 25  Among the multiple subparts this field can be classified, this 
memory will specifically be focused on the ones directly related with the present 
work. 
¶ ENAMINE CATALYSIS 
One of the two first discovered methodologies19 in this field is the 
enamine catalysis, that has become one of the most intensively used 
organocatalytic modes of activation, allowing the functionalisation of carbonyl-
                                            
23 Moyano, A. In Stereoselective Organocatalysis; John Wiley & Sons, Inc.: Hoboken, New 
Jersey, 2013; pp 11–80. 
24 List, B. Synlett 2001, 1675–1686. 
15 a) Hajos, Z. G.; Parrish, D. R. J. Org. Chem. 1974, 39, 1615–1621. b) U. Eder, G. Sauer and 
R. Wiechert, Angew. Chem., Int. Ed. Engl., 1971, 10, 496-497. 
18 Ahrendt, K. A.; Borths, C. J.; MacMillan, D. W. C. J. Am. Chem. Soc. 2000, 122, 4243–4244. 
19 List, B.; Lerner, R. A.; Barbas, C. F. J. Am. Chem. Soc. 2000, 122, 2395–2396. 
25 a) Melchiorre, P.; Marigo, M.; Carlone, A.; Bartoli, G. Angew. Chem. Int. Ed. 2008, 47, 6138–
6171. b) List, B. Chem. Commun. 2006, 819-824. 
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containing compounds at the a-carbon in enantioselective manner (Scheme 
0.2).26 
 
Scheme 0.2. Enantioselective a-functionalisation of enolizable 
carbonyl compounds with a huge variety of electrophiles 
The standard catalytic cycle for a chiral amine-catalysed a-
functionalisation of a carbonyl compound is depicted in Scheme 0.3. A chiral, 2-
substituted pyrrolidine has been chosen as the most representative type of 
catalyst, acting together with an external Brønsted acid co-catalyst AH. The 
generalized enamine mechanism involves in the first step the acid-promoted 
condensation of the carbonyl with the amine to form an iminium ion. One of the 
a-acidic protons of the iminium ion is then removed by the conjugate base of 
the Brønsted acid A-, and the key nucleophilic enamine intermediate is formed. 
Reaction with the electrophile (generally protonated; the protonation can take 
place before or during this step) generates another iminium ion, whose 
hydrolysis liberates the product, the acid, and the amine catalyst, which can 
reenter the catalytic cycle. The Brønsted acid co-catalyst can be a protic solvent 
or an added external acid, or it can be a functional group present in the amine 
catalyst. 
                                            
26 Bertelsen, S.; Jørgensen, K. A. Chem. Soc. Rev. 2009, 38, 2178-2189. 
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Scheme 0.3. Generalized mechanism for the enamine organocatalysis. 
This reversible condensation of the chiral amine with carbonyl 
compounds leads to the formation of a positively charged iminium ion 
intermediate, mimicking the electronic situation of the p orbitals in Lewis acid 
catalysis (Scheme 0.4). On that intermediate, the energy of the lowest 
unoccupied molecular orbital (LUMO) of the system is effectively lowered, thus 
increasing the acidity of the a proton and consequently inducing the 
deprotonation at this position. Then, the enamine intermediate, considered as a 
nucleophilic enolate equivalent, is activated by the raising of the energy of the 
highest occupied molecular orbital (HOMO). 
 
Scheme 0.4. Comparison of the activation of carbonyl compounds by a 
Lewis acid (LA) in enamine aminocatalysis, known as HOMO catalysis. 
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Enaminic catalysis has been successfully employed both in addition 
reactions and in nucleophilic substitutions, with a great variety of electrophiles. 
Besides the aldolic condensation (Scheme 0.1.b),27 there were subsequently 
developed diverse a-functionalisation reactions of aldehydes, 28  such as 
Mannich reactions, 29  enantioselective a-amination reactions with 
azodicarboxylates, 30  hydroxylations with nitrosobenzene, 31  a-alkylations and 
arylations,32 a-halogenations (Cl, Br, I, F),33 and sulfenylations.34 In the Scheme 
0.5. are shown a summary of the a-functionalisation of aldehydes by means of 
enamine catalysis. 
                                            
27 a) Northrup, A. B.; MacMillan, D. W. C. J. Am. Chem. Soc. 2002, 124, 6798–6799. b) 
Northrup, A. B.; MacMillan, D. W. C. Science 2004, 305, 1752–1755. 
28  Revisions about organocatalytic a-heterofunctionalisation of carbonylic compounds: a) 
Franzén, J.; Marigo, M.; Fielenbach, D.; Wabnitz, T. C.; Jørgensen, K. A. J. Am. Chem. Soc. 
2005, 127, 18296–18304. b) Guillena, G.; Ramón, D. J. Tetrahedron: Asymmetry 2006, 17, 
1465–1492. c) Marigo, M.; Jørgensen, K. A. Chem. Commun. 2006, No. 19, 2001–2011. d) 
Ueda, M.; Kano, T.; Maruoka, K. Org. Biomol. Chem. 2009, 7, 2005-2012. 
29 a) Córdova, A.; Watanabe, S.; Tanaka, F.; Notz, W.; Barbas, C. F. J. Am. Chem. Soc. 2002, 
124, 1866–1867. b) Ting, A.; Schaus, S. E. Eur. J. Org. Chem. 2007, 5797–5815. c) Verkade, J. 
M. M.; Hemert, L. J. C. van; Quaedflieg, P. J. L. M.; Rutjes, F. P. J. T. Chem. Soc. Rev. 2008, 
37, 29–41. 
30 a) Janey, J. M. Angew. Chem., Int. Ed. 2005, 44, 4292-4300. b) Duthaler, R. O. Angew. 
Chem. Int. Ed. 2003, 42, 975-978. c) Bogevig, A.; Juhl, K.; Kumaragurubaran, N.; Zhuang, W.; 
Jørgensen, K. A. Angew. Chem., Int. Ed. 2002, 41, 1790-1793. d) List, B. J. Am. Chem. Soc. 
2002, 124, 5656-5657. 
31 a) Merino, P.; Tejero, T. Angew. Chem., Int. Ed. 2004, 43, 2995-2997. b) Palomo, P.; Vera, 
S.; Velilla, I.; Mielgo, A.; Gómez-Bengoa, E. Angew. Chem. Int. Ed. 2007, 46, 8054-8056. c) 
Kuarn, S.; Oelke, A. J.; Shaw, D. M.; Longbottom, D. A.; Ley, S. V. Org. Biomol. Chem. 2007, 5, 
2678-2689. d) Zhong, G. Angew. Chem. Int. Ed. 2003, 42, 4247-4250. 
32 a-Alkylations of aldehydes: a) Shaikh, R. R.; Mazzanti, A.; Petrini, M.; Bartoli, G.; Melchiorre, 
P. Angew. Chem. Int. Ed. 2007, 46, 8707-8710. b) Vignola, N.; List, B. J. Am. Chem. Soc. 2004, 
126, 450-451. a-Arylations of aldehydes: c) Aleman, J.; Cabrera, S.; Maerten, E.; Overgaard, J.; 
Jørgensen, K. A. Angew. Chem. Int. Ed. 2007, 46, 5520-5523. 
33 a-Fluorination of aldehydes: a) Prakash, G. K. S.; Beier, P. Angew. Chem., Int. Ed. 2006, 45, 
2172-2174. b) Pihko, P. M. Angew. Chem. Int. Ed. 2006, 45, 544-547. c) Shibatomi, K.; 
Yamamoto, H. Angew. Chem. Int. Ed. 2008, 47, 5796-5798. d) Steiner, D. D.; Mase, N.; Barbas 
III, C. F. Angew. Chem., Int. Ed. 2005, 44, 3706-3710. e) Beeson, T. D. MacMillan, D. W. C. J. 
Am. Chem. Soc. 2005, 127, 8826-8828. a-Chlorination of aldehydes: f) Brochu, M. P.; Brown, 
S. P.; MacMillan, D. W. C. J. Am. Chem. Soc. 2004, 126, 4108-4109. g) Halland, N.; Braunton, 
A.; Bachmann, S.; Marigo, M.; Jørgensen, K. A. J. Am. Chem. Soc. 2004, 126, 4790-4791. a-
Bromination of adehydes: h) Bertelsen, S.; Halland, N.; Bachmann, S.; Marigo, M.; Braunton, 
A.; Jørgensen, K. A. Chem. Commun. 2005, 4821-4823. 
34 a) Marigo, M.; Wabnitz, T. C.; Fielenbach, D.; Jorgensen, K. A. Angew. Chem. Int. Ed. 2005, 
44, 794-797. b) Enders, D.; Lüttgen, K.; Narine, A. A. Synthesis 2007, 959-980. 
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Scheme 0.5. a-Functionalisation of aldehydes via enamine activation. 
Yet, at the same time, enamine catalysis has been used for conjugated 
additions of aldehydes to several Michael acceptors like nitroalkenes, 35 
vinilketones, 36 ,28a maleimides, 37  phosphonates 38  and sulfones. 39  The more 
                                            
35 a) Wang, W.; Wang, J.; Li, H. Angew. Chem. Int. Ed. 2005, 44, 1369–1371. b) Hayashi, Y.; 
Gotoh, H.; Hayashi, T.; Shoji, M. Angew. Chem. Int. Ed. 2005, 44, 4212–4215. c) García-
García, P.; Ladépêche, A.; Halder, R.; List, B. Angew. Chem. Int. Ed. 2008, 47, 4719–4721. d) 
Ruiz, N.; Reyes, E.; Vicario, J. L.; Badía, D.; Carrillo, L.; Uria, U. Chem. Eur. J. 2008, 14, 9357–
9367. 
36 a) Melchiorre, P.; Jørgensen, K. A. J. Org. Chem. 2003, 68, 4151–4157. b) Peelen, T. J.; Chi, 
Y.; Gellman, S. H. J. Am. Chem. Soc. 2005, 127, 11598–11599. 
28a Franzén, J.; Marigo, M.; Fielenbach, D.; Wabnitz, T. C.; Jørgensen, K. A. J. Am. Chem. Soc. 
2005, 127, 18296–18304. 
37 Zhao, G.-L.; Xu, Y.; Sunden, H.; Eriksson, L.; Sayah, M.; Cordova, A. Chem. Commun. 2007, 
734-735. 
38 Sulzer-Mossé, S.; Tissot, M.; Alexakis, A. Org. Lett. 2007, 9, 3749-3752. 
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representative examples of Michael type additions catalysed with proline or 
derivatives through an enamine activation are depicted in Scheme 0.6. 
 
Scheme 0.6. Conjugated additions of aldehydes to various Michael acceptors. 
¶ IMINIUM CATALYSIS 
Together with enamine catalysis, iminium catalysis is the most 
prominent activation mode in asymmetric aminocatalysis,40 and the second of 
the first discovered methodologies. Initially, the proof of concept was done in a 
Diels Alder type reaction,18 and subsequently applied to carry out 1,3-dipolar 
cycloadditions,41 and afterwards extended to other reactions as Friedel-Crafts 
alkylations, 42  other types of cycloadditions, 43  epoxidations, 44 
                                                                                                                                
39 a) Landa, A.; Puente, A.; Santos, J. I.; Vera, S.; Oiarbide, M.; Palomo, C. Chem. Eur. J. 
2009, 15, 11954-11962. b) Landa, A.; Maestro, M.; Masdeu, C.; Puente, A.; Vera, S.; Oiarbide, 
M.; Palomo, C. Chem. Eur. J. 2009, 15, 1562-1565. c) Mossé, S.; Alexakis, A.; Mareda, J.; 
Bollot, G.; Bernardinelli, G.; Filinchuk, Y. Chem. Eur. J. 2009, 15, 3204-3220. 
40 a) Enders, D.; Wang, C.; Liebich, J. X. Chem. Eur. J. 2009, 15, 11058–11076. b) Erkkilä, A.; 
Majander, I.; Pihko, P. M. Chem. Rev. 2007, 107, 5416–5470. c) Almaşi, D.; Alonso, D. A.; 
Nájera, C. Tetrahedron: Asymmetry 2007, 18, 299–365. d) Tsogoeva, S. B. Eur. J. Org. Chem. 
2007, 1701–1716. 
18 Ahrendt, K. A.; Borths, C. J.; MacMillan, D. W. C. J. Am. Chem. Soc. 2000, 122, 4243–4244. 
41 Jen, W. S.; Wiener, J. J. M.; MacMillan, D. W. C. J. Am. Chem. Soc. 2000, 122, 9874–9875. 
42 a) Paras, N. A.; MacMillan, D. W. C. J. Am. Chem. Soc. 2001, 123, 4370–4371. b) Paras, N. 
A.; MacMillan, D. W. C. J. Am. Chem. Soc. 2002, 124, 7894–7895. c) Okamoto, A.; Kanatani, 
K.; Taiji, T.; Saito, I. J. Am. Chem. Soc. 2003, 125, 1172–1173. 
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cyclopropanations45 and especially Michael additions for a large number of non-
metallic nucleophilic moieties (Scheme 0.7).26 Now it is established as a general 
strategy for the asymmetric conjugate addition of nucleophiles at the b–position 
of conjugated carbonyl compounds.  
 
Scheme 0.7. Enantioselective b-functionalisation of a,b-unsaturated 
carbonyl compounds with a great variety of nucleophiles 
The conventional catalytic cycle for a chiral pyrrolidine-catalysed b-
functionalisation of an a,b-unsaturated carbonyl compound is shown in Scheme 
0.8, and it begins with the acid-promoted condensation of the carbonyl with the 
amine to form an unsaturated iminium ion, more electrophilic than the starting 
unsaturated carbonyl. This reactive intermediate suffers then the addition of the 
nucleophile at the b-position, leading to a,b-functionalised enamine in 
tautomeric equilibrium with an iminium ion. Hydrolysis of this intermediate 
releases both the product and the chiral ammonium salt, which can reenter the 
catalytic cycle. 
                                                                                                                                
43 a) Northrup, A. B.; MacMillan, D. W. C. J. Am. Chem. Soc. 2002, 124, 2458–2460. b) 
Harmata, M.; Ghosh, S. K.; Hong, X.; Wacharasindhu, S.; Kirchhoefer, P. J. Am. Chem. Soc. 
2003, 125, 2058–2059. c) Wilson, R. M.; Jen, W. S.; MacMillan, D. W. C. J. Am. Chem. Soc. 
2005, 127, 11616–11617. 
44 a) Lee, S.; MacMillan, D. W. C. Tetrahedron 2006, 62, 11413-11424. b) Marigo, M.; Franzén, 
J.; Poulsen, T. B.; Zhuang, W.; Jørgensen, K. A. J. Am. Chem. Soc. 2005, 127, 6964-6965. 
45 Kunz, R. K.; MacMillan, D. W. C. J. Am. Chem. Soc. 2005, 127, 3240-3241. 
26 Bertelsen, S.; Jørgensen, K. A. Chem. Soc. Rev. 2009, 38, 2178-2189. 
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Scheme 0.8. Generalized mechanism for the chiral amine-catalysed b–
functionalisation of a,b-unsaturated carbonyls. 
In this case, the reversible condensation of a chiral amine with carbonyl 
conjugated systems leads to the formation of an iminium cation intermediate. 
Here the electronic redistribution facilitates nucleophilic additions, which might 
emulate the equilibrium dynamics and p-orbital electronics that are inherent to 
Lewis acid catalysis (Scheme 0.9). In this way, it is said that there is a LUMO 
activation due to its lowering at the iminium salts, making them more 
electrophilic than the corresponding carbonyl compounds and more reactive 
toward nucleophilic attacks. 
 
Scheme 0.9. Comparison of the activation of conjugated carbonyl 
compounds by a Lewis acid (LA) in iminium aminocatalysis, known as 
LUMO catalysis. 
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Employing this activation via the iminium ion, there have been developed 
a great variety of conjugate addition reactions with diverse chiral catalysts 
bearing a secondary amine.40 This organocatalytic methodology has a really 
wide scope (Scheme 0.10), it has been applied, for example, in additions of 
malonates 46 or nitroalkanes 47  to conjugated aldehydes and ketones, 
enantioselective reductions of b,b-disubstituted a,b-unsaturated aldehydes,48 or 
1,4-additions of sulfur-,49 nitrogen-50 and oxygen-derivatives.51 
                                            
46 For additions to enones: a) Halland, N.; Aburel, P. S.; Jørgensen, K. A. Angew. Chem. Int. 
Ed. 2003, 42, 661–665. b) Knudsen, K. R.; Mitchell, C. E. T.; Ley, S. V. Chem. Commun. 2006, 
44, 66–68. For additions to aldehydes: c) Brandau, S.; Landa, A.; Franzén, J.; Marigo, M.; 
Jørgensen, K. A. Angew. Chem. Int. Ed. 2006, 45, 4305–4309. 
47 a) Prieto, A.; Halland, N.; Jørgensen, K. A. Org. Lett. 2005, 7, 3897–3900. b) Mitchell, C. E. 
T.; Brenner, S. E.; García-Fortanet, J.; Ley, S. V. Org. Biomol. Chem. 2006, 4, 2039–2049. 
48 a) Yang, J. W.; Fonseca, M. T. H.; Vignola, N.; List, B. Angew. Chem. Int. Ed. 2005, 44, 108-
110. b) Ouellet, S. G.; Tuttle, J. B.; MacMillan, D. W. C. J. Am. Chem. Soc. 2005, 127, 32-33. 
49 Marigo, M.; Schulte, T.; Franzén, J.; Jørgensen, K. A. J. Am. Chem. Soc. 2005, 127, 15710-
15711. 
50 a) Chen, Y. K.; Yoshida, M.; MacMillan, D. W. C. J. Am. Chem. Soc. 2006, 128, 9328–9329. 
b) Dinér, P.; Nielsen, M.; Marigo, M.; Jørgensen, K. A. Angew. Chem. Int. Ed. 2007, 46, 1983–
1987. c) Uria, U.; Vicario, J. L.; Badía, D.; Carrillo, L. Chem. Commun. 2007, 2509–2511. d) Lin, 
Q.; Meloni, D.; Pan, Y.; Xia, M.; Rodgers, J.; Shepard, S.; Li, M.; Galya, L.; Metcalf, B.; Yue, T.-
Y.; Liu, P.; Zhou, J. Org. Lett. 2009, 11, 1999–2002. 
51 Bertelsen, S.; Dinér, P.; Johansen, R. L.; Jørgensen, K. A. J. Am. Chem. Soc. 2007, 129, 
1536–1537. 
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Scheme 0.10. Selection of b-functionalisation of conjugated carbonylic compounds. 
In most cases of organocatalysis based on iminium-activation, involving 
the most generalized secondary-amine catalysts, the Michael acceptor is an 
a,b-unsaturated aldehyde, since the generation of the iminium intermediate is 
more efficient with enals than with a,b-unsaturated ketones. That is due to the 
greater steric hindrance of ketones in both sides of the carbonylic group, 
leading to a poorer geometric control of the iminium intermediate (lower 
enantioselectivities) or even preventing the possibility of its formation (Figure 
0.3.a). To avoid this problem, there have been developed primary-amine 
organocatalysts,52 which allow a facile condensation between the enone and 
the aminocatalyst and also a better geometrical regulation given the bigger 
difference between the coplanar substituents of the double bound C=N of the 
iminium ion (Figure 0.3.b). 
                                            
52 a) Bartoli, G.; Melchiorre, P. Synlett 2008, 1759–1772. b) Xu, L.-W.; Lu, Y. Org. Biomol. 
Chem. 2008, 6, 2047. c) Peng, F.; Shao, Z. J. Mol. Catal. A Chem. 2008, 285, 1–13. d) Xu, L.-
W.; Luo, J.; Lu, Y. Chem. Commun. 2009, 1807-1821. e) Jiang, L.; Chen, Y.-C. Catal. Sci. 
Technol. 2011, 1, 354-365. 
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Figure 0.3. Geometric control in the iminium intermediates of secondary and primary-
amine organocatalysts with a,b-unsaturated ketones. 
Some other relevant mechanisms of covalent organocatalysis that won’t 
be discussed here, for not being so prevalent or related with the current 
research work, are the dienamine catalysis, the SOMO catalysis or photoredox 
methodologies among others. 
b) Noncovalent organocatalysis 
As noncovalent organocatalysts, there will be included those which will 
activate the reaction substrate through some weaker interactions different than 
the covalent ones, inter alia, hydrogen-bonding, direct electrostatic activation 
and p interactions.53 While, in some cases, this activation will occur directly 
between the catalyst and the substrate, in others, the organocatalyst may react 
previously with the starting material or with a co-catalyst (for instance, through 
acid-base reactions), to give rise to an intermediate that will be the responsible 
for the asymmetric induction of the reaction. Apart from that, it should be noted 
that these noncovalent interactions can take place by their own or together with 
some covalent activation, and in the latter case the reactivity and the 
enantioselectivity of the organic reaction would probably be improved.54 
Thus, depending on the degree of proton transfer in the transition state, 
one may distinguish between hydrogen-bonding catalysis (when the hydrogen 
is still covalently bonded to the catalyst) and Brønsted acid catalysis (complete 
                                            
53 a) Guerin, D. J.; Miller, S. J. J. Am. Chem. Soc. 2002, 124, 2134–2136. b) Hoashi, Y.; Okino, 
T.; Takemoto, Y. Angew. Chem. Int. Ed. 2005, 44, 4032–4035. c) Hamza, A.; Schubert, G.; 
Soós, T.; Pápai, I. J. Am. Chem. Soc. 2006, 128, 13151–13160. d) Kótai, B.; Kardos, G.; 
Hamza, A.; Farkas, V.; Pápai, I.; Soós, T. Chem. Eur. J. 2014, 20, 5631–5639. e) Holland, M. 
C.; Metternich, J. B.; Daniliuc, C.; Schweizer, W. B.; Gilmour, R. Chem. Eur. J. 2015, 21, 
10031–10038. f) Wang, L.; Chen, J.; Huang, Y. Angew. Chem. Int. Ed. 2015, 54, 15414–15418. 
For analysis of noncovalent interactions in organocatalysis: g) Inokuma, T.; Furukawa, M.; Uno, 
T.; Suzuki, Y.; Yoshida, K.; Yano, Y.; Matsuzaki, K.; Takemoto, Y. Chem. Eur. J. 2011, 17, 
10470–10477. h) Holland, M. C.; Berden, G.; Oomens, J.; Meijer, A. J. H. M.; Schäfer, M.; 
Gilmour, R. Eur. J. Org. Chem. 2014, 5675–5680. 
54 Mathew, S. P.; Klussmann, M.; Iwamura, H.; Wells, Jr., D. H.; Armstrong, A.; Blackmond, D. 
G. Chem. Commun. 2006, 4291-4293. 
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proton transfer from the catalyst to the substrate), but logically several 
intermediate situations are possible (Figure 0.4).55 However, the term hydrogen-
bonding activation is generally used to represent both hydrogen-bonding 
catalysis and Brønsted acid catalysis. 
 
Figure 0.4. Hydrogen-bonding/Brønsted acid continuum. A = acid; B = base. 
HYDROGEN-BONDING ORGANOCATALYSIS 
Hydrogen-bonding catalysis can be defined as a LUMO-lowering 
activation by sharing of a hydrogen atom between the substrate (hydrogen 
bond acceptor) and the catalyst (hydrogen bond donor). The ability of 
hydrogen-bond donors to accelerate organic reactions was first recognized in 
1942, when Wassermann reported his crucial results on the catalysis of Diels–
Alder reactions by phenol or carboxylic acids. 56  Still, the full potential of 
hydrogen-bonding catalysis in asymmetric synthesis was not appreciated until 
1998, when Sigman and Jacobsen described the use of peptide–thiourea 
catalysts in the enantioselective Strecker reaction (Scheme 0.11).17a  
 
Scheme 0.11. Asymmetric Strecker reaction with organocatalytic thiourea. 
The most widely used catalysts of this type are chiral ureas and 
thioureas, chiral amidinium or guanidinium ions, chiral squaramides, and chiral 
                                            
55 a) Doyle, A. G.; Jacobsen, E. N. Chem. Rev. 2007, 107, 5713–5743. b) Connon, S. J. Org. 
Biomol. Chem. 2007, 5, 3407-3417. 
56 Wassermann, A. J. Chem. Soc. 1942, 128, 621-623. 
17a Sigman, M. S.; Jacobsen, E. N. J. Am. Chem. Soc. 1998, 120, 4901-4902. 
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diols (Figure 0.5). Among the variety of chemical transformations with 
hydrogen-bond donor catalysis are included the activation of carbonyls, 57 
imines,17a and epoxides58 toward nucleophilic attack and also the stabilization of 
transition states in Diels–Alder and hetero-Diels–Alder cycloadditions, 59  1,3-
dipolar cycloadditions, 60  Claisen rearrangements, 61  and aldol, Michael 62  or 
Mannich reactions.63 
 
Figure 0.5. Representative chiral hydrogen-bond donor catalysts. 
BIFUNCTIONAL CATALYSIS 
As their name suggests, these organocatalysts interact with the reagents 
in, at least, two different ways throughout separated chemical units. This 
concept of multifunctional asymmetric catalysis has received considerable 
attention in the past years. Concretely, the most usual combinations of dual 
activations are the association of a Brønsted acid either with a Brønsted base 
(Figure 0.6.a) or with a Lewis base (Figure 0.6.b). 
                                            
57 Sohtome, Y.; Hashimoto, Y.; Nagasawa, K. Adv. Synth. Catal. 2005, 347, 1643–1648. 
58 a) Omoto, K.; Fujimoto, H. J. Org. Chem. 2000, 65, 2464–2471. b) Fleming, E. M.; Quigley, 
C.; Rozas, I.; Connon, S. J. J. Org. Chem. 2008, 73, 948–956. 
59 Huang, Y.; Unni, A. K.; Thadani, A. N.; Rawal, V. H. Nature 2003, 424, 146. 
60 Liu, Y.-K.; Liu, H.; Du, W.; Yue, L.; Chen, Y.-C. Chem. Eur. J. 2008, 14, 9873–9877. 
61 Uyeda, C.; Jacobsen, E. N. J. Am. Chem. Soc. 2011, 133, 5062–5075. 
62 Liu, T.-Y.; Long, J.; Li, B.-J.; Jiang, L.; Li, R.; Wu, Y.; Ding, L.-S.; Chen, Y.-C. Org. Biomol. 
Chem. 2006, 4, 2097-2099. 
63 Žabka, M.; Šebesta, R. Molecules 2015, 20, 15500–15524. 
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Figure 0.6. Dual activation of electrophile and nucleophile by a bifunctional catalyst.                       
Nu = Nucleophile; E = Electrophile. 
The synergistic activation of the reactants by acidic and basic sites in the 
catalyst was introduced by Shibasaki and co-workers 64  by means of 
organometallic entities. Simultaneously, asymmetric organocatalysis by 
bifunctional species containing a hydrogen-bond donor in addition to a Brønsted 
basic moiety was foreshadowed by Riant and Kagan, 65  first developed by 
Hatakeyama’s and Takemoto’s groups66 and finally converted into a general 
and reliable strategy that has been shown to be useful in a variety of 
processes.67 
On the other hand, the most symbolic catalysts with a Lewis base moiety 
are a-amino acids, and proline is the highest representative, albeit any chiral 
organic compound having a Lewis base (usually a primary or a secondary 
amine) and a hydrogen bond donor can be included in this category.  
Thus, in proline catalysis (Scheme 0.12) has been demonstrated that 
both the secondary amine and the carboxylic acid moieties of the molecule are 
essential for its organocatalytic reactions;15a the first to form the enamine 
intermediate when condensing with carbonyl groups, and the latter to 
simultaneously engage with an electrophilic reaction partner through either 
                                            
64  a) Shibasaki, M.; Sasai, H.; Arai, T. Angew. Chem. Int. Ed. 1997, 36, 1236–1256. b) 
Shibasaki, M.; Yoshikawa, N. Chem. Rev. 2002, 102, 2187–2210. 
65 Riant, O.; Kagan, H. B. Tetrahedron Lett. 1989, 30, 7403–7406. 
66 a) Iwabuchi, Y.; Nakatani, M.; Yokoyama, N.; Hatakeyama, S. J. Am. Chem. Soc. 1999, 121, 
10219–10220. b) Iwabuchi, Y.; Furukawa, M.; Esumi, T.; Hatakeyama, S. Chem. Commun. 
2001, 7, 2030–2031. c) Okino, T.; Hoashi, Y.; Takemoto, Y. J. Am. Chem. Soc. 2003, 125, 
12672–12673. 
67 a) Wang, Y.; Li, H.; Wang, Y.-Q.; Liu, Y.; Foxman, B. M.; Deng, L. J. Am. Chem. Soc. 2007, 
129, 6364–6365. b) Singh, R. P.; Bartelson, K.; Wang, Y.; Su, H.; Lu, X.; Deng, L. J. Am. Chem. 
Soc. 2008, 130, 2422–2423. c) Chen, Y.-C. Synlett 2008, 1919–1930. d) Siau, W.-Y.; Wang, J. 
Catal. Sci. Technol. 2011, 1, 1298-1310. 
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hydrogen bonding or electrostatic attraction. It is amazing how such a simple 
natural amino acid efficiently imitates the concept of enzymatic catalysis. This 
ability has been developed extensively and with such impressive results that 
proline has ultimately come to be seen as the simplest “enzyme” in nature.68 
 
Scheme 0.12. Bifunctional Brønsted acid-enamine catalysis with proline 
PHASE-TRANSFER CATALYSIS 
After the first successful application of Cinchona alkaloid-based 
quaternary ammonium salts as chiral phase-transfer catalysts in 1984,69 the use 
of chiral quaternary ammonium salts in asymmetric catalysis has experienced a 
notable growth 70  and it has been widely applied for the enantioselective 
preparation of a-amino acids.71 
The generally accepted mechanism for asymmetric phase-transfer 
catalysis, depicted in Scheme 0.13, assumes that the quaternary ammonium 
cation forms a tight ionic complex with the nucleophile anion, generated by 
deprotonation of the neutral pronucleophile at the interphase of the organic and 
aqueous phases by an alkaline hydroxide. This ionic complex reacts with the 
electrophile, liberating the product and the quaternary ammonium salt, which 
returns to the interface for catalyst recycling. 
                                            
68 Movassaghi, M.; Jacobsen, E. N. Science 2002, 298, 1904–1905. 
69 Dolling, U. H.; Davis, P.; Grabowski, E. J. J. J. Am. Chem. Soc. 1984, 106, 446–447. 
70 a) Jew, S.; Park, H. Chem. Commun. 2009, 46, 7090-7108. b) Marcelli, T.; Hiemstra, H. 
Synthesis 2010, 8, 1229–1279. 
71 a) O’Donnell, M. J.; Bennett, W. D.; Wu, S. J. Am. Chem. Soc. 1989, 111, 2353–2355. b) 
Lygo, B.; Wainwright, P. G. Tetrahedron Lett. 1997, 38, 8595–8598. c) Ooi, T.; Takeuchi, M.; 
Kameda, M.; Maruoka, K. J. Am. Chem. Soc. 2000, 122, 5228–5229. d) Nájera, C.; Sansano, J. 
M. Chem. Rev. 2007, 107, 4584–4671. 
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Scheme 0.13. Interphase mechanism for phase-transfer catalysis by a 
chiral quaternary ammonium salt. 
0.1.3. b-AMINO CARBONYL COMPOUNDS: AZA-MICHAEL REACTION 
One of the main goals in organic synthesis is the preparation of nitrogen 
containing structures, as they can be found for instance in natural products, 
bioactive compounds and agrochemicals. Within this general group, b-amino 
carbonyl compounds, beyond themselves show sometimes interesting 
pharmacological properties, they have a recognized relevance as versatile 
intermediates in organic synthesis. Even though their main representatives, b-
amino acids, might be regarded as the building blocks that nature overlooked 
due their seldom occurrence. Although less abundant than their a-analogues, 
they are also present in peptides and in other natural products, such as 
alkaloids or terpenoids and more concretely in the well-known antineoplasic 
drug Paclitaxel or Taxol (Figure 0.7).  
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Figure 0.7. Structure of the natural alkaloid Taxol and the traded drug Paclitaxel. 
Besides, it has been determined that the incorporations of b-amino acids 
into peptides instead of a-amino acids increases their stability against 
degradation by mammalian peptidases. Therefore, they are considered as an 
important tool in the development of drugs capable of withstanding hydrolytic 
degradation for prolonged periods of time. Hence, the field of b-amino acids has 
given rise to a considerable interest in the recent decades, including a multitude 
of synthetic procedures to access these residues and a large number of 
reviews.72 These b-amino units can be classified according to the nomenclature 
suggested by Seebach, 73  depending upon the position of the side chains 
(Figure 0.8). 
 
Figure 0.8. Differential denomination of the b-amino acid skeletons. 
There are four main approaches to obtain optically active amino acids, 
namely biotechnological methods, chemical synthesis using compounds from 
                                            
72 a) Cheng, R. P.; Gellman, S. H.; DeGrado, W. F. Chem. Rev. 2001, 101, 3219–3232. b) Liu, 
M.; Sibi, M. P. Tetrahedron 2002, 58, 7991–8035. c) Schreiber, J. V; Frackenpohl, J.; Moser, F.; 
Fleischmann, T.; Kohler, H.-P. E.; Seebach, D. ChemBioChem 2002, 3, 424. d) Ma, J.-A. 
Angew. Chem. Int. Ed. Engl. 2003, 42, 4290–4299. e) Sewald, N. Angew. Chem. Int. Ed. 2003, 
42, 5794–5795. f) Spiteller, P.; von Nussbaum, F. In Enantioselective Synthesis of β-Amino 
Acids; John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2005; pp 19–91. g) Nájera, C.; Sansano, J. 
M. Chem. Rev. 2007, 107, 4584–4671. h) Sleebs, B.; Van Nguyen, T. T.; Hughes, A. Org. Prep. 
Proced. Int. 2009, 41, 429–478. i) Weiner, B.; Szymański, W.; Janssen, D. B.; Minnaard, A. J.; 
Feringa, B. L. Chem. Soc. Rev. 2010, 39, 1656. j) Sorochinsky, A.; Mikami, K.; Fustero, S.; 
Sánchez-Roselló, M.; Aceña, J.; Soloshonok, V. Synthesis 2011, 3045–3079. 
73 Lelais, G.; Seebach, D. Biopolymers (Peptide Science)  2004, 76, 206–243. 
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the chiral pool, resolution of a racemic mixture, and asymmetric synthesis. 
Traditional diastereoselective synthesis of b-amino acids has been achieved by 
using stoichiometric chiral reagents or auxiliaries; however, the number of 
catalytic asymmetric methods is relatively small in comparison. Even so, in the 
recent years several research groups have described many efficient catalytic 
asymmetric procedures for synthesis of b-amino acids 74 In this context, the 
main approaches for stereoselective synthesis of these structures are the 
formation of a carbon-carbon bond (Mannich-type reactions), the generation of 
a carbon-nitrogen bond (for instance, aza-Michael reaction, a-amination of a-
ketoesters, C-H activation of N-protected methyl amines) and the hydrogenation 
of b-aminoacrylic acid derivatives (Scheme 0.14).75 Within this procedures, one 
of the simplest mechanisms is the conjugated addition of nitrogen nucleophiles 
to a,b-unsaturated acid derivatives, i. e. the aza-Michael reaction.72d  
 
Scheme 0.14. Asymmetric hydrogenation of b-aryl-substituted  b-(acyl amino)acrylates. 
The aza-Michael reaction (AMR) is the most direct way to generate 
carbon-nitrogen bonds, which exhibits also a great simplicity, versatility and 
atom economy. A wide variety of nitrogen nucleophiles (amines, amides, 
oximes, carbamates, sulfonamides, hydrazines, azides or nitrogen-containing 
heterocycles) and Michael acceptors (conjugated aldehydes, ketones, esters, 
amides or nitriles, nitro olefins, vinyl sulfones or vinyl phosphonates) can be 
found as partners of this transformation. Furthermore, the process can be 
                                            
74 a) Ishitani, H.; Ueno, M.; Kobayashi, S. J. Am. Chem. Soc. 1997, 119, 7153–7154. b) Sibi, M. 
P.; Shay, J. J.; Liu, M.; Jasperse, C. P. J. Am. Chem. Soc. 1998, 120, 6615–6616. c) Xu, J.; 
Chen, X.; Wang, M.; Zheng, P.; Song, B.-A.; Chi, Y. R. Angew. Chem. Int. Ed. 2015, 54, 5161–
5165. d) He, J.; Shigenari, T.; Yu, J.-Q. Angew. Chem. Int. Ed. 2015, 54, 6545–6549. e) Kaasik, 
M.; Noole, A.; Reitel, K.; Järving, I.; Kanger, T. Eur. J. Org. Chem. 2015, 1745–1753. f) Xu, F.; 
Wu, Q.; Chen, X.; Lin, X.; Wu, Q. Eur. J. Org. Chem. 2015, 1–10. g) Cheng, J.; Qi, X.; Li, M.; 
Chen, P.; Liu, G. J. Am. Chem. Soc. 2015, 137, 2480–2483. h) Aparici, I.; Guerola, M.; Dialer, 
C.; Simón-Fuentes, A.; Sánchez-Roselló, M.; del Pozo, C.; Fustero, S. Org. Lett. 2015, 17, 
5412–5415. i) Dai, J.; Ren, W.; Wang, H.; Shi, Y. Org. Biomol. Chem. 2015, 13, 8429–8432. j) 
Cheng, J.; Qi, X.; Li, M.; Chen, P.; Liu, G. J. Am. Chem. Soc. 2015, 137, 2480–2483. k) 
Mathew, S.; Jeong, S.-S.; Chung, T.; Lee, S.-H.; Yun, H. Biotechnol. J. 2016, 11, 185–190. 
75 a) Y.-G. Zhou,W. Tang,W.-B.Wang,W. Li, X. Zhang, J. Am. Chem. Soc. 2002, 124, 4952–
4953. b) S.-g. Lee, Y. J. Zhang, Org. Lett. 2002, 4, 2429–2431. c) W. Tang, X. Zhang, Org. Lett. 
2002, 4, 4159–4161. 
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performed under basic or acidic conditions (Scheme 0.15) and even sometimes 
it is a spontaneous reaction, when the donor is very nucleophilic and the 
acceptor is not hindered or deactivated. 
 
Scheme 0.15. AMR under basic or acidic conditions, for the activation of the 
electron donor or the Michael acceptor respectively. Nu = nitrogen-centered 
nucleophile; B = base; LA = Lewis acid. 
Additionally, at the Michael adduct it is generated a new stereogenic 
centre, creating the possibility of developing an asymmetric version, which has 
been less studied with nitrogen nucleophiles than with the carbon classical 
ones. Likewise, the employment of chiral catalysts for this aim hasn’t been so 
developed as the use of chiral nucleophiles or Michael acceptors coordinated to 
chiral auxiliaries.76 A more detailed explanation of the evolution of the aza-
Michael reaction will be elaborated further in the first chapter of this Memory. 
The methodologies described in the present Doctoral Thesis comprise a 
simple way to access different types of enantioenriched nitrogen-containing 
heterocycles by means of organocatalysis. 
                                            
76 a) Xu, L. W.; Xia, C. G. Eur. J. Org. Chem. 2005, 633–639. b) Davies, S. G.; Smith, A. D.; 
Price, P. D. Tetrahedron: Asymmetry 2005, 16, 2833–2891. c) Vicario, J. L.; Badía, D.; Carrillo, 
L.; Etxebarria, J.; Reyes, E.; Ruiz, N. Org. Prep. Proced. Int. 2005, 37, 513–538. d) Krishna, P. 
R.; Sreeshailam, A.; Srinivas, R. Tetrahedron 2009, 65, 9657–9672. e) Sánchez-Roselló, M.; 
Aceña, J. L.; Simón-Fuentes, A.; del Pozo, C. Chem. Soc. Rev. 2014, 43, 7430–7453. 
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0.2. General Objectives 
Considering the previous information and given the importance of the 
asymmetric synthesis in organic chemistry, the objectives of the present 
Doctoral Thesis are focused on one hand, in the design of more general 
methodologies of organocatalytic enantioselective intramolecular aza-Michael 
reactions for a,b-unsaturated ketones and esters (chapters 1-2); and on the 
other hand, in the application of those methodologies to the synthesis of 
structures of high interest, such as sultams (chapter 3) (Scheme 0.16). 
 
 
Scheme 0.16. Agreed targets for the present Doctoral Thesis. 
In this way, the current PhD memory will be structured in three chapters 
as it is shown hereafter: 
Ê Chapter 1: Organocatalytic enantioselective intramolecular aza-Michael 
reaction with conjugated ketones. 
Here it will be studied the addition of carbamates to a,b-unsaturated 
ketones by means of a primary amine organocatalyst derived from the 
cinchone alkaloids. 
Ê Chapter 2: Organocatalytic enantioselective intramolecular aza-Michael 
reaction with conjugated ester surrogates. 
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For the complete extension of the IMAMR to all kind of a,b-unsaturated 
carbonylic compounds, it was performed the reaction between sulfonamides 
and conjugated N-acyl pyrazoles and catalysed by a squaramide 
derivatized with a cinchone alkaloid.  
Moreover, it was implemented an analogous methodology, with the same 
aim, consisting on a tandem peptide-coupling/IMAMR. 
Ê Chapter 3: Organocatalytic synthesis of enantioenriched bicyclic sultams. 
The application of a developed methodology to the synthesis of sultams by 
an enantioselective IMAMR followed by a diastereoselective intramolecular 
Michael reaction is presented. 
  
CHAPTER 1: 
Organocatalytic 
enantioselective 
intramolecular aza-
Michael reaction with 
conjugated ketones 
1 .  O r g a n o c a t a l y t i c  e n a n t i o s e l e c t i v e  i n t r a m o l e c u l a r  a z a - M i c h a e l  r e a c t i o n  w i t h  c o n j u g a t e d  k e t o n e s .
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1.1. Background 
1.1.1. AZA-MICHAEL REACTION 
Herein will be given a detailed description of the aza-Michael reaction 
(AMR), to supplement the previous general introduction. There will be 
considered different general approaches, but mainly centred in the 
enantioselective and intramolecular cases. 
In a general description, there are two main ways to access b-amino 
carbonylic compounds. On one hand, carbon-carbon bond formation between 
imines and enolates (Mannich-type reaction) is one of the methods for the 
construction of this functionality.77 On the other hand, carbon-nitrogen bond 
formation between a,b-unsaturated carbonyl compounds and nitrogen 
nucleophiles provides an alternative route for the same purpose (Scheme 
1.1). 78  However, in the latter case, unlike Michael additions with carbon 
nucleophiles, the asymmetric aza-Michael reaction has been explored to a 
lesser extent, despite being a powerful tool for the synthesis of these valuable 
scaffolds.50a,76a-c,79 
 
Scheme 1.1. Construction of b-amino carbonyl functionality 
                                            
77  a) Ishitani, H.; Ueno, M.; Kobayashi, S. J. Am. Chem. Soc. 2000, 122, 8180–8186. b) 
Verkade, J. M. M.; van Hemert, L. J. C.; Quaedflieg, P. L. L. M.; Rutjes, F. P. J. T. Chem. Soc. 
Rev. 2008, 37, 29-41. c) Ting, A.; Schaus, S. E. Eur. J. Org. Chem. 2007, 5797-5875. 
78 Juaristi, E.; Soloshonok, V. A. In Enantioselective Synthesis of β-Amino Acids; John Wiley & 
Sons, Inc.: Hoboken, NJ, USA, 2005 
79 a) P. Sibi, M.; Manyem, S. Tetrahedron 2000, 56, 8033–8061. b) Vicario, J.; Badía, D.; 
Carrillo, L. Synthesis 2007, 2065–2092. 
50a Chen, Y. K.; Yoshida, M.; MacMillan, D. W. C. J. Am. Chem. Soc. 2006, 128, 9328–9329. 
76 a) Xu, L. W.; Xia, C. G. Eur. J. Org. Chem. 2005, No. 4, 633–639. c) Vicario, J. L.; Badía, D.; 
Carrillo, L.; Etxebarria, J.; Reyes, E.; Ruiz, N. Org. Prep. Proced. Int. 2005, 37, 513–538.  
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No catalyst is generally required in aza-Michael reactions with amines80 
or lithium amides 81  as nucleophiles. Meanwhile, for less reactive nitrogen 
nucleophiles there have been commonly employed base, acid or transition 
metal catalysts to perform the conjugated addition. For instance, Meijere’s 
group described the use of a sub-stoichiometric amount of potassium hydride to 
generate a fraction of the potassium salt of an oxazolidinone, which had a 
sufficient nucleophilicity to undergo the aza-Michael reaction (Scheme 1.2).82 
 
Scheme 1.2. basic catalysed aza-Michael reaction. 
As regards acid catalysis, it was reported by Armstrong a synthesis of 
the A-ring of cylindrospermopsin, using an intramolecular conjugate addition as 
the key step to forming the piperidine ring (Scheme 1.3).83 
 
Scheme 1.3. Intramolecular aza-Michael reaction by means of an acid catalysis. 
Later, it was developed the use of transition metals to catalyse this kind 
of transformations. Initially by means of Palladium complexes84 but soon after 
                                            
80 a) Cardillo, G.; Tomasini, C. Chem. Soc. Rev. 1996, 25, 117–128. b) Cole, D. C. Tetrahedron 
1994, 50, 9517–9582. 
81 Asao, N.; Shimada, T.; Sudo, T.; Tsukada, N.; Yazawa, K.; Gyoung, Y. S.; Uyehara, T.; 
Yamamoto, Y. J. Org. Chem. 1997, 62, 6274–6282. 
82 de Meĳere, A.; Ernst, K.; Zuck, B.; Brandl, M.; Kozhushkov, S. I.; Tamm, M.; Yufit, D. S.; 
Howard, J. A. K.; Labahn, T. Eur. J. Org. Chem. 1999, 3105–3115. 
83 McAlpine, I. J.; Armstrong, R. W. Tetrahedron Lett. 2000, 41, 1849–1853. 
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Kobayashi extended it to other transition metals, 85  catalysing aza-Michael 
reactions of enones with carbamates (Scheme 1.4). Thus, demonstrating that 
some of them were as effective as palladium, but that the conventional oxophilic 
Lewis acids, i. e. BF3·OEt2, AlCl3, SnCl4, Sc(OTf)3, and TiCl4, showed lower 
yields. 
 
Scheme 1.4. Aza-Michael reactions efficiently catalysed by several 
transition metal salts. 
The first approaches to perform asymmetric aza-Michael reactions took 
advantage of the use of chiral auxiliaries; there were employed either chiral 
nitrogen nucleophiles or a,b-unsaturated substrates bearing a chiral ester.86 
Enantioselective approaches lagged behind, and in the late nineties the group 
of Sibi described the first highly enantioselective87 Lewis acid-catalysed addition 
of amines.74b It consisted on the conjugated addition of O-benzylhydroxyl amine 
to unsaturated pyrazolamides (Scheme 1.5) using chiral Lewis acids as 
catalysts.  
 
Scheme 1.5. First highly enantioselective catalysed aza-Michael reaction. 
                                                                                                                                
84 Gaunt, M. J.; Spencer, J. B. Org. Lett. 2001, 3, 25–28. 
85 Kobayashi, S.; Kakumoto, K.; Sugiura, M. Org. Lett. 2002, 4, 1319–1322. 
86 a) Enders, D.; Wahl, H.; Bettray, W. Angew. Chem. Int. Ed. 1995, 34, 455–457. b) Dumas, 
F.; Mezrhab, B.; D’Angelo, J.; Riche, C.; Chiaroni, A. J. Org. Chem. 1996, 61, 2293–2304. 
74b Sibi, M. P.; Shay, J. J.; Liu, M.; Jasperse, C. P. J. Am. Chem. Soc. 1998, 120, 6615–6616. 
87 The first report of an aza-Michael addition with a chiral catalyst dates from two year earlier 
but they just achieve a maximum enantioselectivity of 42%. Falborg, L.; Jørgensen, K. A. J. 
Chem. Soc., Perkin Trans. 1 1996, 53, 2823–2826. 
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Since then, more examples of enantioselective conjugated additions of 
hydroxyl amines to amides or enones appeared in the literature, highlighting 
some other reports of Sibi 88 or Shibasaki,89 using chiral ligands derived from 
bis(oxazoline) and heterobimetallic chiral complexes, respectively. There have 
also been reported some examples employing aromatic amines as nucleophiles 
in this kind of reactions.90 Finally it should be also underlined, the utilization of 
Al-salen complexes developed by Jacobsen to perform the 1,4-addition of 
hydrazoic acid and N-heterocycles to imides and enones with excellent 
enantioselectivities (Scheme 1.6).91 
 
Scheme 1.6. Conjugate addition of HN3 to a,b-unsaturated imides employing the shelf-
stable (salen) Al(III)Me complex as precatalyst. 
Excluding the organocatalytic methodologies, only one report of an 
enantioselective aza-Michael reaction with a less nucleophilic nitrogen, has 
been published by Palomo and co-workers. 92  They described in 2004 the 
                                            
88 a) Sibi, M. P.; Liu, M. Org. Lett. 2000, 2, 3393-3396. b) Sibi, M. P.; Liu, M. Org. Lett. 2001, 3, 
4181-4184. c) Sibi, M. P.; Prabagaran, N.; Ghorpade, S. G.; Jasperse, C. P. J. Am. Chem. Soc. 
2003, 125, 11796-11797. Conjugate addition of hydrazines: d) Sibi, M. P.; Soeta, T. J. Am. 
Chem. Soc. 2007, 129, 4522-4523. 
89 a) Yamagiwa, N.; Matsunaga, S.; Shibasaki, M. J. Am. Chem. Soc. 2003, 125, 16178-16179. 
b) Yamagiwa, N.; Qin, H.; Matsunaga, S.; Shibasaki, M. J. Am. Chem. Soc. 2005, 127, 13419–
13427. 
90 a) Zhuang, W.; Hazell. R. G.; Jørgensen, K. A. Chem. Commun. 2001, 1240-1241. b) 
Hamashima, Y.; Somei, H.; Shimura, Y.; Tamura, T.; Sodeoka, M. Org. Lett. 2004, 6, 1861-
1864. c) Phua, P. H.; White, A. J. P.; deVries, J. G.; Hii, K. K. Adv. Synth. Catal. 2006, 348, 
587-592. d) Li, K.; Hii, K. K. Chem. Commun. 2003, 1132-1133. 
91 For hydrazoic acid additions: a) Myers, J. K.; Jacobsen, E. N. J. Am. Chem. Soc. 1999, 121, 
8959–8960. b) Taylor, M. S.; Zalatan, D. N.; Lerchner, A. M.; Jacobsen, E. N. J. Am. Chem. 
Soc. 2005, 127, 1313-1317. For N-heterocylces additions: c) Gandelman, M.; Jacobsen, E. N. 
Angew. Chem. Int. Ed. 2005, 44, 2393-2397. 
92 Palomo, C.; Oiarbide, M.; Alder, R.; Kelso, M.; Gómez-Bengoa, E.; García, J. M. J. Am. 
Chem. Soc. 2004, 126, 9188-9189. 
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addition of carbamates (H2N-Cbz and H2N-Boc) to different a’-hydroxyenones 
by means of a chiral Cu(II)-bis(oxazoline) complex as catalyst (Scheme 1.7). 
Likewise, examples of the intramolecular version of the aza-Michael reaction 
remain elusive and can thus be considered as a challenging task.  
 
Scheme 1.7. Addition of less nucleophilic carbamates to a’-hydroxyenones 
Notwithstanding, the remarkable success of organocatalysis has also 
reached the AMR, and a burgeoning number of publications of this protocol 
employing chiral organocatalysts have been reported in the last 
decade.40c,50a,79b,93 Most examples described in the literature take place through 
an iminium activation of the Michael acceptor. In this regard, the main challenge 
for this transformation is to control the differential nucleophilicity between the 
donor nitrogen and the aminocatalyst, since both species are nitrogen-centered 
nucleophiles. Thus, it is essential an appropriate choice of both the 
organocatalyst and the nitrogenated nucleophile in order to avoid the 
competition for the activation and the addition, respectively, to be able to 
achieve high enantioselectivities (Scheme 1.8). 
                                            
40c Almaşi, D.; Alonso, D. A.; Nájera, C. Tetrahedron: Asymmetry 2007, 18, 299–365. 
50a Chen, Y. K.; Yoshida, M.; MacMillan, D. W. C. J. Am. Chem. Soc. 2006, 128, 9328–9329. 
79b Vicario, J.; Badía, D.; Carrillo, L. Synthesis 2007, 2065–2092. 
93 a) Tsogoeva, S. B. Eur. J. Org. Chem. 2007, 1701–1716. b) Enders, D.; Wang, C.; Liebich, J. 
X. Chem. Eur. J. 2009, 15, 11058–11076. 
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Scheme 1.8. Nucleophilicity competition in aminocatalysis. 
The first aminocatalytic AMR was described by MacMillan in 2006.50a He 
reported the enantioselective addition of N-sililoxycarbamates to a,b-
unsaturated aldehydes, by virtue of a chiral imidazolidinone developed in his 
own group (Scheme 1.9). The achievement of a highly enantioselective reaction 
with good yields, is due to the elevated nucleophilicity of the nitrogen atom by 
the a-effect94 of the trialkylsililoxy group. Furthermore, the use of the carbamate 
protecting group avoids the reaction reversibility that could lead to a 
background AMR with the subsequent epimerization of the product. 
 
Scheme 1.9. First aminocatalytic AMR performed in MacMillan’s 
group. PG = protecting group. 
Henceforward, several research groups expanded upon this 
transformation with different kinds of nucleophiles and with conjugated 
aldehydes as Michael acceptors. 95  The application of this methodology to 
                                            
94 Heaton, M. M. J. Am. Chem. Soc. 1978, 100, 2004–2008. 
95 Carbamate nucleophiles: a) Li, H.; Wang, J.; Xie, H.; Zu, L.; Jiang, W.; Duesler, E. N.; Wang, 
W. Org. Lett. 2007, 9, 965–968. b) Ibrahem, I.; Rios, R.; Vesely, J.; Zhao, G.-L.; Córdova, A. 
Chem. Commun. 2007, 48, 849–851. c) Sundén, H.; Rios, R.; Ibrahem, I.; Zhao, G.-L.; 
Eriksson, L.; Córdova, A. Adv. Synth. Catal. 2007, 349, 827–832. d) Vesely, J.; Ibrahem, I.; 
Rios, R.; Zhao, G.-L.; Xu, Y.; Córdova, A. Tetrahedron Lett. 2007, 48, 2193–2198. e) Vesely, J.; 
Ibrahem, I.; Zhao, G.-L.; Rios, R.; Córdova, A. Angew. Chem. Int. Ed. 2007, 46, 778–781. f) 
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enones remained virtually unexplored96 until 2008, when Deng et al published 
an AMR with a,b-unsaturated ketones catalysed by a quinine derivative 
functionalised with a primary amine (Scheme 1.10.a).97 Almost at the same 
time, the group of Melchiorre unrolled both a domino Michael addition-
intramolecular aldol sequence and a domino conjugate-cyclisation azidirination 
sequence with conjugated ketones by means of an iminium or iminium/enamine 
organocatalytic activation with a primary amine derived from hydroquinidine 
(Scheme 1.10.b).98 
 
Scheme 1.10. First aminocatalytic AMR with conjugated ketones as Michael acceptors. 
In this context, also worthy of mention are the conjugate additions of N-
heterocycles to a,b-unsaturated ketones published in 2009 by Wang and Zhao. 
The first one exposes the aza-Michael reaction between 1H-benzotriazole and 
5-phenyl-1H-tetrazole and various enones catalysed by a chiral cinchona 
                                                                                                                                
Chen, L.-Y.; He, H.; Pei, B.-J.; Chan, W.-H.; Lee, A. Synthesis 2009, 1573–1577. N-
heterocycles nucleophiles (ref. 50b-d): g) Dinér, P.; Nielsen, M.; Marigo, M.; Jørgensen, K. A. 
Angew. Chem. Int. Ed. 2007, 46, 1983–1987. h) Uria, U.; Vicario, J. L.; Badía, D.; Carrillo, L. 
Chem. Commun. 2007, 2509–2511. i) Lin, Q.; Meloni, D.; Pan, Y.; Xia, M.; Rodgers, J.; 
Shepard, S.; Li, M.; Galya, L.; Metcalf, B.; Yue, T.-Y.; Liu, P.; Zhou, J. Org. Lett. 2009, 11, 
1999–2002. 
96  The first example with enones participating in an aminocatalysed AMR was in an 
enantioselective aza-Diels-Alder reaction catalysed with proline, where the hypothesized 
pathway proceeds through a tandem Mannich/intramolecular aza-Michael sequence. Sundén, 
H.; Ibrahem, I.; Eriksson, L.; Córdova, A. Angew. Chem. Int. Ed. 2005, 44, 4877–4880. 
97 Lu, X.; Deng, L. Angew. Chem. Int. Ed. 2008, 47, 7710–7713. 
98 Pesciaioli, F.; De Vincentiis, F.; Galzerano, P.; Bencivenni, G.; Bartoli, G.; Mazzanti, A.; 
Melchiorre, P. Angew. Chem. Int. Ed. 2008, 47, 8703–8706. 
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alkaloid derived primary amine (Scheme 1.11.a). 99  And the second one 
describes the enantioselective addition of 2-pyrazolin-5-ones to aliphatic 
conjugated ketones, employing the same primary amine organocatalyst derived 
from quinine (Scheme 1.11.b).100 
 
Scheme 1.11. Asymmetric organocatalytic conjugate addition of N-heterocycles to a,b-
unsaturated ketones. 
As we have seen, the primary amines have revealed to be very efficient 
as organocatalysts to activate enones in 1,4-additions, since they avoid the 
problematic in the formation of the iminium intermediate between ketones (or 
other Michael acceptors with steric hindrance) and the usually employed 
secondary-amine organocatalysts (Figure 0.3). In addition, the particular family 
of cinchona alkaloid derivatives (Schemes 1.10 and 1.11) have been widely 
deployed given its bifunctionality. These aminocatalysts activate both the 
electrophile through the formation of the iminium ion, and the nucleophile 
thanks to the deprotonation promoted by the tertiary amine of the quinuclidine. 
Thus, there can be obtained a well-organized transition state that will lead to an 
excellent stereocontrol. 
Although most of the published examples about the organocatalytic aza-
Michael reaction are based on an iminium catalysis, there also exist some 
                                            
99 Luo, G.; Zhang, S.; Duan, W.; Wang, W. Synthesis 2009, 1564–1572. 
100 Gogoi, S.; Zhao, C.-G.; Ding, D. Org. Lett. 2009, 11, 2249–2252. 
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reports of other activation methodologies. In this way, a catalytic peptide 
containing histidine has been employed for the conjugate addition of TMSN3 to 
a,b-unsaturated oxazolidinones.53a, 101  Furthermore, cinchone alkaloids 
derivatives have been also used as chiral bases to perform the 1,4-addition of 
N-heterocycles,102 and azides103 to nitroalkenes. Additionally, they have been 
employed for the conjugate addition of hydrazones to cyclic enones,104 as well 
as for the addition of aniline to diverse chalcones in neat conditions.105 Finally, 
chiral thioureas and its derivatives have been used as organocatalysts for the 
aza-Michael reactions between hydroxyl amines and enoates,106 the same way 
that between O-benzylhydroxyl amine to chalcones.107 
ORGANOCATALYTIC INTRAMOLECUAR AZA-MICHAEL REACTION 
It should be considered that the intramolecular aza-Michael reaction 
(IMAMR) implies a simply direct way to procure nitrogen-containing 
heterocycles, privileged structures for their presence in biologically active 
compounds and for their versatility as synthetic intermediates. However, this 
version has been explored to a lesser extend despite its great synthetic 
potential, especially in an enantioselective manner. The first example dates 
from 2003 with the report of an intramolecular addition of amides to a,b-
unsaturated aldehydes using an imidazolidinone type catalyst and achieving 
tetrahydroisoquinolines with moderate enantioselectivity (Scheme 1.12).108  
                                            
53a Guerin, D. J.; Miller, S. J. J. Am. Chem. Soc. 2002, 124, 2134–2136. 
101 Horstmann, T. E.; Guerin, D. J.; Miller, S. J. Angew. Chem. 2000, 112, 3781–3784. Angew. 
Chem. Int. Ed. 2000, 39, 3635-3638. 
102 Wang, J.; Li, H.; Zu, L.; Wang, W. Org. Lett. 2006, 8, 1391-1394. 
103 Nielsen, M.; Zhuang, W.; Jørgensen, K. A. Tetrahedron 2007, 63, 5849-5854. 
104 Jørgensen, K. A.; Perdicchia, D. J. Org. Chem. 2007, 72, 3565-3568. 
105 Scettri, A.; Massa, A.; Palombi, L.; Villano, R.; Acocella, M. R. Tetrahedron: Asymmetry 
2008, 19, 2149-2152. 
106 Sibi, M. P.; Itoh, K. J. Am. Chem. Soc. 2007, 129, 8064-8065 
107 Pettersen, D.; Piana, P.; Bernardi, L.; Fini, F.; Fochi, M.; Sgarzani, V.; Ricci, A. Tetrahedron 
Lett. 2007, 48, 7805-7808. 
108 Ihara, M.; Takasu, K.; Maiti, S. Heterocycles 2003, 59, 51-55. 
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Scheme 1.12. First aminocatalytic intramolecular aza-Michael reaction. 
The next relevant example was developed in our research group and it 
comprises the organocatalytic and enantioselective intramolecular conjugated 
addition of carbamates to enals.109 The substrates have both functional groups 
separated the appropriate distance to obtain different 5 and 6-membered 
heterocycles, in the presence of the fluorinated Jorgensen-Hayashi diaryl 
prolinol as catalyst. After reducing in situ the formyl group, there was prepared a 
family of amino alcohols with good yields and excellent enantioselectivities 
(Scheme 1.13). Moreover, this methodology was applied for the 
enantioselective synthesis of three natural piperidine alkaloids: (+)-Coniine, (+)-
Sedamine and (+)-Allosedamine. 
 
Scheme 1.13. Highly enantioselective IMAMR between carbamates and 
a,b-unsaturated aldehydes. 
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In the same way, our research group extended this IMAMR methodology 
to o-substituted anilines and benzyl amines bearing a remote a,b-unsaturated 
aldehyde. 110  Thus, a concise way to prepare enantiomerically enriched 
tetrahydroquinolines, tetrahydroisoquinolines, indolines and isoindolines in a 
very simple manner was described (Scheme 1.14). 
 
Scheme 1.14. Enantioselective IMAMR for the preparation of benzofused N-heterocycles. 
Shortly after, the application of the IMAMR was expanded to other 
activation modes, nitrogen nucleophiles and Michael acceptors. The first 
example was published by Umani-Ronchi and Bandini’s group 111  and it 
consisted on a conjugated addition of the indole nitrogen to a,b-unsaturated 
esters to obtain the corresponding tricycles with variable yields and 
enantioselectivities by means of phase transfer catalysis with a chiral 
ammonium salt of cinchonidine derivative (Scheme 1.15). 
 
Scheme 1.15. Extension of the organocatalytic IMAMR to conjugated esters. 
                                            
110 Fustero, S.; Moscardó, J.; Jiménez, D.; Pérez-Carrión, M. D.; Sánchez-Roselló, M.; del 
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111 Bandini, M.; Eichholzer, A.; Tragni, M.; Umani-Ronchi, A. Angew. Chem. Int. Ed. 2008, 47, 
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Then, in 2010, You and co-workers reported the first example of an 
IMAMR with ketones as Michael acceptors.112 They employed an acetamide as 
nitrogen source, a conjugated b-keto-ester as the Michael acceptor and a chiral 
N-trifyl binolphosphoramide as the catalyst (Scheme 1.16.a). The authors 
envisioned that the presence of the b-keto-ester moiety would enhance the 
electrophilicity of the Michael acceptor. In the same year, this methodology was 
improved by Lu,113 when they envisioned that a sulfonyl substituted aniline 
could be used as the nucleophilic component, and by means of a tertiary 
amine-thiourea organic catalyst, they synthesized highly enantioselective 
dihydroquinolones in very good yields(Scheme 1.16.b). 
 
Scheme 1.16. IMAMR of alkyliden b-keto-esters bearing a sulfonamide by means of a 
bifunctional tertiary amine-thiourea organocatalyst. 
Almost at the same time, the nucleophilic addition of an indolic nitrogen 
to aromatic ketones, catalysed by a chiral Brønsted acid, was reported.114. 
Here, indole derivatives bearing a remote chalcone functionality in the position 
2 underwent the IMAMR in the presence of the BINOL-phosphoric acid and 
                                            
112 Z. Feng, Q.-L. Xu, L.-X. Dai and S.-L. You, Heterocycles, 2010, 80, 765-771. 
113 Liu, X.; Lu, Y. Org. Lett. 2010, 12, 5592–5595. 
114 Cai, Q.; Zheng, C.; You, S.-L. Angew. Chem. Int. Ed. 2010, 49, 8666–8669. 
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molecular sieves. Tricyclic indoles were obtained in good yields and excellent 
levels of enantioselection (Scheme 1.17). 
 
Scheme 1.17. IMAMR between indoles and chalcones. 
1.1.2. ENANTIOSELECTIVE SYNTHESIS OF BENZOFUSED HETEROCYLCIC 
SYSTEMS 
Benzofused heterocycles have been the subject of several asymmetric 
syntheses, due to their ubiquitous presence in natural products and to the 
inherent biological activity that this substructure impart in many of these 
compounds.115 In this section it will be shortly reviewed the most prominent and 
recent asymmetric syntheses of indolines, isoindolines, tetrahydroquinolines 
and tetrahydroisoquinoines (Figure 1.1), for being the ones studied in the 
present chapter of this Doctoral Thesis. 
 
Figure 1.1. Reviewed benzofused substructures 
 
 
                                            
115 a) Katritzky, A. R.; Rachwal, S.; Rachwal, B. Tetrahedron 1996, 52, 15031-15070. b) Boger, 
D. L.; Boyce, C. W.; Garbaccio, R. M.; Goldberg, J. A. Chem. Rev. 1997, 97, 787-828. c) Scott, 
J. D.; Williams, R. M. Chem. Rev. 2002, 102, 1669-1730. d) Horton, D. A.; Bourne, G. T.; 
Smythe, M. L. Chem. Rev. 2003, 103, 893-930. e) Chrzanowska, M.; Rozwadowska, M. D. 
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a) Enantioselective synthesis of tetrahydroquinolines 
Within piperidines family, for the catalytic enantioselective synthesis of 
tetrahydroquinolines there can be considered two different strategies.116 The 
first involves the asymmetric hydrogenation of the corresponding aromatic 
quinolines by means of metallic chiral catalysts117 or, more recently, with chiral 
Brønsted acids. 118  For instance, Rueping’s group developed an efficient 
methodology to perform the cascade asymmetric hydrogenation (1,4 hydride 
addition/ isomerization/ 1,2 addition) of quinolines employing BINOL-phosphoric 
acid derivatives, as chiral Brønsted acids catalysts (Scheme 1.18).118a This 
methodology gives access to enantiomerically enriched 2-substituted 
tetrahydroquinolines, and its utility was later exemplified in the preparation of 
the natural product Angustureine. 
 
Scheme 1.18. Synthesis of Angustureine by means of a chiral BINOL-phosphoric acid 
catalyst. 
The second main approach for the enantioselective preparation of 
tetrahydroquinolines is the aza-Diels-Alder reaction. 119  Concretely, it is a 
                                            
116 a) Sridharan, V.; Suryavanshi, P. A.; Menéndez, J. C. Chem. Rev. 2011, 40, 3445-3454. b) 
Kumar, A.; Srivastava, S.; Gupta, G.; Chaturvedi, V.; Sinha, S.; Srivastava, R. ACS Comb. Sci. 
2011, 13, 65-71. 
117 a) Lu, S.-M.; Wang, Y.-Q.; Han, X.-W.; Zhou, Y.-G. Angew. Chem. Int. Ed. 2006, 25, 2260-
2263. b) Wang, Z.-J.; Deng, G.-J.; Li, Y.; He, Y.-M.; Tang, W.-J.; Fan, Q.-H. Org. Lett. 2007, 9, 
1243-1246. c) Wang, C.; Li, C. Q.; Wu, X. F.; Pettman, A.; Xiao, J. L. Angew. Chem., Int. Ed. 
2009, 48, 6524-6528. d) Han, Z.-Y.; Xiao, H.; Chen, X.-H.; Gong, L.-Z. J. Am. Chem. Soc., 
2009, 131, 9182- 9183. e) Tang, W.; Sun, Y.; Xu, L.; Wang, T.; Fan, Q.; Lam, K.-H.; Chan, A. S. 
C. Org. Biomol. Chem. 2010, 8, 3464-3471. 
118 a) Rueping, M.; Antonchick, A. P.; Theismann, T. Angew. Chem. Int. Ed. 2006, 45, 3683-
3686. b) Guo, Q.-S.; Du, D.-M.; Xu, J. Angew. Chem. Int. Ed. 2008, 47, 759-762. c) Rueping, 
M.; Stoeckel, M.; Sugiono, E.; Theissmann, T. Tetrahedron 2010, 66, 6565-6568. 
119 a) Ishitani, H.; Kobayashi, S. Tetrahedron Lett. 1996, 37, 7357-7360. b) Akiyama, T. T.; 
Morita, H.; Fuchibe, K. J. Am. Chem. Soc. 2006, 128, 13070-13071. c) Xie, M. S.; Chen, X. H.; 
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Povarov reaction, comprising an inverse electron demand aza-Diels-Alder 
reaction mechanism to obtain tetrahydroquinolines with good yields, and very 
good enantiomeric and diastereoisomeric excesses favouring the cis isomer. 
This organocatalytic approach can be developed as a regular intermolecular 
transformation between aldimines and enolic ethers (Scheme 1.19.a) or as a 
three component reaction starting from aliphatic aldehydes, anilines and N-vinyl 
benzyl carbamates (Scheme 1.19.b). 
 
Scheme 1.19. Asymmetric organocatalytc Povarov reactions. 
Beside these general procedures, there have been described other ways 
to synthesize enantioenriched tetrahydroquinolines, 120  several of them also 
employing organocatalysts. For instance, the intramolecular aza-Michael 
reaction described in our research group, with carbamates as nucleophiles and 
a,b-unsaturated aldehydes as Michael acceptors and employing a chiral diaryl 
                                                                                                                                
Zhu, Y.; Gao, B.; Lin, L. L.; Liu, X. H.; Feng, X. M. Angew. Chem. Int. Ed. 2010, 49, 3799-3802. 
d) Liu, H.; Dagousset, G.; Masson, G.; Retailleau, P.; Zhu, J. J. Am. Chem. Soc. 2009, 131, 
4598-4599. 
120 a) Martínez-Estíbalez, U.; Sotomayor, N.; Lete, E. Org. Lett. 2009, 11, 1237-1240. b) 
Murarka, S.; Deb, I.; Seidel, D. J. Am. Chem. Soc. 2009, 131, 13226-13227. c) Kang, Y. K.; 
Kim, S M.; Kim, D. Y. J. Am. Chem. Soc. 2010, 132, 11847-11849. d) Mori, K.; Ehara, K.; 
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prolinol catalyst (Scheme 1.14), that, among other final products, it allowed the 
access to tetrahydroquinolines with very good yields and enantioselectivities.110 
It has also been described an alternative methodology based on a C-H 
activation, 121  which is employed in these two organocatalytic synthesis of 
tetrahydroquinolines based on an enantioselective C-H functionalisation 
through a sequence of 1-5 hydride transference followed by a ring closure 
(intern redox process). In one of them the organocatalyst employed is a 
secondary amine derived from diaryl prolinol (Scheme 1.20.a),120c while in the 
second example they use a chiral phosphoric acid as catalyst (Scheme 
1.20.b).120d In both cases the corresponding tetrahydroquinolines where 
obtaining with moderate to good yields and very good enantiomeric excesses. 
 
Scheme 1.20. Organocatalytic asymmetric C-H functionalisation. 
b) Enantioselective synthesis of tetrahydroisoquinolines 
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metals.122 However, presumably the most popular methodology to obtain this 
type of benzofused structures is based on the nucleophilic addition to the C=N 
bond of dihydroisoquinolines.123 A representative example is the publication of 
Sodeoka and co-workers about the asymmetric addition of malonates catalysed 
by Pd(II) chiral complexes (Scheme 1.21). It involves an asymmetric Mannich 
type reaction of malonates with the dihydroisoquinoline iminium ions formed in 
situ.123e 
 
Scheme 1.21. Mannich type reaction between malonates and dihydroisoquinolines 
catalysed by a Pd(II) chiral complex. 
Some procedures that have also been used with the same purpose are 
the Pictet-Spengler synthesis, 124  allylic amination reactions, 125  or 
cycloisomerizations.126 Among them, an interesting example reported by Enders 
expose the organocatalytic synthesis of trans-1,3-disubstituted 
tetrahydroisoquinolines, based on a tandem process reductive amination/ 
intramolecular aza-Michael reaction (Scheme 1.22). 127  Throughout the 
optimised conditions, several methyl ketones bearing Michael acceptors (a,b 
                                            
122 a) Williams, G. D.; Pike, R. A.; Wade, C. E.; Wills, M. Org. Lett. 2003, 5, 4227- 4230. b) 
Tietze, L. F.; Rackelmann, N.; Sekar, G. Angew. Chem. Int. Ed. 2003, 42, 4254-4257. c) Wang, 
Z.-J.; Deng, G.-J.; Li, Y.; He, Y.-M.; Tang, W.-J.; Fan, Q.-H. Org. Lett. 2007, 9, 1243-1246. d) 
Evanno, L.; Ormala, J.; Pihko, P. M. Chem. Eur. J. 2009, 15, 12963-12967. e) Yan, P.-C.; Xie, 
J.-H.; Hou, G.-H.; Wang, L.-X.; Zhou, Q.L. Adv. Synth. Catal. 2009, 351, 3243-3250. 
123 a) Jensen, K. B.; Roberson, M.; Jorgensen, K. A. J. Org. Chem. 2000, 65, 9080- 9084. b) 
Funabashi, F.; Ratni, H.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2001, 123, 10784-10785. 
c) Wang, S.; Seto, C. T. Org. Lett. 2006, 8, 3979-3982. d) Kanemitsu, T.; Yamashita, Y.; 
Nagata, K.; Itoh, T. Synlett 2006, 1595-1597. e) Dubs, C.; Hamashima, Y.; Sasamoto, M.; 
Seidel, T. M.; Suzuki, S.; Hashizume, D.; Sodeoka, M. J. Org. Chem. 2008, 73, 5859-5871. f) 
Hashimoto, T.; Maeda, Y.; Omote, M.; Nakatsu, H.; Maruoka, K. J. Am. Chem. Soc. 2010, 132, 
4076-4077. 
124 a) Nuhant, P.; Raikar, S. B.; Wypych, J. C.; Delpech, B.; Marazano, C. J. Org. Chem. 2009, 
74, 9413-9421. b) Pesnot, T.; Gershater, M. C.; Ward, J. M.; Hailes, H. C. Chem. Commun., 
2011, 47, 3242-3244. 
125 a) Teichert, J. F.; Fañanás-Mastral, M.; Feringa, B. L. Angew. Chem. Int. Ed. 2011, 50, 688-
691. b) Kawai, N.; Abe, R.; Matsuda, M.; Uenishi, J. J. Org. Chem. 2011, 76, 2102-2114. 
126 Hashmi, A. S. K.; Ata, F.; Haufe, P.; Rominger, F. Tetrahedron 2009, 65, 1919-1927. 
127 Enders, D.; Liebich, J. X.; Raabe, G. Chem. Eur. J. 2010, 16, 9763-9766. 
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unsaturated esters and amides) reacted with p-anisidine in the presence of 
benzothiazoline as reducing agent. The intermediate amine cyclised with 
tBuOK, affording exclusively the corresponding trans isomers of the 
tetrahydroisoquinolines with excellent yields and enantioselectivities. 
 
Scheme 1.22. Synthesis of trans-1,3-disubstituted tetrahydroisoquinolines. 
c) Enantioselective synthesis of indolines 
Regarding pyrrolidines family (Figure 1.1), indoline skeleton is the most 
important substructure and, still nowadays, its synthesis is object of study of a 
large number of research groups. 128  In fact, in recent years there have 
appeared a large number of enantioselective synthesis, and again many of 
them are based on the asymmetric hydrogenation of the indol system.129 A 
representative example of this methodology is the synthesis described by 
Rueping and co-workers,129b where a enantioselective reduction of 3H-indoles 
is catalysed by a Brønsted acid in the presence of a derivative of the Hantzsch 
dihydropyridine as hydrogen source (Scheme 1.23). 
                                            
128 a) Boger, D. L.; Coleman, R. S. J. Org. Chem. 1984, 49, 2240–2245. b) Padwa, A.; 
Brodney, M. A.; Dimitroff, M. J. Org. Chem. 1998, 63, 5304–5305. c) Johnston, J. N.; Plotkin, M. 
A.; Viswanathan, R.; Prabhakaran, E. N. Org. Lett. 2001, 3, 1009–1011. d) Anas, S.; Kagan, H. 
B. Tetrahedron: Asymmetry 2009, 20, 2193-2199. e) He, G.; Lu, C.; Zhao, Y.; Nack, W. A.; 
Chen, G. Org. Lett. 2012, 14, 2944–2947. f) Turnpenny, B. W.; Hyman, K. L.; Chemler, S. R. 
Organometallics 2012, 31, 7819–7822. g) Miyaji, R.; Asano, K.; Matsubara, S. Org. Lett. 2013, 
15, 3658–3661. h) Tasker, S. Z.; Jamison, T. F. J. Am. Chem. Soc. 2015, 137, 9531–9534.i) 
Daniels, B. E.; Ni, J.; Reisman, S. E. Angew. Chem. Int. Ed. 2016, 55, 3398–3402. j) Zhao, F.; 
Li, J.; Chen, Y.; Tian, Y.; Wu, C.; Xie, Y.; Zhou, Y.; Wang, J.; Xie, X.; Liu, H. J. Med. Chem. 
2016, 59, 3826–3839. 
129 a) Kuwano, R.; Kaneda, K.; Ito, T.; Sato, K.; Kurokawa, T.; Ito, Y. Org. Lett. 2004, 6, 2213–
2215. b) Baeza, A.; Pfaltz, A. Chem. Eur. J. 2010, 16, 2036–2039. c) Wang, D.-S.; Chen, Q.-A.; 
Li, W.; Yu, C.-B.; Zhou, Y.-G.; Zhang, X. J. Am. Chem. Soc. 2010, 132, 8909–8911. d) Rueping, 
M.; Brinkmann, C.; Antonchick, A. P.; Atodiresei, I. Org. Lett. 2010, 12, 4604–4607. e) Duan, Y.; 
Chen, M.-W.; Ye, Z.-S.; Wang, D.-S.; Chen, Q.-A.; Zhou, Y.-G. Chem. Eur. J. 2011, 17, 7193–
7197. 
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Scheme 1.23. Asymmetric synthesis of indolines by hydrogenation of 3H-indoles. 
Notwithstanding the foregoing, there are also different organometallic 
approaches to synthesize enantioenriched indolines, such as the tandem 
oxidative cyclisation employing a palladium catalyst and (-)-sparteine, described 
by Yang in 2006,130 the intramolecular aminooxygenation of alkenes catalysed 
by a Cu-bisoxazoline (Scheme 1.24),131 and the one-pot synthesis of tricyclic 
indolines developed by Buchwald and co-workers consistent on a Pd-catalysed 
 g–arylation of b,g-unsaturated ketones.132 
 
Scheme 1.24. Asymmetric synthesis of indolines via aminooxygenation of alkenes. 
As well as many and various organocatalytic procedures to prepare 
indolines distinct than hydrogenation have been devised. For instance, in 2004 
Johnston’s group published a phase transfer-catalysed enantioselective 
alkylation of glycinyl imines followed by a free radical-mediated aryl amination, 
                                            
130 Yip, K.; Yang, M.; Law, K.; Zhu, N.; Yang, D. J. Am. Chem. Soc. 2006, 128, 3130–3131. 
131 Fuller, P. H.; Kim, J.-W.; Chemler, S. R. J. Am. Chem. Soc. 2008, 130, 17638–17639. 
132 Hyde, A. M.; Buchwald, S. L. Angew. Chem. Int. Ed. 2008, 47, 177–180. 
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to provide indoline a–amino acids with high enantioselectivites (Scheme 
1.25).133 
 
Scheme 1.25. Enantioselective synthesis of indoline a-amino acids. 
It is also worth mentioning the study of MacMillan and co-workers, they 
designed a cascade process for the preparation of enantioenriched tricyclic 
pyrrolindolines, a subclass of alkaloid structural motifs. 134  The addition-
cyclisation of tryptamines with a,b-unsaturated aldehydes in the presence of 
imidazolidinone catalysts provides the desired products in high yield and 
excellent enantioselectivities. Making use of the iminium catalysis, it is created a 
quaternary stereocenter on the C3 of the indolium intermediate, that cannot 
undergo rearomatization by means of proton loss in contrast to the analogous 
3-H indole addition pathway. As a result, it takes place a 5-exo-heterocyclisation 
of the pendant ethyl amine, thereby generating the sought tricyclic system 
(Scheme 1.26). 
                                            
133 Viswanathan, R.; Prabhakaran, E. N.; Plotkin, M. A.; Johnston, J. N. J. Am. Chem. Soc. 
2003, 125, 163–168. 
134 Austin, J. F.; Kim, S.-G.; Sinz, C. J.; Xiao, W.-J.; MacMillan, D. W. C. Proc. Natl. Acad. Sci. 
2004, 101, 5482–5487. 
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Scheme 1.26. Aminocatalysed synthesis of pyrrolindolines. 
And one of the last examples published is from Matsubara and 
Asano,128g who described the synthesis of indolines using a non-covalent type 
catalyst to cyclise substituted N-benzyloxycarbonyl anilines with aromatic 
conjugated ketones as the best Michael acceptors (Scheme 1.27). In this way 
there were obtained the corresponding indolines with excellent yields and 
enantioselectivities using a quinine-derived bifunctional thiourea.135 
 
Scheme 1.27. Synthesis of 2-substituted indolines through an IMAMR with conjugated 
ketones as acceptors. 
 
                                            
128g Miyaji, R.; Asano, K.; Matsubara, S. Org. Lett. 2013, 15, 3658–3661. 
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d) Enantioselective synthesis of isoindolines 
Lastly, the asymmetric synthesis of compounds with a isoindoline 
substructure has been studied to a lesser extent and most examples are based 
on the use of chiral substrates or chiral auxiliaries, being very few 
enantioselective. In this context, in 2008 Enders and co-workers published the 
first catalytic asymmetric synthesis of 1,3-disubstituted isoindolines (Scheme 
1.28). 136  Which consists on a metal-free one-pot Brønsted acid catalysed 
Friedel-Crafts/base-catalysed aza-Michael addition reaction of bifunctional  e-
iminoenoates and indoles. By using a chiral BINOL-derived N-triflyl 
phosphoramide organocatalyst in the first step, there were obtained the 
isoindoline products in high yields and good diastereo-and enantiomeric ratios. 
 
Scheme 1.28. Asymmetric Brønsted acid catalysed isoindoline synthesis. 
The same type of  e-iminoenoates were employed to prepare another 
family of 1,3-disubstituted isoindolines with slightly better enantioselectivities 
(Scheme 1.29).137 The depicted procedure consists on a domino aza-Morita-
Baylis-Hillman/intramolecular aza-Michael reaction of electron-deficient alkenes 
and N-tosylimines promoted by a chiral acid-base organocatalyst, that is, a 
Lewis base joined to a Brønsted acid through a chiral backbone. 
                                            
136 Enders, D.; Narine, A. A.; Toulgoat, F.; Bisschops, T. Angew. Chem. Int. Ed. 2008, 47, 
5661–5665. 
137 Takizawa, S.; Inoue, N.; Hirata, S.; Sasai, H. Angew. Chem. Int. Ed. 2010, 49, 9725–9729. 
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Scheme 1.29. Organocatalysed domino process based on the aza-MBH 
reaction for an enantioselective synthesis of isoindollines. 
Another example with a different kind of starting material is the 
asymmetric organocatalytic formal double-arylation of azomethines reported in 
2010 (Scheme 1.30).138 By means of a Brønsted acid-catalysed 1,3-dipolar 
addition and a subsequent organic base-mediated isomerization, starting from 
an aldehyde, an aminomalonate and quinone derivatives, there are accessed a 
variety of chiral isoindoline derivatives with high enantiomeric excesses. 
 
Scheme 1.30. Synthesis of highly enantiomerically enriched isioindolines by 
organocatalytic formal double arylation of azomethines. 
Finally, it can be cited two more reports of enantioselective synthesis of 
isoindolines employing organometallic catalysts. One consists on a diastereo- 
and enantioselective catalytic domino Michael addition/Mannich reaction of 
organozinc reagents and acyclic conjugated ketones in the presence of imines, 
to access to chiral isoindolinones with multiple stereocenters, among other b-
                                            
138 Wang, C.; Chen, X.-H.; Zhou, S.-M.; Gong, L.-Z. Chem. Commun. 2010, 46, 1275-1277. 
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aminocarbonyl derivatives (Scheme 1.31.a).139 And the last example to date of 
an asymmetric catalysis, reports an enantioselective intramolecular propargylic 
amination using chiral copper-pybox complexes as catalysts to give 
enantioenriched 1-ethynyl-isoindolines (Scheme 1.31.b).140 
 
Scheme 1.31. Organometallic approaches to enantioenriched isoindolines. 
 
                                            
139 Guo, S.; Xie, Y.; Hu, X.; Xia, C.; Huang, H. Angew. Chem. Int. Ed. 2010, 49, 2728–2731. 
140 Shibata, M.; Nakajima, K.; Nishibayashi, Y. Chem. Commun. 2014, 50, 7874-7877. 
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1.2. Objectives 
Given the importance of the aza-Michael reaction for the creation of C-N 
bonds and because of scarcity of related published literature regarding its 
enantioselective and intramolecular version, the present research work intends 
to develop a general methodology to perform an asymmetric intramolecular 
aza-Michael reaction (IMAMR) employing a,b-unsaturated ketones as Michael 
acceptors and carbamates as nucleophiles (Scheme 1.32) and by means of an 
organocatalyst. Thus, this is aimed at synthesizing a small library of diverse 
enantiomerically enriched cyclic b-amino carbonylic compounds. Depending on 
the chain length of the acyclic or benzofused precursors and on the position of 
the nitrogen atom in them, there will be obtained pyrrolidine-, piperidine-, 
indoline-, isoindoline-, tetrahydroquinoline- or tetrahydroisoquinoline derivatives. 
 
Scheme 1.32. General objectives of the present chapter. 
First, it needs to be synthesized the specific starting materials where the 
IMAMR will be evaluated. To this end, a cross-metathesis reaction (CM) will be 
implemented between vinyl ketones and assorted olefins carriers of protected 
amines (Scheme 1.33). These amines will be in turn prepared starting from 
distinct acyclic and aromatic compounds commercially available and following 
some procedures described in the literature. 
 
Scheme 1.33. Synthesis of the starting materials through a CM. 
Once achieved the desired enones, there will be studied the conditions 
for the IMAMR throughout the application of various chiral aminocatalysts, 
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nitrogen protecting groups, solvents, temperatures, etc. with the purpose of 
optimising a setting to accomplish both a good stereocontrol of the process and 
a good yield. It thereupon was examined the scope of the reaction with the goal 
of generalizing the method for the enantioselective synthesis of nitrogenated 
heterocycles indicated above. 
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1.3. Results and Discussion 
Considering the objectives set out and the previously introduced topics of 
aminocatalysis and the aza-Michael reaction, in this section there will be 
described the more relevant results achieved during the study of the 
asymmetric intramolecular aza-Michael reaction (IMAMR) involving a,b-
unsaturated ketones and carbamates. 
The synthetic strategy adopted for the preparation of this final products 
consists on a two-step sequence cross-metathesis (CM) between protected 
unsaturated amines and vinyl ketones by means of a ruthenium catalyst, 
followed by an IMAMR of the nitrogen nucleophile to the previously generated 
conjugated ketone (Scheme 1.34). 
 
Scheme 1.34. General synthetic strategy for the study of the asymmetric IMAMR with    
a,b-unsaturated ketones as Michael acceptors. 
1.3.1. PREPARATION OF THE STARTING MATERIALS 
The acyclic and aromatic protected amines carrying a terminal olefin 
used as substrates for the cross-metathesis (Figure 1.2) are not commercially 
available. Therefore, they have to be synthesized in the laboratory as it is 
described below. 
 
Figure 1.2. Starting protected amines bearing a remote terminal olefin. 
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1.3.1.1. Synthesis of the N-protected amino-olefins 1 and 2 
Synthesis of protected amines 1 was assembled from commercially 
available 5-hexenenitrile 8, which was reduced to the corresponding volatile 
amine with lithium aluminium hydride. The title amine was protected in situ 
without further purification either as bencyloxycarbonyl amine (N-Cbz) 1a or as 
tert-butyloxycarbonyl amine (N-Boc) 1b (Scheme 1.35.a). Likewise, the amino-
olefin 2 was prepared starting from 4-pentenitrile 10 and following an analogous 
synthetic sequence (Scheme 1.35.b).141 
 
Scheme 1.35. Synthesis of the protected amino-olefins 8 and 9. 
1.3.1.2. Synthesis of the N-Cbz protected o-allyl anilines 3 
o-Allyl anilines 3a-c were prepared following two different pathways 
depending on the commercial availability of the starting materials. On one hand, 
N-allyl aniline 12a and p-methoxy-N-allyl aniline 12b were subjected to an aza-
Claisen rearrangement and the corresponding free amines 13a and 13b were 
protected with benzyl chloroformate to obtain the N-Cbz protected o-allyanilines 
3a and 3b (Scheme 1.36.a). 142  On the other hand, the synthesis of the 
trifluoromethylated compound 3c started from the o-bromo-p-trifluoromethyl-
                                            
141 a) Fustero, S.; Jiménez, D.; Sánchez-Roselló, M.; del Pozo, C. J. Am. Chem. Soc. 2007, 
129, 6700- 6701. b) Chandler, B. D.; Roland, J. T.; Li, Y.; Sorensen, E. J. Org. Lett. 2010, 12, 
2746-2749. 
142 Organ, M. G.; Xu, J., N'Zemba, B. M. Tetrahedron Lett. 2002, 43, 8177-8180. 
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aniline 14 with an initial a Stille cross-coupling followed by the protection with 
Cbz-chloride of the free aniline 13c (Scheme 1.36.b).143 
 
Scheme 1.36. Synthesis of o-allyanilines 3. 
1.3.1.3. Synthesis of the N-Cbz protected o-vinyl benzyl amine 4 
In order to prepare compound 4 there was developed a four-step 
synthesis starting from the commercially available o-bromostyrene 15 (Scheme 
1.37). First of all, it was carried out on the aromatic ring a formylation reaction, 
through a bromine-lithium exchange employing n-BuLi, to obtain the o-
vinylbenzaldehyde 16. 144  Consecutively, the aldehyde was condensed with 
hydroxyl amine in the presence of sodium acetate to form the intermediate 
oxime, which was reduced, with zinc in acetic acid, to obtain the primary o-
vinylbenzyl amine 17.145 Finally, it was protected with benzyl chloroformate to 
achieve the desired product. 
 
Scheme 1.37. Synthesis of o-vinyl benzyl amine 4. 
                                            
143 Hoyt, S. B.; London, C.; Park, M. Tetrahedron Lett. 2009, 50, 1911-1913. 
144 Dieltiens, N.; Stevens, C. V. Synlett 2006, 17, 2771-2776. 
145 Bennasar, M.-L.; Roca, T.; Monerris, M.; Garcia-Diaz, D. J. Org. Chem. 2006, 71, 7028-
7034. 
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1.3.1.4. Synthesis of the N-Cbz protected o-homoallyl anilines 5 
Protected amines 5 were elaborated through an initial allylation of the 
benzylic carbon 146  of the commercial starting materials 18 to form the o-
nitrophehyl methylacetate 19a and the 4,5-dimethoxy analogue 19b. 147 
Subsequent ester hydrolysis and decarboxylation in basic media afforded 
intermediates 20;141b, 148  and finally the reduction of the nitro group to the 
corresponding free amines 21 and their protection with Cbz-chloride rendered 
final products 5 (Scheme 1.38). 
 
Scheme 1.38. Preparation of o-homoallyl anilines 5. 
1.3.1.5. Synthesis of the N-Cbz protected o-allyl benzyl amine 6 
For the preparation of starting protected amine 6 it was taken the 
commercially available o-bromobenzyl bromide 22 to perform a copper-
mediated cross-coupling with vinyl magnesium bromide to obtain compound 23 
bearing a vinyl group at the benzylic position.149 Then, it was formylated with 
magnesium and DMF to give the corresponding aldehyde 24. Afterwards it was 
undertaken a reductive amination followed by a reduction of the oxime with zinc 
to form the primary amine 25, that was subsequently Cbz-protected (Scheme 
1.39). 
                                            
146 Makosza, M.; Tyrala, A. Synth. Commun. 1986, 16, 419-423. 
147 The corresponding acid was esterificated by means of EtOH/Dowex. a) Furniss, B. S.; 
Hannaford, A. J; Smith, P. W. G.; Tatchell, A. R. Vogel´s Textbook of Practical Organic 
Chemistry, 5th ed.; Longman: New York, 1989: p 701. b) Bunce, R. A.; Herron, D. M.; 
Ackerman, M. L. J. Org. Chem. 2000, 65, 2847-2850. 
141b Chandler, B. D.; Roland, J. T.; Li, Y.; Sorensen, Eur. J. Org. Lett. 2010, 12, 2746-2749. 
148 Bull, D. J.; Fray, M. J.; Mackenny, M. C.; Malloy, K. A. Synlett 1996, 647-648. 
149 Knight, J.; Parsons, P. J. J. Chem. Soc., Perkin. Trans. 1 1989, 979-984. 
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Scheme 1.39. Elaboration of the o-allyl benzyl amine 6. 
1.3.1.6. Synthesis of the N-Cbz protected o-vinyl phenethyl amine 7 
The synthesis of the protected amine 7 was a simple two-step sequence, 
consisting first of all on the protection of the amine and then the introduction of 
the vinyl group through a Stille cross-coupling (Scheme 1.40). 
 
Scheme 1.40. Synthesis of o-vinyl phenethyl amine 7. 
1.3.2. CROSS-METATHESIS REACTION 
Once prepared the olefin-carbamates 1-7 exposed above, they were 
subjected to a cross-metathesis reaction with various vinyl ketones with the aim 
of obtaining the corresponding a,b-unsaturated substrates for the subsequent 
IMAMR (Scheme 1.34). But before detailing the results obtained for these 
procedures, there will be introduced some relevant concepts about this cross-
metathesis transformation. 
The olefin metathesis consists on a redistribution of double bonds 
between two alkenes through their cleavage and formation of new ones by 
means of a metallic carbene catalyst (Scheme 1.41).150 In the last decades, due 
                                            
150 a) J. L. Hérisson, Y. Chauvin, Makromol. Chem. 1970, 141, 161–176. b) Schuster, M.; 
Blechert, S. Angew. Chem. Int. Ed. English 1997, 36, 2036–2056. 
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to the great development on the design of new catalysts able to combine a high 
catalytic activity together with a good tolerance to diverse functional groups, this 
procedure has become one of the most efficient methodologies to create new 
carbon-carbon double bonds.151 
 
Scheme 1.41. Mechanism of olefin metathesiss according to the Chauvin model. 
Some examples of alkene and alkyne metathesis reactions are: cross-, 
ring-closing-, enyne-, alkyne- and ring-closing-alkyne-metathesis or ring-
opening-, acyclic-diene and alkyne metathesis polymerizations. Simplified 
schemes of the three more classical ones are depicted in Figure 1.3. Among 
them, the cross-metathesis (CM) is the one that will be developed further below. 
As shown in Scheme 1.35 and Figure 1.3, with an appropriate catalyst, C1=C2 
and C3=C4 can be transposed into C1=C3 and C2=C4. It is perhaps difficult to 
see, at first glance, why one set of olefins would be favoured; this is a key issue, 
as all olefin metathesis reactions are in principle reversible. The possibility that 
products might be re-converted to the starting materials dictates that chemists 
must design reactions that avoid back-tracking.152 To the progress in the use of 
this methodology have contributed on the one hand the new developments in 
more active catalysts, and on the other hand a better understanding of the 
structural characteristics of the olefins to avoid the homodimers formation.153 
                                            
151 Grubbs, R. H. Handbook of Metathesis; Wiley-VCH Verlag: Weinheim, 2003, Vols. 1-3. 
152 Chatterjee, A. K.; Choi, T.-L.; Sanders, D. P.; Grubbs, R. H. J. Am. Chem. Soc. 2003, 125, 
11360–11370. 
153 a) Chatterjee, A. K.; Grubbs, R. H. Org. Lett. 1999, 1, 1751-1753. b) Chatterjee, A. K.; 
Morgan, J. P.; Scholl, M.; Grubbs, R. H. J. Am. Chem. Soc. 2000, 122, 3783-3784. c) Choi, T. 
L.; Lee, C. W.; Chatterjee, A.K.; Grubbs, R. H. J. Am. Chem. Soc. 2001, 123, 10417-10418. d) 
Choi, T. L.; Chatterjee, A. K.; Grubbs, R. H. Angew. Chem., Int. Ed. 2001, 40, 1277-1279. e) 
Chatterjee, A. K.; Sanders, D. P.; Grubbs, R. H. Org. Lett. 2002, 4, 1939-1942. 
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Figure 1.3. Different types of olefin metathesis. 
Regarding the advances in the development of new homogeneous 
catalysts, it could be highlighted the ruthenium carbenes, mainly designed by 
Grubbs and co-workers. And amongst them, the first widely employed 
ruthenium catalyst was the Grubbs first-generation (G-I) complex154  (Figure 
1.4.a). Later, the arrival of the so-called “second-generation” catalysts clearly 
contributed to a greater growth of the cross-metathesis as an efficient synthetic 
methodology. These 2nd-generation catalysts are structurally distinguished for 
the presence of a N-heterocyclic carbene ligand, and there can be highlighted 
the Grubbs second-generation (G-II) catalyst155 (Figure 1.4.b) and the more 
recent one Hoveyda-Grubbs second-generation (HG-II) catalyst 156  (Figure 
1.4.c). 
 
Figure 1.4. Ruthenium carbene catalysts. 
In particular, for the CM reactions performed in the present thesis, it is 
specially suitable the HG-II catalyst since, besides being the most stable and 
functional-group tolerant, it works much better with electron deficient olefins.157 
Taking this into account, the synthesis of the starting materials 27 and 28 was 
performed by reaction of protected amines 1 and 2 with conjugated ketones 
                                            
154 a) Nguyen, S. T.; Johnson, L. K.; Grubbs, R. H. J. Am. Chem. Soc. 1992, 114, 3974-3975. 
b) Schwab, P.; France, M. B.; Ziller, J. W.; Grubbs, R. H. Angew. Chem. Int. Ed. 1995, 34, 
2039-2041. c) Dias, E. L.; Nguyen, S. T.; Grubbs, R. H. J. Am. Chem. Soc. 1997, 119, 3887-
3897. 
155 Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953-956. 
156 Garber, S. B.; Kingsbury, J. S.; Gray, B. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2000, 122, 
8168-8179. 
157 a) Randa, S.; Gessler, S.; Wakamatsu, H.; Blechert, S. Synlett 2001, 430-432. b) Hoveyda, 
A. H.; Gillingham, D. G.; van Veldhuizen, J. J.; Kataoka, O.; Garber, S. B.; Kingsbury, J. S.; 
Garrity, J. P. A. Org. Biomol. Chem. 2004, 2, 8-23. c) Carreras, J.; Avenoza, A.; Busto, J. H.; 
Peregrina, J. M. Org. Lett. 2007, 9, 1235-1238. 
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34a-d in the presence of HG-II. After 12 hours at room temperature there were 
obtained the corresponding a,b-unsaturated ketones 27-28 with good yields 
(Table 1.1). 
Table 1.1. Synthesis of the acyclic a,b-unsaturated substrates 27 and 28. 
 
Entry n R1 R2 PG Product Yield (%)a 
1 1 Me H Cbz 27a 90 
2 1 Me H Boc 27b 95 
3 1 Pr H Cbz 27c 94 
4 1 Pent H Cbz 27d 88 
5 1 Ph Me Cbz 27e 71 
6 0 Me H Cbz 28 76 
a Isolated yields after flash chromatography purification. 
The preparation of the aliphatic products 27a-d proceeded with good 
yields (Table 1.1, entries 1-4). However, aromatic ketone 27a was obtained in 
lower yield (Table 1.1, entries 5). This is probably due to the presence in the 
starting ketone 34 of a methyl group in the b position, since metathesis 
reactions are in general very sensitive to steric hindrance, which also explains 
the presence of some Z-isomer.152 Alternatively, compound 28 (Table 1.1, entry 
6) was also achieved in a lower yield due to the partial in situ cyclisation of 28 to 
the corresponding 5-membered ring (10% yield, easily separable). 158 
Those conditions were further extended to benzofused derivatives. 
Substrates 3-7 underwent CM with conjugated ketone 34a efficiently, rendering 
compounds 29-33 in good yields. Obtained results are depicted in Table 1.2 
Table 1.2. Synthesis of the aromatic a,b-unsaturated substrates 29-33. 
 
                                            
152 Chatterjee, A. K.; Choi, T.-L.; Sanders, D. P.; Grubbs, R. H. J. Am. Chem. Soc. 2003, 125, 
11360–11370. 
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Entry m n R1 R2 Product Yield (%)a 
1 1 0 H H 29a 91 
2 1 0 H MeO 29b 79 
3 1 0 H CF3 29c 69 
4 0 1 H H 30 92 
5 2 0 H H 31a 89 
6 2 0 MeO MeO 31b 83 
7 1 1 H H 32 83 
8 0 2 H H 33 77 
a Isolated yields after flash chromatography purification. 
1.3.3. OPTIMISATION OF THE INTRAMOLECULAR AZA-MICHAEL REACTION 
CONDITIONS 
With starting a,b-unsaturated ketones 27-33 in hand, next step of our 
study was directed to the optimisation of the reaction conditions to perform the 
IMAMR. To this end, several organocatalysts, solvents, temperatures and 
additives were evaluated in order to find the best combination of yield and 
enantioselectivity. 
Initial attempts were performed with a battery of eight different 
organocatalysts, either commercially available or previously prepared in the 
laboratory. The conjugate addition of the acyclic Cbz-protected amine 27a was 
used as a model reaction. The obtained results in the preparation of the 
corresponding piperidine 35a are detailed in Table 1.3. 
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Table 1.3. Results for the organocatalyst analysis in the IMAMR with enone 27a. 
 
Entry Catalyst Additive Time (h) Yield (%)a ee (%)b 
1 I PhCO2H 96 - - 
2 II - 20 92 20 
3 III TFA 15 88 91 
4 IV TFA 20 81 8 
5 V TFA 20 65 13 
6 VI TFA 20 84 14 
7 VI N-Cbz-LPc 96 73 22 
8 VII TFA 20 84 40 
9 VII N-Cbz-LPc 20 73 51 
10 VIII TFA 72 62 13 
a Isolated yields after flash chromatography purification. 
b Determined by chiral stationary phase HPLC.  
c N-bencyloxycarbonyl-L-phenylalanine. 
Initially, it was checked the catalytic activity of the diaryl prolinol 
derivative I, which had given rise to excellent results in analogous reactions with 
a,b-unsaturated aldehydes. However, as it was expected, it was unreactive due 
to the steric hindrance between the ketone and the secondary amine, which 
avoids the formation of the intermediate iminium ion (Table 1.3, entry 1) (Figure 
0.3).159 
                                            
159114 Cai, Q.; Zheng, C.; You, S.-L. Angew. Chem. Int. Ed. 2010, 49, 8666–8669. 
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Since the only previous example of an IMAMR involving conjugated 
ketones was achieved employing a chiral phosphoric acid as catalyst,114 next 
attempt of our study was performed with organocatalyst II (Table 1.3, entry 2). 
Nevertheless, despite it seems to be a good activator for the cyclisation, the 
enantioselectivity was poor. 
Hereafter, all the efforts were centred on the use of primary amines as 
catalysts, since presumably, they will be able to form an iminium intermediate to 
activate the Michael acceptor and to induce an enantioselective addition. Then, 
there was carried out the IMAMR in substrate 27a in the presence of an 
aminocatalyst derived from hydroquinine, concretely the 9-amino-9-deoxi-epi-
hydroquinidine III (Table 1.3, entry 3), and trifluoroacetic acid (TFA) as the 
additive. The reaction was completed with high enantioselectivity (91% ee) and 
good yield (88%) after 15 hours at room temperature. 
The rest of the primary amine-derived chiral organocatalysts, with 
different structural characteristics, in combination with acidic additives did not 
provide the desired product with good enantioselectivities although they 
occurred with reasonable yields. Thus, binaphthyl derived amines IV and V 
(Table 1.3, entries 4-5) produced piperidine 1a with 8 and 13% ee, respectively. 
The 14% of ee achieved with the phenyl glycinol derivative VI (Table 1.3, entry 
6) was slightly improved (until a 22% ee) by changing the TFA as additive for 
the chiral amino acid N-bencyloxycarbonyl-L-phenylalanine (N-Cbz-LP) (Table 
1.3, entry 7). The same effect was observed with the quinuclidine derivative VII, 
despite the higher enantioselectivity reached was only 51% (Table 1.3, entries 
8-9). Chiral sulfonamide VII provided also a less efficient result (Table 1.3, entry 
10). 
Therefore, it seems clear that the cinchone-alkaloid derived primary 
amine III is the ideal organocatalyst to perform the desired transformation. The 
next step was to optimise the rest of the reaction conditions, i. e. additive, 
solvent, temperature and time. Using the same model reaction, the obtained 
results are depicted below (Table 1.4). 
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Table 1.4. Optimisation of the IMAMR of 26a with the OC III. 
 
Entry Additive (mol%) Solvent T (ºC) t (h) Yield (%)a ee (%)b 
1 TFA (40) CHCl3 25 15 88 91 
2 TFA (20) CHCl3 25 15 91 95 
3 TFA (10) CHCl3 25 15 48 91 
4 - CHCl3 25 96 - - 
5 TFA (20) CHCl3 10 24 80 97 
6 TFA (20) CHCl3 4 24 71 95 
7 TFA (20) CHCl3 -10 24 60 75 
8 TFA (20) THF 25 15 78 97 
9 TFA (20) Et2O 25 8 72 97 
10 TFA (20) DCM 25 15 88 93 
11 TFA (20) Toluene 25 15 91 84 
12 TFA (20) iPrOH 25 24 90 47 
13 NLFA (20) CHCl3 25 72 48 87 
14 CSA (20) CHCl3 25 24 60 69 
15 BTFMBA (20) CHCl3 25 48 85 85 
16 pNBA (20) CHCl3 25 15 76 80 
17 DNBSA (20) CHCl3 25 72 64 52 
18 PFPA (20) CHCl3 25 15 93 96 
19 TFA (20) CHCl3 80c 0.5 91 90 
20 TFA (20) CHCl3 60c 1 93 95 
21 PFPA (20) CHCl3 60c 1 94 95 
22 TFA (20) THF 60c 1 60 90 
a Isolated yields after flash chromatography purification. 
b Determined by chiral stationary phase HPLC. 
c Microwave irradiation. 
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First of all, the optimal loading of the additive was examined with TFA. 
We realized that the best results were obtained with a 1:1 ratio catalyst/ additive 
(Table 1.4, entry 2), instead of the originally expected 1:2 ratio (Table 1.4, entry 
1) or the lately checked 2:1 ratio by using just a 10 mol% of TFA (Table 1.3, 
entry 3). Moreover, it was confirmed the need of the acidic additive; when the 
reaction was performed in the absence of it no reaction was observed after 4 
days (Table 1.3, entry 4). 
Secondly, it was tested the temperature at which the best combination of 
yield and enantioselectivity was obtained. When diminishing the temperature to 
4ºC and 10ºC (Table 1.3, entries 5-6) the ee increased slightly but in clear 
detriment of the yield. When the temperature was settled at -10ºC, both the 
yield and the enantioselectivity decreased (Table 1.3, entry 7). 
Concerning the solvent, there were checked some non-polar (toluene, 
Et2O), aprotic polar (DCM, THF) and protic polar (iPrOH) solvents. It was 
observed that there was an excellent asymmetric induction when employing 
THF, Et2O or DCM (Table 1.3, entries 8-10) as solvents, whereas the use of 
toluene or iPrOH led to a significant drop of the ee values (Table 1.3, entries 
11-12). Anyway, the achieved yields were lower than the ones reached with 
chloroform as solvent (Table 1.3, entry 2). 
Regarding the additive, once determined the loading needed, a 
screening of various acids was performed in order to improve the results by 
finding a better interaction with the catalyst. Initially, two different chiral acids, 
the amino acid N-benzyloxycarbonyl-L-phenylalanine (N-Cbz-LP) and the (+)-
10-camphorsulfonic acid (CSA) were tested (Table 1.3, entries 13-14), but both 
proved to act as a mismatch pairs with the catalyst by lowering both yield and 
enantiomeric excess. On the other hand, substituted benzoic acids such as the 
3,5-bis(trifluoromethyl)benzoic acid (BTFMBA) or the p-nitrobenzoic acid (p-
NBA) (Table 1.3, entries 15-16) gave reasonable yields and enantioselectivities 
but still worse than those obtained with TFA. Finally, 52% ee was obtained with 
2,4-dinitrobenzenesulfonic acid (DNBSA) and 96% ee and 93% yield with 
pentafluoropropionic acid (PFPA) (Table 1.3, entries 17-18). 
The last part of our study was directed to determine the influence of 
microwave (MW) irradiation in the process. It has been demonstrated its ability 
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to activate several asymmetric organocatalytic reactions in order to shorten 
reaction time and catalyst loading.160 In our case it was observed that the MW 
irradiation had a positive effect in the reaction time, maintaining comparable 
results of yield and enantioselectivity. Thus, when the IMAMR was performed at 
80ºC, it was obtained a 90% ee and a 91% yield in just 30 minutes (Table 1.3, 
entry 19). By lowering the temperature to 60ºC during 1 hour the enantiomeric 
excess rose to 95%, using either TFA or PFPA as additive (Table 1.3, entry 20-
21). However, when using THF as solvent worse results were achieved than 
those obtained with the same solvent at room temperature (Table 1.3, entry 22 
vs. 8). 
Therefore, piperidine 35a was obtained with 93% yield and a 96% 
enantiomeric excess with the optimised conditions, that is, when performing the 
IMAMR at 25ºC, during 15 hours and employing CHCl3 as solvent, the 
hydroquinidine derivative III as catalyst and PFPA as additive, the two latter 
ones with a 20 mol% loading (Table 1.4, entry 18). There were also optimised 
the conditions to carry out the transformation under MW irradiation, at 60ºC and 
during 1 hour, maintaining the other reaction conditions in the same way than at 
room temperature, thereby obtaining piperidine 35a with 94% yield and 95% ee 
(Table 1.4, entry 21). 
1.3.4. ENANTIOSELECTIVE SYNTHESIS OF MONOCYCLIC N-HETEROCYCLES: 
PIPERIDINES 35 AND PYRROLIDINE 36 
Once determined the optimum reaction conditions to perform the 
IMAMR, they were extended to the rest of starting materials 27-28. The 
obtained results are summarized in Table 1.5. The type of carbamate did not 
affect significantly the process and both N-Cbz-piperidine 35a and N-Boc-
piperidine 35b were obtained with excellent yields and enantioselectivities 
(Table 1.5, entries 1, 2). 
                                            
160 a) de la Hoz, A.; Díaz-Ortiz, Á.; Moreno, A. Chem. Soc. Rev. 2005, 34, 164–178. b) 
Hosseini, M.; Stiasni, N.; Barbieri, V.; Kappe, C. O. J. Org. Chem. 2007, 72, 1417–1424. c) 
Polshettiwar, V.; Varma, R. S. Acc. Chem. Res. 2008, 41, 629–639. d) Diaba, F.; Bonjoch, J. 
Org. Biomol. Chem. 2009, 7, 2517–2519. e) Procopio, A.; De Nino, A.; Nardi, M.; Oliverio, M.; 
Paonessa, R.; Pasceri, R. Synlett 2010, 1849–1853. f) Enders, D.; Krüll, R.; Bettray, W. 
Synthesis 2010, 567–572. g) Massolo, E.; Benaglia, M.; Parravicini, D.; Brenna, D.; Annunziata, 
R. Tetrahedron Lett. 2014, 55, 6639–6642. 
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Likewise, the IMAMR was highly efficient for the preparation of the 
propyl- and pentyl-substituted piperidines 35c and 35d with yields over 90% 
and the enantiomeric excesses up to 98% (Table 1.5, entries 3, 4). 
Nevertheless, for the transformation with the aromatic ketone 27e it was needed 
a higher reaction time (240 hours) and the corresponding piperidine 35e was 
obtained in excellent ee but just with a moderate yield (Table 1.5, entry 5). On 
the other hand, the synthesis of pyrrolidine 36 proceeded with slightly lower 
yield and enantioselectivity, 80% and 82% respectively (Table 1.5, entry 6). 
Finally, when the same piperidines 35b-e (Table 1.5, entries 7-10) and 
pyrrolidine 36 (Table 1.5, entry 11) were prepared under the MW irradiation-
optimised conditions, there were obtained with comparable results of both yield 
and enantiomeric excess to those achieved at room temperature. 
Table 1.5. Extension of the scope of the IMAMR for the enantioselective synthesis of 
piperidines 35 and pyrrolidine 36, both at room temperature and under MW irradiation. 
 
Entry n SM PG R T (ºC) t (h) Prod. Yield (%)a ee (%)b 
1 1 27a Cbz Me 25 15 35a 93 96 
2 1 27b Boc Me 25 15 35b 92 93 
3 1 27c Cbz Pr 25 15 35c 95 98 
4 1 27d Cbz Pent 25 15 35d 92 98 
5 1 27e Cbz Ph 25 240 35e 58 93 
6 0 28 Cbz Me 25 24 36 80 82 
7 1 27b Boc Me 60c 1 35b 97 90 
8 1 27c Cbz Pr 60c 1 35c 94 96 
9 1 27d Cbz Pent 60c 1 35d 89 97 
10 1 27e Cbz Ph 60c 4 35e 75 84 
11 0 28 Cbz Me 60c 1 36 85 79 
a Isolated yields after flash chromatography purification. 
b Determined by chiral stationary phase HPLC. 
c Microwave irradiation. 
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The absolute configuration of the newly created stereocenter was 
determined to be R by comparing the optical rotation values of compounds 35a-
d and 36 with those published in the literature. 161  Moreover, it is worth 
mentioning that the synthesis of piperidines 35a and 35b constitute a formal 
synthesis of the alkaloid pelletierine,108,110,162 only remaining the removal of the 
nitrogen protecting group. Likewise, starting from compounds 35c and 35d, 
there could be easily prepared various members of the tetraponerine 
family.161e,f;163 Additionally, the reduction of the Cbz group in 2f would lead to 
the skeleton of the pyrrolidine alkaloid hygrine (Figure 1.5).164 
 
Figure 1.5. Natural alkaloids possibly derived from the synthesized chiral products. 
1.3.5. ENANTIOSELECTIVE SYNTHESIS OF BENZOFUSED N-HETEROCYCLES: 
INDOLINES 37, ISOINDOLINES 38, TETRAHYDROQUINOLINES 39 AND 
TETRAHYDROISOQUINOLINES 40-41. 
The extension of this protocol to the synthesis of several benzofused 
heterocycles was examined next. The optimal conditions for the IMAMR were 
applied to conveniently functionalised aniline, benzyl amine and phenethyl 
amine substrates 3-7 (Figure 1.2) to obtain enantiomerically enriched indolines, 
                                            
161 For 1a: a) Takahata, H.; Kubota, M.; Takahashi, S.; Momose, T. Tetrahedron: Asymmetry 
1996, 7, 3047–3054. b) See ref. 109: Fustero, S.; Jiménez, D.; Moscardó, J.; Catalán, S.; del 
Pozo, C. Org. Lett. 2007, 9, 5283–5286. For 1b: c) Davies, S. G.; Fletcher, A. M.; Roberts, P. 
M.; Smith, A. D. Tetrahedron 2009, 65, 10192–10213. d) Coldham, I.; Leonori, D. J. Org. Chem. 
2010, 75, 4069–4077. For 1c and 1d: e) Macours, P.; Braekman, J. C.; Daloze, D. Tetrahedron 
1995, 51, 1415–1428. f) Airiau, E.; Girard, N.; Pizzeti, M.; Salvadori, J.; Taddei, M.; Mann, A. J. 
Org. Chem. 2010, 75, 8670–8673. For 2: g) Majik, M. S.; Tilve, S. G. Tetrahedron Lett. 2010, 
51, 2900–2902. 
108 Ihara, M.; Takasu, K.; Maiti, S. Heterocycles 2003, 59, 51-55. 
110 Fustero, S.; Moscardó, J.; Jiménez, D.; Pérez-Carrión, M. D.; Sánchez-Roselló, M.; del 
Pozo, C. Chem. Eur. J. 2008, 14, 9868–9872. 
162 a) Carlson, E. C.; Rathbone, L. K.; Yang, H.; Collett, N. D.; Carter, R. G. J. Org. Chem. 
2008, 73, 5155–5158. b) Galinovsky, F.; Bianchetti, G.; Vogl, O. Monatshefte für Chemie 1953, 
84, 1221–1227.  
163 Stragies, R.; Blechert, S. J. Am. Chem. Soc. 2000, 122, 9584–9591. 
164 Lee, J.-H.; Jeong, B.-S.; Ku, J.-M.; Jew, S.; Park, H. J. Org. Chem. 2006, 71, 6690–6692. 
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isoindolines, tetrahydroquinolines, and tetrahydroisoquinolines 37-49 (Table 
1.6). 
Pyrrolidine benzofused products 37a and 38 were obtained in excellent 
yields and ee values either at room temperature or under microwave heating at 
60ºC (Table 1.6, entries 1, 2). Even better results were achieved in the 
preparation of the two tetrahydroisoquinolines 40 and 41 (Table 1.6, entries 5, 
6). The synthesis of the tetrahydroquinoline derivative 39a proceeded with 
lower enantioselectivity, concretely 88% and 86% of ee at room temperature 
and 60ºC, respectively (Table 1.6, entry 3). However, this ee value, as well as 
the yield of the aza-Michael product, improved when two methoxy groups were 
attached to the aromatic ring (Table 1.6, entry 4). This is probably due to the 
enhanced nitrogen nucleophilicity of the starting material 31b, making the 
conjugate addition faster, thus avoiding alternative reaction pathways promoted 
by protons liberated during the process (Brønsted acid catalysis).  
This non-selective process, on account of the released protons, would 
compete with the iminium activation by the organocatalyst and decrease the 
enantioselectivity of the overall reaction. This effect was proved by comparing 
the results achieved in the synthesis of indolines 37b and 37c, with an electron-
donating (MeO-) and an electron-withdrawing group (F3C-), respectively. 
Whereas 37b was obtained in good yield and enantioselectivity (Table 1.6, 
entry 7), the aza-Michael addition on compound 29c bearing a trifluoromethyl 
moiety was less efficient (Table 1.6, entry 8). Both at room temperature and 
under MW irradiation, these reactions proceeded in lower yield, and significantly 
diminished ee. 
It can be seen that due to electronic issues related to the nitrogen 
nucleophilicity, there are slight differences, especially referring to yields, 
between aniline-, benzyl amine- and phenethyl amine-substrates. In the cases 
where it is an aniline-nitrogen, the delocalization of the lonely electron pair 
decreases its nucleophilicity, making it less accessible for the conjugated 
addition and, therefore, the obtained results are not so good. 
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Table 1.6. Extension of the scope of the IMAMR for the enantioselective synthesis of 
benzofused N-heterocycles 37-41, both at room temperature and under MW irradiation. 
 
Product Yield (%)a,c ee (%)b,c Yield (%)a,d ee (%)b,d 
1 
 
90 93 83 91 
2 
 
96 93 91 92 
3 
 
 
80 88 93 86 
4 
 
95 91 92 87 
5 
 
97 97 95 97 
6 
 
94 98 91 96 
7 
 
85 92 81 90 
III (20 mol%)
PFPA (20 mol%)
CHCl3
.
29-33 37-41
N
H
O
Cbz( )n
( )m
N O
Cbz( )n
( )m
R
R'
R
R'
N
Cbz
O
37a
N
O
Cbz
38
N
Cbz
O
39a
N
Cbz
O
39b
MeO
MeO
N
Cbz
O 40
N
Cbz
O
41
N
Cbz
O
37b
MeO
  
Chapter 1 Results and Discussion 
  
77 
8 
 
71 68 68 63 
a Isolated yields after flash chromatography purification. 
b Determined by chiral stationary phase HPLC. 
c Stirring at 25ºC during 20 hours. 
d Microwave heating at 60ºC during 1 hour. 
1.3.6. MECHANISTIC PROPOSAL FOR THE INTRAMOLECULAR AZA-MICHAEL 
REACTION BETWEEN CARBAMATES AND  a,b-UNSATURATED KETONES 
The mechanism commonly invoked to rationalize the organocatalytic 
conjugate additions of nitrogen nucleophiles to a,b-unsaturated carbonyl 
compounds involves activation of the Michael acceptor by the catalyst through 
the formation of an iminium ion, thereby facilitating the intramolecular addition of 
the nucleophile to the b-carbon. It is thus proposed a possible mechanism that 
accounts for the R stereochemical assignment mentioned above.  
First, the primary amine catalyst would react with the enone (27a in 
Scheme 1.42) to form an iminium intermediate under the acid conditions. 
Simultaneously, the quinuclidine nitrogen would be protonated and a hydrogen-
bond interaction would be established with the carbamate carbonyl oxygen. In 
this conformation, the attack of the nitrogen nucleophile would take place onto 
the Re face of the less sterically constrained (E)-iminium transition state A to 
furnish the aza-Michael product [(R)-35a in Scheme 1.42] after hydrolysis. 
N
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Scheme 1.42. Plausible mechanistic pathway and transition state of the IMAMR. 
1.4. Recent contributions to the IMAMR with enones 
Together with this study developed in our research group, the same year 
there appeared two other publications related to the IMAMR with a,b-
unsaturated ketones as Michael acceptors. In one case they developed a 
cinchonine-derived thiourea catalysed desymmetrization of 
cyclohexandienones, affording a series of highly enantioenriched pyrrolidine 
and morpholine derivatives in excellent yields (Scheme 1.43.a). 165  In the 
second case, they obtained 2-substitued six- and five-membered heterocycles 
enantioselectively, using the catalytic combination of a chiral primary-tertiary 
diamine and a simple achiral Brønsted acid (Scheme 1.43.b).166 
                                            
165 Gu, Q.; You, S.-L. Chem. Sci. 2011, 2, 1519. 
166 Liu, J. D.; Chen, Y. C.; Zhang, G. B.; Li, Z. Q.; Chen, P.; Du, J. Y.; Tu, Y. Q.; Fan, C. A. Adv. 
Synth. Catal. 2011, 353, 2721–2730. 
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Scheme 1.43. IMAMR reported the same year of our publication. 
Later, there were published some methodologies to prepare 
enantioenriched aza-flavanones using an organocatalytic 6-endo aza-Michael 
addition catalysed either by a chiral N-trifyl binolphosphoramide,167 a cinchone-
derived thiourea168 or a chiral phosphoric acid.169 In the first case, starting from 
N-allyl or N-benzyl anilines substituted with a chalcone moiety in the ortho 
position, the IMAMR afforded dihydroquinolones in good yields and with 
moderate enantioselectivies (Scheme 1.44.a). Using the second procedure, 
there were prepared in good yields and excellent enantioselectivities a variety 
of 2-aryl-, 2-vinyl and 2-methyl-aza-flavanones (Scheme 1.44.b). And in the last 
example, the desired products were synthesized based on a chiral phosphoric 
acid catalysed intramolecular aza-Michael addition using N-unprotected 2-
aminophenyl vinyl ketones as substrates in good yields and high 
enantioselectivities (Scheme 1.44.c). 
 
                                            
167 Rueping, M., Moreth, S. A., Bolte, M. Z. Z. Naturforsch. B 2012, 67, 1021-1029. 
168 Cheng, S.; Zhao, L.; Yu, S. Adv. Synth. Catal. 2014, 356, 982–986. 
169 Saito, K.; Moriya, Y.; Akiyama, T. Org. Lett. 2015, 17, 3202–3205. 
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Scheme 1.44. Enantioselective synthesis of aza-flavanones. 
In 2013, Yu et al described the preparation of enantioenriched 2-
substituted pyrrolidines and benzopyrrolidines, either through an intramolecular 
aza-Michael addition catalysed by a phosphoric acid or via domino cross-
metathesis/ intramolecular aza-Michael reaction promoted by the cooperation of 
the Hoveyda-Grubbs II catalyst and the same chiral phosphoric acid (Scheme 
1.45).170 
                                            
170 Liu, H.; Zeng, C.; Guo, J.; Zhang, M.; Yu, S. RSC Adv. 2013, 3, 1666–1668. 
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Scheme 1.45. Synthesis of enantioenriched 2-subtituted pyrrolidines. 
This last example, exposes an enantioselective synthesis of 3-
substituted 1,2-oxazines via an organocatalytic intramolecular aza-Michael 
addition. 171  Thus, by means of a quinine-derived primary-tertiary diamine 
catalyst and pentafluoropropionic acid as co-catalyst, there was performed the 
6-exo-trig conjugate addition to obtain the corresponding products in high yields 
and good enantioselectivities (Scheme 1.46). 
 
Scheme 1.46. Organocatalytic synthesis of chiral oxazines through an IMAMR. 
 
                                            
171 Cheng, S.; Yu, S. Org. Biomol. Chem. 2014, 12, 8607–8610. 
NH
PG
R
O
N
PG
R
O
Phosphoric acid (10 mol%)
PhCH3, -20ºC
O
O
P
O
OH
SiPh3
SiPh3
R
O
+
NHCbz
( )m
( )n
m=0, n=1
m=1, n=0
HG-II (5 mol%)
Phosphoric acid (10 mol%)
CH2Cl2, 0ºC
60-76%
87:13-97:3 e.r.
R = Ar, alkyl
PG = Boc, Cbz
84-97%
91:9-98:2 e.r.
R = Ar, alkyl
NH
R
O
( )m
( )n
N
N
H2N
MeO
PGHN
O
R
O
O
N
PG
R
O
Aminocat. (10-20 mol%) 
PFP (10-20 mol%)
1,4-dioxane, 25-60ºC
2 days
PG = Cbz, Boc, CO2Me
R = alkyl, Ar
55-99 %
 86:14-98:2 er

  
Chapter 1 Conclusions 
  
83 
1.5. Conclusions 
In this research work, a general protocol for a highly enantioselective 
organocatalytic intramolecular aza-Michael reaction has been developed, 
employing carbamates as nitrogen nucleophiles and a,b-unsaturated ketones 
as Michael acceptors.172 
Through this procedure it was possible to obtain a small library of 
fourteen compounds with excellent yields and enantioselectivities. Concretely, 
2-substituted piperidines (35) and pyrrolidine (36), and differently substituted 
indolines (37), isoindolines (38), tetrahydroquinolines (39) and 
tetrahydroisoquinolines (40 and 41) have been prepared (Figure 1.6). These 
nitrogenated heterocycles have a great interest due to their presence in many 
natural products with biological activity. 
 
Figure 1.6. Substructures of the final products. 
The combination of 9-amino-9-deoxy-epi-hydroquinidine and pentafluoro-
propionic acid has been demonstrated as an efficient catalytic system for this 
conjugate addition. 
Interestingly, the cyclisation step under microwave irradiation led to 
comparable results in terms of yield and ee to those obtained at room 
temperature. This is, as far as we know, the first report of a microwave 
accelerating effect in a Michael-type reaction catalysed by a cinchona alkaloid 
derivative. 
                                            
172 Fustero, S.; del Pozo, C.; Mulet, C.; Lazaro, R.; Sánchez-Roselló, M. Chem. Eur. J. 2011, 
17, 14267–14272. 
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1.6. Experimental Section 
1.6.1. GENERAL METHODS 
1.6.1.1. Spectroscopical and physical technics 
NMR SPECTROSCOPY (1H, 13C, 19F) 
NMR spectra were recorded on a Bruker 300 MHz spectrometer, running 
at 300 MHz for 1H, 13C and 19F using deuterated chloroform (CDCl3) or 
methanol (CD3OD) as solvent. Chemical shifts (d) are given in ppm relative to 
the residual solvent signals of non-deuterated chloroform (7.26 ppm), methanol 
(3.31 ppm) and acetone (2.05 ppm) for 1H NMR; deuterated chloroform (77.0 
ppm), deuterated methanol (49.0 ppm) and deuterated acetone (29.84 ppm)  for 
13C NMR; the internal reference of trichlorofluoromethane (0.0 ppm) for 19F 
NMR. Coupling constants (J) are given in Hertz (Hz). The letters m, s, d, t and q 
stand for multiplet, singlet, doublet, triplet and quartet, respectively. The letters 
br indicate that the signal is broad.  
MASS SPECTROSCOPY 
Mass spectra were recorded on a VG AUTOESPEC (micromass) 
spectrometer, employing the electronic impact (EI) technic performed at 70 eV, 
whereas the acceleration speed of the ions beam Cs+ at the fast atom 
bombardment (FAB) spectra was 30,000 V. The listed values for each 
compounds of the memory are expressed in units of m/z. 
IR ANALYSIS 
Infrared spectra were taken with a FT-IR apparatus. 
DETERMINATION OF THE ENANTIOMERIC RATIO 
The enantiomeric ratios were generally determined with the aid of high-
performance liquid chromatography (HPLC) analysis (Jasco PU-2089 Plus 
pump and a Jasco MD-2010 detector) of the corresponding solutions of the 
compounds in mixtures of hexane: ipropanol as eluents. 
The chiral columns employed are: 
ê Chiracel OD-H column (25 cm x 0.46 cm) 
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ê Chiralpack AD column (25 cm x 0.46 cm) 
DETERMINATION OF THE OPTICAL ROTATION 
Optical rotations were measured on either a Perkin-Elmer 241 
polarimeter or a Jasco P-1020 polarimeter, employing a sodium lamp as 
radiation source and spectroscopic grade chloroform to prepare the solutions in 
a 10 cm long cell. 
DETERMINATION OF THE MELTING POINT 
Melting points have been determined either with a Cambridge 
Instrusments or with a Büchi melting point P-450 apparatus. 
1.6.1.2. Cromatographic technics 
THIN-LAYER CROMATOGRAPHY 
Reactions and purifications were monitored with the aid of thin-layer 
chromatography (TLC) on 0.25 mm precoated Merck silica gel plates actives in 
UV light (Kiesegel 60 F254 on aluminium). Visualization was carried out with 
254nm UV light and employing the appropriate stain, such as aqueous ceric 
ammonium molybdate solution, potassium permanganate and p-anisaldehyde. 
FLASH CROMATOGRAPHY 
Flash column chromatography purifications was performed with the 
indicated solvents on silica gel 60 (particle size 0.040-0.063 mm). 
1.6.1.3. Solvents drying 
The employed solvents were either distilled and dried under nitrogen 
atmosphere prior to use:173 THF and toluene were distilled from sodium, CH2Cl2 
from calcium hydride; or anhydrous category solvents proceeding from 
commercial sources, being used without any previous purification. 
1.6.1.4. Reagents and reaction conditions 
The employed reagents were obtained of the best possible grade from 
commercial sources and were directly used. Air-sensitive reagents were 
                                            
173  Purification of Laboratory Chemicals 2nd edition; Perrin, D. D.; Ed. Pergamon Press; 
England, 1988. 
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employed under nitrogen atmosphere. Reactions were carried out under 
nitrogen atmosphere unless otherwise indicated.  
MICROWAVE IRRADIATION 
Microwave reactions were carried out at 0.1M solution in a 0.5-2 mL vial 
with an Initiatorä 2.0 (Biotage). The solutions were pre-stirred before the 
irradiation was started. The absorbance of the solvent was set as “normal” and 
4-5 bars at 100ºC were reached. The reaction time was initiated as soon the 
system reached the input temperature, although approximately two minutes 
were needed to reach it. 
1.6.2. SYNTHESIS OF THE N-PROTECTED a,b-UNSATURATED KETOAMINES 
27-33 
 
To a solution of N-protected amine 1-7 (1.0 equiv.) in CH2Cl2 (0.1 M) 
under nitrogen atmosphere, the corresponding conjugated ketone 34 (3.0 
equiv.) and Hoveyda-Grubbs 2nd generation catalyst (5 mol%) were added. 
The resulting solution was stirred for 12 h at room temperature and then, 
solvents were removed and the crude mixture purified by flash chromatography 
with hexanes: ethyl acetate as eluents. Amines 27b141b and 28141a had been 
previously described. 174 
(E)-8-Benzyloxycarbonyl amino-3-octen-2-one (27a) 
 
Physical state: Pale yellow oil 
Empiric Formula: C16H21NO3 
Molecular weight (g/mol): 275.35 
Yield (%): 90 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 1.48-1.53 (m, 4H), 2.15-2.26 (m, 2H), 2.21 (s, 
3H), 3.15-3.21 (m, 2H), 4.94 (br s, 1H), 5.07 
                                            
141 a) Fustero, S.; Jiménez, D.; Sánchez-Roselló, M.; del Pozo, C. J. Am. Chem. Soc. 2007, 
129, 6700-6701. b) Chandler, B. D.; Roland, J. T.; Li, Y.; Sorensen, E. J. Org. Lett. 2010, 12, 
2746-2749. 
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(s, 2H), 6.04 (d, J = 16.2 Hz, 1H), 6.70-6.80 
(m, 1H), 7.28-7.35 (m, 5H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 25.0 (CH2), 26.8 (CH3), 29.4 (CH2), 31.9 
(CH2), 40.6 (CH2), 66.5 (CH2), 128.0 (CH), 
128.2 (CH), 128.4 (CH), 131.4 (CH) 136.5 (C), 
147.6 (CH), 156.3 (C), 198.6 (C) 
HRMS (EI+): Calcd. for C16H21NO3 [M+]: 275.1521, found: 275.1519 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 3:1 
as eluent. 
ê 27a (212 mg) was obtained from methyl vinyl ketone and N-
benzyloxycarbonyl-5-hexenamine. 
 
(E)-10-Benzyloxycarbonyl amino-5-decen-4-one (27c) 
 
Physical state: Pale brown solid 
Empiric Formula: C18H25NO3 
Molecular weight (g/mol): 303.40 
Yield (%): 94 
Melting point (ºC): 45-47 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 0.93 (t, J = 7.4 Hz, 3H), 1.50-1.57 (m, 2H), 
1.59-1.69 (m, 4H), 2.19-2.26 (m, 2H), 2.50 (t, J 
= 7.4 Hz, 2H), 3.17-3.24 (m, 2H), 4.77 (br s, 
1H), 5.09 (s, 2H), 6.08 (d, J = 15.1 Hz, 1H), 
6.73-6.83 (m, 1H), 7.32-7.36 (m, 5H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 13.8 (CH3), 17.6 (CH2), 25.2 (CH2), 29.5 (CH2), 
31.9 (CH2), 40.7 (CH2), 42.0 (CH2), 66.6 (CH2), 
128.1 (CH), 128.5 (CH), 130.6 (2CH), 136.5 
(C), 146.3 (CH), 156.4 (C), 200.7 (C) 
HRMS (EI+): Calcd. for C18H25NO3 [M+]: 303.1834, found: 303.1842 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 5:1 
as eluent. 
ê 27c (244 mg) was obtained from propyl vinyl ketone and N-
benzyloxycarbonyl-5-hexenamine 
 
(E)-12-Benzyloxycarbonyl amino-7-dodecen-6-one (27d) 
 
Physical state: Pale brown solid 
Empiric Formula: C16H21NO3 
Molecular weight (g/mol): 331.46 
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Yield (%): 88 
Melting point (ºC): 44-46 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 0.89 (t, J = 6.9 Hz, 3H), 1.25-1.33 (m, 4H), 
1.48-1.68 (m, 6H), 2.19-2.26 (m, 2H), 2.51 (t, J 
= 7.4 Hz, 2H), 3.17-3.24 (m, 2H), 4.77 (br s, 
1H), 5.09 (m, 2H), 6.08 (d, J = 16.0 Hz, 1H), 
6.73-6.83 (m, 1H), 7.33-7.36 (m, 5H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 13.9 (CH3), 22.5 (CH2), 23.9 (CH2), 25.2 
(CH2), 29.5 (CH2), 31.5 (CH2), 31.9 (CH2), 
40.2 (CH2), 40.7 (CH2), 66.6 (CH2), 128.1 
(2CH), 128.5 (CH), 130.6 (CH), 136.5 (C), 
146.2 (CH), 156.4 (C), 200.8 (C) 
HRMS (EI+): Calcd. for C20H29NO3 [M+]: 331.2159, found: 331.2147 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 5:1 
as eluent. 
ê 27d (250 mg) was obtained from pentyl vinyl ketone and N-
benzyloxycarbonyl-5-hexenamine. 
   
(E)-7-Benzyloxycarbonyl amino-1-phenyl-2-hepten-1-one (27e) 
 
Physical state: Pale brown solid 
Empiric Formula: C21H23NO3 
Molecular weight (g/mol): 337.42 
Yield (%): 71 
Melting point (ºC): 40-42 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 1.54-1.57 (m, 4H), 2.31-2.34 (m, 2H), 3.18-
3.23 (m, 2H), 4.87 (br s, 1H), 5.09 (s, 2H), 
6.87 (d, J = 15.4 Hz, 1H), 6.98-7.07 (m, 1H), 
7.30-7.35 (m, 5H), 7.43-7.57 (m, 3H), 7.90-
7.93 (m, 2H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 25.2 (CH2), 29.6 (CH2), 32.3 (CH2), 40.7 
(CH2), 66.6 (CH2), 126.2 (CH), 128.1 (CH), 
128.5 (2CH), 132.6 (CH), 136.5 (C), 137.8 (C), 
149.0 (CH), 156.4 (C), 190.7 (C) 
HRMS (EI+): Calcd. for C21H23NO3 [M+1]: 338.1756, found: 338.1763 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 3:1 
as eluent. 
ê 27e (206 mg) was obtained from (E)-1-phenyl-2-buten-1-one and N-
benzyloxycarbonyl-5-hexenamine. 
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(E)-5-(2-Benzyloxycarbonyl amino)phenyl-3-penten-2-one (29a) 
 
Physical state: Pale brown solid 
Empiric Formula: C19H19NO3 
Molecular weight (g/mol): 309.37 
Yield (%): 91 
Melting point (ºC): 47-49 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 2.07 (s, 3H), 3.40 (d, J = 6.3 Hz, 2H), 5.07 (s, 
2H), 5.88 (dt, J = 15.9, 1.4 Hz, 1H), 6.55 (br 
s, 1H), 6.71-6.81 (m, 1H), 7.03 (d, J = 4.1 
Hz, 2H), 7.15-7.28 (m, 6H), 7.56 (d, J = 7.7 
Hz, 1H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 27.0 (CH3), 34.4 (CH2), 67.0 (CH2), 125.4 
(CH), 127.8 (CH), 127.9 (CH), 128.1 (CH), 
128.2 (CH), 128.4 (CH), 130.1 (CH), 131.9 
(CH), 135.4 (C), 135.9 (C), 136.5 (C), 144.6 
(CH), 154.0 (C), 198.0 (C) 
HRMS (EI+): Calcd. for C19H19NO3 [M+]: 309.1365, found: 309.1363 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 3:1 
as eluent. 
ê 29a (210 mg) was obtained from methyl vinyl ketone and N-
benzyloxycarbonyl-2-allyl aniline.110175 
  
(E)-Benzyl 4-methoxy-2-(4-oxopent-2-enyl)phenylcarbamate (29b) 
 
Physical state: Pale brown solid 
Empiric Formula: C20H22NO4 
Molecular weight (g/mol): 339.39 
Yield (%): 79 
Melting point (ºC): 62-64 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 2.20 (s, 3H), 3.47 (dd, J = 6.3, 1.6 Hz, 2H), 
3.78 (s, 3H) 5.98 (dd, J = 15.9, 1.6 Hz, 1H), 
6.21 (br s, 1H), 6.70 (d, J = 3.0 Hz, 1H), 6.79-
6.90 (m, 2H), 7.34-7.37 (m, 6H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 27.1 (CH3), 34.8 (CH2), 55.4 (CH3), 67.2 
(CH2), 112.8 (CH), 115.7 (CH), 128.1 (C), 
128.3 (CH), 128.6 (CH), 132.1 (CH), 136.1 
                                            
110 Fustero, S.; Moscardó, J.; Jiménez, D.; Pérez-Carrión, M. D.; Sánchez-Roselló, M.; del 
Pozo, C. Chem. Eur. J. 2008, 14, 9868–9872. 
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(C), 144.7 (CH), 154.7 (C), 156.2 (C), 171.1 
(C), 198.8 (C) 
HRMS (EI+): Calcd. for C20H22NO4 [M+H+]: 340.1553, found: 340.1543 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 5:1 
as eluent. 
ê 29b (178 mg) was obtained from methyl vinyl ketone and N-
benzyloxycarbonyl-4-methoxy-2-allyl aniline. 
 
(E)-5-(2-benzyloxycarbonyl amino-4-trifluoromethyl)phenyl-3-penten-2-one 
(29c) 
 
Physical state: Pale brown solid 
Empiric Formula: C20H19NO3F3 
Molecular weight 
(g/mol): 
377.36 
Yield (%): 69 
Melting point (ºC): 90-92 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 2.22 (s, 3H), 3.55 (dd, J = 6.2, 1.7 Hz, 2H), 
5.20 (s, 2H), 5.99 (dt, J = 16.0, 1.7 Hz, 1H), 
6.55 (br s, 1H), 6.84 (dt, J = 16.0, 6.0 Hz, 
1H), 7.37-7.41 (m, 6H), 7.56 (dd, J = 8.4, 1.7 
Hz, 1H), 8.03 (d, J = 9.0 Hz, 1H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 27.4 (CH2), 34.4 (CH3), 67.6 (CH3), 121.9 
(CH), 123.9 (q, J = 271.5 Hz, CF3), 125.4 (q, 
J = 3.9 Hz, CH), 126.5 (q, J = 33.0 Hz, C), 
127.2 (q, J = 3.9 Hz, CH), 128.5 (CH), 128.6 
(CH), 128.7 (CH), 132.5 (CH), 135.5 (C), 
139.0 (C), 142.7 (CH), 153.3 (C), 197.6 (C) 
19F NMR (CDCl3, 282.4 MHz) δ (ppm): -72.6 (s, 3F) 
HRMS (EI+): Calcd. for C20H19NO3F3 [M+H+]: 378.1313, found: 378.1312 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 5:1 
as eluent. 
ê 29c (155 mg) was obtained from methyl vinyl ketone and N-
benzyloxycarbonyl-4-trifluoromethyl-2-allyl aniline. 
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(E)-4-(2-Benzyloxycarbonyl aminomethyl)phenyl-3-buten-2-one (30) 
 
Physical state: Pale yellow oil 
Empiric Formula: C19H19NO3 
Molecular weight (g/mol): 309.37 
Yield (%): 92 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 2.34 (s, 3H), 4.54 (d, J = 5.9 Hz, 2H), 5.06 (br 
s, 1H), 5.12 (s, 2H), 6.60 (d, J = 16.1 Hz, 1H), 
7.29-7.37 (m, 8H), 7.60 (d, J = 7.6 Hz, 1H),  
7.84 (d, J = 16.1 Hz, 1H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 27.0 (CH3), 43.0 (CH2), 66.9 (CH2), 127.0 
(CH), 128.0 (CH), 128.2 (CH), 128.4 (CH), 
128.5 (CH), 129.6 (CH), 129.8 (CH), 130.3 
(CH), 133.5 (C), 136.5 (C), 137.3 (C), 140.0 
(CH), 155.9 (C), 198.8 (C) 
HRMS (EI+): Calcd. for C19H19NO3 [M+1]: 310.1443, found: 310.1446 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 3:1 
as eluent. 
ê 30 (213 mg) was obtained from methyl vinyl ketone and N-
benzyloxycarbonyl-2-vinylbenzyl amine.110 
(E)-6-(2-Benzyloxycarbonyl amino)phenyl-3-hexen-2-one (31a) 
 
Physical state: Pale yellow oil 
Empiric Formula: C20H21NO3 
Molecular weight (g/mol): 323.39 
Yield (%): 89 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 2.20 (s, 3H), 2.46-2.53 (m, 2H), 2.70-2.75 (m, 
2H), 5.20 (s, 2H), 6.07 (dt, J = 16.0 and 1.5 
Hz, 1H), 6.54 (br s, 1H), 6.72-6.82 (m, 1H), 
7.08-7.17 (m, 2H), 7-21-7.24 (m, 1H), 7.33-
7.41 (m, 5H), 7.68 (d, J = 7.5 Hz, 1H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 26.9 (CH3), 29.7 (CH2), 32.2 (CH2), 67.1 
(CH2), 123.5 (CH), 125.2 (CH), 127.3 (CH), 
128.3 (CH), 128.6 (CH), 129.2 (CH), 131.8 
(CH), 135.0 (C), 136.0 (C), 137.8 (C), 146.3 
(CH), 154.1 (C), 198.4 (C) 
HRMS (EI+): Calcd. for C20H21NO3 [M+]: 323.1521, found: 323.1525 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 3:1 
as eluent. 
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108 Ihara, M.; Takasu, K.; Maiti, S. Heterocycles 2003, 59, 51-55. 
ê 31a (205 mg) was obtained from methyl vinyl ketone and N-
Benzyloxycarbonyl-2-homoallyl aniline.110 
(E)-6-(2-Benzyloxycarbonyl amino-4,5-dimethoxy)phenyl-3-hexen-2-one 
(31b) 
 
Physical state: Pale yellow oil 
Empiric Formula: C22H25NO5 
Molecular weight (g/mol): 383.44 
Yield (%): 83 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 2.21 (s, 3H), 2.42-2.50 (m, 2H), 2.64-2.70 (m, 
2H), 3.84 (s, 6H), 5.19 (m, 2H), 6.07 (d, J = 
16.0 Hz, 1H), 6.32 (br s, 1H), 6.72 (s, 1H), 
6.74-6.81 (m, 1H), 7.18 (s, 1H), 7.35-7.39 (m, 
5H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 27.0 (CH3), 29.6 (CH2), 32.9 (CH2), 55.9 
(CH3), 56.1 (CH3), 67.2 (CH2), 108.4 (CH), 
112.1 (CH), 127.6 (C), 128.3 (CH), 128.4 
(CH), 128.6 (2CH), 131.8 (C), 136.0 (C), 146.4 
(CH), 146.7 (C), 147.7 (C), 154.5 (C), 198.4 
(C) 
HRMS (EI+): Calcd. for C22H25NO5 [M+]: 383.1733, found: 383.1729 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 3:1 
as eluent. 
ê 31b (186 mg) was obtained from methyl vinyl ketone and N-
benzyloxycarbonyl-4,5-dimethoxy-2-homoallyl aniline.108176 
(E)-5-(2-Benzyloxycarbonyl aminomethyl)phenyl-3-penten-2-one (32) 
 
Physical state: Pale yellow oil 
Empiric Formula: C20H21NO3 
Molecular weight (g/mol): 323.39 
Yield (%): 83 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 2.18 (s, 3H), 3.58 (d, J = 6.0 Hz, 2H), 4.35 (d, 
J = 5.9 Hz, 2H), 4.93 (br s, 1H), 5.10 (s, 2H), 
5.94 (d, J = 15.6 Hz, 1H), 6-85-6.94 (m, 1H), 
7.12-7.33 (m, 9H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 26.0 (CH3), 35.4 (CH2), 42.8 (CH2), 66.9 
MeO
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1.6.3. MICHAEL ADDUCTS SYNTHESIS: PREPARATION OF 2-SUBSTITUTED 
NITROGEN HETEROCYCLES 35-41 
 
                                            
177 O. Okitsu, R. Suzuki, S. Kobayashi, J. Org. Chem. 2001, 66, 809-823. 
III (20 mol%)
PFPA (20 mol%)
CHCl3
A) 25˚C; B) MW, 60˚C
27-33 35-41
N
H N
NH2
OMe
N
H
R1
O
PG( )m
( )n
N
R1
O
PG( )m
( )n
R2
R2
R2
R2
(CH2), 127.4 (CH), 128.1 (CH), 128.2 (CH), 
128.3 (CH), 128.5 (CH), 129.1 (CH), 130.4 
(CH), 132.0 (CH), 135.9 (C), 136.1 (C), 136.3 
(C), 145.9 (CH), 156.0 (C), 198.3 (C) 
HRMS (EI+): Calcd. for C20H21NO3 [M+]: 323.1521, found: 323.1522 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 3:1 
as eluent. 
ê 32 (192 mg) was obtained from methyl vinyl ketone and N-
benzyloxycarbonyl-2-allylbenzyl amine.110,177 
(E)-4-(2-Benzyloxycarbonyl aminoethyl)phenyl-3-buten-2-one (33) 
 
Physical state: Pale yellow oil 
Empiric Formula: C20H21NO3 
Molecular weight (g/mol): 323.39 
Yield (%): 77 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 2.42 (s, 3H), 3.00 (t, J = 7.30 Hz, 2H), 3.35-
3.42 (m, 2H), 4.89 (br s, 1H), 5.09 (s, 2H), 
6.64 (d, J = 16.1 Hz, 1H), 7.19-7.36 (m, 8H), 
7.60 (d, J = 7.1 Hz, 1H), 7.91 (d, J = 16.1 Hz, 
1H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 27.5 (CH3), 33.6 (CH2), 42.2 (CH2), 66.7 
(CH2), 126.8 (CH), 127.3 (CH), 128.1 (CH), 
128.1 (CH), 128.5 (CH), 129.0 (CH), 130.4 
(CH), 130.5 (CH), 133.5 (C), 136.4 (C), 138.5 
(CH), 140.3 (CH), 156.3 (C), 198.6 (C) 
HRMS (EI+): Calcd. for C20H21NO3 [M+]: 323.1521, found: 323.1522 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 3:1 
as eluent. 
ê 33 (177 mg) was obtained from methyl vinyl ketone and N-
benzyloxycarbonyl-2-vinylphenethyl amine.110 
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Methodology A 
In a 10 mL round bottomed flask, a,b-unsaturated ketones 27-33 (1.0 
equiv.) were dissolved in chloroform (0.1 M). A mixture of catalyst III (20 mol%) 
and pentafluoropropionic acid (PFPA) (20 mol%, added from a freshly prepared 
stock solution in chloroform) was added and the resulting solution was stirred at 
room temperature. After 12-96 hours, the crude reaction mixture was subjected 
to flash chromatography on silica gel using mixtures of hexanes: ethyl acetate 
3:1-5:1 as eluents to afford the corresponding heterocycles 35-41. The 
enantiomeric ratios were determined by means of HPLC analysis with a 
Chiracel OD-H column (25 cm x 0.46 cm). 
Methodology B 
The corresponding a,b-unsaturated ketones (27-33) (1.0 equiv.) were 
dissolved in chloroform (0.1M) in a microwave vial and then, catalyst III (20 
mol%) and PFPA (20 mol%, added from a freshly prepared stock solution in 
CHCl3) were successively added. The vial was sealed and the corresponding 
solution was heated under microwave irradiation at 60 ºC for 1-4h. After this 
time, the crude reaction mixture was purified by means of flash chromatography 
on silica gel using the appropriate eluent (hexanes: ethyl acetate 3:1-5:1) to 
afford the corresponding heterocycles 35-41. The enantiomeric ratios were 
determined by means of HPLC analysis with a Chiracel OD-H column (25 cm x 
0.46 cm).  
 
 
                                            
161a Takahata, H.; Kubota, M.; Takahashi, S.; Momose, T. Tetrahedron: Asymmetry 1996, 7, 
3047–3054. 
(2R)-N-Benzyloxycarbonyl-2-(2-oxopropyl)piperidine (35a)161a178 
 
Physical state: Colorless oil 
Empiric Formula: C16H21NO3 
Molecular weight (g/mol): 275.35 
Optical rotation [a]D25: +11.6 (c 1.0, CHCl3) [lit. 
+10.2 (c 2.5, CHCl3)]161a 
Remarks: ê 35a (38 mg) was obtained from 27a in 93% yield and 96% ee at room 
temperature [94% yield (39 mg) and 95% ee at 60oC under microwave 
irradiation]. 
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161c Davies, S. G.; Fletcher, A. M.; Roberts, P. M.; Smith, A. D. Tetrahedron 2009, 65, 10192–
10213. 
161e Macours, P.; Braekman, J. C.; Daloze, D. Tetrahedron 1995, 51, 1415–1428. 
ê Spectroscopic data in agreement with those previously reported in the 
literature.161a 
ê The ee values were determined by HPLC analysis using a Chiracel OD-H 
column (hexane: isopropanol 95:5); flow rate = 1.0 mL/min, tmajor= 14.1 
min, tminor=14.8 min. 
(2R)-N-t-Butoxycarbonyl-2-(2-oxopropyl)piperidine (35b)161c 
 
Physical state: Colorless oil 
Empiric Formula: C13H23NO3 
Molecular weight (g/mol): 241.33 
Optical rotation [a]D25: +4.1 (c 1.0, CHCl3). [lit. 
+8.2 (c 2.0, CHCl3)]161c 
Remarks: ê 35b (33 mg) was obtained from 27b in 92% yield and 93% ee at room 
temperature [97% yield (35 mg) and 90% ee at 60oC under microwave 
irradiation]. 
ê Spectroscopic data in agreement with those previously reported in the 
literature.161c 
ê The ee values were determined by HPLC analysis using a Chiracel OD-H 
column (hexane:isopropanol 98:2); flow rate = 1.0 mL/min, tmajor=7.3 min, 
tminor=8.5 min. 
(2R)-N-Benzyloxycarbonyl-2-(2-oxopentyl)piperidine (35c)161e179 
 
Physical state: Colorless oil 
Empiric Formula: C18H25NO3 
Molecular weight (g/mol): 303.18 
Optical rotation [a]D25: +4.6 (c 1.0, CHCl3) [lit. 
+4.4 (c 1.54, CHCl3)]161e 
Remarks: ê 35c (43 mg) was obtained from 27c in 95% yield and 98% ee at room 
temperature [94% yield (42 mg) and 96% ee at 60oC under microwave 
irradiation]. 
ê Spectroscopic data in agreement with those previously reported in the 
literature.161e 
ê The ee values were determined by HPLC analysis using a Chiracel OD-H 
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177 O. Okitsu, R. Suzuki, S. Kobayashi, J. Org. Chem. 2001, 66, 809-823. 
180 Okitsu, O.; Suzuki, R.; Kobayashi, S. Synlett 2000, 989-990. 
161g Majik, M. S.; Tilve, S. G. Tetrahedron Lett. 2010, 51, 2900–2902. 
column (hexane:isopropanol 95:5); flow rate = 1.0 mL/min, tmajor=10.5 
min, tminor=9.0 min. 
(2R)-N-Benzyloxycarbonyl-2-(2-oxoheptyl)piperidine (35d)161a 
 
Physical state: Colorless oil 
Empiric Formula: C20H29NO3 
Molecular weight (g/mol): 331.46 
Optical rotation [a]D25: +3.2 (c 1.0, CHCl3) [lit. 
+9.5 (c 0.64, CHCl3)].161a 
Remarks: ê 35d (46 mg) was obtained from 27d in 92% yield and 98% ee at room 
temperature [89% yield (44 mg) and 97% ee at 60oC under microwave 
irradiation]. 
ê Spectroscopic data in agreement with those previously reported in the 
literature.161a  
ê The ee values were determined by HPLC analysis using a Chiracel OD-H 
column (hexane:isopropanol 95:5); flow rate = 1.0 mL/min, tmajor=8.4 min, 
tminor=7.1 min. 
(2R)-N-Benzyloxycarbonyl -2-(2-oxo-2-phenylethyl)piperidine (35e)180 
 
Physical state: Colorless oil 
Empiric Formula: C21H23NO3 
Molecular weight (g/mol): 337.42 
Optical rotation [a]D25: -16.6 (c 1.0, CHCl3) 
Remarks: ê 35e (29 mg) was obtained from 27e in 58% yield and 93% ee at room 
temperature [75% yield (38 mg) and 84% ee at 60oC under microwave 
irradiation]. 
ê Spectroscopic data in agreement with those previously reported in the 
literature.177,180 
ê The ee values were determined by HPLC analysis using a Chiracel OD-H 
column (hexane:isopropanol 95:5); flow rate = 1.0 mL/min, tmajor=17.0 
min, tminor=15.9 min. 
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(2R)-N-Benzyloxycarbonyl-2-(2-oxoheptyl)pyrrolidine (36)161g 
 
Physical state: Colorless oil 
Empiric Formula: C15H19NO3 
Molecular weight (g/mol): 261.32 
Optical rotation [a]D25: +35.8 (c 1.0, CHCl3) [lit. -
37.5 (c 0.72, CHCl3) for 
the opposite 
enantiomer].161g 
Remarks: ê 36 (31 mg) was obtained from 28 in 80% yield and 82% ee at room 
temperature [85% yield (33 mg) and 79% ee at 60oC under microwave 
irradiation]. 
ê Spectroscopic data in agreement with those previously reported in the 
literature.161g 
ê The ee values were determined by HPLC analysis using a Chiracel OD-H 
column (hexane:isopropanol 95:5); flow rate = 1.0 mL/min, tmajor=20.3 
min, tminor=16.5 min. 
(2R)-N-Benzyloxycarbonyl-2-(2-oxopropyl)indoline (37a)  
 
Physical state: Colorless oil 
Empiric Formula: C19H19NO3 
Molecular weight (g/mol): 309.37 
Optical rotation [a]D25: +82.5 (c 1.0, CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 2.10 (s, 3H), 2.61-2.73 (m, 2H), 3.00-3.04 (m, 
1H), 3.45 (dd, J = 16.6 and 9.6 Hz, 1H), 4.83-
4.89 (m, 1H), 5.29 (s, 2H), 6.94-6.99 (m, 1H), 
7.12-7.17 (m, 2H), 7.33-7.41 (m, 5H), 7.70-
7.81 (m, 1H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 30.4 (CH3), 34.5 (CH2), 48.2 (CH2), 55.6 (CH) 
67.3 (CH2), 115.4 (CH), 123.1 (CH), 125.1 
(CH), 127.6 (CH), 128.1 (CH), 128.3 (CH), 
128.6 (CH), 129.7 (C), 136.1 (C), 136.7 (C), 
161.0 (C), 206.7 (C) 
IR (film spectroscopy) n (cm-1): 3489, 2884, 1707, 1600, 1482, 1402, 1128, 
751 
HRMS (EI+): Calcd. for C19H19NO3 [M+]: 309.1365, found: 309.1369 
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Remarks: ê 37a (42 mg) was obtained from 29a in 90% yield and 93% ee at room 
temperature [83% yield (38 mg) and 91% ee at 60oC under microwave 
irradiation]. 
ê The ee values were determined by HPLC analysis using a Chiracel 
OD-H column (hexane:isopropanol 95:5); flow rate = 1.0 mL/min, 
tmajor=19.4 min, tminor=15.8 min. 
(2R)-N-Benzyloxycarbonyl-5-methoxy-2-(2-oxopropyl)indoline (37b)  
 
Physical state: White solid 
Empiric Formula: C20H22NO4 
Molecular weight (g/mol): 339.39 
Melting point (ºC): 85-87 
Optical rotation [a]D25: +82.5 (c 1.0, CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 2.04-2.12 (m, 3H), 2.61-2.70 (m, 2H), 2.90-
3.18 (m, 1H), 3.43 (dd, J = 15.0, 9.0 Hz, 1H), 
3.76 (s, 3H), 4.84 (tt, J = 16.7, 9.6 Hz, 1H), 
5.27 (s, 2H), 6.71 (m, 2H), 7.32-7.45 (m, 5H), 
7.72 (br s, 1H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 30.4 (CH3), 34.7 (CH2), 48.3 (CH2), 55.6 
(CH3), 60.4 (CH), 67.1 (CH2), 111.3 (CH), 
112.3 (CH), 112.9 (CH), 128.1 (CH), 128.3 
(CH), 128.6 (CH), 128.8 (C), 131.2 (C), 134.8 
(C), 136.2 (C), 156.0 (C), 206.8 (C) 
IR (film spectroscopy) n (cm-1): 3543, 3402, 2819, 1692, 1494, 1398, 1265, 
1120, 743 
HRMS (EI+): Calcd. for C20H22NO4 [M+H+]: 340.1543, found: 340.1542 
Remarks: ê 37b (46 mg) was obtained from 29b in 85% yield and 92% ee at room 
temperature [81% yield (41 mg) and 90% ee at 60oC under 
microwave irradiation]. 
ê The ee values were determined by HPLC analysis using a Chiracel 
OD-H column (hexane:isopropanol 90:10); flow rate = 1.0 mL/min, 
tmajor=22.8 min, tminor=17.8 min. 
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(2R)-N-Benzyloxycarbonyl-5-trifluoromethyl-2-(2-oxopropyl)indoline (37c)  
 
Physical state: White solid 
Empiric Formula: C20H19NO3F3 
Molecular weight (g/mol): 377.36 
Melting point (ºC): 120-122 
Optical rotation [a]D25: +35.7 (c 1.0, CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 2.11 (s, 3H), 2.62-2.78 (m, 2H), 3.04 (br s, 
1H), 3.49 (dd, J = 16.9, 9.6 Hz, 1H), 4.90 (tt, 
J = 10.0, 2.7 Hz, 1H), 5.30 (dd, J = 14.8, 
12.3 Hz, 2H), 7.20-7.45 (m, 7H), 7.76 (br s, 
1H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 30.4 (CH3), 34.3 (CH2), 47.9 (CH2), 56.1 
(CH), 67.8 (CH2), 115.1 (CH), 122.2 (q, J = 
3.8 Hz, CH), 124.7 (q, J = 271.7 Hz, CF3), 
125.2 (q, J = 33.4 Hz, C), 125.4 (q, J = 3.8 
Hz, CH), 128.3 (CH), 128.5 (CH), 128.7 
(CH), 130.6 (C), 135.7 (C), 152.5 (C), 206.3 
(C) 
19F NMR (CDCl3, 282.4 MHz) δ (ppm): -72.1 (s, 3F) 
IR (film spectroscopy) n (cm-1): 3611, 3562, 3055, 2880, 1741, 1707, 1364, 
1219, 823 
HRMS (EI+): Calcd. for C20H19NO3F3 [M+H+]: 378.1313, found: 378.1304 
Remarks: ê 37c (36 mg) was obtained from 29c in 71% yield and 68% ee at room 
temperature [68% yield (34 mg) and 63% ee at 60oC under 
microwave irradiation]. 
ê The ee values were determined by HPLC analysis using a Chiracel 
OD-H column (hexane:isopropanol 90:10); flow rate = 1.0 mL/min, 
tmajor=10.0 min, tminor=13.6 min. 
(1R)-N-Benzyloxycarbonyl-1-(2-oxopropyl)isoindoline (38) 
 
Physical state: Colorless oil 
Empiric Formula: C19H19NO3 
Molecular weight (g/mol): 309.37 
Optical rotation [a]D25: +90.6 (c 1.0, CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 2.00 (s, 1H), 2.14 (s, 2H), 2.77-2.97 (m, 1H), 
3.11 (dd, J = 16.8, 3.3 Hz, 0.5H), 3.32 (dd, J 
= 17.1, 3.5 Hz, 0.5H), 4.65-4.85 (m, 2H), 
5.14-5.27 (m, 2H), 5.49-5.52 (m, 1H), 7.22-
N
O
Cbz
F3C
N Cbz
O
 
 
 
Chapter 1 Experimental Section 
  
101 
 
7.40 (m, 9H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 30.6 (CH3), 48.5 (CH2), 50.0 (CH2), 51.8 
(CH2), 52.2 (CH2), 58.9 (CH), 59.7 (CH), 66.9 
(CH2), 67.1 (CH2), 122.4 (CH), 122.6 (CH), 
122.9 (CH), 123.0 (CH), 127.7 (CH), 127.9 
(CH), 128.0 (CH), 128.1 (CH), 128.1 (CH), 
128.5 (CH), 135.9 (C), 136.2 (C), 136.4 (C), 
136.6 (C), 140.2 (C), 140.7 (C), 154.5 (C), 
206.2 (C), 206.4 (C) 
IR (film spectroscopy) n (cm-1): 3487, 3334, 1692, 1646, 1204, 1101, 759 
HRMS (EI+): Calcd. for C19H19NO3 [M+]: 309.1365, found: 309.1369 
Remarks: ê 38 (45 mg) was obtained from 30 in 96% yield and 93% ee at room 
temperature [91% yield (42 mg) and 92% ee at 60oC under microwave 
irradiation]. 
ê 1H and 13C NMR show the presence of rotamers about the carbamate 
bond in ca. 3:2 ratio. 
ê The ee values were determined by HPLC analysis using a Chiracel 
OD-H column (hexane:isopropanol 90:10); flow rate = 1.0 mL/min, 
tmajor=21.2 min, tminor=15.9 min. 
(2R)-N-Benzyloxycarbonyl-2-(2-oxopropyl)tetrahydroquinoline (39a) 
 
Physical state: Colorless oil 
Empiric Formula: C20H21NO3 
Molecular weight (g/mol): 323.39 
Optical rotation [a]D25: +76.3 (c 1.0, CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 1.54-1.65 (m, 1H), 2.09 (s, 3H), 2.30-2.41 (m, 
1H), 2.48 (dd, J = 16.1 and 8.1 Hz, 1H), 2.65-
2.7 (m, 2H), 2.80 (dd, J = 16.1 and 5.6 Hz, 
1H), 4.94-5.03 (m, 1H), 5.22 (dd, J = 33.5 
and 12.5 Hz, 2H), 7.02-7.17 (m, 3H), 7.30-
7.37 (m, 5H), 7.50 (d, J = 8.1 Hz, 1H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 24.7 (CH2), 29.1 (CH2), 30.3 (CH3), 47.5 
(CH2), 49.9 (CH), 67.6 (CH2), 124.5 (CH), 
125.6 (CH), 126.2 (CH), 127.9 (CH), 128.1 
(CH), 128.5 (2CH), 131.5 (C), 136.2 (C), 
136.3 (C), 154.5 (C), 206.5 (C) 
IR (film spectroscopy) n (cm-1): 3749, 3498, 3055, 2872, 1699, 1414, 1349, 
1109, 881, 763 
HRMS (EI+): Calcd. for C20H21NO3 [M+]: 323.1521, found: 323.1512 
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Remarks: ê 39a (39 mg) was obtained from 31a in 80% yield and 88% ee at room 
temperature [93% yield (45 mg) and 86% ee at 60oC under microwave 
irradiation]. 
ê The ee values were determined by HPLC analysis using a Chiracel 
OD-H column (hexane:isopropanol 95:5); flow rate = 1.0 mL/min, 
tmajor=20.6 min, tminor=19.3 min. 
(3R)-N-Benzyloxycarbonyl-3-(2-oxopropyl)tetrahydroisoquinoline (40) 
 
Physical state: Colorless oil 
Empiric Formula: C20H21NO3 
Molecular weight (g/mol): 323.39 
Optical rotation [a]D25: -34.4 (c 1.0, CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 2.01 (s, 1.5H), 2.13 (s, 1.5H), 2.41-2.49 (m, 
1H), 2.53-2.80 (m, 2H), 3.08-3.14 (m, 1H), 
4.38 (d, J = 17.0 Hz, 1H), 4.81 (d, J = 16.0 
Hz, 1H), 4.85-5.02 (m, 1H), 5.18 (s, 2H), 
7.10-7.38 (m, 9H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 30.2 (CH3), 30.3 (CH3), 32.9 (CH2), 33.1 
(CH2), 43.3 (CH2), 43.4 (CH2), 45.8 (CH2), 
46.1 (CH2), 46.5 (CH), 67.3 (CH2), 126.1 
(CH), 126.2 (CH), 126.5 (CH), 126.9 (CH), 
128.0 (CH), 128.1 (CH), 128.5 (CH), 129.1 
(CH), 129.3 (CH), 132.3 (C), 132.4 (C), 132.6 
(C), 136.5 (C), 155.2 (C), 155.3 (C), 206.4 
(C), 206.6 (C) 
IR (film spectroscopy) n (cm-1): 3745, 3619, 3494, 3024, 2793, 1715, 1421, 
1357, 1216, 872 
HRMS (EI+): Calcd. for C22H25NO5 [M+]: 383.1733, found: 383.1738 
Remarks: ê 40 (47 mg) was obtained from 32 in 97% yield and 97% ee at room 
temperature [95% yield (46 mg) and 97% ee at 60oC under microwave 
irradiation]. 
ê 1H and 13C NMR show the presence of rotamers about the carbamate 
bond in ca. 1:1 ratio. 
ê The ee values were determined by HPLC analysis using a Chiracel 
OD-H column (hexane:isopropanol 90:10); flow rate = 1.0 mL/min, 
tmajor=16.4 min, tminor=12.3 min. 
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(1S)-N-Benzyloxycarbonyl-1-(2-oxopropyl)tetrahydroisoquinoline (41) 
 
Physical state: Colorless oil 
Empiric Formula: C20H21NO3 
Molecular weight (g/mol): 323.39 
Optical rotation [a]D25: +78.2 (c 1.0, CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 2.04 (s, 1.5H), 2.25 (s, 1.5H), 2.74-2.89 (m, 
4H), 3.32-3.50 (m, 1H), 3.97-4.03 (m, 0.5H), 
4.14-4.19 (m, 0.5H), 5.10-5.22 (m, 2H), 5.67-
5.73 (m, 1H), 7.13-7.37 (m, 9H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 28.2 (CH2), 28.4 (CH2), 30.1 (CH3), 30.5 
(CH3), 38.5 (CH2), 38.8 (CH2), 51.1 (CH), 
51.4 (CH2), 51.6 (CH2), 67.3 (CH2), 67.4 
(CH2), 126.5 (CH), 126.7 (CH), 126.9 (CH), 
127.0 (CH), 127.8 (CH), 128.0 (CH), 128.1 
(CH) 128.5 (CH), 128.9 (CH), 129.0 (CH), 
134.0 (C), 134.1 (C), 136.5 (C), 136.6 (C), 
155.0 (C), 155.4 (C), 205.7 (C), 206.1 (C) 
IR (film spectroscopy) n (cm-1): 3745, 3611, 2886, 1688, 1534, 1421, 1094, 
879 
HRMS (EI+): Calcd. for C20H21NO3 [M+]: 323.1521, found: 323.1519 
Remarks: ê 41 (46 mg) was obtained from 33 in 94% yield and 98% ee at room 
temperature [91% yield (44 mg) and 97% ee at 60oC under microwave 
irradiation]. 
ê 1H and 13C NMR show the presence of rotamers about the carbamate 
bond in ca. 1:1 ratio. 
ê The ee values were determined by HPLC analysis using a Chiracel 
OD-H column (hexane:isopropanol 85:15); flow rate = 1.0 mL/min, 
tmajor=14.5 min, tminor=13.9 min. 
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1.6.4. HPLC TRACES OF ENANTIOENRICHED COMPOUNDS 35-41 
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2.1. Background 
2.1.1. ORGANOCATALYTIC ACTIVATION OF ESTERS AND ESTER SURROGATES 
Ester functionality plays a central role in biological and synthetic organic 
transformations. However, its use in the area of organocatalysis is still quite 
limited because the most commonly employed organocatalytic activation 
modes, the iminium and enamine pathways, cannot be applied to esters unlike 
their ketone and aldehyde counterparts. Therefore, other activation 
mechanisms are required to make esters and acid derivatives more reactive. 
In 2001 it was described the first organocatalytic approach to the living 
ring-opening polymerization (ROP) of lactide through a transesterification 
reaction.180 This new approximation implied a highly desirable alternative to 
traditional organometallic approaches for the development of biodegradable 
polymers. Since then, organic catalysis for this kind of controlled 
polymerizations has been extended employing assorted organocatalysts such 
as N-heterocyclic carbenes181 guanidines,182 phosphines183 or pyridine derived 
bases180 which involved a nucleophilic mechanism (Scheme 2.1.a), or 
thioureas 184  and protonated phosphazenes 185  working through a hydrogen-
bonding activation (Scheme 2.1.b). 
                                            
180 Nederberg, F.; Connor, E. F.; Möller, M.; Glauser, T.; Hedrick, J. L. Angew. Chem. Int. Ed. 
2001, 40, 2712–2715. 
181 Connor, E. F.; Nyce, G. W.; Myers, M.; Möck, A.; Hedrick, J. L. J. Am. Chem. Soc. 2002, 
124, 914–915.  
182 a) Lohmeijer, B. G. G.; Pratt, R. C.; Leibfarth, F.; Logan, J. W.; Long, D. A.; Dove, A. P.; 
Nederberg, F.; Choi, J.; Wade, C.; Waymouth, R. M.; Hedrick, J. L. Macromolecules 2006, 39, 
8574–8583. b) Pratt, R. C.; Lohmeijer, B. G. G.; Long, D. A.; Waymouth, R. M.; Hedrick, J. L. J. 
Am. Chem. Soc. 2006, 128, 4556–4557. 
183 Myers, M.; Connor, E. F.; Glauser, T.; Möck, A.; Nyce, G.; Hedrick, J. L. J. Polym. Sci. Part 
A Polym. Chem. 2002, 40, 844–851. 
184 Dove, A. P.; Pratt, R. C.; Lohmeijer, B. G. G.; Waymouth, R. M.; Hedrick, J. L. J. Am. Chem. 
Soc. 2005, 127, 13798–13799. 
185 Jardel, D.; Davies, C.; Peruch, F.; Massip, S.; Bibal, B. Adv. Synth. Catal. 2016, 358, 1110–
1118. 
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Scheme 2.1. ROP of a lactide by (a) phosphines or (b) thioureas. 
On the other hand, regarding the activation of conjugated esters in 
asymmetric organocatalysis, these and other organic catalysts have also 
been used in different chemical transformations. Among them, N-heterocyclic 
carbenes (NHC) are probably the most widely used family of catalysts for this 
purpose.186 Initially they were employed to catalyse transesterification reactions 
activating the ester moiety.187 Recently, they have been used for the HOMO 
activation of saturated a-aryl acetic esters to generate enolate intermediates for 
enantioselective reactions; 188  and in formal LUMO activations of a,b-
unsaturated esters for highly enantioselective reactions, generally with 
enamides.189 In the latter, the key step involves the addition of the NHC catalyst 
to the conjugated ester to form an a,b-unsaturated acyl azolium intermediate, 
which has an increased electrophilicity at the b-carbon. However, the formal 
                                            
186 a) Marion, N.; Díez-González, S.; Nolan, S. P. Angew. Chem. Int. Ed. 2007, 46, 2988–3000. 
b) Bugaut, X.; Glorius, F. Chem. Soc. Rev. 2012, 41, 3511. c) Enders, D.; Niemeier, O.; 
Henseler, A. Chem. Rev. 2007, 107, 5606–5655. 
187 a) Grasa, G. A.; Kissling, R. M.; Nolan, S. P. 2002, 2–5. b) Nyce, G. W.; Lamboy, J. A.; 
Connor, E. F.; Waymouth, R. M.; Hedrick, J. L. Org. Lett. 2002, 4, 3587–3590. c) Ryan, S. J.; 
Candish, L.; Lupton, D. W. J. Am. Chem. Soc. 2009, 131, 14176–14177. d) Candish, L.; Lupton, 
D. W. Org. Biomol. Chem. 2011, 9, 8182–8189. e) Candish, L.; Lupton, D. W. Chem. Sci. 2012, 
3, 380–383. f) Ryan, S. J.; Candish, L.; Lupton, D. W. Chem. Soc. Rev. 2013, 42, 4906–4917. 
188 Hao, L.; Du, Y.; Lv, H.; Chen, X.; Jiang, H.; Shao, Y.; Chi, Y. R. Org. Lett. 2012, 14, 2154–
2157. 
189 a) Cheng, J.; Huang, Z.; Chi, Y. R. Angew. Chem. Int. Ed. 2013, 52, 8592–8596. b) Hao, L.; 
Chen, S.; Xu, J.; Tiwari, B.; Fu, Z.; Li, T.; Lim, J.; Chi, Y. R. Org. Lett. 2013, 15, 4956–4959. c) 
Chauhan, P.; Enders, D. Angew. Chem. Int. Ed. 2014, 53, 1485–1487. 
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1,4-addition is postulated to be achieved through a 1,2-addition followed by an 
aza-Claisen type rearrangement (Scheme 2.2). 
 
Scheme 2.2. Activation of conjugated esters for a domino addition/lactamization. 
The use of nucleophilic phosphine organocatalysts to activate 
unsaturated carbonyl compounds was published by Roush in 2004.190 It was 
described the activation of conjugated esters by phosphines in several 
transformations, such as the Rauhut-Currier, the Morita-Baylis-Hillman and the 
Michael addition reactions among others. Concretely, for the latter the proposed 
mechanism involves the formation of a zwitterionic phosphine-alkene adduct 
intermediate, that behaves as the general base of the reaction deprotonating 
the carbon acid of the nucleophile, which then undergoes Michael addition to 
another a,b-unsaturated carbonylic compound (Scheme 2.3). 
                                            
190 Methot, J. L.; Roush, W. R. Adv. Synth. Catal. 2004, 346, 1035–1050. 
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Scheme 2.3. Phosphine-catalysed Michael addition of carbon acids. 
Regarding hydrogen bonding organocatalysts, there have been 
described a great variety of examples and a selection of the more 
representatives will be outlined below. They are classified according to the type 
of the transformation, oxa-, sulfa- and classic Michael reactions, and in some 
cases also depending on the nature of the catalyst employed. 
Takemoto191 and later Matsubara,192 recently published enantioselective 
intramolecular oxa-Michael reactions of a,b-unsaturated amides, thioesters and 
esters. On the one hand, Takemoto’s report employs a chiral benzothiadiazine 
to activate conjugated amides and esters as electrophiles and facilitate the 
production of a variety of O-heterocycles with very good yields and 
enantioselectivities (Scheme 2.4.a). On the other hand, Matsubara introduced 
isolated examples of conjugated thioesters or esters as Michael acceptors. First 
in the preparation of cyclic acetals, employing formaldehyde as nucleophile in 
an asymmetric oxa-Michael addition to g-hydroxy-a,b-unsaturated carbonyl 
compounds using a quinine-derived thiourea organocatalyst through hemiacetal 
intermediates (Scheme 2.4.b). After, in the asymmetric synthesis of spiroketal 
structures through the relay formation of contiguous oxacycles, in which the 
                                            
191 Kobayashi, Y.; Taniguchi, Y.; Hayama, N.; Inokuma, T.; Takemoto, Y. Angew. Chem. Int. 
Ed. 2013, 52, 11114–11118. 
192 a) Yoneda, N.; Hotta, A.; Asano, K.; Matsubara, S. Org. Lett. 2014, 16, 6264–6266. b) 
Yoneda, N.; Fukata, Y.; Asano, K.; Matsubara, S. Angew. Chem. Int. Ed. 2015, 54, 15497–
15500. c) Miyaji, R.; Asano, K.; Matsubara, S. Org. Biomol. Chem. 2014, 12, 119–122. 
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bifunctional aminothiourea organocatalyst imparts high enantioselectivity 
(Scheme 2.4.c). 
 
Scheme 2.4. Asymmetric intramolecular oxa-Michael reactions 
Recently, it has been described by Dixon the enantioselective sulfa-
Michael addition to unactivated a-substituted acrylate esters using a second 
generation bifunctional iminophosphorane (BIMP) superbase organocatalyst.193 
Here they overcome the low inherent conjugated ester electrophilicity by raisin 
the Brønsted basicity of the catalyst. In this way, there were achieved good 
levels of reactivity and excellent enantioselectivities across a diverse range of 
alkyl thiols and acrylate esters (Scheme 2.5). 
                                            
193 Farley, A. J. M.; Sandford, C.; Dixon, D. J. J. Am. Chem. Soc. 2015, 137, 15992–15995. 
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Scheme 2.5. Sulfa-Michael addition of thiol pro-nucleophiles to conjugated esters. 
The same year, Dixon’s group also published the employment of simple 
aminocatalysts for the enantioselective desymmetrization of prochiral 
cyclohexanones through intramolecular Michael addition to a,b-unsaturated 
esters.194 They developed a primary amine catalysed Michael addition of a 
ketone to unactivated conjugated esters, providing access to the morphan 
scaffold in high enantio- and diastereoselectivity (Scheme 2.6.a). Computational 
studies to probe the origins of the high enantiocontrol were performed, and the 
results of the calculations identified a new low-molecular-weight catalyst that 
can impart the same level of enantioselectivity (Scheme 2.6.b). 
 
Scheme 2.6. Desymmetrization by intramolecular Michael reaction to conjugated esters. 
There have also been reported several guanidine-catalysed 
enantioselective 1,4-additions of carbon-centred nucleophiles to a,b-
                                            
194 Gammack Yamagata, A. D.; Datta, S.; Jackson, K. E.; Stegbauer, L.; Paton, R. S.; Dixon, D. 
J. Angew. Chem. Int. Ed. 2015, 54, 4899–4903. 
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unsaturated esters, thioesters and amides. 195  For instance, an unsaturated 
lactone underwent Michael addition with a 1,3-dithiomalonate to give the 
desired product with good yield and excellent enantioselectivity in the presence 
of a catalytic amount of a chiral bicyclic guanidine (Scheme 2.7.). 
 
Scheme 2.7. Asymmetric Michael addition to an unsaturated furanone. 
2.1.2. AZA-MICHAEL REACTIONS WITH ESTER DERIVATIVES AS MICHAEL 
ACCEPTORS 
Finally, regarding aza-Michael reactions there are really few examples 
with a,b-unsaturated esters or thioesters. On the one hand, Weiß et al reported 
in 2012 a proof of concept for the asymmetric aza-Michael addition with readily 
available alkyl enoate as substrate in the presence of a chiral phase-transfer 
catalyst (PTC), leading to the enantioenriched adduct. However, the asymmetric 
induction remained limited to enantiomeric excesses of up to 37% (Scheme 
2.8).196 The electrophilicity of the Michael acceptor is enhanced by adding a 
CF3-substituent at the b-position, whereas the N-nucleophile is activated by the 
a-effect of the alkoxy group.94 Furthermore, it is necessary the addition of a 
stoichiometric amount of a basic solution to the reaction mixture. 
                                            
195 Chiral Guanidines in Michael Reactions, Nájera, C.; Yus, M. Springer Berlin Heidelberg: 
Berlin, Heidelberg, 2015; pp. 1–34 and references therein. 
196 Weiß, M.; Borchert, S.; Rémond, E.; Jugé, S.; Gröger, H. Heteroat. Chem. 2012, 23, 202–
209. 
94 Heaton, M. M. J. Am. Chem. Soc. 1978, 100, 2004–2008. 
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Scheme 2.8. Aza-Michael addition to conjugated esters with an alkoxy carbamate. 
Matsubara and Asano reported also two isolated examples of 
intramolecular aza-Michael additions of aniline carbamates to conjugated 
thioesters by means of bifunctional quinine-derived amino(thio)urea 
catalysts.128g The corresponding 2-substituted indolines were prepared with 
moderate yields and enantioselectivities (Scheme 2.9). 
 
Scheme 2.9. Asymmetric IMAMR with a,b-unsaturated thioesters to synthesize indolines. 
On the other hand, Bandini and Umani-Ronchi published in 2008111,197 
the first and only direct protocol until the moment198 for aza-Michael additions to 
a,b-unsaturated esters. As it consists on an intramolecular aza-Michael 
                                            
128g Miyaji, R.; Asano, K.; Matsubara, S. Org. Lett. 2013, 15, 3658–3661. 
197 For theoretical studies: Bandini, M.; Bottoni, A.; Eichholzer, A.; Miscione, G. Pietro; Stenta, 
M. Chem. Eur. J. 2010, 16, 12462–12473. 
111 Bandini, M.; Eichholzer, A.; Tragni, M.; Umani-Ronchi, A. Angew. Chem. Int. Ed. 2008, 47, 
3238–3241. 
198 There have been also used b-keto-esters for IMAMR, but in those cases the enone was the 
Michael acceptor, activated by the ester at the b-position, which was subsequently removed 
(Scheme 1.16). a) See ref. 112: Z. Feng, Q.-L. Xu, L.-X. Dai and S.-L. You, Heterocycles, 2010, 
80, 765. b) See ref. 113: Liu, X.; Lu, Y. Org. Lett. 2010, 12, 5592–5595. c) Xiao, X.; Liu, X.; 
Dong, S.; Cai, Y.; Lin, L.; Feng, X. Chem. Eur. J. 2012, 18, 15922–15926. 
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reaction, it has already been mentioned in the corresponding section in Chapter 
1. However, given the relevance in this conjugate esters branch, it has been 
newly referred. Here the indole nitrogen is added to a,b-unsaturated esters 
affording tricycles with good yields and enantioselectivities by means of phase 
transfer catalysis with a chiral ammonium salt of cinchonidine derivative 
(Scheme 2.9). 
 
Scheme 2.9. Aza-Michael addition to conjugated esters with an indolic nitrogen.  
In addition, Takemoto’s group described, for the first time, the use of 
aminoboronic acids as efficient catalysts for the direct intramolecular hetero-
Michael addition of a,b-unsaturated carboxylic acids. 199  Furthermore, they 
developed an asymmetric version of this protocol using a dual catalytic system 
composed of an aminothiourea and an arylboronic acid allowing the 
successfully synthesis of the desired heterocycles in high yields and ee’s 
(Scheme 2.1.a). The overall utility of this protocol was demonstrated by a one-
pot enantioselective synthesis of (+)-Erythrococcamide B, which proceeded via 
sequential Michael and amidation reactions (Scheme 2.1.b). 
                                            
199 Azuma, T.; Murata, A.; Kobayashi, Y.; Inokuma, T.; Takemoto, Y. Org. Lett. 2014, 16, 4256–
4259. 
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Scheme 2.10. Construction of asymmetric heterocyclic compounds with intramolecular 
hetero-Michael reactions with a,b-unsaturated carboxylic acids as electrophiles. 
2.1.3. ORGANOCATALYTIC INTRAMOLECULAR AZA-MICHAEL REACTIONS IN 
DOMINO PROCESSES 
The ability to create complex molecules in only a few steps has long 
been the dream of chemists. Now, with the development of domino reactions, 
the dream has become almost true for the laboratory chemist, at least partly. In 
addition, this kind of transformations are frequently used not only in basic 
research but also in applied chemistry.200 
Nowadays, the main issue is the efficiency of a synthesis, which can be 
defined as the increase of complexity per transformation. Notably, modern 
syntheses must obey the needs of our environment, which includes the 
preservation of resources and the avoidance of toxic reagents as well as toxic 
                                            
200 a) Tietze, L. F. Chem. Rev. 1996, 96, 115–136. b) Parsons, P. J.; Penkett, C. S.; Shell, A. J. 
Chem. Rev. 1996, 96, 195–206. c) Tietze, L. F.; Brasche, G.; Gericke, K. M. In Domino 
Reactions in Organic Synthesis; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 
2006. d) Enders, D.; Grondal, C.; Hüttl, M. R. M. Angew. Chem. Int. Ed. 2007, 46, 1570–1581. 
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solvents.201 Such an approach has advantages not only for Nature but also in 
terms of economics, as it allows reductions to be mad in production time as well 
as in the amounts of waste products. 
For a long time, the general procedure for the synthesis of organic 
compounds has been a stepwise formation of individual bonds in the target 
molecules, with work-up stages after each transformation. In contrast, the 
denominated domino reactions202 would comprise transformations of two or 
more bond-forming reactions under identical reaction conditions, in which the 
latter transformations take place at the functionalities obtained in the former-
bond constructing reactions. 
Inside classification of domino processes, the anionic domino reactions 
are the most often encountered in the chemical literature, being included in this 
group those where the primary step in the process is the attack of either an 
anion or a pseudo anion, as an uncharged nucleophile, onto an electrophilic 
center. Therefore, transformations such as Michael addition, aldol reactions or 
peptide couplings can be included in this category. 
Concretely, organocatalytic intramolecular aza-Michael reactions 
(IMAMR) have been involved in several domino processes, such as the 
sequences IMAMR/ alkylation, 203  aza-Morita-Baylis-Hillman/ IMAMR,135 
Mannich/ IMAMR,204 aminoxylation/ IMAMR,205 or hydroxylation/  IMAMR.206 As 
                                            
201 a) Sheldon, R. a. Pure Appl. Chem. 2000, 72, 1233–1246. b) Sheldon, R. a. Green Chem. 
2005, 7, 267-278. 
202 The word tandem is often used to describe this type of process, but it is less appropriate as 
the encyclopedia defines tandem as “locally, two after each other”, as on a tandem bicycle. 
Thus, the term tandem does not fit so well with the time-resolved aspects of the domino reaction 
type. For a proper example of a tandem reaction, where individual transformations of 
independent functionalities take place under the same reaction conditions, see: Roush, W. R.; 
Sciotti, R. J. J. Am. Chem. Soc. 1998, 120, 7411–7419. 
135 Takizawa, S.; Inoue, N.; Hirata, S.; Sasai, H. Angew. Chem. Int. Ed. 2010, 49, 9725–9729. 
203 Guo, J.; Yu, S. Org. Biomol. Chem. 2015, 13, 1179–1186. 
204 a) Enders, D.; Goddertz, D. P.; Beceno, C.; Raabe, G. Adv. Synth. Catal. 2010, 352, 2863-
2868. b) Yang, H.; Carter, R. G. J. Org. Chem. 2009, 74, 5151-5156. c) Rueping, M.; Azap, C. 
Angew. Chem. Int. Ed. 2006, 45, 7832-7835. d) Itoh, T.; Yokoya, M.; Miyauchi, K.; Nagata, K.; 
Ohsawa, A. Org. Lett. 2003, 5, 4301–4304. e) Itoh, T.; Yokoya, M.; Miyauchi, K.; Nagata, K.; 
Ohsawa, A. Org. Lett. 2006, 8, 1533–1535. f) Khaliel, S.; Nandakumar, M. V.; Krautscheid, H.; 
Schneider, C. Synlett. 2008, 2705-2707. g) See Ref. 96: Sundén, H.; Ibrahem, I.; Eriksson, L.; 
Córdova, A. Angew. Chem. Int. Ed. 2005, 44, 4877–4880. 
205 a) Lu, M.; Zhu, D.; Lu, Y. P.; Hou, Y. X.; Tan, B.; Zhong, G. F. Angew. Chem. Int. Ed. 2008, 
47, 10187-10191. b) Zhu, D.; Lu, M.; Chua, P. J.; Tan, B.; Wang, F.; Yang, X.; Zhong, G. Org. 
Lett. 2008, 10, 4585-4588. 
206 Yamamoto, Y.; Momiyama, N.; Yamamoto, H. J. Am. Chem. Soc. 2004, 126, 5962–5963. 
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noted, most of the cases have the IMAMR as the second step of the sequence, 
what makes especially sense when a,b-unsaturated esters are the Michael 
acceptors, because the previous reaction will be generating a more nucleophilic 
intermediate able to react with those less electrophilic moieties. 
Activated ester equivalents have been involved in two examples of 
organocatalytic domino sequences with IMAMR. On the one hand, Schneider’s 
group reported in 2008204f a proline-catalysed domino Mannich/ aza-Michael 
reaction of chiral 7-oxo-2-enimides containing an aldehyde moiety tethered to 
an a,b-unsaturated oxazolidinone with glyoxyl imines to furnish highly 
substituted pipecolic esters in moderate yields and excellent stereocontrol 
(Scheme 2.11). Throughout this process two new s bonds and three new 
stereogenic centers are formed as a single stereoisomer as it was already 
demonstrated by Barbas and co-workers for similar Mannich reactions.29 
 
Scheme 2.11. Domino Mannich/ IMAMR to an activated ester surrogate 
On the other hand, a,b-unsaturated diesters where involved in an 
asymmetric organocatalytic domino aminoxylation/ aza-Michael reaction for the 
synthesis of multifunctionalised tetrahydro-1,2-oxazines.207 The C-O/ C-N bond 
formations are achieved in moderate to good yields with excellent diastereo- 
(<99:1 d.r.) and enantioselectivities (92% to >99% ee) by means of L-proline 
catalyst (Scheme 2.12). 
                                            
207 Zhu, D.; Lu, M.; Chua, P. J.; Tan, B.; Wang, F.; Yang, X.; Zhong, G. Org. Lett. 2008, 10, 
4585–4588. 
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Scheme 2.12. Asymmetric domino aminoxylation/ IMAMR which conjugated diesters. 
In addition, Enders and co-workers reported an efficient domino 
Mannich/aza-Michael reaction204a between N-protected aryl aldimines and g-
malonate-substituted a,b-unsaturated methyl esters promoted by a bifunctional 
thiourea catalyst. This methodology furnishes 2,5-cis-configured 
polyfunctionalised pyrrolidines in good to excellent yields, enantioselectivities 
and excellent diastereoselectivities (Scheme 2.13). They initially intended to 
perform the same protocol with simple conjugated esters but that Michael 
acceptor nature was not sufficiently electrophilic to enable a direct subsequent 
aza-Michael addition with the generated secondary amine. 
 
Scheme 2.13. Asymmetric synthesis of pyrrolidines through a domino Mannich/ IMAMR 
with conjugated diesters. 
Apart from that, there have been also described some IMAMR to 
conjugated esters in organocatalysed domino processes, generally for the 
preparation of benzofused scaffolds. 208  Enders published in 2008 the first 
catalytic asymmetric synthesis of 1,3-disubstituted isoindolines, based on a 
metal-free one-pot Brønsted acid catalysed Friedel-Crafts/ base-catalysed aza-
                                            
208 The following transformations described in Schemes 2.14-16 have already been partially 
discussed in the benzofused heterocycles Section 1.1.2., at Schemes 1.22, 28-29 in 
tetrahydroisoquinolines and isoindolines subsections, respectively. 
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Michael addition reaction of bifunctional e-iminoenoates and indoles.136 Chiral 
BINOL-derived N-triflyl phosphoramides catalysed the initial Friedel-Crafts 
reaction and the isoindoline products were obtained in high yields and excellent 
diastereo- and enantiomeric ratios (Scheme 2.14). 
 
Scheme 2.14. One-pot Friedel-Crafts/ IMAMR with e-iminoenoates. 
Sasai and co-workers137 described the enantioselective synthesis of 
insoindolines, through an organocatalysed aza-Morita-Baylis-
Hillman/intramolecular aza-Michael reaction of a,b-unsaturated esters and N-
tosylimines promoted by the chiral acid-base catalyst (S)-2-diphenylphosphanyl-
[1,1’]binaphtalenyl-2-ol. This procedure easily accessed to afford 1,3-
disbustitued isoindolines in good yields with excellent diastereo- and 
enantioselectivities (Scheme 2.15). 209 
                                            
136 Enders, D.; Narine, A. A.; Toulgoat, F.; Bisschops, T. Angew. Chem. Int. Ed. 2008, 47, 
5661–5665. 
137 Takizawa, S.; Inoue, N.; Hirata, S.; Sasai, H. Angew. Chem. Int. Ed. 2010, 49, 9725–9729. 
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Scheme 2.15. aza-MBH/intramolecular aza-Michael addition domino reaction. 
A domino strategy consisting of a reductive amination/ aza-Michael 
addition sequence was successfully applied by Enders et al. for the asymmetric 
synthesis of trans-1,3-disubstituted tetrahydroisoquinolines.127 Using a chiral 
phosphoric acid as an organocatalyst and a biphenyl-substituted 
benzothiazoline as hydride source, they reacted p-anisidine with keto enoates 
to yield the reductive amination intermediates, that would suffer the IMAMR to 
reach the final products (Scheme 2.16.a). Notably, an indole-derived trans-
disubstituted b-carboline was also obtained with this three-component 
sequence in excellent yield and stereoselectivity (Scheme 2.16.b). 210 
                                            
127 Enders, D.; Liebich, J. X.; Raabe, G. Chem. Eur. J. 2010, 16, 9763–9766. 
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Scheme 2.16. Reductive amination/ IMAMR with a,b-unsaturated esters. 
Finally, in 2014 has been published an elegant synergistic catalytic 
system comprising a ruthenium complex with a chiral Brønsted acid for an 
enantioselective four-component Mannich/cascade aza-Michael reaction. 211 
The ruthenium-associated ammonium ylides successfully trapped with in situ 
generated imines indicates a septwise process of proton transfer in the 
ruthenium catalysed carbenoid N-H insertion reaction. This transformation 
features a mild, rapid, and efficient method to synthesize 1,3,4-tetrasubstitued 
tetrahydroisoquinolines bearing a quaternary stereogenic carbon center from 
simple starting precursors in moderate yields with high diastereo- and 
enantioselectivity (Scheme 2.17). 
                                            
211 Jiang, J.; Ma, X.; Ji, C.; Guo, Z.; Shi, T.; Liu, S.; Hu, W. Chem. Eur. J. 2014, 20, 1505–1509. 
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Scheme 2.17. Asymmetric Mannich/ IMAMR cascade with a,b-unsaturated-esters. 
2.1.4. CONJUGATED ESTER SURROGATES AS ACCEPTORS IN MICHAEL-TYPE 
REACTIONS 
As it has been seen, a,b-unsaturated esters are poor Michael acceptors 
and their application in organocatalysed conjugated additions is compromised 
by their low reactivity. This problem can be overcome by using activated ester 
surrogates, which facilitate the activation of the electrophilic moiety. In the 
literature there can be found several functional groups acting as ester 
equivalents, such as fluorinated derivatives (a),212 acyl oxazolidinones (b),213 
pyrrolidinone (c),213 imides (d),214 phosphonates (e),215 pyrroles (f),216 pyrazoles 
                                            
212 Fang, X.; Dong, X.-Q.; Liu, Y.-Y.; Wang, C.-J. Tetrahedron Lett. 2013, 54, 4509–4511. 
213 For oxazolidinones: a) Evans, D. a; Scheidt, K. a; Johnston, J. N.; Willis, M. C. J. Am. 
Chem. Soc. 2001, 123, 4480–4491. b) Hird, A. W.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2003, 
42, 1276–1279. c) Zhuang, W.; Hazell, R. G.; Jørgensen, K. A. Chem. Commun. 2001, 1240–
1241. d) Kanemasa, S. J. Synth. Org. Chem. Japan 2003, 61, 1073–1080. e) See Ref. 204f: 
Khaliel, S.; Nandakumar, M.; Krautscheid, H.; Schneider, C. Synlett 2008, 2705–2707. For 
pyrrolidinones: f) See Ref 53b: Hoashi, Y.; Okino, T.; Takemoto, Y. Angew. Chem. Int. Ed. 
2005, 44, 4032–4035. For both of them: g) See Ref. 53a: Guerin, D. J.; Miller, S. J. J. Am. 
Chem. Soc. 2002, 124, 2134–2136. h) Sibi, M. P.; Manyem, S.; Zimmerman, J. Chem. Rev. 
2003, 103, 3263–3296. i) Zhang, W.; Tan, D.; Lee, R.; Tong, G.; Chen, W.; Qi, B.; Huang, K.-
W.; Tan, C.-H.; Jiang, Z. Angew. Chem. Int. Ed. 2012, 51, 10069–10073. 
214 a) Goodman, S. N.; Jacobsen, E. N. Adv. Synth. Catal. 2002, 344, 953–956. b) Sammis, G. 
M.; Jacobsen, E. N. J. Am. Chem. Soc. 2003, 125, 4442–4443. c) Sibi, M. P.; Prabagaran, N.; 
Ghorpade, S. G.; Jasperse, C. P. J. Am. Chem. Soc. 2003, 125, 11796–11797. d) Myers, J. K.; 
Jacobsen, E. N. J. Am. Chem. Soc. 1999, 121, 8959–8960. e) Taylor, M. S.; Jacobsen, E. N. J. 
Am. Chem. Soc. 2003, 125, 11204–11205. f) Sallio, R.; Lebrun, S.; Schifano-Faux, N.; 
Goossens, J. F.; Agbossou-Niedercorn, F.; Deniau, E.; Michon, C. Synlett 2013, 24, 1785–
1790. 
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(g)213d,217 and pyrazolidinones (h).218 In addition, there have been also added 
extra functionalities to enhance the conjugated ester’s electrophilicity, such as 
an extra ester group at the geminal carbon219 (i) or an a-keto residue220 (j) 
(Figure 2.1). 
 
Figure 2.1. Ester equivalents used to activate the Michael acceptor. 
Given the relevance in the present memory, there will pointed out some 
examples containing a,b-unsaturated N-acyl pyrazole as electrophiles in 
conjugate additions. Sibi described in 2007217b an efficient conjugate hydroxyl 
amine addition to enoates that proceed with high levels of enantioselectivity 
using a bifunctional organocatalyst. Overall, it was achieved good substrate 
scope for the addition of amines to pyrazole derived enoates using a thiourea 
                                                                                                                                
215 a) Evans, D. A.; Scheidt, K. A.; Fandrick, K. R.; Lam, H. W.; Wu, J. J. Am. Chem. Soc. 
2003, 125, 10780–10781. b) Bachu, P.; Akiyama, T. Chem. Commun. 2010, 46, 4112-4114. c) 
Jiang, H.; Paixão, M. W.; Monge, D.; Jørgensen, K. A. J. Am. Chem. Soc. 2010, 132, 2775–
2783. 
216 a) Lee, S. D.; Brook, M. A.; Chan, T. H. Tetrahedron Lett. 1983, 24, 1569–1572. b) 
Matsunaga, S.; Kinoshita, T.; Okada, S.; Harada, S.; Shibasaki, M. J. Am. Chem. Soc. 2004, 
126, 7559–7570. c) Harada, S.; Handa, S.; Matsunaga, S.; Shibasaki, M. Angew. Chem. Int. 
Ed. 2005, 44, 4365–4368. d) Evans, D. A.; Borg, G.; Scheidt, K. A. Angew. Chem. Int. Ed. 2002, 
41, 3188–3191. 
217 a) Itoh, K.; Kanemasa, S. J. Am. Chem. Soc. 2002, 124, 13394–13395. b) See Ref. 106: 
Sibi, M. P.; Itoh, K. J. Am. Chem. Soc. 2007, 129, 8064-8065. c) See Ref. 74b: Sibi, M. P.; 
Shay, J. J.; Liu, M.; Jasperse, C. P. J. Am. Chem. Soc. 1998, 120, 6615–6616. d) Dong, X.-Q.; 
Fang, X.; Tao, H.-Y.; Zhou, X.; Wang, C.-J. Adv. Synth. Catal. 2012, 354, 1141–1147. e) Dong, 
X.-Q.; Fang, X.; Tao, H.-Y.; Zhou, X.; Wang, C.-J. Chem. Commun. 2012, 48, 7238-7240. 
218 Sibi, M. P.; Liu, M. Org. Lett. 2001, 3, 4181–4184. 
219 Enders, D.; Göddertz, D. P.; Beceño, C.; Raabe, G. Adv. Synth. Catal. 2010, 352, 2863–
2868. 
220 Xu, D.-Q.; Wang, Y.-F.; Zhang, W.; Luo, S.-P.; Zhong, A.-G.; Xia, A.-B.; Xu, Z.-Y. Chem. 
Eur. J. 2010, 16, 4177–4180. 
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catalyst, providing access to a variety of enantioenriched b-amino acid 
derivatives (Scheme 2.17.a). Their results also indicate that the pyrazole 
template plays a crucial role in providing H-bond acceptor sites for better 
organization and hence higher levels of selectivity in these organocatalytic 
reactions (Scheme 2.17.b). 
 
Scheme 2.17. Thiourea catalysed asymmetric intermolecular aza-Michael reaction. 
In 2012 Wang published two complementary procedures involving 
organocatalytic asymmetric sulfa-Michael additions to N-acyl pyrazoles. In the 
first one,217d a variety of thiols reacted with the easily available trans-4,4,4-
trifluorocrotonamide in excellent yields and good to excellent 
enantioselectivities (Scheme 2.18.a). They also evaluated the role of the 
pyrazole motif and the electron-withdrawing CF3 group, revealing the 
importance of both of them especially for a higher stereocontrol. In the 
second,217e they developed a direct construction of highly substitutes and 
biologically active thiochromanes via a sulfa-Michael-aldol reaction of 2-
mercaptobenzaldehyde with various a,b-unsaturated N-acyl pyrazoles, 
obtaining excellent diastereoselectivities and enantioselectivities for both b-aryl 
and b-alkyl conjugated substrates (Scheme 2.18.b). 
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Scheme 2.18. Organocatalytic asymmetric sulfa-Michael additions to N-acyl pyrazoles. 
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2.2. Objectives 
Because of the relevance of nitrogen-containing heterocycles and its 
synthesis in a straightforward manner with the intramolecular aza-Michael 
reaction (IMAMR), it seemed an appealing matter to complete the project, 
started several years ago in our research group, aimed at the development of 
convenient methodologies to carry out the IMAMR in an asymmetric 
organocatalytic fashion. The objective was to extend this procedure to 
conjugated esters as Michael acceptors, 221  since it had been already 
successfully applied to a,b-unsaturated aldehydes and ketones.222 
It was a real challenge, the use of the ester functionality in this setting, 
because the most commonly employed organocatalytic activation modes, that 
is, the iminium and enamine pathways, cannot be applied to esters, unlike their 
ketone and aldehyde counterparts. Therefore, other types of activation, such as 
hydrogen bonding are required for the activations of esters and derivatives.  
Initially, it was needed to find the appropriate combination of nitrogen 
nucleophile and organocatalyst to perform the enantioselective IMAMR with 
conjugated esters. However, at the end also the Michael acceptor required to 
be changed to an ester surrogate, able to be activated and later to be easily 
transformed into the equivalent ester (Scheme 2.18). 
 
Scheme 2.18. Initial objective of the present chapter. 
Finally, it was our desire to develop a domino process to prepare some 
other N-heterocycles combining a peptide coupling with the enantioselective 
                                            
221 Only one example of an organocatalytic direct IMAMR involving conjugated esters as 
Michael acceptors has been reported to date: (Ref. 111) Bandini, M.; Eichholzer, A.; Tragni, M.; 
Umani-Ronchi, A. Angew. Chem. Int. Ed. 2008, 47, 3238–3241. 
222 For enals: a)109 Fustero, S.; Jiménez, D.; Moscardó, J.; Catalán, S.; del Pozo, C. Org. Lett. 
2007, 9, 5283–5286. b)110 Fustero, S.; Moscardó, J.; Jiménez, D.; Pérez-Carrión, M. D.; 
Sánchez-Roselló, M.; del Pozo, C. Chem. Eur. J. 2008, 14, 9868–9872. c)172 Fustero, S.; del 
Pozo, C.; Mulet, C.; Lazaro, R.; Sánchez-Roselló, M. Chem. Eur. J. 2011, 17, 14267–14272. 
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IMAMR, starting from the corresponding conjugated carboxylic acids (Scheme 
2.19). 
 
Scheme 2.19. Desired domino peptide coupling-IMAMR
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2.3. Results and discussion 
In light of the low reactivity of the a,b-unsaturated esters, it was 
envisioned that a more nucleophilic nitrogen would be necessary to develop the 
sought intramolecular aza-Michael reaction (IMAMR). Moreover, given the 
inability of esters to be activated through an iminium covalent activation, the 
introduction of additional hydrogen bonding anchorage points at the substrates 
would also be interesting for both the activation and the chiral induction. 
2.3.1. SEARCH OF SUITABLE STARTING MATERIALS 
2.3.1.1. Study of alkyl amine conjugated esters 42 and 43 
SYNTHESIS OF BENZYL AMINE 42 
In a first attempt, a secondary amine seemed to be a good partner for the 
IMAMR, since the more nucleophilic amine (when compared with the usual 
carbamates employed in those processes) would compensate the lower 
reactivity of conjugated esters. To this end, benzyl amine 42 and the 
pyridylmethyl amine 43 bearing an a,b-unsaturated ethyl ester were 
synthesized (Figure 2.2).  
 
Figure 2.2. Desired starting materials 42 and 43. 
Starting from the commercial available 5-hexenenitrile 8, it was reduced 
to the corresponding primary amine with lithium aluminium hydride and 
condensed in situ with benzaldehyde to give imine 45, that was reduced to the 
benzyl amine by means of sodium borohydride. The next step of the sequence 
was a cross-metathesis (CM) with the ruthenium catalyst Hoveyda-Grubbs 
second-generation (HG-II). Since the catalyst could be poisoned by a 
secondary amine, 46 should be previously protected; the optimised 
approximation was to use di-tert-butyl dicarbonate to generate the Boc 
carbamate 47, that underwent the CM with ethyl acrylate with good yield. 
N
H
OEt
O NH N
OEt
O
42 43
  
Chapter 2 Results and Discussion 
  
152 
Finally, the secondary amine was deprotected with trifluoroacetic acid. 
However, when the free amine was released at neutral pH the desired 
compound 42 was never isolated, since it suffered a spontaneous racemic 
cyclisation. To avoid this undesired situation, it was isolated as the 
corresponding ammonium trifuoroacetate salt 42’ maintaining acid pH (Scheme 
2.20). 
 
Scheme 2.20. Approximation to the synthesis of benzyl amine 42. 
INTRAMOLECULAR AZA-MICHAEL REACTIONS OF ALKYL AMMONIUM SALT 42’ 
Benzyl ammonium 42’ was used as starting material to perform the 
desired IMAMR with a battery of 14 different organocatalysts (Figure 2.3) in the 
presence of base. Unfortunately, only in some cases the desired product was 
obtained and always in racemic form, indicating that the base-mediated 
cyclisation is faster that the organocatalysed process. 
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Figure 2.3. First batch of tested organocatalysts. 
Thiourea I, in combination with triethyl amine, gave 33% of racemic 
product 50 after one week at room temperature. The phase-transfer catalyst 
(PTC) II together with aqueous KOH produced after 3 days the racemic adduct 
with 40% yield. PTC III produced the racemic product with 62% yield in the 
presence of K2CO3. Hydroquinine IV combined with tBuOK did not yield the 
Michael adduct, whereas quinine V with K2CO3 provided the cyclic product 50 
with 86% yield but also racemic. When cinchonidine VI was used with tBuOK no 
reaction was observed. Hydroquinidine derived ethers VII and VIII gave racemic 
compound 50 with 65% and 50% yield, respectively. L-arginine IX either naked 
or as hydrochloride was not able to induce the Michael reaction. Sparteine X, 
with a catalytic amount of K2CO3, produced racemic Michael adduct 50. 
However, binaphtyl diamine XI did not give rise to the desired product with 
catalytic K2CO3. Finally, with hydroxyphenyl diamine XII in the presence of 
catalytic K2CO3 provided 79% of racemic product 50. 
SYNTHESIS OF PYRIDYL AMINE 43 
Conjugated ester 43’ bearing the pyridyl unit in the ammonium salt was 
prepared next, since the heterocycle would provide an extra hydrogen bond 
acceptor point, and a better coordination with the organocatalyst would be 
expected. The synthetic sequence applied was analogous to the one used for 
compound 42’. However, in this case the final Boc-deprotection could not be 
completed, remaining always unprotected 53 unreacted. Thus, to avoid this 
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problem the ammonium chloride compound 43’’ was prepared, showing now a 
complete conversion from 53 with a solution of hydrochloric acid in dioxane. 
Again, after release of the amine functionality at pH=7 the spontaneous 
cyclisation occurred, giving rise to the racemic Michael adduct 54 (Scheme 
2.21). 
 
Scheme 2.21. Approximation to the synthesis of pyridyl amine 43. 
INTRAMOLECULAR AZA-MICHAEL REACTIONS OF ALKYL AMMONIUM SALT 
43’’ 
With the substrate in hand, the first attempt was performed using a 
hydrogen bond activation, with the hydroquinidine thiourea I as catalyst. 
However, as no reaction was observed it was added a prochiral base, trans-2,5-
dimethylpiperazine. The desired compound 54 was finally obtained but, either 
employing acetonitrile, chloroform, tetrahydrofurane or toluene as solvent, was 
isolated as a racemic product. In order to favour the thiourea activation of the 
starting material, microwave irradiation was tested in absence of base, however 
it did not’ succeed (Scheme 2.22.a). Likewise, the trifluoroacetate salt 43’ gave 
the racemic Michael adduct by means of PTC II and III in the presence of a 
substoichiometric charge of aqueous KOH at -45ºC (Scheme 2.22.b). 
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Scheme 2.22. Cyclisation of the trifluoroacetate salt 43’. 
When chlorhydrate 43’’ was used as starting material instead of 
trifluoroacetate 43’, piperidine 54 was not obtained with thiourea I as catalyst. 
When employing PTC II the reaction temperature needed to be risen to room 
temperature and an extra charge of 50 mol% of aqueous potassium hydroxide 
was added to allow the aza-Michael reaction to takes place, although without 
asymmetric induction. The difference of reactivity between ammonium salts 43’ 
and 43’’ could be explained on the basis of the basicity of the trifluoroacetate 
anion of the starting material. Therefore, it was performed an anionic exchange 
with bromide and chloride PTC II and III by means of Amberlyst A26 resin to 
prepare the analogous hydroxide PTC II’ and III’. 223  However, the desired 
IMAMR just took place by adding 0.8 equivalents of K2CO3 and rising 
temperature to 0ºC, obtaining again the racemic Michael adduct (Scheme 2.23). 
 
Scheme 2.23. Cyclisation of the chlorhydrate salt 43’’. 
                                            
223 Shirakawa, S.; Terao, S. J.; He, R.; Maruoka, K. Chem. Commun. 2011, 47, 10557-10559. 
N
H2
N
OEt
O
CF3CO2-
43'
N
N
OEt
O
54
N
N
OEt
O
54
OMe
N
N
H
I
N
N
H
S
CF3
CF3
N
H N
OH
F3C
Br
II III
I (20 mol%)
solvent
H
N
N
H II or III (10 mol%)
25% aq. KOH (50 mol%)
toluene, -45ºC
.
(a) (b)
N
H N
OHCl
N
H2
N
OEt
O
Cl-
43''
N
H N
OH
F3C
II' III'
II' or III' (10 mol%)
K2CO3 (80 mol%)
H2O/DCM, -45ºC to 0ºC
.
N
H N
OHOHOH
N
N
OEt
O
54
  
Chapter 2 Results and Discussion 
  
156 
2.3.1.2. Study of sulfonamide conjugated esters 55 and 56 
SYNTHESIS OF SUBSTRATS 55 AND 56 
Since alkyl amines were too nucleophilic and the classically used 
carbamates were not reactive enough, it was sought a nitrogen source with an 
intermediate nucleophilicity. In this way, sulfonamides reach those 
requirements, showing also higher acidity of the amine hydrogen and offering 
both oxygens to possible additional anchorage points for a hydrogen bond 
activation. Thus, there were synthesized pyridine-2-sulfonamide ester 55 and 
benzenesulfonamide ester 56 (Figure 2.4). 
 
Figure 2.4. Starting sulfonamide a,b-unsaturated esters 55 and 56. 
These starting materials were prepared following the synthetic sequence 
shown hereunder (Scheme 2.24). Starting from hexenenitrile 8, after reduction 
with lithium aluminium hydride, it was obtained the primary amine 9, which was 
in situ added to sulfonyl chlorides 58 and 59 in the presence of pyridine to give 
sulfonamide olefins 60 and 61 224  respectively in moderate yields. 
Benzenesulfonyl chloride 59 was commercially available, whereas pyridine-2-
sulfonyl chloride 58 needed to be prepared in situ by oxidation of pyridine-2-
thiol 57 to react with 9 without isolation.225 Terminal olefins 60 and 61 gave 
upon cross-metathesis with catalyst Hoveyda-Grubbs second generation (HG-
II) with the corresponding acrylates the desired compounds 55 and 56 with very 
good yields.226 
                                            
224 Luo, S.-P.; Guo, L.-D.; Gao, L.-H.; Li, S.; Huang, P.-Q. Chem. Eur. J. 2013, 19, 87–91. 
225 García-Rubia, A.; Urones, B.; Gómez Arrayás, R.; Carretero, J. C. Angew. Chem. 2011, 
123, 11119–11123. Angew. Chem. Int. Ed. 2011, 50, 10927–10931. 
226 Fustero, S.; Monteagudo, S.; Sánchez-Roselló, M.; Flores, S.; Barrio, P.; del Pozo, C. 
Chem. Eur. J. 2010, 16, 9835–9845. 
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Scheme 2.24. Preparation of sulfonamide esters 55 and 56. 
INTRAMOLECULAR AZA-MICHAEL REACTIONS OF SULFONAMIDES 55 AND 56 
The cyclisation of conjugated ester 55 was firstly attempted with the 
classical combination172 of primary-amine hydroquinidine with trifluoroacetic 
acid in chloroform used for enones, however it did not react. Then it was tested 
as hydrogen-bonding organocatalyst the hydroquinidine-thiourea I, but it did not 
succeed promoting the desired IMAMR either alone or in the presence of bases 
like the trans-2,5-dimethylpiperazine or K2CO3 in racemic manner. 
Notwithstanding, the use of squaramide ACS in the presence of K2CO3 gave 
rise to the Michael adduct 63 but still as a racemic mixture (Scheme 2.25.a). 
Then, it was confirmed the necessity of a base to undergo the conjugate 
addition when substrate 56 could not be transformed into the corresponding 
piperidine 64 just in the presence of the squaramide (Scheme 2.25.b).227 
 
Scheme 2.25. Cyclisation of the sulfonamide a,b-unsaturated esters 55 and 56. 
                                            
172 Fustero, S.; del Pozo, C.; Mulet, C.; Lazaro, R.; Sánchez-Roselló, M. Chem. Eur. J. 2011, 
17, 14267–14272. 
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2.3.1.3. Study of N-Cbz-protected amine conjugated ester and 
surrogates 65-68 
SYNTHESIS OF SUBSTRATES 65-68 
Once proved the difficulty to activate a,b-unsaturated esters as Michael 
acceptors for the desired enantioselective IMAMR, there were prepared several 
ester surrogates expected to act both as ester equivalents and as better 
electrophiles. They were combined initially with benzyloxycarbonyl (Cbz) 
protected amines, since this kind of carbamate moiety is easily accessible. 
Thus, there were synthesized the conjugated N-acyl pyrrol 65, N-acyl pyrazole 
66 and Weinreb amide 67. It was also prepared the analogous compound 68 
with an ethyl ester group to experimentally compare its reactivity also with the 
previously mentioned surrogates 65-67. 
 
Figure 2.5. Starting carbamates functionalised with a,b-unsaturated ester and surrogates. 
The conjugated ester 68 was simply prepared in good yield by CM 
reaction of carbamate 1a with ethyl acrylate 48 (Scheme 2.26.a). The synthetic 
sequence for the ester surrogates consisted on the preparation of the 
corresponding a,b-unsaturated CM counterparts, that were combined with the 
terminal olefin 1a following the CM reaction conditions. On the one hand, 
conjugated N-acyl pyrrol 71 was prepared by the nucleophilic substitution of 
methyl acryl amide 69 to 2,5-dimethoxytetrahydrofuran 70 in the presence of 
acetic acid.228 Then, after CM reaction with olefin 1a (previously described in 
Chapter 1) it was obtained the desired product 65 with good yield (Scheme 
2.26.b). On the other hand, given the commercial availability of pyrazole 72, it 
was reacted with acryloyl chloride 73 to give adduct 74 with excellent yield. 
Although the subsequent CM reaction could not arrive to completion (67% 
conversion), final product 66 was obtained with good yield (Scheme 2.26.c). 
Likewise, Weinreb amine hydrochloride 75 combined with acryloyl chloride 73 
                                            
228 Evans, D. A.; Borg, G.; Scheidt, K. A. Angew. Chem. Int. Ed. 2002, 41, 3188–3191. 
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gave conjugate amide 76 with moderate yield.229 And the following CM reaction 
to obtain compound 67 proceed also with low yield and incomplete conversion 
(Scheme 2.26.d). 
 
Scheme 2.26. Synthesis of conjugated ester 68 and ester surrogates 65-67. 
INTRAMOLECULAR AZA-MICHAEL REACTIONS OF CARBAMATES 65-68 
With the sought starting materials on hand, the cyclisation conditions 
were studied. a,b-Unsaturated ester 68 remained unaltered after 60 h in the 
presence of ACS catalyst, either at room temperature or in CHCl3 under reflux. 
Regarding pyrrolamide 65, it decomposed with tetrabutyl ammonium fluoride 
(TBAF) and produced cyclic piperidine 77 in only 15% yield in presence of 
tBuOK. When acidic conditions were used, it did not react employing 
                                            
229 Corminboeuf, O.; Renaud, P. Org. Lett. 2002, 4, 1735–1738. 
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trifluoroacetic acid (TFA), but with (1S)-(+)-camphorsulfonic acid (CSA) it gave 
Michael adduct 77 in 45% yield, which could be improved to a 70% by 
microwave irradiation at 120ºC (Scheme 2.27). Then, it was combined primary-
amine hydroquinidine with CSA expecting some chiral induction, however just 
the racemic piperidine 77 was obtained in all cases. Nevertheless, compounds 
66 and 67 did not cyclise neither with tBuOK nor with the hydrogen-bonding 
organocatalysts like squaramides or thioureas. 
 
Scheme 2.27. Best result obtained for cyclisation of starting material 65. 
2.3.1.4. Study of sulfonamide conjugated ester surrogates 78-82 
SYNTHESIS OF SUBSTRATE CANDIDATES 78-80 
After this tough trial/error-based development process, it was designed a 
family of starting materials for the IMAMR that possessed both a sulfonamide as 
nitrogen nucleophile, and an ester surrogate as Michael acceptor. Thus, 
sulfonamide would provide a more acidic hydrogen and more anchoring points 
for catalysis, and the ester surrogate would show a higher electrophilicity and 
again more hydrogen-bond acceptors positions for enhance catalysis (Figure 
2.6). 
 
Figure 2.6. Starting sulfonamides functionalised with a,b-unsaturated 
ester surrogates 78-80. 
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The initial approximation for the synthesis of compounds 78 and 79 was 
following the aforementioned preparation of the protected amines with the 
terminal olefin; in this case the CM reaction of sulfonamide 61 with the 
previously prepared N-acyl pyrrol 71 and N-methoxy-N-methyl amide 76 
respectively. However, after several attempts these transformations did not 
proceed (Scheme 2.28). 
 
Scheme 2.28. Unsuccessful CM reactions for the synthesis of 78 and 79.  
For the preparation of the Weinreb amide derivative 79 it was found an 
alternative route230 that comprised a CM reaction of 61 with tert-butyl acrylate 
62, followed by the ester hydrolysis in acidic media of 56 with 10 equivalents of 
TFA to give the corresponding acid 81. Then, this compound was converted 
into an acyl chloride that would react with Weinreb amine hydrochloride 75 in 
the presence of triethyl amine and 4-dimethyl aminopyridine, to finally give rise 
to the desired product 79 but with a low yield (Scheme 2.29). It was tried an 
alternative peptide coupling for this last step but it did not produce the desired 
amide. 
                                            
230 Fustero, S.; Báez, C.; Sánchez-Roselló, M.; Asensio, A.; Miro, J.; del Pozo, C. Synthesis 
2012, 44, 1863–1873. 
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Scheme 2.29. Preparation of Weinreb-amide derivative 79. 
Initially, N-acyl pyrazoles 80a and 80b were prepared following the 
stablished sequence of separately preparing sulfonamides 60 and 61 and 
pyrazole amide 74 to make them react afterwards in a CM reaction producing 
the starting-material candidates 80a and 80b for the IMAMR. However, 
conversion in both cases was poor and the yield of the converted part just 
moderate (Scheme 2.30; Table 2.1. entries 1-2).  
 
Scheme 2.30. Preparation of N-acyl pyrazoles 80a and 80b. 
Given the importance of this substrates, that will be commented later, 
there was developed a thorough optimisation of this CM reaction conditions 
(Table 2.1). When the transformation was undergone in reflux of 
dichloromethane conversion diminished although the yield improved (Table 2.1. 
entries 3-4). Additives did not help either; Ti(EtO)4 avoided formation of the 
desired product (Table 2.1. entry 5) and p-TSA led to the racemic cyclisation of 
the formed compound 80b (Table 2.1. entry 6). Heating the crude to 60ºC under 
microwave irradiation (MW) improved the yield but not the conversion (Table 
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2.1. entry 7). The employment of toluene or dichloroethane as solvents gave 
worse results in terms of yield (Table 2.1. entries 8-9). A second addition of the 
catalyst enhanced the yield of the converted starting material comparing to the 
same conditions with just one loading of HG-II (Table 2.1. entries 10 vs. 2). The 
addition of the 20 mol% loading of HG-II in four times employing p-
toluenesulfonamide 82 as substrate lead to higher conversion and yield after 24 
hours at room temperature (Table 2.1. entry 11). However, the same conditions 
utilizing the ruthenium catalyst Grubbs second generation (G-II) could not give 
any better result (Table 2.1. entry 12). Given the yield enhancement achieved 
with MW irradiation, it was studied its combination with the 4-step catalyst 
addition together with a higher concentration of the crude (Table 2.1. entry 13), 
obtaining a better conversion with good yield after heating at 100ºC during 5 
minutes after each load of HG-II. A higher concentration of 1 M respect to the 
usually employed 0.1 M seemed to respond favourably, although when it was 
performed in neat conditions (Table 2.1. entry 14) results weren’t better. An 
extra ruthenium catalyst with an indene functionalization was tried out, not 
giving better results at either at 0.1M or 1M concentration (Table 2.1. entries 15-
16). Finally, the cross-metathesis reaction of sufonamide 83 with the optimised 
conditions of 20 mol% HG-II added in four steps while heating at 100ºC under 
MW during a total of 20 minutes gave rise to a good conversion and an 
excellent yield (Table 2.1. entry 17). 
Table 2.1. Optimisation of the cross-metathesis reaction to prepare N-acyl pyrazole 
sulfonamides 80a-b. 
 
Entry Prod. [Ru] (mol%) Solvent T (ºC) t (h) Yield (%)a Conv. (%) 
1 80 HG-II (20) DCM 25 24 88 46 
2 81 HG-II (10) DCM 25 16 65 36 
3 81 HG-II (10) DCM 25-45 24 70 35 
4 81 HG-II (10) DCM 45 48 96 26 
5 81 HG-II (10)b DCM 45 24 0 33 
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6 81 HG-II (10)c DCM 25-45 2 29d 91 
7 80 HG-II (10) DCM 60e 2 83 24 
8 81 HG-II (10) toluene 100e 2 44 50 
9 81 HG-II (15) DCE 80 24 22 64 
10 81 HG-II (10+10) DCM 25 24 82 33 
11 82 HG-II (5x4) DCM 25 24 94 53 
12 82 G-II (5x4) DCM 25 24 71 48 
13 81 HG-II (5x4) DCMf 100e 0.33g 70 78 
14 81 HG-II (5x4) - 100e 0.33g 63 60 
15 81 indene (5x4) DCM 100e 0.33g 26 30 
16 81 indene (5x4) DCMf 100e 0.33g 40 28 
17 82 HG-II (5x4) DCMf 100e 0.33g 94 53 
a Isolated yields after flash chromatography purification of the converted SM. 
b 10 mol% Ti(EtO)4 added 
c 2 eq. pTSA231 added 
d Desired product partially cyclised to the racemic Michael adduct 
e Microwave irradiation 
f 1 Molar (usually 0.1M) 
g 20 minutes 
Thus, the optimised synthesis of a sulfonamide with an a,b-unsaturated 
N-acyl pyrazole consisted in the preparation of tosyl amide 83232 starting from 
hexenenitrile 8 and tosyl chloride 82 following the stablished conditions of nitrile 
reduction with LiAlH4 and amine protection with pyridine. Then it was performed 
the CM reaction with the previously prepared counterpart 74 in DCM (1M) and 
20 mol% HG-II catalyst added in 4 times followed by 5 minutes of MW 
irradiation at 100ºC, to give rise to the desired product 80c in excellent yield and 
moderate conversion (Scheme 2.31). 
 
Scheme 2.31. Synthesis of tosyl amide 82. 
                                            
231 Cuñat, A. C.; Flores, S.; Oliver, J.; Fustero, S. Eur. J. Org. Chem. 2011, 2011, 7317–7323. 
232 Hegedus, L. S.; McKearin, J. M. J. Am. Chem. Soc. 1982, 104, 2444–2451. 
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INTRAMOLECULAR AZA-MICHAEL REACTIONS OF SULFONAMIDES 79, 80A-C 
Sulfonamide 79 functionalised with a conjugated Weinreb amide as ester 
surrogate was cyclised with tBuOK to prepare the racemic Michael adduct and 
try to separate its enantiomers with a chiral column in the HPLC. However, this 
separation could not be achieved and this substrate was dismissed.  
The very first attempt of an asymmetric IMAMR performed with the family 
of N-acyl pyrazole substrates was with sulfonamide 80a in the presence of 
squaramide ACS in CHCl3 as solvent at room temperature (Scheme 2.32). After 
88h the reaction hadn’t finished, however it was finally accomplished the 
desired chiral induction and Michael adduct 84a was obtained with 88.5:11.5 er 
and moderate yield. 
 
Scheme 2.32. First accomplished asymmetric IMAMR with 
conjugated N-acyl pyrazole 80a. 
Hence, some other squaramide analogues were prepared in order to find 
the best match pair of catalyst-substrate (Scheme 2.33). Starting from 
cyclobutenedione 85 it was initially performed the nucleophilic substitution with 
aniline 86 to give the one-side functionalised squaramide 87. This crude could 
be added to the previously deprotonated diamine 88 to give rise to squaramide 
91, that was then methylated with formaldehyde and formic acid in methanol to 
give the tertiary-amine functionalised aniline-cyclohexane squaramide (ACS). 
The crude of 87 was subjected, in parallel, to a nucleophilic substitution with the 
primary-amine hydroquinidine 90 to produce aniline-hydroquinidine squaramide 
(AHS).233 On the other hand, when compound 85 was combined with benzyl 
amine 91 yielded intermediate 92, which after the nucleophilic addition of amine 
90 originated benzyl amine-hydroquinidine squaramide (BHS).234 Finally, the 
                                            
233 Konishi, H.; Lam, T. Y.; Malerich, J. P.; Rawal, V. H. Org. Lett. 2010, 12, 2028–2031. 
234 Malerich, J. P.; Hagihara, K.; Rawal, V. H. J. Am. Chem. Soc. 2008, 130, 14416–14417. 
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doubly substituted with hydroquinidine-hydroquinidine squaramide (HHS) was 
obtained with excellent yield from 85.235 
 
Scheme 2.33. Synthesis of squaramide organocatalysts. 
With this family of squaramides in hand, the IMAMR was evaluated in 
order to find out the optimal conditions by modifying the aromatic ring of the 
sulfonamide, the catalyst and its loading, the solvent and the temperature as it 
is shown in Table 2.2. 
Table 2.2. Optimisation of the IMAMR with N-acyl pyrazole sulfonamides 80a-c to obtain 
piperidines 84a-c. 
 
 
                                            
235 Woong Lee, J.; Hi Ryu, T.; Suk Oh, J.; Yong Bae, H.; Bin Jang, H.; Eui Song, C. Chem. 
Commun. 2009, 7224-7226. 
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Entry SM Catalyst (mol%) Solvent T (ºC) Yield (%)a erb 
1 80a ACS (15) CHCl3 25 45 88.5:11.5 
2 80a ACS (15) THF 25 - - 
3 80a ACS (15) CH3CN 25 - - 
4 80a ACS (15) Toluene 25 47 85:15 
5 80b ACS (15) CHCl3 25 95 93:7 
6 80b I CHCl3 25 48 90:10 
7 80b ACS (15) Toluene 0 10 92:8 
8 80b ACS (10) DCE 85 58 89:11 
9 80b ACS (10) DCE 60c 60 92.5:7.5 
10 80a BHS (15) CHCl3 25 72 89.5:10.5 
11 80b BHS (10) CHCl3 25 52 96:4 
12 80b AHS (10) CHCl3 25 55 98:2 
13 80b AHS (10) CHCl3 60c 55 96.5:3.5 
14 80b AHS (15) CHCl3 60c 53 96.5:3.5 
15 80b AHS (5) CHCl3 60c 30 96.5:3.5 
16 80b AHS (10) DCE 60c 45 97:3 
17 80b AHS (10) Et2O 60c 50 97.5:2.5 
18 80b AHS (10) Acetone 60c 20 96.5:3.5 
19 80b AHS (10) MeNO2 60c 51 96.5:3.5 
20 80a BHS (10) CHCl3d 60c 48 92.5:7.5 
21 80a BHS (10) CHCl3e 60c 42 92:8 
22 80a BHS (10) CHCl3/Et2O 60c 30 91.5:8.5 
23 80a BHS (10) CHCl3/MeNO2 60c 10 80.5:19.5 
24 80a AHS (10) CHCl3 60-100c 66 90.5:9.5 
25 80a AHS (10) CHCl3 100c 86 87.5:12.5 
26 80b AHS (10) CHCl3 60-100c 91 95.5:4.5 
27 80b AHS (10) CHCl3 100c 89 93:7 
28 80b AHS (10) CPMEf 90c 92 96.5:3.5 
29 80c AHS (10) CPMEf 60-100c 82 97:3 
30 80c AHS (10) CHCl3 25 - - 
31 80c AHS (10) CPMEf 25 8 97.5:2.5 
32 80c AHS (10) CPMEf 90c 91 96:4 
33 80c AHS (10) CPMEf 110 92 95:5 
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34 80c HHS (10) CPMEf 90c 25 92:8 
a Isolated yields after flash chromatography purification. 
b Determined by chiral stationary phase HPLC 
c Microwave irradiation 
d 0.2 Molar (usually 0.1M) 
e 0.05 Molar 
f Cyclopentyl methyl ether 
After screening a number of solvents it was initially thought that 
chloroform was the optimum one (Table 2.2. entries 2-4, 7-9, 16-19, 22-23) in 
terms of both yield and stereoselectivity (Table 2.2. entry 26). However, after 
some extra bibliographic research,236 it was finally identified cyclopentyl methyl 
ether (CPME) as the most suitable solvent both for the obtained results and its 
chemical properties (e.g. boiling point and solubility). Among the five tested 
organocatalysts, squaramides ACS, BHS, AHS and HHS and thiourea I, the 
aniline-hydroquinidine squaramide (AHS) was found to give the better chiral 
induction (Table 2.2, entries 12 vs. 5, 11; entries 32 vs. 34) with the optimal 
loading of 10 mol% (Table 2.2, entries 13 vs. 14, 15). Regarding thermal 
conditions, the studied IMAMR was monitored at room temperature, at 0ºC, at 
solvent reflux and with microwave irradiation, being finally determined 90ºC with 
microwave irradiation as the optimal conditions for the synthesis of piperidines 
84 (Table 2.2. entries 28, 32).  
Besides all the variations included in Table 2.2. it was also checked out 
that the employment of additives such as benzoic acid, TFA or tetrabutyl 
ammonium iodide, just led to a worse progress of the reaction. 
2.3.2. ENANTIOSELECTIVE SYNTHESIS OF PIPERIDINES, PYRROLIDINES, 
ISOINDOLINE AND TETRAHYDROISOQUINOLINES 84 AND 93-96 
The optimised intramolecular aza-Michael reaction (IMAMR), employing 
aromatic sulfonamides as nucleophiles and an a,b-unsaturated 3,5-dimethyl 
pyrazole (DMP) as Michael acceptor, was applied to the synthesis of differently 
functionalised piperidines (84), pyrrolidines (93), isolindoline (94) and 
                                            
236 a) Watanabe, K.; Yamagiwa, N.; Torisawa, Y. Org. Process Res. Dev. 2007, 11, 251–258. 
b) Asano, K.; Matsubara, S. J. Am. Chem. Soc. 2011, 133, 16711–16713. c) Okamura, T.; 
Asano, K.; Matsubara, S. Chem. Commun. 2012, 48, 5076-5078. 
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tetrahydroisoquinolines (95-96) (Figure 2.7) with excellent yields and good to 
very good enantioselectivities (Table 2.3). 
 
Figure 2.7. Scope of the optimised IMAMR with ester surrogates. 
Substrates for the synthesis of products 84d-e and 94-96 were prepared 
following analogous procedures to those described previously in this Memory 
for the protection of the free amines and the CM reactions with pyrazole amide 
74. Compound 101 was obtained in good yield, whereas preparation of 102 had 
lower yield (Scheme 2.34.a). Synthesis of 104a and 104b starting from 4-
pentenenitrile 10 proceed with moderate yields for both in the construction of 
sulfonamides 103a 237  and 103b224 and in the subsequent CM reactions 
(Scheme 2.34.b). Amine 17 (Scheme 1.37) was protected with tosyl chloride 82 
giving compound 105238 with low yield, as well as it happened with the following 
CM reaction with conjugated DMP 74 (Scheme 2.34.c). Likewise, amine 25 
(Scheme 1.39) gave rise to tosyl amide 107239 with poor yield, although CM 
reaction to obtain compound 108 proceeded with good yield (Scheme 2.34.d). 
Finally, starting from commercial phenethyl amine 26 it was synthesized 
protected amine 109240 with very good yield, to then prepare compound 110 
through CM reaction with low yield (Scheme 2.34.d).  
                                            
237 Zeng, W.; Chemler, S. R. J. Am. Chem. Soc. 2007, 129, 12948–12949. 
224 Luo, S.-P.; Guo, L.-D.; Gao, L.-H.; Li, S.; Huang, P.-Q. Chem. Eur. J. 2013, 19, 87–91. 
238 Bennasar, M. L.; Roca, T.; Monerris, M.; García-Díaz, D. J. Org. Chem. 2006, 71, 7028–
7034. 
239 Hegedus, L. S.; Allen, G. F.; Bozell, J. J.; Waterman, E. L. J. Am. Chem. Soc. 1978, 100, 
5800–5807. 
240 Sherman, E. S.; Fuller, P. H.; Kasi, D.; Chemler, S. R. J. Org. Chem. 2007, 72, 3896–3905. 
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Scheme 2.34. Synthesis of conjugated-DMP substrates for IMAMR. 
In order to prove the influence of the electronic requirements of the 
aromatic sulfonamide in the process, substrates containing both electron-
donating and electron-withdrawing substituents were synthesized. In all cases, 
piperidine derivatives 84a-e were obtained in very good yields (70-92%) and 
enantioselectivities (up to 96.5:3.5 er. Table 2.3, entries 1-5). However, the 
formation of the pyrrolidine counterparts took place with decreased 
enantioselectivity, giving rise to compounds 93a-b with 90:10 and 88:12 er, 
respectively (Table 2.3, entries 6-7).241  This protocol was next extended to 
                                            
241 The formation of five-membered rings by intramolecular organocatalytic reactions was found 
to be less effective than the corresponding six-membered rings: a) Nodes, W. J.; Nutt, D. R.; 
Chippindale, A. M.; Cobb, A. J. A. J. Am. Chem. Soc. 2009, 131, 16016–16017. b) See Ref. 
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benzofused derivatives 106, 108 and 110. Thus, isoindoline 94 and 
tetrahydroisoquinoline 95 were obtained in good yield (93 and 84% 
respectively) and enantioselectivity (90:10 and 93.5:6.5 er, respectively. Table 
2.3, entries 8-9). 1-Substituted tetrahydroisoquinoline 96 was also efficiently 
synthesized, although enantioselection was in this case lower (85:15 er. Table 
2.3, entry 10). 
Table 2.3. Extension of the scope of the IMAMR for the enantioselective synthesis of 
monocyclic 84 and 93 and benzofused 94-96 N-heterocycles. 
 
Entry m n SM X R T (ºC) t (h) Prod. Yield (%)a erb 
1 1 1 80a N H 25c 120 84a 71 92.5:7.5 
2 1 1 80b C H 90 4 84b 92 96.5:3.5 
3 1 1 80c C Me 90 4 84c 91 96:4 
4 1 1 101 C MeO 90 5 84d 70 96.5:3.5 
5 1 1 102 C CF3 90 5 84e 91 95:5 
6 1 0 104a C H 60 2 93a 98 90:10 
7 1 0 104b C Me 40 5 93b 84 88:12 
8 1 0 106 C Me 60 4 94 93 90:10 
9 1 1 108 C Me 60 4 95 84 93.5:6.5 
10 2 0 110 C Me 60 4 96 88 85:15 
a Isolated yields after flash chromatography purification. 
b Determined by chiral stationary phase HPLC 
c Without microwave irradiation 
2.3.3. ENANTIOSELECTIVE SYNTHESIS OF 6-MEMBERED RING N-
HETEROCYCLES THROUGH A DOMINO PROCESS 
The results presented in Table 2.3 show that this IMAMR is especially 
efficient in the formation of piperidine derivatives and therefore, it was decided 
to evaluate the synthesis of different 6-membered ring heterocycles by means 
of this methodology. To this end, it was first considered the possibility of 
                                                                                                                                
172: Fustero, S.; del Pozo, C.; Mulet, C.; Lazaro, R.; Sánchez-Roselló, M. Chem. Eur. J. 2011, 
17, 14267–14272. 
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synthesize a morpholine derivative. The corresponding conjugated 
pyrazolamide substrate for the IMAMR should be obtained through a CM 
reaction between 113 and 3,5-dimethylpyrazol acryl amide 74 in the presence 
of ruthenium catalyst Hoveyda-Grubbs second generation (HG-II) in a similar 
way than other substrates had been previously prepared. However, this CM 
reaction on compound 113 did not proceed even when the reaction mixture was 
heated under reflux in the presence of a Lewis acid [Ti(EtO)4] or a Brønsted 
acid (p-TSA). 
At this point, it was decided to employ an alternative synthetic approach 
to access the desired IMAMR substrate 116, analogous in the first steps to that 
employed for the preparation of the Weinreb amide derivative 79 (Scheme 
2.29). Once synthesized 113242 through a controlled alkylation of ethanolamine 
111 with allyl bromide 112 by means of tetrabutyl ammonium iodide and sodium 
hydroxide, the route designed involved the CM between 113 and tert-butyl 
acrylate 62, followed by ester deprotection on compound 114 and peptide 
coupling (PC) of a,b-unsaturated acid 115 with 3,5-dimethyl pyrazole (DMP) 72. 
Unfortunately, under the conditions employed to effect the PC, racemic 
morpholine derivative 84f, arising from the IMAMR of intermediate 116, was 
directly obtained (Scheme 2.35.a). Despite this unexpected result, it was 
envisioned the potential of developing a domino enantioselective process in the 
presence of chiral squaramide AHS. To our delight, treatment of acid 115 with 
AHS, diisopropyl carbodiimide (DIC), and DMP 72 in CPME at 50ºC under 
microwave irradiation, led to the formation of the morpholine derivative 84f in 
83% yield and 99.5:0.5 er (Scheme 2.35.b). 
                                            
242 Lu, Z.; Stahl, S. S. Org. Lett. 2012, 14, 1234–1237. 
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Scheme 2.35. Development of an organocatalytic domino PC-IMAMR. 
This domino protocol was next extended to substrates depicted in Figure 
2.8. Besides morpholine derivative 84f, this methodology was efficient in the 
formation of other 6-membered rings such as geminal-substituted piperidines 
84g and 84h or keto piperazine 84i, which were obtained in moderate yields 
and good enantioselectivities. Compound 84c was also obtained through this 
domino procedure with similar results in terms of enantioselectivity when 
compared to the stepwise process, although in lower yield (Table 2.3, entry 3). 
In the formation of pyrrolidine 93b some erosion of enantioselectivity also 
occurred (Table 2.3, entry 7). 
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Figure 2.8. Products obtained through the organocatalytic domino PC-IMAMR. 
Preparation of the rest of conjugated acid substrates for the domino PC-
IMAMR are described in Scheme 2.36. Addition of LDA-deprotonated 
isobutyronitrile 117 to 4-bromobutene 118,243 followed by the stablished nitrile 
reduction and amine protection gave sulfonamide 119 with three-step moderate 
yield. The subsequent CM reaction with tert-butyl acrylate and ester hydrolysis 
proceed with good yields to obtain compound 121 (Scheme 2.36.a). Synthesis 
of product 126 followed an analogous sequence of CM reaction and TFA ester 
hydrolysis, but in this case the first step was the addition of diethyl 2-
allylmalonate to N-tosyl aziridine in presence of potassium bis(trimethyl)amide 
(KHMDS) giving rise to substrate for CM reaction 124 with moderate yield 
(Scheme 2.36.b). Preparation of substrate for the preparation of piperazinone 
substructure 131 proceeded with very good yields in the four steps of the 
sequence (Scheme 2.36.c), which started with the formation of acyl chloride 
derivative of N-tosyl glycine by means of oxalyl chloride and the subsequent 
nucleophilic substitution of benzylallyl amine in presence of triethyl amine to 
obtain 129. Finally, compounds 134 and 135 were obtained with excellent yields 
starting from the previously described tosyl amides 83 and 103b (Scheme 
2.36.d). 
                                            
243 Gribkov, D. V; Hultzsch, K. C.; Hampel, F. J. Am. Chem. Soc. 2006, 128, 3748–3759. 
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Scheme 2.36. Preparation of substrates for the domino PC-IMAMR. 
2.3.4. TRANSFORMATION OF SURROGATES INTO THE CORRESPONDING 
ENANTIOENRICHED ESTERS 
The transformation of the pyrazole moiety of pyrrolidine 93b into the ethyl 
ester derivative 136 was successfully achieved by treatment with 4-dimethyl 
aminopyridine (DMAP) in ethanol under reflux conditions (Scheme 2.37.a). 
Comparison of the optical rotation ([a]D) value of 136 with that reported in the 
literature led to the conclusion that the newly created stereocenter holds the S 
absolute configuration.244 The same stereochemical outcome was assumed for 
all other compounds of the IMAMR. Additionally, DMP substituent of 
piperazinone 84i was also converted into an ethyl ester, obtaining product 137 
with excellent yield (Scheme 2.37.b). Preparation of 137 was necessary to 
determine the er ratio of 84i because it was impossible to separate its 
enantiomers with the HPLC. Likewise, 137 could not be separated with any 
                                            
244 Joselice e Silva, M.; Cottier, L.; Srivastava, R. M.; Sinou, D.; Thozet, A. Carbohydr. Res. 
2005, 340, 309–314. 
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chiral column using HPLC analysis. However, the enantiomeric relation was 
finally obtained by means of a NMR study of the diastereoisomers formed in a 
solution of 137 (0.8 mL, 10 mg/mL) after the progressive addition of portions of 
a solution of europium tris[3-(trifluoromethylhydroxymethylene)-(+)-camphorate] 
in CDCl3 (0.225 mL, 20 mg/mL). After the addition of three portions, the 
separation of one of the NMR signals was satisfactory. 
 
Scheme 2.37. Transformation of pyrazole amides into the corresponding esters. 
2.3.5. MECHANISTIC PROPOSAL FOR THE INTRAMOLECULAR AZA-MICHAEL 
REACTION BETWEEN SULFONAMIDES AND  a,b-UNSATURATED N-ACYL 
PYRAZOLES 
Eventually, a possible mechanism that accounts for the S stereochemical 
assignment mentioned above244 has been postulated (Figure 2.9). The 
preferred approach would result from a combination of an acid-base reaction 
and multiple hydrogen bonding interactions. Sulfonamide group 245  in the 
substrate would be deprotonated by the quinuclidine moiety in the squaramide 
catalyst. At the same time, squaramide-amine hydrogens would establish two 
hydrogen bonds each one with sulfonamide oxygens and with the carbonyl 
oxygen or the DMP nitrogen. This would fix the transition state, thereby 
promoting the attack of the nitrogen nucleophile on the Si face of the double 
bond. 
                                            
245 Sulfonamides are more acidic than carbamates. 
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Figure 2.9. Elected transition state of the IMAMR. 
However, this is just a presumption of a plausible transition state and 
many others could be designed. For instance, two years ago when the results 
of this study where published, the defended mechanism consisted on a p-
stacking with an aromatic sandwich of the two rings of the substrate and one of 
the squaramide, combined with multiple hydrogen bonding interactions. Here 
again, the sulfonamide group would be deprotonated by the quinuclidine 
moiety, and two hydrogen bonds would be established between the oxygen 
atoms in the substrate and the N-H bonds in the catalyst. This approach would 
promote also the attack on the Si face of the double bond (Figure 2.10). 
Nevertheless, it does not actively involve any dimethyl pyrazole nitrogen, which 
has been considered pivotal for this transformation. Therefore, despite this was 
the first postulation, it has been chosen preferably the former transition state 
(Figure 2.9) to explain the chirality induction in the IMAMR. 
 
Figure 2.10. Plausible transition state of the IMAMR. 
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2.4. Conclusions 
The described research work, has led to the development of an 
organocatalytic enantioselective intramolecular aza-Michael reaction (IMAMR) 
of sulfonamides bearing a remote a,b-unsaturated pyrazole amide.246 
Aniline-hydroquinidine squaramide (AHS) was found to be the best 
catalyst to activate the sophisticated-designed starting materials throughout 
several hydrogen bond interactions. The role of AHS for this transformation, 
could be performed both in a step wise and in a domino fashion combined with 
a peptide coupling reaction. Allowing the access to a diverse range of 
enantioenriched heterocyclic b-amino esters, since it has been demonstrated 
the facility of conversion of the dimethyl pyrazole into a ester moiety. 
Therefore, the use of pyrazole amides as ester synthetic equivalents is a 
very convenient strategy to perform this transformation with conjugated esters 
as Michael acceptors, a process that has remained elusive to date. 
 
                                            
246 Sánchez-Roselló, M.; Mulet, C.; Guerola, M.; del Pozo, C.; Fustero, S. Chem. Eur. J. 2014, 
20, 15697–15701. 
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2.5. Experimental Section 
DETERMINATION OF THE ENANTIOMERIC RATIO 
In the specific case of compound 86i it was sought an alternative 
procedure using the Europium tris[3-(trifluoromethylhydroxymethylene)-(+)-
camphorate] complex to form diastereoisomers that could be separately 
detected with 1H NMR. 
2.5.1. PREPARATION OF THE TERMINAL-OLEFIN N-PROTECTED AMINES 
 
Amines 1a,172 61,224 83,232 103a,237 103b,224 105,238 107,239 109,240 
113242 and 119243 had been previously described. 
2.5.1.1. General procedure for the preparation of N-protected amines, 
including 99, 100 
 
To a suspension of LiAlH4 (6 mmol) in diethyl ether (10 mL) was added 
dropwise 5- hexenenitrile (2,0 mmol) at room temperature. After heating for 2h 
at reflux, the suspension was allowed to reach room temperature and 
Na2SO4·10H2O was added with vigorous stirring until aluminium salts turned 
white. The suspension was filtered through a short pad of Celite® washing with 
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small portions of diethyl ether. The filtrate was concentrated under vacuum 
obtaining a yellow oil that used without further purification. 
The crude amine was dissolved in THF (10 mL) and pyridine (2.4 equiv.) 
was added at 0 ºC followed by sulfonyl chloride (1.5 equiv.). The reaction 
mixture was allowed to reach room temperature overnight and then it was 
hydrolised with NH4Cl saturated, extracted with ethyl acetate and dried over 
Na2SO4 anhydrous. Finally, solvents were removed and the crude mixture 
purified by flash chromatography with hexanes: ethyl acetate as eluents. 
 
 
 
 
 
N-(5-Hexenyl)-4-methoxybenzenesulfonamide (99) 
 
Physical state: Pale yellow oil 
Empiric Formula: C13H19NO3S 
Molecular weight (g/mol): 269.36 
Yield (%): 42 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.70 (d, J = 8.8 Hz, 2H), 6.86 (d, J = 8.8 Hz, 
2H), 5.66 – 5.49 (m, 1H), 5.40 (br s, 1H), 
4.89 – 4.71 (m, 2H), 3.72 (s, 3H), 2.77 (q, J = 
6.5 Hz, 2H), 1.84 (q, J = 6.5 Hz, 2H), 1.41 – 
1.17 (m, 4H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 163.1, 138.4, 131.8, 129.3, 114.7, 114.2, 
55.2, 42.5, 32.6, 28.3, 25.2 
HRMS (EI+): Calcd. for C13H19NO3S [M+]: 270.1158, found: 270.1160 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 5:1 
as eluent. 
N-(5-Hexenyl)-4-(trifluoromethyl)benzenesulfonamide (100) 
 
Physical state: White solid 
Empiric Formula: C13H16F3NO2S 
Molecular weight (g/mol): 307.33 
Yield (%): 69 
Melting point (ºC): 77-79 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 8.00 (d, J = 8.2 Hz, 2H), 7.77 (d, J = 8.2 Hz, 
2H), 5.69 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 
5.02 (br t, J = 5.8 Hz, 1H), 4.97 – 4.87 (m, 
2H), 2.97 (dt, J = 6.7, 6.7 Hz, 2H), 2.02 – 
N
H
S
O O
OMe
N
H
S
O O
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2.5.1.2. Synthesis of diethyl 2-allyl-2-{2-[(4-methylphenyl)sulfonamido] 
ethyl}malonate 124 
 
KHMDS (2.4 ml, 0.5M solution in toluene) was added to a solution of 
diethyl 2-allylmalonate (200 mg, 1.0 mmol) in THF (5 mL) at 0 ºC. The mixture 
was stirred for 20 min and then another solution of N-tosyl aziridine (216 mg, 
1.1 mmol) in THF (5 mL) was added dropwise. The mixture was stirred for 5 
additional hours, hydrolysed with saturated ammonium chloride (10 mL), 
extracted with EtOAc (3 x 5 mL) and dried over anhydrous Na2SO4. 
 
EtO2C
CO2Et N Ts
KHMDS, DCM
N
H
Ts
EtO2C
EtO2C
1.92 (m, 2H), 1.54 – 1.42 (m, 2H), 1.41 – 
1.29 (m, 2H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 143.81, 138.03, 134.44 (q, 2JCF = 33 Hz), 
127.67, 126.39 (q, 3JCF = 4 Hz), 123.36 (q, 
1JCF = 272 Hz), 43.26, 33.11, 29.08, 25.73 
19F NMR (CDCl3, 282.4 MHz) δ (ppm): −63.6 (s, 3F) 
HRMS (EI+): Calcd. for C13H16F3NO2 [M+]: 308.0927, found: 308.0923 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 8:1 
as eluent. 
Diethyl 2-allyl-2-{2-[(4-methylphenyl)sulfonamido] ethyl}malonate (124) 
 
Physical state: Colorless oil 
Empiric Formula: C19H27NO6S 
Molecular weight (g/mol): 397.49 
Yield (%): 44 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.71 (d, J = 8.1 Hz, 2H), 7.29 (d, J = 7.9 Hz, 
2H), 5.63–5.46 (m, 1H), 5.10–4.98 (m, 2H), 
4.63 (t, J = 6.2 Hz, 1H), 4.16 (q, J = 7.1 Hz, 
4H), 3.03–2.91 (m, 2H), 2.59 (d, J = 7.4 Hz, 
2H), 2.42 (s, 3H), 2.08–1.99 (m, 2H), 1.22 
(t, J = 7.1 Hz, 6H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 170.83, 143.46, 136.94, 131.93, 129.76, 
127.19, 119.60, 61.81, 56.18, 39.29, 37.96, 
32.91, 21.70, 14.21 
HRMS (EI+): Calcd. for C19H27NO6S [M+]: 398.1632, found: 398.1623 
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2.5.1.3. Synthesis of N-Allyl-N-benzyl-2-[(4-methylphenyl)sulfonamido] 
acetamide 129 
 
Oxalyl chloride (1.2 mmol, 2.0M solution in DCM) and two drops of DMF 
were successively added to a solution of N-tosyl glycine (1.0 mmol) in DCM (5 
mL) under nitrogen at 0 ºC, and the resulting mixture stirred at this temperature 
for 1 h. Then, a solution of benzyl allyl amine (1.2 mmol) and triethyl amine (3 
mmol) in DCM (5 mL) was added dropwise. The reaction was stirred overnight, 
hydrolysed with saturated ammonium chloride (10 mL), extracted with DCM (3 x 
5 mL) and dried over anhydrous Na2SO4. 
 
 
N
HN
Ts
Bn
O
CO2H
NHTs 1) (ClCO)2, DMF/DCM
2) BnNHAllyl, Et3N, DCM
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 2:1 
as eluent. 
N-Allyl-N-benzyl-2-[(4-methylphenyl)sulfonamido]acetamide (129) 
 
Physical state: Colorless oil 
Empiric Formula: C19H22N2O3S 
Molecular weight (g/mol): 358.46 
Yield (%): 75 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.71 (d, J = 7.6 Hz, 1.27H), 7.65 (d, J = 7.6 
Hz, 0.73H), 7.32–7.22 (m, 5H), 7.17–6.93 
(m, 2H), 5.80–5.67 (m, 1H), 5.35–5.27 (m, 
1H), 5.24–5.14 (m, 1H), 4.72 (s, 1.28H), 
4.56 (s, 0.72H), 4.22–3.91 (m, 4H), 2.81 (s, 
3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 167.4, 167.1, 143.5, 136.3, 136.1, 135.9, 
135.2, 131.9, 131.3, 129.7, 129.1, 128.7, 
128.2, 127.9, 127.7, 127.3, 126.3, 118.3, 
117.5, 49.1, 48.6, 48.1, 43.8, 43.6, 21.6 
HRMS (EI+): Calcd. for C19H22N2O3S [M+]: 359.1385, found: 359.1382 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 3:1 
as eluent. 
ê 1H and 13C NMR show the presence of rotamers about the amide 
bond in ca. 1.3:0.7 ratio. 
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2.5.2. PREPARATION OF THE a,b-UNSATURATED N-PROTECTED AMINES 
CANDIDATES FOR IMAMR SUBSTRATES 
Method A: Cross-metathesis reaction with ethyl acrylate 
 
To a solution of N-protected amine (1.0 equiv.) in CH2Cl2 (0.1 M) under 
nitrogen atmosphere, ethyl acrylate (3.0 equiv.) and Hoveyda-Grubbs 2nd 
generation catalyst (8 mol%) were added. The resulting solution was stirred for 
12 h at room temperature and then, solvents were removed and the crude 
mixture purified by flash chromatography with hexanes: ethyl acetate as 
eluents. 
Method B: Cross-metathesis reaction with 3,5-dimethylpyrazol acryl amide 
 
To a solution of N-protected amine (1.0 equiv.) in CH2Cl2 (0.1 M) under 
nitrogen atmosphere in a microwave vial, and 3,5-dimethylpyrazol acryl amide 
(3.0 equiv.) and an initial 5 mol% charge of Hoveyda-Grubbs 2nd generation 
catalyst were added. The mixture was heated under microwave irradiation at 
100 ºC for 5 minutes. Three more portions of catalyst (20 mol% total) were 
successively added while heating each time at the same temperature and time. 
Finally, solvents were removed and the crude reaction mixture purified by flash 
chromatography with hexanes: ethyl acetate as eluents. 
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Ethyl (E)-7-(2-Pyridinesulfonamido)-2-heptenoate (55) 
 
Physical state: Brown thick oil 
Empiric Formula: C17H23NO4 
Molecular weight (g/mol): 312.38 
Yield (%): 98 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 8.70 (dd, J = 4.6, 1.3, 1H), 8.01 (dd, J = 
7.7, 1.3 Hz, 1H), 7.92 (ddd, J = 7.7, 7.7, 1.3 
Hz, 1H), 7.50 (ddd, J = 7.7, 4.6, 1.3 Hz, 
1H), 6.87 (dt, J = 14.1, 6.8 Hz, 1H), 5.77 
(dt, J = 14.1, 1.3 Hz, 1H), 5.02 (br t, J = 6.0 
Hz, 1H), 4.18 (q, J = 7.1 Hz, 2H), 3.09 – 
3.03 (m, 2H), 2.20 – 2.13 (m, 2H), 1.58 – 
1.43 (m, 4H), 1.28 (t, J = 7.1 Hz, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 166.66, 157.64, 150.19, 148.26, 138.20, 
126.79, 122.33, 122.00, 60.36, 43.52, 
31.58, 29.38, 24.97, 14.40 
HRMS (EI+): Calcd. for C14H20N2O4S [M+]: 313.1177, found: 313.1162 
Remarks: ê By means of the procedure described as Method A. 
ê Purification by flash chromatography with hexanes: ethyl acetate 2:1 
as eluent. 
Benzyl (E)-[7-(3,5-Dimethyl-1H-pyrazol-1-yl)-7-oxo-5-heptenyl]carbamate 
(66) 
 
Physical state: Pale brown oil 
Empiric Formula: C20H25N3O3 
Molecular weight (g/mol): 355.44 
Yield (%): 88 (67% conv.) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.27 – 7.18 (m, 6H), 7.13 – 7.01 (m, 1H), 
5.89 (s, 1H), 5.01 (br s, 2H), 4.72 (br s, 1H), 
3.19 – 2.99 (m, 2H), 2.48 (s, 3H), 2.38 – 
2.23 (m, 2H), 2.17 (s, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 165.24, 156.52, 151.96, 150.74, 144.53, 
136.72, 128.62, 128.20, 128.20, 121.70, 
111.43, 66.75, 40.89, 32.36, 29.70, 25.36, 
14.74, 13.93 
HRMS (EI+): Calcd. for C20H25N3O3 [M+]: 356.1929, found: 356.1930 
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Remarks: ê By means of the procedure described as Method B. 
ê Purification by flash chromatography with hexanes: ethyl acetate 5:1 
as eluent. 
Ethyl (E)-7-(Benzyloxycarbonyl amino)-2-heptenoate (68) 
 
Physical state: Colorless oil 
Empiric Formula: C17H23NO4 
Molecular weight (g/mol): 305.37 
Yield (%): 82 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.21 – 7.02 (m, 5H), 6.71 (dt, J = 15.5, 6.9 
Hz, 1H), 5.60 (dt, J = 15.5, 1.3 Hz, 1H), 
4.88 (s, 2H), 4.73 (br s, 1H), 3.96 (q, J = 
7.1 Hz, 2H), 3.06 – 2.88 (m, 2H), 2.08 – 
1.90 (m, 2H), 1.38 – 1.15 (m, 4H), 1.07 (t, J 
= 7.1 Hz, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 166.65, 156.51, 148.54, 136.69, 128.54, 
128.11, 128.11, 121.75, 66.63, 60.23, 
40.77, 31.72, 29.53, 25.16, 14.30 
HRMS (EI+): Calcd. for C17H23NO4 [M+]: 306.1840, found: 306.1835 
Remarks: ê By means of the procedure described as Method A. 
ê Purification by flash chromatography with hexanes: ethyl acetate 5:1 
as eluent. 
 
(E)-N-[7-(3,5-Dimethyl-1H-pyrazol-1-yl)-7-oxo-5-heptenyl]-2-pyridine 
sulfonamide (80a) 
 
Physical state: Colorless oil 
Empiric Formula: C17H22N4O3S 
Molecular weight (g/mol): 362.45 
Yield (%): 89% (46% conv.) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 8.67 (dd, J = 4.8, 1.1 Hz, 1H), 7.97 (d, J = 
7.7 Hz, 1H), 7.87 (ddd, J = 7.7, 7.1, 1.1 Hz, 
1H), 7.45 (dd, J = 7.1, 4.8 Hz, 1H), 7.19 (d, 
J = 15.6 Hz, 1H), 7.04 (dt, J = 15.6, 6.7 Hz, 
1H), 5.94 (s, 1H), 5.82 (br t, J = 5.4 Hz, 
1H), 3.09 – 2.94 (m, 2H), 2.51 (s, 3H), 2.26 
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– 2.16 (m, 5H), 1.54 – 1.42 (m, 4H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 165.54, 157.87, 152.29, 150.91, 150.41, 
144.72, 138.52, 126.99, 122.57, 121.76, 
111.54, 43.01, 31.69, 28.93, 24.56, 14.20, 
13.37 
HRMS (EI+): Calcd. for C17H22N4O3S [M+]: 363.1485, found: 363.1487 
Remarks: ê By means of the procedure described as Method B. 
ê Purification by flash chromatography with hexanes: ethyl acetate 3:1 
as eluent. 
(E)-N-[7-(3,5-Dimethyl-1H-pyrazol-1-yl)-7-oxo-5-heptenyl]benzene 
sulfonamide (80b) 
 
Physical state: Brown oil 
Empiric Formula: C18H23N3O3S 
Molecular weight (g/mol): 361.46 
Yield (%): 71% (35% conv.) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 8.67 (dd, J = 4.8, 1.1 Hz, 1H), 7.97 (d, J = 
7.7 Hz, 1H), 7.87 (ddd, J = 7.7, 7.1, 1.1 Hz, 
1H), 7.45 (dd, J = 7.1, 4.8 Hz, 1H), 7.19 (d, 
J = 15.6 Hz, 1H), 7.04 (dt, J = 15.6, 6.7 Hz, 
1H), 5.94 (s, 1H), 5.82 (br t, J = 5.4 Hz, 
1H), 3.09 – 2.94 (m, 2H), 2.51 (s, 3H), 2.26 
– 2.16 (m, 5H), 1.54 – 1.42 (m, 4H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 165.07, 164.92, 151.94, 151.90, 150.39, 
149.37, 144.40, 140.01, 132.61, 129.13, 
127.03, 122.04, 121.63, 111.40, 42.92, 
42.60, 32.00, 29.61, 29.10, 28.20, 25.00, 
14.60, 13.80 
HRMS (EI+): Calcd. for C18H23N3O3S [M+]: 362.1533, found: 362.1531 
Remarks: ê By means of the procedure described as Method B. 
ê Purification by flash chromatography with hexanes: ethyl acetate 4:1 
as eluent. 
ê 1H  and 13C NMR show the presence of rotamers in ca. 1:1 ratio 
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(E)-N-[7-(3,5-Dimethyl-1H-pyrazol-1-yl)-7-oxo-5-heptenyl]-4-methyl 
benzenesulfonamide (80c) 
 
Physical state: Brown oil 
Empiric Formula: C19H25N3O3S 
Molecular weight (g/mol): 375.49 
Yield (%): 94% (53% conv.) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.71 (d, J = 8.1 Hz, 2H), 7.25 (d, J = 8.1 Hz, 
2H), 7.19 (d, J = 15.6 Hz, 1H), 7.04 (dt, J = 
15.6, 6.7 Hz, 1H), 5.94 (s, 1H), 5.20 (br t, J 
= 5.1 Hz, 1H), 2.99 – 2.80 (m, 2H), 2.51 (s, 
3H), 2.36 (s, 3H), 2.27 – 2.14 (m, 5H), 1.56 
– 1.37 (m, 4H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 165.54, 152.28, 150.98, 144.70, 143.69, 
137.19, 129.97, 127.33, 121.69, 111.54, 
42.57, 31.69, 28.65, 24.62, 21.08, 14.20, 
13.37 
HRMS (EI+): Calcd. for C19H25N3O3S [M+]: 376.1689, found: 376.1690 
Remarks: ê By means of the procedure described as Method B. 
ê Purification by flash chromatography with hexanes: ethyl acetate 8:1 
as eluent. 
(E)-N-[7-(3,5-Dimethyl-1H-pyrazol-1-yl)-7-oxo-5-heptenyl]-4-methoxy 
benzenesulfonamide (101) 
 
Physical state: Brown oil 
Empiric Formula: C19H25N3O4S 
Molecular weight (g/mol): 391.49 
Yield (%): 75% (40% conv.) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.77 (d, J = 8.4 Hz, 2H), 7.21 (dd, J = 15.7, 
0.7 Hz, 1H), 7.12 – 6.99 (m, 1H), 6.93 (d, J 
= 8.4 Hz, 2H), 5.94 (s, 1H), 5.05 (br s, 1H), 
3.81 (s, 3H), 2.97 – 2.82 (m, 2H), 2.52 (s, 
3H), 2.24 – 2.17 (m, 5H), 1.58 – 1.37 (m, 
4H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 165.56, 163.31, 152.28, 150.86, 144.74, 
131.88, 129.49, 121.82, 114.43, 111.53, 
55.43, 42.60, 31.71, 28.73, 24.70, 14.17, 
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13.36 
HRMS (EI+): Calcd. for C19H25N3O4S [M+]: 392.1639, found: 392.1633 
Remarks: ê By means of the procedure described as Method B. 
ê Purification by flash chromatography with hexanes: ethyl acetate 3:1 
as eluent. 
(E)-N-[7-(3,5-Dimethyl-1H-pyrazol-1-yl)-7-oxo-5-heptenyl]-4-
(trifluoromethyl)benzenesulfonamide (102) 
 
Physical state: Pale pink solid 
Empiric Formula: C19H22F3N3O3S 
Molecular weight (g/mol): 391.49 
Yield (%): 20% (50% conv.) 
Melting point (ºC): 79-81 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.93 (d, J = 8.0 Hz, 2H), 7.70 (d, J = 8.0 
Hz, 2H), 7.23 – 7.14 (m, 1H), 7.03 (dt, J 
= 15.6, 6.7 Hz, 1H), 5.91 (s, 1H), 4.96 
(br s, 1H), 2.97 – 2.89 (m, 2H), 2.49 (s, 
3H), 2.30 – 2.21 (m, 2H), 2.18 (s, 3H), 
1.51 – 1.39 (m, 4H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 165.04, 152.01, 150.09, 147.64, 
144.51, 143.75, 127.65, 126.39, 
121.87, 111.48, 43.21, 32.11, 29.39, 
25.16, 14.80, 14.00 
19F NMR (CDCl3, 282.4 MHz) δ (ppm): -63.31 (s, 3F) 
HRMS (EI+): Calcd. for C19H22F3N3O3S [M+]: 430.1407, found: 430.1403 
Remarks: ê By means of the procedure described as Method B. 
ê Purification by flash chromatography with hexanes: ethyl acetate 6:1 
as eluent. 
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(E)-N-[6-(3,5-Dimethyl-1H-pyrazol-1-yl)-6-oxo-4-hexenyl]benzene 
sulfonamide (104a) 
 
Physical state: Pale brown foam 
Empiric Formula: C17H21N3O3S 
Molecular weight (g/mol): 347.43 
Yield (%): 81% (33% conv.) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.85 – 7.79 (m, 2H), 7.58 – 7.43 (m, 3H), 
7.29 – 7.20 (m, 1H), 7.06 (dt, J = 14.3, 6.3 
Hz, 1H), 6.07 (s, 1H), 5.03 (br s, 1H), 3.35 
(dt, J = 6.3, 6.2 Hz, 2H), 2.93 (s, 3H), 2.77 
– 2.68 (m, 2H), 2.65 (s, 3H), 2.21 – 2.10 
(m, 2H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 164.91, 151.97, 149.18, 144.45, 140.01, 
132.71, 129.20, 127.07, 122.19, 111.48, 
42.77, 29.75, 28.40, 14.78, 13.99 
HRMS (EI+): Calcd. for C17H21N3O3S [M+]: 348.1376, found: 348.1373 
Remarks: ê By means of the procedure described as Method B. 
ê Purification by flash chromatography with hexanes: ethyl acetate 6:1 
as eluent. 
(E)-N-[6-(3,5-Dimethyl-1H-pyrazol-1-yl)-6-oxo-4-hexenyl]-4-methyl 
benzenesulfonamide (104b) 
 
Physical state: Brown oil 
Empiric Formula: C18H23N3O3S 
Molecular weight (g/mol): 361.46 
Yield (%): 50% (66% conv.) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.74 (d, J = 8.4 Hz, 2H), 7.28 (d, J = 8.4 Hz, 
2H), 7.26 – 7.21 (m, 1H), 7.04 (dt, J = 15.6, 
6.9 Hz, 1H), 5.97 (s, 1H), 4.93 (br s, 1H), 
2.97 (dt, J = 6.7, 6.9 Hz, 2H), 2.54 (s, 3H), 
2.39 (s, 3H), 2.31 (dd, J = 6.7, 6.8 Hz, 2H), 
2.24 (s, 3H), 1.73 – 1.63 (m, 2H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 165.55, 152.49, 149.83, 144.91, 143.96, 
137.40, 130.17, 127.49, 122.42, 111.71, 
42.47, 29.42, 27.98, 21.25, 14.32, 13.52 
HRMS (EI+): Calcd. for C18H23N3O3S [M+]: 362.1533, found: 362.1532 
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Remarks: ê By means of the procedure described as Method B. 
ê Purification by flash chromatography with hexanes: ethyl acetate 8:1 
as eluent. 
(E)-N-{2-[3-(3,5-Dimethyl-1H-pyrazol-1-yl)-3-oxo-1-propenyl]benzyl}-4-
methylbenzenesulfonamide (106) 
 
Physical state: Brown solid 
Empiric Formula: C22H23N3O3S 
Molecular weight (g/mol): 409.50 
Yield (%): 30% (46% conv.) 
Melting point (ºC): 121-123 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.75 – 7.65 (m, 3H), 7.64 – 7.59 (m, 1H), 
7.28 – 7.17 (m, 5H), 5.97 (s, 1H), 5.09 (br t, 
J = 6.0 Hz, 1H), 4.24 (d, J = 6.0 Hz, 2H), 
2.55 (s, 3H), 2.36 (s, 3H), 2.23 (s, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 164.44, 151.55, 143.82, 142.81, 141.11, 
136.12, 134.88, 132.94, 129.72, 129.10, 
129.02, 127.70, 126.71, 126.44, 119.98, 
110.75, 43.46, 20.15, 13.20, 12.40 
HRMS (EI+): Calcd. for C22H23N3O3S [M+]: 410.1533, found: 410.1532 
Remarks: ê By means of the procedure described as Method B. 
ê Purification by flash chromatography with hexanes: ethyl acetate 4:1 
as eluent. 
(E)-N-{2-[4-(3,5-Dimethyl-1H-pyrazol-1-yl)-4-oxo-2-butenyl]benzyl}-4-
methylbenzenesulfonamide (108) 
 
Physical state: Brown oil 
Empiric Formula: C23H25N3O3S 
Molecular weight (g/mol): 423.53 
Yield (%): 61% (53% conv.) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.66 – 7.60 (m, 2H), 7.42 – 7.38 (m, 1H), 
7.29 – 7.28 (m, 2H), 7.27 (s, 2H), 7.15 (dd, 
J = 5.4, 3.4 Hz, 1H), 7.13 – 7.06 (m, 1H), 
6.98 – 6.91 (m, 1H), 6.02 (s, 1H), 5.14 (t, J 
= 5.8 Hz, 1H), 4.10 – 4.06 (m, 2H), 3.61 – 
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3.53 (m, 2H), 2.59 (s, 3H), 2.44 (s, 3H), 
2.30 (s, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 164.73, 152.52, 147.83, 144.31, 143.46, 
136.49, 135.94, 134.35, 130.41, 130.24, 
129.63, 128.68, 127.61, 127.03, 122.79, 
111.51, 44.87, 35.81, 21.51, 14.47, 13.85 
HRMS (EI+): Calcd. for C23H25N3O3S [M+]: 424.1689, found: 424.1686 
Remarks: ê By means of the procedure described as Method B. 
ê Purification by flash chromatography with hexanes: ethyl acetate 6:1 
as eluent. 
(E)-N-{2-[3-(3,5-Dimethyl-1H-pyrazol-1-yl)-3-oxo-1-propenyl]phenethyl}-4-
methylbenzenesulfonamide (110) 
 
Physical state: Brown oil 
Empiric Formula: C23H25N3O3S 
Molecular weight (g/mol): 423.53 
Yield (%): 24% (50% conv.) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 8.03 (d, J = 15.8 Hz, 1H), 7.79 (d, J = 15.8 
Hz, 1H), 7.73 (dd, J = 7.6, 1.2 Hz, 1H), 7.69 
– 7.65 (m, 2H), 7.36 – 7.28 (m, 2H), 7.24 
(d, J = 8.1 Hz, 2H), 7.20 – 7.15 (m, 2H), 
6.03 (s, 1H), 4.48 (br t, J = 6.2 Hz, 1H), 
3.18 (td, J = 7.1, 6.2 Hz, 2H), 3.00 (t, J = 
7.1 Hz, 2H), 2.62 (s, 3H), 2.38 (s, 3H), 2.29 
(s, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 165.29, 152.27, 144.59, 143.54, 142.49, 
137.75, 136.99, 133.72, 130.91, 130.70, 
129.88, 127.89, 127.62, 127.22, 120.18, 
111.74, 44.05, 33.73, 21.60, 14.80, 13.99 
HRMS (EI+): Calcd. for C23H25N3O3S [M+]: 424.1689, found: 424.1685 
Remarks: ê By means of the procedure described as Method B. 
ê Purification by flash chromatography with hexanes: ethyl acetate 5:1 
as eluent. 
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2.5.3. MICHAEL ADDUCTS SYNTHESIS: PREPARATION OF 2-SUBSTITUTED 
NITROGEN HETEROCYCLES 84A-E AND 93-96 
 
The corresponding a,b-unsaturated N-acyl pyrazole 1 or 3 (1.0 equiv.) 
was dissolved in cyclopentyl methyl ether (CPME) (0.1M) in a microwave vial 
and then catalyst AHS (10 mol%) was added. The vial was sealed and the 
corresponding solution was heated under microwave irradiation at 40-90 ºC for 
2-5h. After this time, the crude reaction mixture was purified by means of flash 
chromatography on silica gel using the appropriate eluent. 
N
H
SO2Ar
O
N N
AHS (10 mol%)
CPME, 2-5h
MW 40-90ºC
N
SO2Ar
O
N N
84, 93-96
( )n ( )n
( )m( )m
AHS
N
H
OO
N
H
N
OMeN
CF3
F3C
(S)-1-(3,5-Dimethyl-1H-pyrazol-1-yl)-2-[1-(2-pyridylsulfonyl)piperidin-2-yl]-
1-ethanone (84a) 
 
Physical state: Colorless oil 
Empiric Formula: C17H22N4O3S 
Molecular weight (g/mol): 362.45 
Yield (%): 48% 
Enantiomeric relation: 92.5:7.5 
Optical rotation [a]D25: -17.7 (c 1.0 CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 8.60 (ddd, J = 4.7, 1.6, 0.9 Hz, 1H), 7.99 – 
7.92 (m, 1H), 7.88 – 7.77 (m, 1H), 7.39 
(ddd, J = 7.6, 4.7, 1.2 Hz, 1H), 5.93 (s, 1H), 
4.81 (br s, 1H), 3.99 (dd, J = 13.8, 3.2 Hz, 
1H), 3.41 (d, J = 7.1 Hz, 2H), 3.33 – 3.19 
(m, 1H), 2.45 (s, 3H), 2.22 (s, 3H), 1.72 – 
1.58 (m, 6H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 171.95, 159.39, 152.54, 150.46, 144.59, 
138.21, 126.57, 122.68, 111.59, 50.16, 
42.01, 35.98, 28.36, 24.84, 18.37, 14.18, 
13.55 
HRMS (EI+): Calcd. for C17H22N4O3S [M+]: 363.1485, found: 363.1492 
Remarks: ê Reaction performed at 60ºC for 4 hours, employing CHCl3 as solvent 
and BHS as catalyst in this case. 
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ê Purification by flash chromatography with hexanes: ethyl acetate 7:1 
as eluent. 
ê The er value was determined by HPLC analysis using a Chiracel OD-
H column (hexane: isopropanol 92:8); flow rate = 1.0 mL/min 
(S)-1-(3,5-Dimethyl-1H-pyrazol-1-yl)-2-[1-(phenylsulfonyl)piperidin-2-yl]-1-
ethanone (84b) 
 
Physical state: Colorless oil 
Empiric Formula: C18H23N3O3S 
Molecular weight (g/mol): 361.46 
Yield (%): 92% 
Enantiomeric relation: 96.5:3.5 
Optical rotation [a]D25: -5.8 (c 1.0 CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.84 – 7.79 (m, 2H), 7.54 – 7.41 (m, 3H), 
5.93 (s, 1H), 4.80 – 4.69 (m, 1H), 3.86 (dd, 
J = 14.0, 3.8 Hz, 1H), 3.42 (dd, J = 15.5, 
8.4 Hz, 1H), 3.25 (dd, J = 15.5, 6.1 Hz, 1H), 
3.20 – 3.08 (m, 1H), 2.48 (s, 3H), 2.22 (s, 
3H), 1.46 – 1.30 (m, 2H), 0.92 – 0.78 (m, 
1H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 209.88, 171.94, 152.66, 144.62, 141.86, 
132.66, 129.40, 127.39, 111.69, 49.83, 
41.16, 35.80, 28.02, 24.62, 18.30, 14.22, 
13.55 
HRMS (EI+): Calcd. for C18H23N3O3S [M+]: 362.1533, found: 362.1531 
Remarks: ê Reaction performed at 90ºC for 4 hours. 
ê Purification by flash chromatography with hexanes: ethyl acetate 10:1 
as eluent. 
ê The er value was determined by HPLC analysis using a Chiracel OD-
H column (hexane: isopropanol 92:8); flow rate = 1.0 mL/min 
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(S)-1-(3,5-Dimethyl-1H-pyrazol-1-yl)-2-(1-tosylpiperidin-2-yl)-1-ethanone 
(84c) 
 
Physical state: Brown oil 
Empiric Formula: C19H25N3O3S 
Molecular weight (g/mol): 375.49 
Yield (%): 91% 
Enantiomeric relation: 96:4 
Optical rotation [a]D25: -16.2 (c 1.0 CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.69 (d, J = 8.1 Hz, 2H), 7.22 (d, J = 8.1 Hz, 
2H), 5.93 (s, 1H), 4.72 (br s, 1H), 3.85 (dd, 
J = 13.7, 3.8 Hz, 1H), 3.40 (dd, J = 15.6, 
8.4 Hz, 1H), 3.23 (dd, J = 15.6, 6.1 Hz, 1H), 
3.17 – 3.05 (m, 1H), 2.48 (s, 3H), 2.38 (s, 
3H), 2.22 (s, 3H), 1.64 – 1.50 (m, 6H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 171.39, 152.15, 144.17, 142.97, 138.40, 
129.68, 127.13, 111.41, 49.88, 41.29, 
35.96, 28.28, 24.92, 21.63, 18.67, 14.62, 
13.95 
HRMS (EI+): Calcd. for C19H25N3O3S [M+]: 376.1689, found: 376.1678 
Remarks: ê Reaction performed at 90ºC for 4 hours. 
ê Purification by flash chromatography with hexanes: ethyl acetate 6:1 
as eluent. 
ê The er value was determined by HPLC analysis using a Chiracel OD-
H column (hexane: isopropanol 92:8); flow rate = 1.0 mL/min. 
(S)-1-(3,5-Dimethyl-1H-pyrazol-1-yl)-2-{1-[(4-methoxyphenyl)sulfonyl] 
piperidin-2-yl}-1-ethanone (84d) 
 
Physical state: Brown oil 
Empiric Formula: C19H25N3O4S 
Molecular weight (g/mol): 391.49 
Yield (%): 70% 
Enantiomeric relation: 96.5:3.5 
Optical rotation [a]D25: -18.9 (c 1.0 CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.74 (d, J = 8.9 Hz, 2H), 6.89 (d, J = 8.9 Hz, 
2H), 5.93 (s, 1H), 4.74 – 4.67 (m, 1H), 3.86 
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– 3.81 (m, 4H), 3.40 (dd, J = 15.5, 8.3 Hz, 
1H), 3.25 (dd, J = 15.5, 6.1 Hz, 1H), 3.15 – 
3.08 (m, 1H), 2.49 (s, 3H), 2.22 (s, 3H), 
1.64 – 1.57 (m, 6H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 172.03, 163.22, 152.55, 144.58, 133.57, 
129.58, 114.44, 111.63, 55.52, 49.77, 
41.05, 35.82, 28.13, 24.72, 18.42, 14.16, 
13.51 
HRMS (EI+): Calcd. for C19H25N3O4S [M+]: 392.1639, found: 392.1632 
Remarks: ê Reaction performed at 90ºC for 5 hours. 
ê Purification by flash chromatography with hexanes: ethyl acetate 4:1 
as eluent. 
ê The er value was determined by HPLC analysis using a Chiracel OD-
H column (hexane: isopropanol 92:8); flow rate = 1.0 mL/min 
(S)-1-(3,5-Dimethyl-1H-pyrazol-1-yl)-2-{1-[(4-trifluoromethylphenyl) 
sulfonyl]piperidin-2-yl}-1-ethanone (84e) 
 
Physical state: Pale pink solid 
Empiric Formula: C19H22F3N3O3S 
Molecular weight (g/mol): 429.46 
Yield (%): 91% 
Melting point (ºC): 96-98 
Enantiomeric relation: 95.5:4.5 
Optical rotation [a]D25: -6.7 (c 1.0 CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.91 (d, J = 8.1 Hz, 2H), 7.67 (d, J = 8.1 Hz, 
2H), 5.92 (s, 1H), 4.77 (dd, J = 8.8, 5.3 Hz, 
1H), 3.89 (dd, J = 13.8, 4.3 Hz, 1H), 3.32 
(dd, J = 7.1, 5.3 Hz, 2H), 3.24 – 3.14 (m, 
1H), 2.43 (s, 3H), 2.21 (s, 3H), 1.67 – 1.63 
(m, 6H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 171.69, 152.77, 145.59, 144.59, 134.35 (q, 
2JCF = 33 Hz), 127.84, 126.45, 123,76 (q, 
1JCF = 272 Hz), 111.83, 50.33, 41.39, 36.02, 
28.58, 24.97, 18.36, 14.09, 13.47 
19F NMR (CDCl3, 282.4 MHz) δ (ppm): -63.54 (s, 3F) 
HRMS (EI+): Calcd. for C19H22F3N3O3S [M+]: 430.1407, found: 430.1409 
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Remarks: ê Reaction performed at 90ºC for 5 hours. 
ê Purification by flash chromatography with hexanes: ethyl acetate 5:1 
as eluent. 
ê The er value was determined by HPLC analysis using a Chiracel OD-
H column (hexane: isopropanol 92:8); flow rate = 1.0 mL/min 
(S)-1-(3,5-Dimethyl-1H-pyrazol-1-yl)-2-[1-(phenylsulfonyl)pyrrolidin-2-yl]-1-
ethanone (93a) 
 
Physical state: Brown oil 
Empiric Formula: C17H21N3O3S 
Molecular weight (g/mol): 347.43 
Yield (%): 98% 
Enantiomeric relation: 90:10 
Optical rotation [a]D25: -18.8 (c 1.0 CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.91 – 7.84 (m, 2H), 7.63 – 7.48 (m, 3H), 
5.96 (s, 1H), 4.20 (ddt, J = 11.0, 7.3, 3.8 
Hz, 1H), 3.73 (dd, J = 17.4, 3.8 Hz, 1H), 
3.56 – 3.47 (m, 1H), 3.42 (dd, J = 17.4, 
10.0 Hz, 1H), 3.20 – 3.08 (m, 1H), 2.53 (s, 
3H), 2.24 (s, 3H), 1.85 – 1.53 (m, 4H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 172.50, 152.79, 144.50, 137.60, 133.16, 
129.53, 128.03, 111.56, 56.39, 49.09, 
42.53, 31.70, 23.58, 14.21, 13.57 
HRMS (EI+): Calcd. for C17H21N3O3S [M+]: 348.1376, found: 348.1373 
Remarks: ê Reaction performed at 60ºC for 2 hours. 
ê Purification by flash chromatography with hexanes: ethyl acetate 4:1 
as eluent. 
ê The er value was determined by HPLC analysis using a Chiracel OD-
H column (hexane: isopropanol 92:8); flow rate = 1.0 mL/min 
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(S)-1-(3,5-Dimethyl-1H-pyrazol-1-yl)-2-(1-tosylpyrrolidin-2-yl)-1-ethanone 
(93b) 
 
Physical state: Pale pink solid 
Empiric Formula: C18H23N3O3S 
Molecular weight (g/mol): 361.46 
Yield (%): 84% 
Melting point (ºC): 127-129 
Enantiomeric relation: 88:12 
Optical rotation [a]D25: -84.5 (c 1.0 CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.75 (d, J = 8.1 Hz, 2H), 7.31 (d, J = 8.1 Hz, 
2H), 5.95 (s, 1H), 4.18 (ddd, J = 13.2, 7.5, 
3.6 Hz, 1H), 3.72 (dd, J = 17.3, 3.6 Hz, 1H), 
3.52 – 3.46 (m, 1H), 3.40 (dd, J = 17.3, 
10.0 Hz, 1H), 3.12 (dt, J = 10.3, 7.5 Hz, 
1H), 2.52 (s, 3H), 2.42 (s, 3H), 2.24 (s, 3H), 
1.90 – 1.81 (m, 1H), 1.80 – 1.73 (m, 1H), 
1.69 – 1.62 (m, 1H), 1.59 – 1.52 (m, 1H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 170.15, 150.35, 142.09, 141.56, 132.34, 
127.75, 125.71, 109.14, 54.00, 46.71, 
40.19, 29.34, 21.23, 18.95, 11.81, 11.19 
HRMS (EI+): Calcd. for C18H23N3O3S [M+]: 362.1533, found: 362.1533 
Remarks: ê Reaction performed at 40ºC for 5 hours. 
ê Purification by flash chromatography with hexanes: ethyl acetate 5:1 
as eluent. 
ê The er value was determined by HPLC analysis using a Chiracel OD-
H column (hexane: isopropanol 92:8); flow rate = 1.0 mL/min 
(R)-1-(3,5-Dimethyl-1H-pyrazol-1-yl)-2-(2-tosylisoindolin-1-yl)-1-ethanone 
(94) 
 
Physical state: Pale pink solid 
Empiric Formula: C22H23N3O3S 
Molecular weight (g/mol): 409.50 
Yield (%): 93% 
Melting point (ºC): 128-130 
Enantiomeric relation: 93:7 
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Optical rotation [a]D25: -125.3 (c 1.0 CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.76 (d, J = 8.3 Hz, 2H), 7.27 – 7.23 (m, 2H), 
7.22 – 7.11 (m, 4H), 5.96 (s, 1H), 5.60 – 5.50 
(m, 1H), 4.80 (dd, J = 14.0, 2.5 Hz, 1H), 4.60 
(d, J = 14.0 Hz, 1H), 4.01 (dd, J = 17.7, 4.1 
Hz, 1H), 3.75 (dd, J = 17.7, 7.6 Hz, 1H), 2.57 
(s, 3H), 2.36 (s, 3H), 2.22 (s, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 171.51, 152.49, 144.41, 144.00, 140.45, 
136.05, 134.72, 130.17, 128.38, 128.24, 
127.98, 123.27, 122.74, 111.55, 62.11, 
54.28, 44.67, 21.87, 14.87, 14.19 
HRMS (EI+): Calcd. for C22H23N3O3S [M+]: 410.1533, found: 410.1535 
Remarks: ê Reaction performed at 60ºC for 4 hours. 
ê Purification by flash chromatography with hexanes: ethyl acetate 8:1 
as eluent. 
ê The er value was determined by HPLC analysis using a Chiracel OD-
H column (hexane: isopropanol 92:8); flow rate = 1.0 mL/min 
(S)-1-(3,5-Dimethyl-1H-pyrazol-1-yl)-2-(2-tosyl-1,2,3,4-
tetrahydroisoquinolin-3-yl)-1-ethanone (95) 
 
Physical state: Orange solid 
Empiric Formula: C23H25N3O3S 
Molecular weight (g/mol): 423.53 
Yield (%): 84% 
Melting point (ºC): 125-127 
Enantiomeric relation: 93.5:6.5 
Optical rotation [a]D25: -125.3 (c 1.0 CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.58 (d, J = 8.3 Hz, 2H), 7.29 – 7.24 (m, 1H), 
7.18 – 7.02 (m, 4H), 7.02 – 6.89 (m, 1H), 
5.94 (s, 1H), 5.78 – 5.64 (m, 1H), 3.87 (ddd, 
J = 14.1, 5.6, 3.3 Hz, 1H), 3.73 – 3.57 (m, 
1H), 3.56 – 3.45 (m, 2H), 2.88 – 2.62 (m, 
2H), 2.51 (s, 3H), 2.31 (s, 3H), 2.23 (s, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 171.01, 152.60, 144.74, 143.54, 137.91, 
136.37, 133.58, 129.77, 129.46, 127.54, 
127.54, 127.22, 126.87, 111.46, 53.27, 
44.15, 39.40, 26.81, 21.20, 14.15, 13.59 
HRMS (EI+): Calcd. for C23H25N3O3S [M+]: 424.1689, found: 424.1685 
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Remarks: ê Reaction performed at 60ºC for 4 hours. 
ê Purification by flash chromatography with hexanes: ethyl acetate 8:1 
as eluent. 
ê The er value was determined by HPLC analysis using a Chiracel OD-
H column (hexane: isopropanol 99:1); flow rate = 2.5 mL/min 
(R)-1-(3,5-Dimethyl-1H-pyrazol-1-yl)-2-(2-tosyl-1,2,3,4-
tetrahydroisoquinolin-1-yl)-1-ethanone (96) 
 
Physical state: Colorless oil 
Empiric Formula: C23H25N3O3S 
Molecular weight (g/mol): 423.53 
Yield (%): 88% 
Enantiomeric relation: 85:15 
Optical rotation [a]D25: -70.3 (c 1.0 CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.68 (d, J = 8.3 Hz, 2H), 7.23 – 6.95 (m, 6H), 
5.92 (s, 1H), 4.95 – 4.80 (m, 1H), 4.73 (d, J = 
16.4 Hz, 1H), 4.44 (d, J = 16.4 Hz, 1H), 3.31 
– 3.09 (m, 2H), 2.99 (dd, J = 16.2, 5.7 Hz, 
1H), 2.72 (dd, J = 16.2, 2.2 Hz, 1H), 2.50 (s, 
3H), 2.35 (s, 3H), 2.17 (s, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 171.29, 152.22, 144.17, 143.38, 136.86, 
131.93, 131.78, 129.72, 129.00, 127.33, 
127.15, 126.62, 126.24, 111.39, 48.91, 
43.77, 38.48, 29.85, 21.60, 14.56, 13.86 
HRMS (EI+): Calcd. for C23H25N3O3S [M+]: 424.1689, found: 424.1685 
Remarks: ê Reaction performed at 60ºC for 4 hours. 
ê Purification by flash chromatography with hexanes: ethyl acetate 10:1 
as eluent. 
ê The er value was determined by HPLC analysis using a Chiracel OD-
H column (hexane: isopropanol 20 minutes gradient 92:8 to 99:1); flow 
rate = 1.0 mL/min 
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2.5.4. MICHAEL ADDUCTS SYNTHESIS: PREPARATION OF SULFONAMIDO 
ESTERS AND SULFONAMIDO ACIDS 
 
To a solution of terminal-olefin N-protected amine (1.0 equiv.) in CH2Cl2 
(0.1 M) under nitrogen atmosphere, titanium tetraethoxide (10 mol%), tert-butyl 
acrylate (5.0 equiv.) and Hoveyda-Grubbs 2nd generation catalyst [HG-II] (10 
mol%) were sequentially added. The resulting solution was refluxed for 2-4 
hours and, after cooling to room temperature, solvents were removed and the 
crude mixture purified by flash chromatography with hexanes: ethyl acetate as 
eluents.  
The tert-butyl a,b-unsaturated ester was dissolved in CH2Cl2 (0.1 M) and 
trifluoroacetic acid (10.0 equiv.) was added at 0 ºC. The resulting solution was 
allowed to warm to room temperature and stirred for 4-12 hours. Solvents were 
then removed to give the corresponding conjugated acids that were employed 
without further purification. 
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tert-Butyl (E)-4-[2-(4-Methylphenyl)sulfonamidoethoxy]-2-butenoate (114) 
 
Physical state: Pale yellow oil 
Empiric Formula: C17H25NO5S 
Molecular weight (g/mol): 355.45 
Yield (%): 70%  
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.62 (d, J = 7.4 Hz, 2H), 7.26 (d, J = 7.4 Hz, 
2H), 6.60 (dt, J = 14.3, 5.4 Hz, 1H), 5.89 (d, 
J = 14.3 Hz, 1H), 4.23 (d, J = 5.4 Hz, 2H), 
3.96 (br s, 2H), 3.55 (t, J = 4.6 Hz, 2H), 
3.12 (s, 1H), 2.76 (s, 3H), 1.87 (s, 9H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 164.81, 143.64, 140.96, 136.21, 129.78, 
127.14, 125.76, 80.73, 60.90, 50.16, 49.78, 
28.07, 21.54 
HRMS (EI+): Calcd. for C17H25NO5S [M+]: 356.1587, found: 356.1584 
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Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 2:1 
as eluent. 
tert-Butyl (E)-4-[2-(4-Methylphenyl)sulfonamidoethoxy]-2-butenoate (115) 
 
Physical state: Grey foam 
Empiric Formula: C13H17NO5S 
Molecular weight (g/mol): 299.34 
Yield (%): 90%  
1H-RMN (Acetone, 300 MHz) δ 
(ppm): 
7.30 (d, J = 7.4 Hz, 2H), 6.98 (d, J = 7.4 Hz, 2H), 
6.41 (dt, J = 14.4, 5.3 Hz, 1H), 5.67 (d, J = 14.4 Hz, 
1H), 3.91 (dd, J = 5.3, 1.3 Hz, 2H), 3.54 (t, J = 5.6 
Hz, 2H), 3.19 (t, J = 5.6 Hz, 2H), 2.39 (s, 3H) 
13C-RMN (Acetone, 75.5 MHz) 
δ (ppm): 
167.1, 144.4, 144.1, 137.7, 130.4, 127.9, 124.2, 
61.2, 51.2, 50.4, 21.3 
HRMS (EI+): Calcd. for C13H17NO5S [M+]: 300.0900, found: 300.0902 
tert-Butyl (E)-6,6-Dimethyl-7-[(4-methylphenyl)sulfonamide}-2-heptenoate 
(120) 
 
Physical state: Brown oil 
Empiric Formula: C20H31NO4S 
Molecular weight (g/mol): 381.53 
Yield (%): 88%  
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.70 (d, J = 7.5 Hz, 2H), 7.30 (d, J = 7.5 Hz, 
2H), 6.81 (dt, J = 14.3, 6.2 Hz, 1H), 5.80 
(dt, J = 14.3, 1.4 Hz, 1H), 4.98 (br t, J = 6.3 
Hz, 1H), 3.04 (d, J = 6.3 Hz, 2H), 2.81 (s, 
3H), 2.51 – 2.40 (m, 2H), 1.93 (s, 9H), 1.83 
– 1.75 (m, 2H), 1.36 (s, 6H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 166.0, 147.7, 143.4, 137.0, 129.8, 127.1, 
123.1, 80.2, 52.9, 37.7, 34.0, 28.3, 26.6, 
25.0, 21.7 
HRMS (EI+): Calcd. for C20H31NO4S [M+]: 382.2040, found: 382.2040 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 10:1 
as eluent. 
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(E)-6,6-Dimethyl-7-[(4-methylphenyl)sulfonamide}-2-heptenoic acid (121) 
 
Physical state: Brown foam 
Empiric Formula: C16H23NO4S 
Molecular weight (g/mol): 325.42 
Yield (%): 82%  
1H-RMN (CD3OD , 300 MHz) δ (ppm): 8.93 (d, J = 7.4 Hz, 2H), 8.59 (d, J = 7.4 Hz, 
2H), 8.18 (dt, J = 14.4, 6.2 Hz, 1H), 7.13 
(dt, J = 14.4, 1.4 Hz, 1H), 4.23 (s, 2H), 4.05 
(s, 3H), 3.86 – 3.69 (m, 2H), 3.14 – 2.97 (m, 
2H), 2.62 (s, 6H) 
13C-RMN (CD3OD, 75.5 MHz) δ (ppm): 170.0, 151.5, 144.4, 139.1, 130.6, 127.9, 
122.1, 53.7, 38.6, 34.9, 27.8, 25.3, 21.5 
HRMS (EI+): Calcd. for C16H23NO4S [M+]: 326.1421, found: 326.1413 
1-(tert-Butyl) 4,4-Diethyl (E)-6-[(4-methylphenyl)sulfonamide]-1-hexene-
1,4,4-tricarboxylate (125) 
 
Physical state: Yellow oil 
Empiric Formula: C24H35NO8S 
Molecular weight (g/mol): 497.60 
Yield (%): 72%  
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.67 (d, J = 7.5 Hz, 2H), 7.29 (d, J = 7.5 Hz, 
2H), 6.64 (dt, J = 14.2, 7.0 Hz, 1H), 5.86 
(dt, J = 14.2, 1.2 Hz, 1H), 4.90 (br t, J = 5.9 
Hz, 1H), 4.43 (q, J = 6.6 Hz, 4H), 3.37 – 
3.28 (m, 2H), 3.07 (dd, J = 7.0, 1.2 Hz, 2H), 
2.81 (s, 3H), 2.47 (t, J = 6.2 Hz, 2H), 1.93 
(s, 9H), 1.72 (t, J = 6.6 Hz, 6H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 170.4, 165.1, 143.5, 140.6, 136.8, 129.8, 
127.1, 127.1, 80.7, 62.1, 56.0, 39.3, 36.2, 
33.3, 28.3, 21.7, 14.2 
HRMS (EI+): Calcd. for C24H35NO8S [M+]: 498.3117, found: 498.3111 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 5:1 
as eluent. 
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(E)-5,5-Bis(ethoxycarbonyl)-7-[(4-methylphenyl)sulfonamide]-2-heptenoic 
acid (126) 
 
Physical state: White foam 
Empiric Formula: C20H27NO8S 
Molecular weight (g/mol): 441.50 
Yield (%): 98%  
1H-RMN (CDCl3 , 300 MHz) δ (ppm): 7.65 (d, J = 7.6 Hz, 2H), 7.27 (d, J = 7.6 
Hz, 2H), 6.81 (dt, J = 14.2, 7.0 Hz, 1H), 
5.93 (d, J = 14.2 Hz, 1H), 5.4 (br s, 1H), 
4.41 (q, J = 6.5 Hz, 4H), 3.29 (br t, J = 
6.6 Hz, 2H), 3.10 (d, J = 7.0 Hz, 2H), 
2.78 (s, 3H), 2.47 (br t, J = 6.6 Hz, 2H), 
1.69 (t, J = 6.5 Hz, 6H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 171.1, 170.8, 144.7, 144.1, 137.2, 130.3, 
128.7, 127.6, 62.7, 56.4, 39.6, 36.6, 33.6, 
22.2, 14.7 
HRMS (EI+): Calcd. for C20H27NO8S [M+]: 442.1530, found: 442.1517 
tert-Butyl (E)-7-[(4-Methylphenyl)sulfonamide]-2-heptenoate (130) 
 
Physical state: Colorless oil 
Empiric Formula: C24H30N2O5S 
Molecular weight (g/mol): 458.57 
Yield (%): 86%  
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.60 (d, J = 7.6 Hz, 1H), 7.55 (d, J = 7.6 Hz, 
1H), 7.26 – 7.11 (m, 5H), 7.02 – 6.95 (m, 
1H), 6.93 – 6.87 (m, 1H), 6.61 – 6.46 (m, 
1H), 5.81 – 5.62 (m, 2H), 4.62 (s, 1H), 4.47 
(s, 1H), 4.23 – 4.14 (m, 1H), 4.01 (d, J = 
4.2 Hz, 1H), 3.97 (dd, J = 4.6, 2.9 Hz, 2H), 
2.71 (s, 3H), 1.85 (s, 4.5H), 1.82 (s, 4.5H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 167.3, 167.2, 164.8, 164.4, 143.7, 140.0, 
139.5, 136.0, 135.9, 135.9, 134.7, 129.8, 
129.2, 128.8, 128.2, 128.2, 128.0, 127.3, 
127.3, 126.3, 125.2, 124.9, 81.3, 80.9, 
49.8, 49.4, 46.7, 46.4, 43.9, 43.7, 28.2, 
21.7, 21.7 
HRMS (EI+): Calcd. for C24H30N2O5S [M+]: 459.2109, found: 459.2107 
N
H
OH
TsO
EtO2C
EtO2C
N
HN OtBu
TsO
Bn
O
  
Chapter 2 Experimental Section 
  
206 
 
 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 4:1 
as eluent. 
ê 1H and 13C NMR show the presence of rotamers in ca. 1:1 ratio. 
(E)-4-{N-Benzyl-2-[(4-methylphenyl)sulfonamido]acetamido}-2-butenoic 
acid (131) 
 
Physical state: Dark brown foam 
Empiric Formula: C20H22N2O5S 
Molecular weight (g/mol): 402.47 
Yield (%): 99%  
1H-RMN (CDCl3 , 300 MHz) δ (ppm): 10.88 (br s, 1H), 7.68 (d, J = 7.7 Hz, 1H), 
7.63 (d, J = 7.7 Hz, 1H), 7.32 – 7.23 (m, 5H), 
7.13 – 7.06 (m, 1H), 7.06 – 6.97 (m, 1H), 
6.89 – 6.82 (m, 1H), 6.82 – 6.75 (m, 1H), 
6.14 (br s, 1H), 5.93 – 5.86 (m, 1H), 5.86 – 
5.79 (m, 1H), 4.72 (s, 1H), 4.62 (s, 1H), 4.39 
– 4.06 (m, 4H), 2.78 (s, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 170.4, 169.9, 168.5, 144.3, 144.0, 143.9, 
143.6, 135.8, 135.4, 134.3, 130.1, 129.8, 
129.3, 128.9, 128.4, 128.2, 128.2, 127.2, 
126.5, 122.3, 50.6, 49.8, 47.2, 46.8, 44.0, 
21.7 
HRMS (EI+): Calcd. for C20H22N2O5S [M+]: 403.2350, found: 403.2347 
Remarks: ê 1H and 13C NMR show the presence of rotamers in ca. 1:1 ratio. 
tert-Butyl (E)-7-[(4-Methylphenyl)sulfonamide]-2-heptenoate (132) 
 
Physical state: Pale yellow oil 
Empiric Formula: C18H27NO4S 
Molecular weight (g/mol): 353.48 
Yield (%): 90%  
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.58 (d, J = 7.4 Hz, 2H), 7.17 (d, J = 7.4 Hz, 
2H), 6.77 – 6.56 (m, 1H), 5.68 (dt, J = 14.3, 
1.3 Hz, 1H), 5.17 (br s, 1H), 3.14 (dt, J = 
6.2, 6.5 Hz, 2H), 2.68 (s, 3H), 2.38 (tdd, J = 
6.5, 6.4, 1.3 Hz, 2H), 1.84 – 1.75 (m, 13H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 165.91, 147.02, 143.27, 136.96, 129.66, 
127.04, 123.36, 80.13, 42.93, 31.42, 29.06, 
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28.24, 25.05, 21.60 
HRMS (EI+): Calcd. for C18H27NO4S [M+]: 354.1694, found: 354.1689 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 5:1 
as eluent. 
(E)-7-[(4-Methylphenyl)sulfonamido]-2-heptenoic acid (134) 
 
Physical state: Brown solid 
Empiric Formula: C14H19NO4S 
Molecular weight (g/mol): 297.43 
Yield (%): 96%  
Melting point (ºC): 92-94 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.74 (d, J = 8.3 Hz, 2H), 7.30 (d, J = 8.0 Hz, 
2H), 6.98 (dt, J = 15.6 and 6.9 Hz, 1H), 
5.77 (dt, J = 15.6 and 1.4 Hz, 1H), 5.25 (t, J 
= 6.1 Hz, 1H), 2.96–2.90 (m, 2H), 2.42 (s, 
3H), 2.20-2.13 (m, 2H), 1.48–1.44 (m, 4H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 171.4, 151.3, 143.3, 136.7, 129.6, 126.9, 
120.9, 42.6, 31.4, 28.8, 24.6, 21.4 
HRMS (EI+): Calcd. for C14H19NO4S [M+]: 298.1068, found: 298.1063 
tert-Butyl (E)-6-[(4-Methylphenyl)sulfonamide]-2-hexenoate (133) 
 
Physical state: Yellow oil 
Empiric Formula: C17H25NO4S 
Molecular weight (g/mol): 339.45 
Yield (%): 97%  
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.70 (d, J = 7.5 Hz, 2H), 7.30 (d, J = 7.5 Hz, 
2H), 6.85 – 6.69 (m, 1H), 5.80 (d, J = 14.3 
Hz, 1H), 4.87 (br s, 1H), 3.30 (dt, J = 6.2, 6.3 
Hz, 2H), 2.81 (s, 3H), 2.57 (dt, J = 6.4, 6.5 
Hz, 2H), 2.17 – 2.00 (m, 2H), 1.93 (s, 9H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 165.80, 145.97, 143.54, 136.98, 129.82, 
127.15, 123.99, 80.38, 42.73, 42.73, 29.07, 
28.33, 21.72 
HRMS (EI+): Calcd. for C17H25NO4S [M+]: 340.1538, found: 340.1535 
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2.5.5. GENERAL PROCEDURE FOR THE DOMINO PC-IMAMR: PREPARATION OF 
2-SUBSTITUTED NITROGEN HETEROCYCLES 84C,F-I AND 93B. 
 
The corresponding a,b-unsaturated acid (1.0 equiv.) was dissolved in 
cyclopentyl methyl ether (CPME) (0.1M) in a microwave vial and then, 
diisopropyl carbodiimide (DIC) (1.5 equiv.), 3,5-dimetylpyrazol (1.2 equiv.) and 
catalyst AHS (20 mol%) were added sequentially. The vial was sealed and the 
solution was heated under microwave irradiation at 50-90 ºC for <1-7 hours. 
After this time, the crude reaction mixture was purified by means of flash 
chromatography on silica gel using the appropriate eluent. 
 
 
N
HY
X
Ts
CO2H
( )n
NHN
DIC, AHS (20 mol%)
CPME, MW 40-90ºC
N
Y
X
N
Ts O
N
( )n
84, 93 AHS
N
H
OO
N
H
N
OMeN
CF3
F3C
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 5:1 
as eluent. 
(E)-6-[(4-Methylphenyl)sulfonamido]-2-hexenoic acid (135) 
 
Physical state: White foam 
Empiric Formula: C13H17NO4S 
Molecular weight (g/mol): 283.34 
Yield (%): 95%  
1H-RMN (Acetone, 300 MHz) δ 
(ppm): 
7.33 – 7.23 (m, 2H), 7.01 – 6.91 (m, 2H), 6.48 (dt, J 
= 14.3, 6.4 Hz, 1H), 6.06 (br t, J = 5.4 Hz, 1H), 5.48 
(dt, J = 14.3, 1.4 Hz, 1H), 2.86 (dt, J = 5.4, 5.9 Hz, 
2H), 2.38 (s, 3H), 2.28 – 2.19 (m, 2H), 1.74 – 1.63 
(m, 2H) 
13C-RMN (Acetone, 75.5 MHz) 
δ (ppm): 
167.26, 149.00, 143.60, 138.93, 130.27, 127.61, 
122.51, 43.15, 29.33, 28.78, 21.36 
HRMS (EI+): Calcd. for C13H17NO4S [M+]: 284.0951, found: 284.0951 
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(S)-1-(3,5-Dimethyl-1H-pyrazol-1-yl)-2-(1-tosylpiperidin-2-yl)-1-ethanone 
(84c) 
 
Physical state: Brown oil 
Empiric Formula: C19H25N3O3S 
Molecular weight (g/mol): 375.49 
Yield (%): 62 
Enantiomeric relation: 95:5 
Optical rotation [a]D25: -16.2 (c 1.0, CHCl3) 
Remarks: ê Reaction performed at 90ºC for 6 hours. 
ê The spectroscopic data are in agreement with those previously reported. 
ê The er value was determined by HPLC analysis using a Chiracel OD-H 
column (hexane: isopropanol 92:8); flow rate = 1.0 mL/min. 
(R)-1-(3,5-Dimethyl-1H-pyrazol-1-yl)-2-(4-tosylmorpholin-3-yl)-1-ethanone 
(84f) 
 
Physical state: Pale yellow solid 
Empiric Formula: C18H23N3O4S 
Molecular weight (g/mol): 377.46 
Yield (%): 83% 
Melting point (ºC): 117-119 
Enantiomeric relation: 99.7:0.3 
Optical rotation [a]D25: -16.2 (c 1.0 CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.60 (d, J = 7.6 Hz, 2H), 7.33 (d, J = 7.3 Hz, 
2H), 6.05 (d, J = 0.7 Hz, 1H), 4.50 – 4.37 (m, 
1H), 4.17 (ddd, J = 10.7, 3.1, 1.6 Hz, 1H), 
4.06 – 3.90 (m, 2H), 3.85 – 3.75 (m, 1H), 
3.66 (dd, J = 15.0, 7.5 Hz, 1H), 3.42 (dd, J = 
15.0, 4.1 Hz, 1H), 2.90 (d, J = 0.9 Hz, 3H), 
2.87 – 2.78 (m, 4H), 2.66 (dd, J = 10.4, 9.3 
Hz, 1H), 2.61 (s, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 130.3, 128.4, 112.0, 72.0, 66.4, 50.4, 45.9, 
39.6, 22.1, 15.0, 14.4 
HRMS (EI+): Calcd. for C18H23N3O4S [M+]: 378.1482, found: 378.1475 
N O
N N
Ts
N
O N
TsO
N
  
Chapter 2 Experimental Section 
  
210 
 
 
Remarks: ê Reaction performed at 50ºC for 1 hour. 
ê Purification by flash chromatography with hexanes: ethyl acetate 4:1 
as eluent. 
ê The er value was determined by HPLC analysis using a Chiracel OD-
H column (hexane: isopropanol 95:5); flow rate = 1.0 mL/min 
(S)-2-(5,5-Dimethyl-1-tosylpiperidin-2-yl)-1-(3,5-dimethyl-1H-pyrazol-1-yl)-1-
ethanone (84g) 
 
Physical state: Colorless oil 
Empiric Formula: C21H29N3O3S 
Molecular weight (g/mol): 403.54 
Yield (%): 53% 
Enantiomeric relation: 94:6 
Optical rotation [a]D25: +3.4 (c 1.0 CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.65 (d, J = 7.7 Hz, 2H), 7.20 (d, J = 7.7 Hz, 
2H), 6.03 (s, 1H), 4.97 – 4.85 (m, 1H), 3.74 
(dd, J = 12.0, 1.0 Hz, 1H), 3.67 (dd, J = 14.5, 
8.7 Hz, 1H), 3.31 (ddd, J = 14.5, 4.1, 1.0 Hz, 
1H), 3.16 (d, J = 12.0 Hz, 1H), 2.85 (s, 3H), 
2.76 (s, 3H), 2.62 (s, 3H), 2.36 – 2.27 (m, 
1H), 1.97 – 1.93 (m, 1H), 1.93 – 1.87 (m, 
1H), 1.81 – 1.76 (m, 1H), 1.45 (s, 3H), 1.43 
(s, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 171.4, 152.0, 144.0, 142.8, 138.2, 129.5, 
127.1, 111.4, 51.7, 49.2, 34.8, 32.2, 30.7, 
29.1, 25.3, 23.7, 21.7, 14.7, 14.0 
HRMS (EI+): Calcd. for C21H29N3O3S [M+]: 404.2002, found: 404.2000 
Remarks: ê Reaction performed at 40ºC for 3 hours. 
ê Purification by flash chromatography with hexanes: ethyl acetate 6:1 
as eluent. 
ê The er value was determined by HPLC analysis using a Chiracel OD-
H column (hexane: isopropanol 98:2); flow rate = 1.5 mL/min 
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Diethyl (S)-2-[2-(3,5-Dimethyl-1H-pyrazol-1-yl)-2-oxoethyl]-1-
tosylpiperidine-4,4-dicarboxylate (84h) 
 
Physical state: Colorless oil 
Empiric Formula: C25H33N3O7S 
Molecular weight (g/mol): 519.61 
Yield (%): 53% 
Enantiomeric relation: 94:6 
Optical rotation [a]D25: -1.1 (c 1.0 CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.64 (d, J = 7.4 Hz, 2H), 7.23 (d, J = 7.4 Hz, 
2H), 6.02 (s, 1H), 5.00 – 4.89 (m, 1H), 4.48 – 
4.23 (m, 4H), 4.15 – 4.05 (m, 1H), 3.81 – 
3.69 (m, 1H), 3.62 (dd, J = 15.6, 7.8 Hz, 1H), 
3.50 (dd, J = 15.6, 6.0 Hz, 1H), 2.90 – 2.82 
(m, 4H), 2.78 (s, 3H), 2.76 – 2.69 (m, 1H), 
2.66 – 2.55 (m, 4H), 2.17 – 2.08 (m, 1H), 
1.69 – 1.58 (m, 6H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 171.1, 170.8, 170.6, 151.9, 143.9, 143.2, 
137.9, 129.7, 127.1, 111.2, 62.1, 62.0, 50.9, 
48.5, 38.7, 37.3, 32.0, 29.8, 21.7, 14.8, 14.1, 
14.0, 13.8 
HRMS (EI+): Calcd. for C25H33N3O7S [M+]: 520.2112, found: 520.2108 
Remarks: ê Reaction performed at 50ºC for 7 hours, adding 40 mol% of AHS. 
ê Purification by flash chromatography with hexanes: ethyl acetate 5:1 
as eluent. 
ê The er value was determined by HPLC analysis using a Chiracel AD 
column (hexane: isopropanol 80:20); flow rate = 1.0 mL/min. 
(R)-1-Benzyl-5-(2-(3,5-dimethyl-1H-pyrazol-1-yl)-2-oxoethyl)-4-
tosylpiperazin-2-one (84i) 
 
Physical state: Colorless oil 
Empiric Formula: C25H28N4O4S 
Molecular weight (g/mol): 480.58 
Yield (%): 53% 
Enantiomeric relation: 93:7 
Optical rotation [a]D25: -9.6 (c 1.0 CHCl3) 
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1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.64 (d, J = 7.7 Hz, 2H), 7.30 – 7.26 (m, 2H), 
7.16 – 7.06 (m, 5H), 6.04 (s, 1H), 4.97 (d, J = 
13.3 Hz, 1H), 4.89 – 4.76 (m, 1H), 4.55 (d, J 
= 16.3 Hz, 1H), 4.44 (d, J = 13.3 Hz, 1H), 
4.24 (d, J = 16.3 Hz, 1H), 3.69 (dd, J = 11.6, 
3.9 Hz, 1H), 3.60 (dd, J = 15.6, 8.6 Hz, 1H), 
3.52 – 3.43 (m, 2H), 2.80 (s, 3H), 2.77 (s, 
3H), 2.62 (s, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 171.2, 170.1, 164.3, 152.4, 144.1, 144.0, 
135.8, 135.7, 130.0, 128.6, 128.5, 127.7, 
127.3, 111.6, 67.2, 60.5, 53.6, 49.8, 48.3, 
48.3, 45.4, 35.9, 31.8, 22.9, 21.8, 21.2, 14.4, 
14.3, 13.9 
HRMS (EI+): Calcd. for C25H28N4O4S [M+]: 481.1904, found: 481.1897 
Remarks: ê Reaction performed at 40ºC for 5 hours. 
ê Purification by flash chromatography with hexanes: ethyl acetate 10:1 
as eluent. 
ê The er value was determined by complexation with a europium salt. 
ê 1H and 13C NMR show the presence of rotamers 
(S)-1-(3,5-Dimethyl-1H-pyrazol-1-yl)-2-(1-tosylpyrrolidin-2-yl)-1-ethanone 
(93b) 
 
Physical state: Pale pink solid 
Empiric Formula: C18H23N3O3S 
Molecular weight (g/mol): 361.46 
Yield (%): 57 
Melting point (ºC): 127-129 
Enantiomeric relation: 82:18 
Optical rotation [a]D25: -84.5 (c 1.0, CHCl3) 
Remarks: ê Reaction performed at 50ºC for 2 hours. 
ê The spectroscopic data are in agreement with those previously reported. 
ê The er value was determined by HPLC analysis using a Chiracel OD-H 
column (hexane: isopropanol 92:8); flow rate = 1.0 mL/min 
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2.5.6. GENERAL PROCEDURE FOR THE TRANSFORMATION OF 
PYRAZOLAMIDES 84 AND 93 INTO ESTERS 136 AND 137 
 
To a solution of heterocycle 86 or 95 (1.0 equiv.) in EtOH (0.1 M), 4-
(dimethyl amino)pyridine (DMAP) (30 mol%) was added. The resulting solution 
was refluxed for 4 hours and, after cooling to room temperature, solvents were 
removed and the crude mixture was purified by flash chromatography with 
hexanes: ethyl acetate as eluents. 
 
 
 
DMAP (30 mol%)
EtOH Δ
N
Y
X
N
Ts O
N
( )n
84, 93
N
Y
X
Ts O( )
n
136, 137
OEt
Ethyl (R)-2-(1-Tosylpyrrolidin-2-yl)acetate (136) 
 
Physical state: Colorless oil 
Empiric Formula: C15H21NO4S 
Molecular weight (g/mol): 311.40 
Yield (%): 78% 
Optical rotation [a]D25: -70.0 (c 1.0 CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.74 (d, J = 8.1 Hz, 2H), 7.32 (d, J = 8.1 Hz, 
2H), 4.14 (q, J = 7.1, 2H), 4.03 – 3.89 (m, 
1H), 3.50 – 3.38 (m, 1H), 3.18 – 3.01 (m, 
2H), 2.55 – 2.45 (m, 1H), 2.43 (s, 3H), 1.82 – 
1.70 (m, 2H), 1.68 – 1.62 (m, 1H), 1.58 – 
1.49 (m, 1H), 1.26 (t, J= 7.1 Hz, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 171.5, 143.7, 134.3, 129.9, 127.8, 60.6, 56.7, 
49.3, 41.6, 31.8, 23.9, 21.7, 14.3 
HRMS (EI+): Calcd. for C15H21NO4S [M+]: 312.2325, found: 312.2319 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 5:1 
as eluent. 
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Ethyl (R)-2-(4-Benzyl-5-oxo-1-tosylpiperazin-2-yl)acetate (137) 
 
Physical state: Colorless oil 
Empiric Formula: C22H26N2O5S 
Molecular weight (g/mol): 430.52 
Yield (%): 92% 
Optical rotation [a]D25: +1.2 (c 1.0 CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 7.69 (d, J = 6.6 Hz, 2H), 7.35 – 7.26 (m, 5H), 
7.09 (dd, J = 6.6, 2.9 Hz, 2H), 4.66 (d, J = 
14.4 Hz, 1H), 4.46 – 4.34 (m, 1H), 4.28 (d, J 
= 3.6 Hz, 1H), 4.23 (s, 1H), 4.07 – 3.89 (m, 
2H), 3.81 (d, J = 17.7 Hz, 1H), 3.33 (dd, J = 
13.0, 4.5 Hz, 1H), 3.13 (dd, J = 13.0, 2.7 Hz, 
1H), 2.46 – 2.40 (m, 4H), 1.25 (s, 1H), 1.17 
(t, J = 7.1 Hz, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 169.9, 164.4, 144.3, 135.7, 135.5, 130.2, 
128.8, 128.5, 128.0, 127.4, 61.2, 49.9, 48.5, 
48.2, 45.5, 34.9, 21.8, 14.2 
HRMS (EI+): Calcd. for C22H26N2O5S [M+]: 431.1596, found: 431.1588 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 5:1 
as eluent. 
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2.5.7. HPLC TRACES AND NMR ER DETERMINATION SPECTRA OF 
ENANTIOENRICHED COMPOUNDS 84 AND 93-96 
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3.1. Background 
3.1.1. MICHAEL ADDITIONS TO VINYL SULFONES 
Sulfones are widely used intermediates of unique synthetic versatility in 
organic synthesis. Conjugated additions of carbon nucleophiles to vinyl sulfones 
constitute a class of synthetically valuable C-C bond forming reactions. 
Accordingly, considerable efforts have been devoted to the development of the 
asymmetric version of those types of additions. Although significant advances 
have been made in the use of the chiral auxiliary strategy, enantioselective 
catalytic Michael additions remained elusive until more or less ten years ago.247 
First of all, two studies that highlighted the importance of the substituents 
in the vinyl sulfone for its role as Michael acceptor will be introduced, which 
could result interesting for the understanding of the results reported below in 
this PhD thesis.  
Roush reported in 2003 248  the dependence of the reactivity of the 
Michael acceptor on the nature of the sulfonyl substituent (SO2R) (Scheme 3.1). 
The rates of the Michael addition of 2’-(phenethyl)thiol, in the presence of 
triethyl amine, vary over 3 orders of magnitude, with phenyl vinyl sulfonate 
esters (R = SO2OPh) being ca. 3000-fold more reactive than N-benzyl vinyl 
sulfonamides (R = SO2NHBn). The relative rates of Michael addition to a,b-
unsaturated esters, amides, and ketones are readily understood when 
considering of the electrophilicity of the enoyl b-carbon. However, the situation 
differs for conjugate addition reactions of vinyl sulfonyl acceptors. As these 
compounds undergo conjugate additions, the reactive intermediate is an a-
carbanion, which is stabilised by the sulfur atom of the sulfonyl unit. In contrast 
to enoyl Michael acceptors, electronic effects arising from the linking oxygen or 
nitrogen atoms of the sulfonate ester and sulfonamide groups are exclusively 
                                            
247 a) Pinheiro, S.; Guingant, A.; Desmaële, D.; d’Angelo, J. Tetrahedron: Asymmetry 1992, 3, 
1003-1006. b) d’Angelo, J.; Revial, G. Tetrahedron: Asymmetry 1991, 2, 199-202. c) Enders, D.; 
Müller, S. F.; Raabe, G.; Runsink, J. Eur. J. Org. Chem. 2000, 879-892. d) Sanki, A. K.; Suresh, 
C. G.; Falgune, U. D.; Pathak, T. Org. Lett. 2003, 5, 1285-1288. e) See Ref. 40c: Almaşi, D.; 
Alonso, D. A.; Nájera, C. Tetrahedron: Asymmetry 2007, 18, 299–365. 
248 Reddick, J. J.; Cheng, J.; Roush, W. R. Org. Lett. 2003, 5, 1967–1970. 
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inductive. Therefore, strong s-electron-withdrawing inductive effects would be 
expected to stabilize the a-carbanion formation.  
 
Scheme 3.1. Relative pseudo-first-order rate constants in Michael additions to differently 
R-substituted vinyl sulfones. 
Then, in 2007 Posner et al. reported the unexpected steric effects of 
“remote” alkyl groups on the rate of conjugate additions to alkyl a,b-ethylenic 
sulfones.249 They showed that what are widely considered to be remote alkyl 
groups in –CH=CHS(O)n–alkyl systems are actually not remote from the b-
carbon of these Michael acceptors. Molecular modelling shows clearly that the 
alkyl groups in these conjugated systems shield the b-carbons. Competition 
experiments established that the relative rates of Michael addition are in the 
following order: Et > iPr > tBu. 
 
Scheme 3.2. Relative rates of formation of the Michael adduct depending on the b’-
substituents.  
                                            
249 Usera, A. R.; Posner, G. H. J. Org. Chem. 2007, 72, 2329–2334. 
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Focusing now on the organocatalytic approaches, Deng published in 
2005 the first highly enantioselective catalytic conjugate addition to vinyl 
sulfones.250 a-Cyanoacetates bearing a range of alkyl or aryl groups, of varying 
electronic and steric properties, underwent efficient enantioselective addition to 
aryl vinyl sulfones, providing the Michael adduct bearing the all-carbon 
quaternary stereocenter in excellent enantioselectivity and good to excellent 
yield by means of cinchona alkaloid organocatalysts (Scheme 3.3). They also 
applied this procedure to develop a new catalytic approach for the asymmetric 
synthesis of the biologically significant a,a-disubstituted amino acids. A similar 
study employing a-substituted cyanoacetates and a chiral bifunctional thiourea 
catalyst was developed by Chen et al. shortly after.62 
 
Scheme 3.3. Enantioselective Michael addition of a-cyanoacetates to vinyl sulfones. 
On the other hand, Alexakis has developed several studies related to 
conjugate additions to vinyl sulfones.251 Although they could not accomplish the 
reaction with mono-activated vinyl sulfones, his research group demonstrated 
the principle of double activation through the presence of geminal sulfonyl 
groups for inducing reactivity. They disclosed the first intermolecular 
enantioselective organocatalytic Michael reaction of aldehydes with vinyl 
sulfones employing a catalytic system of chiral amine with diphenyl prolinol silyl 
ether (Scheme 3.4).251a Thus, leading to optically active g-gem-sulfonyl 
aldehydes, with good yields and enantioselectivities, as useful tunable chiral 
                                            
250 Li, H.; Song, J.; Liu, X.; Deng, L. J. Am. Chem. Soc. 2005, 127, 8948–8949. 
62 Liu, T.-Y.; Long, J.; Li, B.-J.; Jiang, L.; Li, R.; Wu, Y.; Ding, L.-S.; Chen, Y.-C. Org. Biomol. 
Chem. 2006, 4, 2097-2099. 
251 a) Sulzer-Mossé, S.; Alexakis, A.; Mareda, J.; Bollot, G.; Bernardinelli, G.; Filinchuk, Y. 
Chem. Eur. J. 2009, 15, 3204–3220. b) Sulzer-Mossé, S.; Alexakis, A. Chem. Commun. 2007, 
3123-3135. c) Mossé, S.; Alexakis, A. Org. Lett. 2005, 7, 4361–4364. d) Mossé, S.; Laars, M.; 
Kriis, K.; Kanger, T.; Alexakis, A. Org. Lett. 2006, 8, 2559–2562. 
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synthons. The analogous addition of ketones to conjugated sulfones has not 
been described yet.40c 
 
Scheme 3.4. Asymmetric conjugate addition of aldehydes to vinyl bis(sulfone). 
In addition, Lu’s research group published the conjugate additions of 
nitroalkanes252 and oxindoles253 to vinyl bis(sulfone) molecules by means of 
thiourea organocatalysts. In 2009, they reported the first organocatalytic 
enantioselective Michael reaction between nitroalkanes and vinyl sulfone 
promoted by a quinidine-derived thiourea catalyst (Scheme 3.5.a). This 
procedure, together with facile reduction and desulfonilation, represents a novel 
approach to access a-branched chiral amines. Then, in 2010 they disclosed 
highly enantioselective Michael additions of both 3-aryl- and 3-alkyl-
disubstituted oxindoles to conjugated sulfone by means of bifunctional and 
trifunctional thiourea catalyst containing natural amino acid residues (Scheme 
3.5.b). 
                                            
40c Almaşi, D.; Alonso, D. A.; Nájera, C. Tetrahedron: Asymmetry 2007, 18, 299–365. 
252 Zhu, Q.; Lu, Y. Org. Lett. 2009, 11, 1721–1724. 
253 Zhu, Q.; Lu, Y. Angew. Chem. Int. Ed. 2010, 49, 7753–7756. 
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Scheme 3.5. Cinchona-derived thiourea catalysed Michael additions to vinyl bis(sulfone). 
More recently, a highly enantioselective Michael addition of 3-aryl-N-Boc-
oxindoles to the mono-activated phenyl vinyl sulfone catalysed by a quinine 
derived bifunctional amine-thiourea-bearing sulfonamide as multiple hydrogen-
bonding donor catalyst was published.254 The corresponding adducts, which 
contain a chiral quaternary carbon center at the 3-position of the oxindole, were 
obtained in good yields (52-86%) with very good enantioselectivities (83-98% 
ee). 
 
Scheme 3.6. Enantioselective Michael addition of oxindoles to phenyl vinyl sulfone. 
                                            
254 Zhao, M.-X.; Tang, W.-H.; Chen, M.-X.; Wei, D.-K.; Dai, T.-L.; Shi, M. Eur. J. Org. Chem. 
2011, 2011, 6078–6084. 
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Finally, regarding intramolecular conjugate additions to vinyl sulfones 
there are two noteworthy examples. Prunet et al. developed in 2002 a new 
method to make sulfone synthons with a syn 1,3-diol motif, which constitute 
models for the C16-C24 portion of cytotoxic Dolabelides (Scheme 3.7). The 
intramolecular oxa-Michael reaction in the presence of benzaldehyde and a 
catalytic amount of potassium tert-butoxide proceeded in good yields and 
selectivity starting from homoallylic alcohols functionalized with a 
toluenesulfone. 
 
Scheme 3.7. Stereoselective intramolecular conjugate addition in the synthesis of 
Dolabelides precursors. 
Then, in 2010 Alexakis research group disclosed the first organocatalytic 
intramolecular Michael addition of aldehydes bearing various vinyl sulfones in 
good yields with good enantioselectivities and diastereoselectivities.255 In the 
intermolecular version, no reaction occurred with mono-activated phenyl vinyl 
sulfone; whereas in the intramolecular version, full conversion was observed. 
This reaction was promoted by a readily available trans-4-hydrozyprolyl amide, 
and the catalytic reaction might involve an activation of the sulfone by a 
hydrogen-bonding interaction (Scheme 3.8). 
                                            
255  Bournaud, C.; Marchal, E.; Quintard, A.; Sulzer-Mossé, S.; Alexakis, A. Tetrahedron: 
Asymmetry 2010, 21, 1666–1673. 
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Scheme 3.8. Intramolecular Michael addition to vinyl sulfones. 
3.1.2. SULTAMS 
Significant interest has been directed toward cyclic sulfonamides, also 
known as sultams. These compounds possess unique physical and chemical 
properties, rendering them attractive targets for probing biological systems.256 
Although not found in nature,257 sultams are known as privileged structures in 
drug discovery due to their diverse biological properties.258 The more prominent 
include the Ampiroxicam anti-inflammatory agent (Figure 3.1.a), 259 
benzodithiazine dioxides displaying anti-HIV-1 activity (Figure 3.1.b), 260 
antiepileptic agent Sulthiame (Figure 3.1.c),261 Brinzolamide for the treatment of 
glaucoma (Figure 3.1.d)262 and anti-Alzheimer compounds as BACE-1 inhibitors 
(Figure 3.1.e).263 
                                            
256 a) Asad, N.; Samarakoon, T. B.; Zang, Q.; Loh, J. K.; Javed, S.; Hanson, P. R. Org. Lett. 
2014, 16, 82–85. b) Ukrainets, I. V; Petrushova, L. A.; Dzyubenko, S. P.; Sim, G. Chem. 
Heterocycl. Compd. 2014, 50, 103–110. c) Valente, C.; Guedes, R. C.; Moreira, R.; Iley, J.; Gut, 
J.; Rosenthal, P. J. Bioorg. Med. Chem. Lett. 2006, 16, 4115–4119. d) Fu, L.N. Letters in 
Organic Chemistry, 2014, 11, 13-17 
257 Cyclic sulfonamides (sultams) can be considered to be the functional analogues of the 
corresponding lactam structures: Hinchliffe, P. S.; Wood, J. M.; Davis, A. M.; Austin, R. P.; 
Beckett, R. P.; Page, M. I. Org. Biomol. Chem. 2003, 1, 67–80. 
258 a) A. Scozzafava, T. Owa, A. Mastrolorenzo and C. T. Supuran, Curr. Med. Chem., 2003, 
10, 925-953; b) M. D. McReynolds, J. M. Dougherty and R. R. Hanson, Chem. Rev., 2004, 104, 
2239-2258; c) Z. Liu and Y. Takeuchi, Heterocycles, 2009, 78, 1387-1412; d) K. C. Majumdar, 
S. Mondal, Chem. Rev., 2011, 111, 7749-7773; e) V. A. Rassadin, D. S. Grosheva, A. A. 
Tomashevskii, V. V. Sokolov, Chem. Heterocycl. Compd., 2013, 49, 39-65. 
259 Rabasseda, X.; Hopkins, S. J. Drugs Today 1994, 30, 557–563. 
260 F. Brzozowski, F. Saczewski, N. Neamati, Bioorg. Med. Chem. Lett., 2006, 16, 5298-5302. 
261 Tanimukai, H.; Inui, M.; Hariguchi, S.; Kaneko, Z. Biochem. Pharmacol. 1965, 14, 961–970. 
262 Wroblewski, T.; Graul, A.; Castaner, J. Drugs Future 1998, 23, 365-369. 
263 N. Charrier, B. Clarke, L. Cutler, E. Demont, C. Dingwall, R. Duns- don, J. Hawkins, C. 
Howes, J. Hubbard, I. Hussain, G. Maile, R. Matico, J. Mosley, A. Naylor, A. O’Brian, S. 
Redshaw, P. Rowland, V. Soleil, K. J. Smith, S. Sweitzer, P. Theobald, D. Vesey, D. S. Walter, 
G. Wayne, Bioorg. Med. Chem. Lett. 2009, 19, 3674-3678. 
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Figure 3.1. Biologically active sultams. 
Furthermore, these scaffolds have been utilized as reagents to perform 
specific organic transformations and also, they have been used as chiral 
auxiliaries to carry out asymmetric synthesis. Concretely, the applications of 
Oppolzer camphorsultam (Figure 3.2.a), first reported in 1984,264 have grown 
rapidly over the past few years and nowadays is considered to be one of the 
most useful and suitable chiral auxiliaries for asymmetric synthesis. Back to 
initial papers by Oppolzer et al.265 and continuous reports by others266 proved 
the usefulness of the sultam for controlling stereochemistry in the absence of 
any chelating metals. Since then, much attention has been paid to the thermal 
chemistry of acryloyl derivatives of Oppolzer’s sultam (Figure 3.2.b). 267 
                                            
264 Oppolzer, W.; Chauis, C.; Bernardinelli, G. Helv. Chim. Acta, 1984, 67, 1397-1401. 
265 a) Oppolzer, W. Tetrahedron, 1987, 43, 1969-2004 b) Oppolzer, W. Pure Appl. Chem. 1990, 
62, 1241–1250. c) Oppolzer, W.; Poli, G.; Kingma, A. J.; Starkemann, C.; Bernardinelli, G. Helv. 
Chim. Acta 1998, 81, 324–329. d) Oppolzer, W.; Poli, G.; Starkemann, C.; Bemardinelli, G. 
Tetrahedron Lett. 1988, 29, 3559–3562. 
266 a) Ahn, K. H.; Ham, C.; Kim, S.-K.; Cho, C.-W. J. Org. Chem. 1997, 62, 7047-7048. b) 
Kumaraswamy, G.; Padmaja, M.; Markondaiah, B.; Jena, N.; Sridhar, B.; Kiran, M. U. J. Org. 
Chem., 2006, 71, 337-340. c) Shinada, T.; Oe, K.; Ohfune, Y. Tetrahedron Lett. 2012, 53, 3250-
3253. d) Takao, K.-I.; Sakamoto, S.; Touati, M. A.; Kusakawa, Y.; Tadano, K.-I. Molecules 2012, 
17, 13330–13344. e) Heravi, M. M.; Zadsirjan, V. Tetrahedron: Asymmetry 2014, 25, 1061–
1090. 
267 Hyean Kim, B.; Curran, D. P. Tetrahedron 1993, 49, 293–318. 
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Oppolzer’s research group also described shortly after a family of chiral toluene-
2,a-sultam auxiliaries derived from saccharin (Figure 3.2.c).268 
 
Figure 3.2. Sultams as chiral auxiliaries. 
Consequently, a simple and convenient method for their synthesis has 
been required in order to access all that sultams have to offer. Currently, 
methods 269  that have been used to prepare sultams include Diels–Alder 
reactions, 270  radical cyclisations, 271  ring-closing metathesis reactions, 272 
nucleophilic aromatic substitutions,273 cyclisations of aminosulfonyl chlorides,274 
and intramolecular Heck reactions.275 Michael reactions to access this scaffolds 
are not a generalized methodology but there is a remarkable example from 
2008,276 where the first examples of intramolecular oxa-Michael and Baylis-
Hillman reactions to vinyl sulfonamides is described for the preparation of five-, 
six-, seven- and eight-membered ring sultams with excellent yields and good to 
                                            
268 a) Oppolzer, W.; Rodriguez, I.; Starkemann, C.; Walther, E. Tetrahedron Lett. 1990, 31, 
5019–5022. b) Ahn, K. H.; Kim, S.-K.; Ham, C. Tetrahedron Lett. 1998, 39, 6321–6322. c) Ahn, 
K. H.; Baek, H.-H.; Lee, S. J.; Cho, C.-W. J. Org. Chem. 2000, 65, 7690–7696. 
269 For recent reviews on the synthesis of sultams, see: a) Szostak, M.; Aube, J. Chem. Rev. 
2013, 113, 5701–5765. b) Rassadin, V. A.; Grosheva, D. S.; Tomashevskiy, A. A.; Sokolov, V. 
V. Chem. Heterocycl. Compd. 2013, 49, 39–65. c) Majumdar, K. C.; Mondal, S. Chem. Rev. 
2011, 111, 7749–7773. 
270 a) Greig, I. R.; Tozer, M. J.; Wright, P. T. Org. Lett. 2001, 3, 369– 371. b) Rogachev, V. O.; 
Filimonov, V. D.; Fröhlich, R.; Kataeva, O.; Metz, P. Heterocycles 2006, 67, 589– 595. 
271 a) Paquette, L. A.; Barton, W. R. S.; Gallucci, J. C. Org. Lett. 2004, 6, 1313–1315; b) Ueda, 
M.; Miyabe, H.; Nishimura, A.; Miyata, O.; Takemoto, Y.; Naito, T. Org. Lett. 2003, 5, 3835–
3838. 
272 a) McReynolds, M. D.; Dougherty, J.M.; Hanson, P. R. Chem. Rev. 2004, 104, 2239–2258. 
b) Jiménez-Hopkins, M.; Hanson, P. R. Org. Lett. 2008, 10, 2223–2226. 
273 Wojciechowski, K.; Kosinski, S.Tetrahedron 2001, 57, 5009– 5014 
274 Enders, D.; Moll, A.; Bats, J.W. Eur. J. Org. Chem. 2006, 1271– 1284. 
275 a) Evans, P.; McCabe, T.; Morgan, B. S.; Reau, S. Org. Lett. 2005, 7, 43–46. b) Merten, S.; 
Fröhlich, R.; Kataeva, O.; Metz, P. Adv. Synth. Catal. 2005, 347, 754–758. c) Grigg, R.; York, 
M. Tetrahedron Lett. 2000, 41, 7255–7258. 
276 Zhou, A.; Hanson, P. R. Org. Lett. 2008, 10, 2951–2954. 
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excellent levels of diastereoselectivity throughout the Baylis-Hillman study 
(Scheme 3.9). 
 
Scheme 3.9. Synthesis of enantioenriched sultams. 
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3.2. Objectives 
Considering the aforementioned significance of sultams as privileged 
structures, it seemed an attractive and very appealing strategy to combine the 
previously studied organocatalytic intramolecular aza-Michael reaction (IMAMR) 
with a second intramolecular Michael addition, to eventually prepare a new 
family of bicyclic sultams. Thus, the key of this sequence rely on the use of vinyl 
sulfonamides as both, nitrogen nucleophiles and Michael acceptors. 
The preparation of the starting materials would involve a selective cross-
metathesis (CM) reaction with the terminal olefin. Next, the conditions for the 
enantioselective IMAMR needed to be set to create the C-N bond. Finally, the 
sulfonamide moiety properly functionalised to act as the Michael acceptor would 
allow the following diastereoselective intramolecular Michael reaction (IMMR) 
generating a new C-C bond and affording bicyclic sultams with two new 
stereocenters (Scheme 3.10). Both the step-wise and the domino approaches 
will be evaluated. 
 
Scheme 3.10. Initial goal of the present chapter. 
The sought molecules imply a very exclusive family of enantioenriched 
sultams, given the bridgehead position of the sulfonamide nitrogen, not reported 
to date in enantiomerically enriched manner.  
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3.3. Results and Discussion 
Taking into account the previously introduced objectives, the selected 
results show the synthetic strategy for the desired highly functionalized starting 
materials, followed by the optimization of the first cyclisation (IMAMR) and then 
the different approaches for the final preparation of the targeted bicyclic 
sultams. 
3.3.1. PREPARATION OF THE STARTING MATERIALS 
The starting materials of choice were vinyl sulfonamides 140 bearing a 
conjugated ketone in a remote position, in turn prepared by means of a CM 
reaction of starting sulfonamides 139 containing the terminal olefin moiety.  
Conjugated ketones were selected as Michael acceptors for the first 
cyclization step. Thus, using the methodology developed in the first chapter, the 
initial IMAMR will be evaluated. On the other hand, vinyl sulfonamides were the 
Michael acceptors of the second cyclization step, due to more simple access to 
those derivatives. Furthermore, the incorporation of substitution at the b-position 
of the starting vinyl sulfone would form an additional chiral center, increasing 
the complexity of the overall process. The synthesis of vinyl sulfonamides 140 is 
depicted below in Scheme 3.11. 
 
Scheme 3.11. Synthesis of starting material 140. 
3.3.1.1. Synthesis of the conjugated sulfonamide-olefin 139 
The synthesis of 139 started with nitrile 8. Its preparation was performed 
by initial reduction of the nitrile functionality to the primary amine by means of 
lithium aluminium hydride. Then, amine 9 was treated, without further 
purification, with 2-chloroethane-1-sulfonyl chloride, and the corresponding 
sulfonamide underwent elimination of HCl under the basic reaction conditions, 
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generating the vinyl sulfone. Thus, the desired conjugated sulfonamide was 
finally obtained in a 3-step protocol in good yield (Scheme 3.12). 
 
Scheme 3.12. Preparation of vinyl sulfonamide 139. 
3.3.1.2. Selective cross-metathesis reaction: Synthesis of a,b-
unsaturated sulfonamide-ketones 140.  
Once prepared starting sulfonamide 139, it was subjected to a cross-
metathesis (CM) reaction with various vinyl ketones with the aim of obtaining 
the corresponding a,b-unsaturated substrates 140 for the subsequent conjugate 
additions (Figure 3.11). 
 
Figure 3.11. Starting materials for the synthesis of bicyclic sultams. 
Given the presence of two different terminal double bonds in substrate 
139, regioselectivity problems would arise in the CM reaction. Additionally, a 
competitive ring closing metathesis reaction would also occur. Therefore, three 
possible scenarios have to be considered: the desired CM with the isolated 
olefin (Figure 3.12.a), a CM reaction with the vinyl sulfonamide (Figure 3.12.b) 
and a ring-closing-metathesis (RCM) cyclisation (Figure 3.12.c).  
 
Figure 3.12. Plausible metathesis reactions with substrates 139. 
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Based on electronic considerations, Grubbs 277  has developed a 
classification of olefins in four different types according to their ability to undergo 
CM reactions.152 Using this data, is possible to make some predictions 
regarding the most favoured CM pair, as well as the propensity of the involved 
olefins to suffer homodimerization. A general trend could be extracted from this 
study; when the two olefins have a greater difference, which means that they 
belong to more separated olefin types, more favourable will be a CM reaction 
between them. 
Preparation of compounds 140 involved a CM reaction between olefin 
139 and alkyl- or aryl-vinyl ketones 34. According to the previously mentioned 
classification, compound 139 contain two types of olefins; the vinyl sulfonamide 
is a type III olefin whereas the isolated olefin can be considered as a type I 
olefin. On the other hand, conjugated ketones 34a-c are olefins of type II 
whereas 34d, that bears substitution at the b-position, is a type III olefin. The 
most reactive olefin in CM reactions is the isolated one of compound 139; this 
type I olefin would react in a more favourable manner with conjugated ketones 
of type II (or type III). Olefins of type I have a high homodimerization ratio, but 
this could be avoided by adding a big excess of the conjugated ketone (usually 
3 equivalents). Vinyl sulfonamides (olefins of type III) are low reactive olefins in 
CM reactions, which means that in the reaction of 139 and 34 it can be 
achieved a regioselective process to access the desired conjugated ketones 
140 (Figure 3.13). 
The RCM reaction could be also a competitive reaction. Compound 139 
would undergo RCM rendering an 8-membered ring sultam. Although those 
intramolecular processes are more favourable entropically than the 
intermolecular CM reaction, in this case the slow rate of formation of an 8-
membered ring and the use of diluted reactions would allow us to direct the 
process to the CM product. 
                                            
277 Grubbs, R. H. Tetrahedron 2004, 60, 7117–7140 and references therein. 
152 Chatterjee, A. K.; Choi, T.-L.; Sanders, D. P.; Grubbs, R. H. J. Am. Chem. Soc. 2003, 125, 
11360–11370. 
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Figure 3.13. Classification of the involved olefins in 139 and 34. 
Taking into account what has been exposed in the first chapter with 
regard to CM catalysts, it was chosen Hoveyda-Grubbs 2nd generation catalyst 
in DCM as solvent to optimize the desired transformation employing substrate 
139 (Table 3.1). At room temperature the reaction did not progress satisfactorily 
(28% yield) (Table 3.1, entry 1) and at reflux the RCM product was observed as 
the major product (Table 3.1, entry 2). The increase of the catalyst loading 
(added in two times) was traduced in a slight improvement of the desired 
product until 40% (Table 3.1, entry 3). This result was improved by adding a 20 
mol% of a Lewis acid (titanium isopropoxide) which coordinates the ketone 
oxygen making the enone more reactive for the CM reaction (Table 3.1, entry 
4). Finally, the best results (86% yield) were obtained with a total load of 24 
mol% of HG-II and seven equivalents of the conjugated ketone distributed into 
three separate additions (Table 3.1, entry 5). 
Table 3.1. Optimization of the regioselective CM reaction 
 
Entry HG-II (mol%) additive T (ºC) Yield (%)a 
1 8 - 25 28 
2 8 - 45 RCMb 
3 16 - 25 40 
4 16 Ti(iPrO)4c 25 53 
5 24 Ti(iPrO)4c 25 86 
a Isolated yields after flash chromatography purification. 
b Ring-closing-metathesis product mainly obtained 
c 20 mol% loading 
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Then the optimized reaction conditions were applied to the synthesis of 
the different a,b-unsaturated sulfonamide-ketones 140 (Table 3.2). Compounds 
140a-c (Table 3.2, entries 1-3) were obtained with good yields. However, 
synthesis of 140e wasn’t very efficient (Table 3.2, entry 4) due to the 
aforementioned problematic selectivity and also because of the steric sensitivity 
of the CM reaction, the methyl group at the R2 position would make the 
transformation rate slower, occurring in this way some side reactions such as 
the RCM and the formation of the Z-isomer (10% yield). 
Table 3.2. Synthesis of the conjugated sulfonamide-ketones 140 
 
Entry ketone R1 R2 Product Yield (%)a 
1 34a Me H 140a 86 
2 34b Pr H 140b 81 
3 34c Pent H 140c 66 
4 34d Ph Me 140d 31 
a Isolated yields after flash chromatography purification 
3.3.2. ENANTIOSELECTIVE INTRAMOLECULAR AZA-MICHAEL REACTION OF 
a,b-UNSATURATED SULFONAMIDE-KETONES 140 278 
With starting a,b-unsaturated ketones 140 in hand, next step was the 
optimization of the IMAMR conditions, taking as starting point the study 
disclosed in the first chapter172 and sulfonamide 140a as a model substrate. 
Thus, hydroquinidine primary amine (HQNH2) was chosen as organocatalyst 
and trifluoroacetic acid (TFA) as additive, evaluating different solvents and 
temperatures in order to find the best combination in terms of yield and 
enantioselectivity (Table 3.3).  
Equimolecular amounts of both catalyst and additive (20 mol%) in CHCl3 
as solvent was firstly tested, yielding the Michael adduct 141a with quite good 
                                            
172 Fustero, S.; del Pozo, C.; Mulet, C.; Lazaro, R.; Sánchez-Roselló, M. Chem. Eur. J. 2011, 
17, 14267–14272. 
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efficiency and enantiocontrol (Table 3.3, entry 1) after 24 hours of reaction at 
room temperature. Variation of the solvent to tetrahydrofuran gave slightly 
worse results, giving rise to 141a with only 47% yield and 82:18 er (Table 3.3, 
entry 2). Diminishing the reaction temperature to 0 ºC, enantioselectivities were 
improved, although yields were poor and incomplete conversion was achieved 
even after 5 days (Table 3.3, entries 3 and 4). Likewise, when the reaction was 
performed under microwave heating neither the yield nor the enantioenrichment 
of the product were improved (Table 3.3, entry 5). The employment of a highly 
polar solvent like acetonitrile did not allow the reaction to happen (Table 3.3, 
entry 6). A modification of the catalyst: additive ratio from 1:1 to 2:1 implied a 
drastic drop both in the yield and the enantiomeric relation in CHCl3 or THF as 
solvents (Table 3.3, entries 7 and 8). By decreasing the loadings, it was 
maintained enantioselectivity with slightly lower yield (Table 3.3, entries 9-10). 
The use of cyclopentyl methyl ether (CPME) as solvent, inspired by the good 
results obtained in the second chapter,67 did not lead to a higher enantiocontrol 
but the results were also good (Table 3.3, entry 11). Finally, a serendipitous 
miscalculation made us realize that a 1:2 combination of catalyst: additive of 13 
and 26 mol% loadings, respectively, conduct to the best enantioselection (Table 
3.3, entry 12). Other catalysts such as a squaramide and a BINOL phosphoric 
acid were also tested without any success.279 
Table 3.3. Optimization of the IMAMR with conjugated sulfonamide-ketone 140a. 
 
Entry HQNH2  (mol%) 
TFA  
(mol%) T (⁰C) t (h) Solvent Yield (%) er 
1 20 20 25 24 CHCl3 57 92:8 
2 20 20 25 24 THF 47 82:18 
3 20 20 0 120 CHCl3 22a 95:5 
                                            
67 Sánchez-Roselló, M.; Mulet, C.; Guerola, M.; del Pozo, C.; Fustero, S. Chem. Eur. J. 2014, 
20, 15697–15701. 
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4 20 20 0 120 THF 50a 94:6 
5 20 20 100b 10 CHCl3 55 87:13 
6 20 20 25 120 CH3CN - - 
7 20 10 25 72 CHCl3 25 60:40 
8 20 10 25 72 THF 13 55:45 
9 15 15 25 22 CHCl3 58 95.5:4.5 
10 10 10 25 24 CHCl3 40 96:4 
11 11 11 25 13 CPME 85 96:4 
12 13 26 25 17 CHCl3 76 97:3 
a Incomplete conversion after 5 days of reaction 
b Microwave irradiation 
The optimal IMAMR conditions (Table 3.3, entry 13) were extended to 
the rest of the prepared starting materials 140 to obtain a small library of 
enantioenriched N-heterocycles (Figure 3.3) with very good yields and excellent 
enantioselectivities in the synthesis of piperidines 141a-d. The assignment of 
the absolute configuration of the newly created stereocenter has been 
determined to be R in consistence with the previously described methodology 
for the organocatalytic IMAMR of conjugated ketones with HQNH2, which 
extension to the present transformation seems reasonable (Scheme 1.42). 
Furthermore, it was later confirmed by an X-ray analysis of a crystalline sultam 
(Figure 3.6). 
 
Figure 3.3. Scope of the IMAMR of a,b-unsaturated sulfonamide-ketones 140. 
It is important to point out here that to date, it was not possible to perform 
both cyclisations in a domino manner. All the attempts mentioned in Table 3 
indicated that the process stop after the IMAMR. That means that the synthesis 
of the desired bicyclic lactams has to be performed in a step-wise fashion. 
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3.3.3. DIASTEREOSELECTIVE INTRAMOLECULAR MICHAEL REACTION OF N-
HETEROCYCLIC a,b-UNSATURATED SULFONAMIDES 141 
With the chiral N-heterocycles 141 in hand, the last step of the present 
study was to develop a diastereoselective IMMR to synthesize the desired 
enantioenriched sultams 142. Initially, it was performed the synthesis of final 
products in a racemic manner. To this end, it was envisioned the possibility of 
performing both cyclisations in a domino fashion, under basic catalysis. To our 
delight, when compounds 140 were treated with NaH, the domino protocol took 
place in a very efficient way in only 4-6 h, giving rise to the bicyclic sultams 142 
in good yields and complete diastereoselectivity (Scheme 3.13). 
 
Scheme 3.13. Synthesis of the racemic bicyclic sultams 142. 
With this result, the next step was the preparation of sultams 142 in a 
enantiomerically enriched manner. Since it was not possible to perform the 
organocatalytic process in a tandem fashion, piperidines 141 were subjected to 
the intramolecular Michael addition in basic media. Again, the application of the 
conditions developed for the racemic synthesis was very effective, giving rise to 
the final sultams 142 in good yields with sodium hydride in THF/DMF (Figure 
3.4). 
  
Figure 3.4. Desired bicyclic sultams 142. 
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products (except sultam 145d that contains an aromatic ring) were able to 
significantly absorb UV light. It was attempted the alternative procedure for the 
determination of the enantioselectivity used in the second chapter, consisting 
on the formation of diastereoisomers with a europium salt in order to unfold any 
of the 1H-NMR signals. However, their spectra were quite complex and any of 
the signals reacted in the aimed way. Finally, an alternative HPLC apparatus, 
with a refractive index detector (RID) instead of the UV one led us to determine 
the final enantiomeric excesses. To our disenchantment, all of the synthesized 
sultams (step-wise and one-pot prepared) resulted to be racemic. Apparently, a 
retro-aza-Michael reaction was taking place with the use of NaH (Scheme 3.14), 
epimerizing in this way the chiral stereocenter initially created with aid of the 
organocatalyst. 
 
Scheme 3.14. Base-mediated retro-aza-Michael reaction and racemic synthesis of 142. 
With a proper methodology to examine sultams chirality in hand, it was 
developed a thoroughly study to discover the IMMR conditions that could avoid 
the undesired retro-aza-Michael reaction (Table 3.4). A variety of bases, acids 
and organocatalysts (Table 3.4, entries 1-18) were tested unsuccessfully until a 
slight chirality maintenance was finally achieved (22% ee) with the use of a 
Verkade’s base (Table 3.4, entry 19). However, by modifying the reaction 
conditions it could not be accomplished a good combination of yield and 
enantiocontrol with any Verkade’s base (Table 3.4, entries 20-23). Was the use 
of phosphazene base P2-Et, included in superbases family, 280  which finally 
came up with an acceptable rate of chirality and yield of the bicyclic sultam 
(Table 3.4, entry 24). The change of the solvent from THF to toluene did not 
allowed the reaction to be completed (Table 3.4, entry 25). And by reducing the 
loading of the base to 10 mol% there was any further improvement in the 
chirality maintenance and a longer reaction time was needed for a slightly lower 
                                            
280 Schlosser, M. Pure Appl. Chem. 1988, 60, 1627–1634. 
N
O
S
O O
R1
141
N S
O2
COR1
NaH
H
H
H
N
H
S
O O
R1
O
140
NaH N
O
S
O O
R1
(±)-142
  
Chapter 3 Results and Discussion 
  
254 
yield (Table 3.4, entry 26). The employment of a bulkier phosphazene 
superbase, seeking a better stereocontrol, resulted to be too hindered to allow 
the reaction to proceed (Table 3.4, entry 27). 
Table 3.4. Optimization of the IMMR of N-heterocyclic conjugated sulfonamides 144. 
 
 
Entry Reactants Solvent T (ºC) Results 
1 LiHMDS THF -78/0/25/67 SM 
2 KHMDS THF 25 Decomp. 
3 tBuOK THF 25a Racemic prod. 
4 BF3OEt2 THF 25 SM 
5 BF3OEt2 DCM 60-80b SM 
6 TBAF THF 25 SM 
7 DBU THF 25 SM 
8 Thiourea+ L-arginine MeOH 25 SM 
9 Thiourea+trans-2,5- dimethylpiperazine DCM 45
 SM 
10 CF3SO3TMS+Et3N +BF3OEt2 
Et2O 0 to 25 Side product 
11 trans-2,5-dimethyl piperazine MEOH 25 Side product 
12 trans-2,5-dimethyl piperazine DCM 45 Side product 
13 Pyrrolidine MeOH 25/65 Side product 
14 L-proline MeOH 25 Side product 
15 L-proline DMF 25 Side product 
16 BEMPc THF 67 Racemic prod. 
17 BEMPc THF 70-120b Racemic prod. 
18 BEMPc THF 160b Side product. 
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19 iPr-Verkade’s based THF 25 93%, 22% ee 
20 iPr-Verkade’s based THF -78 to -40 95%, 50% ee 
21 iPr-Verkade’s based THF -40e 78%, 22% ee 
22 iPr-Verkade’s based THF -78e,f 24%, 95% eeh 
23 iBu-Verkade’s baseg THF -78e SM 
24 Phosphazene base P2-Eti THF -78e,j 77%, 84% eeh 
25 Phosphazene base P2-Eti Toluene -78e 33% (50%conv.) 
26 Phosphazene base P2-Eti THF -78e,k 70%, 88% eel 
27 Phosphazene base P2-tBum THF -78e,j SM 
a 20 minutes 
b Microwave irradiation 
c 2-tert-Butylimino-2-diethyl amino-1,3-dimethylperhydro-1,3,2-diazaphosphorine 
d 2,8,9-Triisopropyl-2,5,8,9-tetraaza-1-phosphabicyclo[3,3,3]undecane 
e MS 4Å, vial heated with microwave irradiation at 120ºC for 10 minutes 
f 26 hours 
g 2,8,9-Triisobutyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane 
h SM: 141a (95% ee) 
i 1-Ethyl-2,2,4,4,4-pentakis(dimethyl amino)-2λ5,4λ5-catenadi(phosphazene) 
j 1 equiv. base, 2 hours 
k 0,1 equiv. base, 24 hours 
l SM: 141b (97% ee) 
m 1-tert-Butyl-2,2,4,4,4-pentakis(dimethyl amino)-2λ5,4λ5-catenadi(phosphazene) 
Then, according to entry 24, the use of 1 equivalent of the phosphazene 
base P2-Et in THF during 2 hours of reaction at -78ºC chosen as the optimal 
condition for the IMMR, were applied for the synthesis of the five bicyclic 
sultams 142 (Figure 3.5). They were all obtained with good yields and moderate 
to good enantiomeric excesses, with a slight erosion of the chirality from that of 
the starting piperidines 141 (Figure 3.3). Conversely, the diastereoselectivity of 
the second cycloaddition was complete (>99% d.r.) as it could be checked in 
the more sensitive UVD-HPLC of the aromatic sultam 142d as well as in the 
NMR spectra, where just one diastereoisomer was observed. 
 
Figure 3.5. Scope of chiral bicyclic sultams 142. 
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The absolute configuration of the final products was determined by X-
Ray analysis of crystals of sultam 142a, possible given the solid consistence of 
these sultams. Thus, it was confirmed the anti-configuration of the two 
stereocenters as (C14S, C14aR) according to the structure shown in Figure 3.6, 
as well as the expected R configuration of the first-created stereocenter. The 
same stereochemical evolution was assumed of all sultams 142. 
 
Figure 3.6. X-Ray of sultam 142a. 
3.3.4. COMPLEMENTARY ONGOING WORK 
Two complementary studies related to the project showed in the present 
chapter have been initiated. The first one is the extension of the scope of the 
process to 5-membered rings and to benzofused derivatives (Scheme 3.15.a). 
The second one, as a consequence of the problems encountered in the second 
cyclization step, involve the modification of this synthetic sequence to access a 
different family of bicyclic sultams (Scheme 3.15.b). 
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Scheme 3.15. Complementary work within the sultams project. 
The extension of the scope to benzofused derivatives is currently 
ongoing, and some problems related with the preparation of the starting 
materials have to be solved. Regarding the synthesis of sultams containing a 
five membered ring, the initial studies indicated that the IMAMR takes place with 
low levels of stereocontrol. Additionally, the use of the phosphazene base P2-Et 
does not avoid the racemization of the final products.  
The synthesis of the second family of sultams 143, was designed 
involving a Wittig reaction over the ketone moiety of substrates 141, followed by 
a RCM reaction with the vinyl sulfonamide. An initial attempt was performed in 
substrate 141a, which was subjected to the corresponding Wittig reagent. 
Unfortunately, the phosphorus ylide acted as a base and the racemization of 
the starting material was produced (Scheme 3.16). 
 
Scheme 3.16. Attempt of Wittig reaction to access sultams 143. 
To overcome this problem, a methylenation reaction that avoid basic 
media was performed. In this context, it was described in the literature that 
Petasis reagent could act as an efficient methylenating agent without the need 
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of a base. 281  Therefore, when compound 141a was treated with Cp2TiMe2 
(Petasis reagent) in toluene at reflux for 20 hours, the methylenation of the 
ketone was produced efficiently. With the dienic compound 144 in hand, the 
RCM reaction was carried out with second generation Hoveyda-Grubbs catalyst 
(HG-II), affording the desired sultam 143 in good yield. An HPLC analysis 
showed that the integrity of the chiral center was maintained in this sequence, 
and bicyclic sultam 143a was obtained with a small erosion of the final ee 
(Scheme 3.17). The extension of this methodology to the rest of starting 
ketones 141 is currently underway in our laboratory. 
 
Scheme 3.17. Alternative route from piperidines 141 for the synthesis of sultams 143. 
 
                                            
281 a) Petasis N. A., Bzowej E. I., J. Am. Chem. Soc. 1990, 112, 6392–6394. b) Tetrahedron 
Letters 1995, 36, 2393-2396. c) Adriaenssens L. V., Hartley R. C., J. Org. Chem. 2007, 72, 
10287–10290. 
N
O
S
O O
N
S
O O
Cp2TiMe2 
Toluene Δ
20 h
N
S
O O
HG-II (20 mol%)
Toluene Δ
24 h
143a
71%
92:8 er
144a
75%
141a
* *
*
 
 
 
Chapter 3   Conclusions 
  
259 
3.4. Conclusions 
A step-wise procedure for the synthesis of enantiomerically enriched 
bicyclic sultams has been performed. It is started with an enantioselective 
intramolecular aza-Michael reaction of a sulfonamide nucleophile to an a,b-
unsaturated ketone by means of a catalytic system composed by a molecule of 
9-amino-9-deoxy-epi-hydroquinidine organocatalyst (HQNH2) and two 
molecules of trifluoroacetic acid. Followed by a superbase-mediated 
diastereoselective intramolecular Michael reaction of the a-carbonylic carbon to 
the conjugated sulfonamide. 
This methodology is a nice combination of the two studies performed in 
the previous chapters and allows the access to an especial family of sultams 
with the nitrogen in the bridgehead position of the bicycle, structures not 
reported to date. 
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3.5. Experimental Section 
X-RAY DETERMINATION 
X-ray diffraction analysis of compound 142a was performed with an 
automatic four cycles diffractometer with Kappa geometry: KappaCCD (nonius). 
This apparatus held an Oxford low temperature system and an informatics 
platform for the control, processing and resolution of the crystalline structures. 
DETERMINATION OF THE ENANTIOMERIC RATIO 
All the aliphatic sultams were analysed with an HPLC Agilent 1100 series 
equipped with a refractive index detector (RID). 
3.5.1. PREPARATION OF FUNCTIONALISED SULFONAMIDES 142 
 
To a suspension of LiAlH4 (6 mmol) in diethyl ether (10 mL) was added 
dropwise nitrile 8 (2,0 mmol) at room temperature. After heating for 2h at reflux, 
the suspension was allowed to reach room temperature and Na2SO4·10H2O 
was added with vigorous stirring until aluminium salts turned white. The 
suspension was filtered through a short pad of Celite® washing with small 
portions of diethyl ether. The filtrate was concentrated under vacuum obtaining 
a yellow oil that used without further purification.  
The crude amine was dissolved in CH2Cl2 (4 mL) and triethyl amine (2.0 
equiv.) was added at 0 ºC followed by 2-chloroethane-1-sulfonyl chloride (1.0 
equiv.). The reaction mixture was allowed to reach room temperature overnight 
and then it was hydrolised with HCl (3 molar), extracted with CH2Cl2 and dried 
over Na2SO4 anhydrous. Finally, solvents were removed and the crude mixture 
purified by flash chromatography with hexanes: ethyl acetate as eluents. 
CN
1) LiAlH4, Et2O Δ 2h
 
2) Et3N, DCM
N
H
S
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3.5.2. SYNTHESIS OF N-CONJUGATED SULFONAMIDE a,b-UNSATURATED 
KETOAMINES 140 
 
 To a solution of N-protected amine 139 (1.0 equiv.) in CH2Cl2 (0.3 M) 
under nitrogen atmosphere, the corresponding conjugated ketone 34 (3.0 
equiv.), titanium isopropoxide (20 mol%) and an initial 8 mol% charge of 
Hoveyda-Grubbs 2nd generation catalyst were added. Two more portions of 
catalyst (24 mol% total) were added together with 2.0 more equivalents of 
ketone, after 2-3 hours stirring the crude at room temperature. The resulting 
solution was overall stirred for 12 h at room temperature and then solvents were 
removed and the crude mixture purified by flash chromatography with hexanes: 
ethyl acetate as eluents. 
 
 
HG-II (24 mol%)
Ti(iPrO)4 (20 mol%)
DCM, r.t., 24 h
N N
RuClCl
OiPr
MesMes
139
R2 R1
O
+
HG-II
N
H
S
O O
N
H
S
O O
R1
O
34 140a-d
N-(5-hexenyl)ethenesulfonamide (139) 
 
Physical state: Pale yellow oil 
Empiric Formula: C8H15NO2S 
Molecular weight (g/mol): 189.27 
Yield (%): 46 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 6.50 (dd, J = 16.6, 9.9 Hz, 1H), 6.19 (dd, J = 
16.6, 0.7 Hz, 1H), 5.91 (dd, J = 9.9, 0.4 Hz, 
1H), 5.84 – 5.65 (m, 1H), 4.94 (tdd, J = 10.2, 
1.9, 1.1 Hz, 3H), 2.97 (dd, J = 13.4, 6.6 Hz, 
2H), 2.02 (t, J = 7.1 Hz, 2H), 1.60 – 1.47 (m, 
2H), 1.47 – 1.34 (m, 2H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 138.6, 136.3, 126.9, 115.3, 43.3, 33.5, 29.6, 
26.1 
HRMS (EI+): Calcd. for C8H15NO2S [M+]: 190.0896, found: 190,0890 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 5:1 
as eluent. 
N
H
S
O O
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(E)-N-(7-oxo-5-octenyl)ethenesulfonamide (140a) 
 
Physical state: Brown oil 
Empiric Formula: C10H17NO3S 
Molecular weight (g/mol): 231.31 
Yield (%): 86 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 6.76 (dt, J = 15.9, 6.9 Hz, 1H), 6.50 (dd, J = 
16.5, 9.8 Hz, 1H), 6.23 (d, J = 16.6 Hz, 1H), 
6.07 (dt, J = 15.9, 1.4 Hz, 1H), 5.94 (dd, J = 
9.9, 3.9 Hz, 1H), 4.58 (s, 1H), 3.10 – 2.92 (m, 
2H), 2.34 – 2.15 (m, 5H), 1.65 – 1.45 (m, 4H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 198.9, 147.8, 135.9, 131.5, 126.4, 42.6, 31.7, 
29.2, 26.8, 24.9 
HRMS (EI+): Calcd. for C10H17NO3S [M+]: 232,1002, found: 232,1005 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 1:1 
as eluent. 
N
H
S
O O
O
(E)-N-(7-oxo-5-decenyl)ethenesulfonamide (140b) 
 
Physical state: Brown oil 
Empiric Formula: C12H21NO3S 
Molecular weight (g/mol): 259.36 
Yield (%): 81 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 6.75 (dt, J = 15.9, 6.9, 1H), 6.47 (dd, J = 16.6, 
9.9, 1H), 6.17 (d, J = 16.6, 1H), 6.05 (dt, J = 
15.9, 1.5, 1H), 5.90 (d, J = 9.9, 1H), 4.98 (t, 
J=5.9, 1H), 2.97 (q, J=6.5, 2H), 2.46 (t, J=7.3, 
2H), 2.19 (td, J=6.9, 5.8, 2H), 1.67 – 1.41 (m, 
6H), 0.88 (t, J=7.4, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 201.0, 146.4, 135.9, 130.7, 126.6, 42.7, 42.1, 
31.8, 29.3, 25.0, 17.7, 13.8 
HRMS (EI+): Calcd. for C12H21NO3S [M+]: 260,1315, found: 260,1308 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 1:1 
as eluent. 
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(E)-N-(7-oxo-5-dodecenyl)ethenesulfonamide (140c) 
 
Physical state: Brown oil 
Empiric Formula: C14H25NO3S 
Molecular weight (g/mol): 287.42 
Yield (%): 66 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 6.42 (dd, J = 16.5, 9.7, 1H), 6.20 (d, J = 16.5, 
1H), 5.88 (d, J = 9.7, 1H), 4.50 – 4.31 (m, 1H), 
3.63 (d, J = 12.8, 1H), 3.04 – 2.91 (m, 1H), 
2.81 – 2.74 (m, 2H), 1.74 – 1.45 (m, 8H), 1.38 
– 1.16 (m, 4H), 0.89 (t, J = 7.0, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 208.6, 136.4, 126.1, 49.0, 43.3, 41.2, 31.5, 
28.7, 25.5, 25.4, 23.5, 22.6, 18.8, 14.0 
HRMS (EI+): Calcd. for C14H25NO3S [M+]: 288,4255, found: 288,1625 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 1:1 
as eluent. 
 
N
H
S
O O
O
(E)-N-(7-oxo-7-phenyl-5-heptenyl)ethenesulfonamide (140d) 
 
Physical state: Brown oil 
Empiric Formula: C15H19NO3S 
Molecular weight (g/mol): 293.38 
Yield (%): 35 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 8.01 – 7.86 (m, 2H), 7.59 – 7.50 (m, 1H), 7.49 
– 7.41 (m, 2H), 7.00 (dd, J = 14.3, 7.6, 1H), 
6.88 (d, J = 15.4, 1H), 6.50 (dd, J = 16.5, 9.9, 
1H), 6.22 (d, J = 16.5, 1H), 5.92 (d, J = 9.8, 
1H), 4.73 (s, 1H), 3.02 (t, J = 6.2, 3H), 2.43 – 
2.22 (m, 2H), 1.59 (dd, J = 8.3, 5.1, 4H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 190.9, 148.9, 137.9, 136.0, 132.9, 128.7, 
128.4 126.7, 126.4, 42.8, 32.2, 29.5, 25.2 
HRMS (EI+): Calcd. for C15H19NO3S [M+]: 294,3885, found: 294,1157 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 1:1 
as eluent. 
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3.5.3. AZA-MICHAEL ADDUCT SYNTHESIS: PREPARATION OF 2-SUBSTITUTED 
NITROGEN HETEROCYCLES 141 
 
In a 25 mL round bottomed flask, a,b-unsaturated ketones 140a-d (1.0 
equiv.) were dissolved in chloroform (0.1 M). A mixture of catalyst HQNH2 (13 
mol%) and trifluoroacetic acid (TFA) (26 mol%, added from a freshly prepared 
stock solution in chloroform) was added and the resulting solution was stirred at 
room temperature. After 24-96 hours, the crude reaction mixture was subjected 
to flash chromatography on silica gel using mixtures of hexanes: ethyl acetate 
as eluents to afford the corresponding N-heterocycles 141a-d. The 
enantiomeric ratios were determined by means of HPLC analysis with a 
Chiralpack AD column (25 cm x 0.46 cm). 
 
13 mol% HQNH2
26 mol% TFA
CHCl3, r.t., 12h
.
N
H
S
O O
R1
O
N
O
S
O O
R1
140a-d
N
H N
NH2
OMe
HQNH2
141a-d
1-(1-(vinylsulfonyl)piperidin-2-yl)-2-propanone (141a) 
 
Physical state: Colorless oil 
Empiric Formula: C10H17NO3S 
Molecular weight (g/mol): 231.31 
Yield (%): 76 
Enantiomeric relation: 97:3 
Optical rotation [a]D25: +20 (c 1.0, CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 6.50 – 6.35 (m, 1H), 6.20 (dd, J = 16.5, 0.5, 
1H), 5.89 (dd, J = 9.7, 0.5, 1H), 4.42 (dd, J = 
12.8, 5.5, 1H), 3.62 (d, J = 12.8, 1H), 2.98 (dd, 
J = 14.5, 11.6, 1H), 2.81 (d, J = 7.1, 2H), 2.23 
– 2.11 (m, 3H), 1.79 – 1.43 (m, 7H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 206.1, 136.3, 126.2, 49.0, 44.7, 41.3, 30.4, 
28.7, 25.3, 18.8 
HRMS (EI+): Calcd. for C10H17NO3S [M+]: 232.1002, found: 232,0996 
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Remarks: ê Reaction stirred during 17 hours. 
ê Purification by flash chromatography with hexanes: ethyl acetate 2:1 
as eluent. 
ê The er value was determined by HPLC analysis using a Chiralpack 
AD column (hexane: isopropanol 90:10); flow rate = 1.0 mL/min, 
tmajor=21.0 min, tminor=18.9 min 
1-(1-(vinylsulfonyl)piperidin-2-yl)-2-pentanone (141b) 
 
Physical state: Yellow oil 
Empiric Formula: C12H21NO3S 
Molecular weight (g/mol): 259.36 
Yield (%): 71 
Enantiomeric relation: 98.5:1.5 
Optical rotation [a]D25: -10 (c 1.0, CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 6.43 (dd, J = 16.5, 9.7, 1H), 6.20 (d, J = 16.5, 
1H), 5.88 (d, J = 9.7, 1H), 4.42 (dd, J = 12.2, 
5.8, 1H), 3.63 (d, J = 13.0, 1H), 3.03 – 2.91 
(m, 1H), 2.85 – 2.70 (m, 2H), 2.42 (t, J = 7.3, 
2H), 1.76 – 1.43 (m, 8H), 0.91 (t, J = 7.4, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 208.5, 136.4, 126.1, 49.0, 45.7, 43.7, 41.2, 
28.7, 25.4, 18.8, 17.3, 13.8 
HRMS (EI+): Calcd. for C12H21NO3S [M+]: 260,1315, found: 260,1310 
Remarks: ê Reaction stirred during 21 hours. 
ê Purification by flash chromatography with hexanes: ethyl acetate 2:1 
as eluent. 
ê The er value was determined by HPLC analysis using a Chiralpack 
AD column (hexane: isopropanol 90:10); flow rate = 1.0 mL/min, 
tmajor=13.0 min, tminor=9.9 min 
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1-(1-(vinylsulfonyl)piperidin-2-yl)-2-heptanone (141c) 
 
Physical state: Yellow oil 
Empiric Formula: C14H25NO3S 
Molecular weight (g/mol): 287.42 
Yield (%): 90 
Enantiomeric relation: 98.5:2.5 
Optical rotation [a]D25: +1,5 (c 1.0, CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 6.42 (dd, J = 16.5, 9.7, 1H), 6.20 (d, J = 16.5, 
1H), 5.88 (d, J = 9.7, 1H), 4.51 – 4.33 (m, 1H), 
3.63 (d, J = 12.8, 1H), 3.05 – 2.89 (m, 1H), 
2.82 – 2.74 (m, 2H), 2.47 – 2.38 (m, 2H), 1.78 
– 1.45 (m, 8H), 1.39 – 1.16 (m, 4H), 0.89 (t, J 
= 7.0, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 208.6, 136.4, 126.1, 49.0, 43.6, 43.3, 41.2, 
31.5, 28.7, 25.5, 25.4, 23.5, 22.6, 18.8, 14.0 
HRMS (EI+): Calcd. for C14H25NO3S [M+]: 288,4255, found: 288,1625 
Remarks: ê Reaction stirred during 18 hours. 
ê Purification by flash chromatography with hexanes: ethyl acetate 2:1 
as eluent. 
ê The er value was determined by HPLC analysis using a Chiralpack 
AD column (hexane: isopropanol 90:10); flow rate = 1.0 mL/min, 
tmajor=10.9 min, tminor=9.1 min 
1-phenyl-2-(1-(vinylsulfonyl)piperidin-2-yl)-1-ethanone (141d) 
 
Physical state: Colorless oil 
Empiric Formula: C15H19NO3S 
Molecular weight (g/mol): 287.42 
Yield (%): 85 
Enantiomeric relation: 97.5:2.5 
Optical rotation [a]D25: -1,2 (c 1.0, CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 8.06 – 7.90 (m, 2H), 7.63 – 7.54 (m, 1H), 7.54 
– 7.43 (m, 2H), 6.43 (dd, J = 16.5, 9.7, 1H), 
6.20 (d, J = 16.5, 1H), 5.85 (d, J = 9.7, 1H), 
4.59 (dd, J = 10.6, 7.2, 1H), 3.78 – 3.64 (m, 
1H), 3.48 – 3.27 (m, 2H), 3.16 – 3.01 (m, 1H), 
1.87 – 1.41 (m, 6H) 
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3.5.4. MICHAEL ADDUCT SYNTHESIS: PREPARATION OF SULTAMS 142 
 
A microwave oven-dried vial was filled with oven-dried MS 4Å and 
stirring bar and heated at 120ºC during 10 minutes under microwave irradiation. 
Then, piperidine 141a-d (1.0 equiv.) was dissolved in THF (0.1 M) and 
introduced into the vial. After immersing it in a -78ºC acetone bath, 
phosphazene base P2-Et was added and the resulting mixture was stirred at 
that temperature for 2 hours. Then the crude reaction mixture was hydrolysed 
with HCl 1M, extracted with AcOEt and dried over Na2SO4 anhydrous. Finally it 
was subjected to flash chromatography on silica gel using mixtures of hexanes: 
ethyl acetate as eluents to afford the corresponding bicyclic sultams 142a-e. 
The enantiomeric ratios were determined by means of RID- or UVD-HPLC 
analysis with a Chiracel OD-H column (25 cm x 0.46 cm). 
 
1eq. P2-Et
MS 4Å, THF 
-78ºC, 2h
N
O
S
O O
R1
141a-d
N
O
S
O O
R1
N P
N
N
N P
N
N
N
P2-Et
142a-d
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 197.7, 136.7, 136.3, 133.6, 128.9, 128.4, 
126.1, 49.6, 41.3, 39.7, 28.3, 25.5, 18.8 
HRMS (EI+): Calcd. for C15H19NO3S [M+]: 294,3885, found: 294,1156 
Remarks: ê Reaction stirred during 144 hours. 
ê Purification by flash chromatography with hexanes: ethyl acetate 2:1 
as eluent. 
ê The er value was determined by HPLC analysis using a Chiralpack 
AD column (hexane: isopropanol 90:10); flow rate = 1.0 mL/min, 
tmajor=29.7 min, tminor=16.2 min 
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1-((4S,4aR)-1,1-dioxidooctahydropyrido[1,2-b][1,2]thiazin-4-yl)-1-ethanone 
(142a) 
 
Physical state: White solid 
Empiric Formula: C10H17NO3S 
Molecular weight (g/mol): 231.31 
Yield (%): 77 
Melting point (ºC) 34-36 
Enantiomeric relation: 93:7 
Optical rotation [a]D25: +1,9 (c 1.0, CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 3.78 (ddd, J = 10.5, 6.5, 4.0, 1H), 3.40 – 3.24 
(m, 1H), 3.20 – 2.95 (m, 3H), 2.86 (ddd, J = 
12.5, 10.9, 3.8, 1H), 2.44 – 2.25 (m, 1H), 2.25 
– 2.10 (m, 4H), 1.83 – 1.19 (m, 9H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 208.1, 58.5, 50.0, 45.2, 42.1, 29.8, 29.5, 26.1, 
24.7, 21.0 
HRMS (EI+): Calcd. for C10H17NO3S [M+]: 232,1002, found: 232,0996 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 1:1 
as eluent. 
ê The er value was determined by RID-HPLC analysis using a Chiracel 
OD-H column (hexane: isopropanol 85:15); flow rate = 1.0 mL/min, 
tmajor= 23.2 min, tminor= 20.3 min 
1-((4S,4aR)-1,1-dioxidooctahydropyrido[1,2-b][1,2]thiazin-4-yl)-1-butanone 
(142b) 
 
Physical state: White solid 
Empiric Formula: C12H21NO3S 
Molecular weight (g/mol): 259.36 
Yield (%): 70 
Melting point (ºC): 193-195 
Enantiomeric relation: 94:6 
Optical rotation [a]D25:  (c 1.0, CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 3.72 (ddd, J = 10.7, 6.7, 4.0, 1H), 3.35 – 3.21 
(m, 1H), 3.12 – 2.89 (m, 3H), 2.79 (ddd, J = 
12.5, 10.8, 3.7, 1H), 2.51 – 2.19 (m, 3H), 2.05 
(dq, J = 14.1, 3.8, 1H), 1.75 – 1.14 (m, 8H), 
0.91 – 0.77 (m, 3H) 
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13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 210.5, 58.9, 49.6, 45.6, 45.4, 42.3, 29.8, 26.5, 
24.9, 21.4, 17.0, 14.1 
HRMS (EI+): Calcd. for C12H21NO3S [M+]: 260,1276 , found: 260,1312 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 1:1 
as eluent. 
ê The er value was determined by RID-HPLC analysis using a Chiracel 
OD-H column (hexane: isopropanol 85:15); flow rate = 1.0 mL/min, 
tmajor=17.4 min, tminor=15.0 min 
1-((4S,4aR)-1,1-dioxidooctahydropyrido[1,2-b][1,2]thiazin-4-yl)-1-hexanone 
(142c) 
 
Physical state: White solid 
Empiric Formula: C12H21NO3S 
Molecular weight (g/mol): 287.42 
Yield (%): 73 
Melting point (ºC): >310ºC 
Enantiomeric relation: 95:5 
Optical rotation [a]D25:  (c 1.0, CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 3.79 (ddd, J = 10.6, 6.6, 3.9, 1H), 3.41 – 3.28 
(m, 1H), 3.19 – 2.92 (m, 3H), 2.92 – 2.80 (m, 
1H), 2.60 – 2.24 (m, 3H), 2.21 – 2.05 (m, 1H), 
1.84 – 1.14 (m, 12H), 0.89 (dd, J=9.1, 4.8, 3H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 210.7, 58.9, 49.6, 45.6, 43.5, 42.3, 31.7, 29.8, 
26.5, 24.9, 23.3, 22.8, 21.4, 14.3 
HRMS (EI+): Calcd. for C12H21NO3S [M+]: 288,1519, found: 288,1632 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 1:1 
as eluent. 
ê The er value was determined by RID-HPLC analysis using a Chiracel 
OD-H column (hexane: isopropanol 85:15); flow rate = 1.0 mL/min, 
tmajor=15.2 min, tminor=13.3 min 
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1-((4S,4aR)-1,1-dioxidooctahydropyrido[1,2-b][1,2]thiazin-4-
yl)(phenyl)methanone (142d) 
 
Physical state: White solid 
Empiric Formula: C15H19NO3S 
Molecular weight (g/mol): 293.38 
Yield (%): 80 
Melting point (ºC): 105-108 
Enantiomeric relation: 90:10 
Optical rotation [a]D25:  (c 1.0, CHCl3) 
1H-RMN (CDCl3, 300 MHz) δ (ppm): 8.00 – 7.93 (m, 2H), 7.67 – 7.60 (m, 1H), 7.56 
– 7.48 (m, 2H), 3.97 (ddd, J = 10.7, 6.6, 3.8, 
1H), 3.78 (ddd, J = 12.3, 10.4, 3.5, 1H), 3.54 – 
3.43 (m, 1H), 3.22 – 3.12 (m, 2H), 3.13 – 3.01 
(m, 1H), 2.49 (dddd, J = 14.2, 12.3, 10.4, 6.9, 
1H), 2.28 – 2.14 (m, 1H), 1.87 – 1.44 (m, 6H) 
13C-RMN (CDCl3, 75.5 MHz) δ (ppm): 200.3, 136.4, 134.1, 129.2, 128.4, 59.7, 45.8, 
44.0, 42.1, 29.8, 27.2, 24.7, 21.6 
HRMS (EI+): Calcd. for C15H19NO3S [M+]: 294,3885, found: 294,1158 
Remarks: ê Purification by flash chromatography with hexanes: ethyl acetate 1:1 
as eluent. 
ê The er value was determined by UVD-HPLC analysis using a Chiracel 
OD-H column (hexane: isopropanol 85:15); flow rate = 1.0 mL/min, 
tmajor=51.0 min, tminor=43.2 min 
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3.5.5. HPLC TRACES OF ENANTIOENRICHED COMPOUNDS 141 AND 142 
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